##GENOME_BUILD=GRCh38
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 2021_12-46-g4bfa8ad9
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140549_01	GS140550_01	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	1022518	1022518	G	T	hom	hom	het	off-target	QUAL=3744;DP=63,45,56;AF=0.98,1.00,0.64;MQM=60;SAP=305;ABP=13	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+56G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron2/38:c.463+56G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron2/36:c.463+56G>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron2/36:c.463+56G>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/37:n.534+56G>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677944 [benign DISEASE=not provided];			rs2799064	0.3285	0.3451	9381,.					2.94			COSV65071508	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041950	1041950	T	C	hom	hom	hom		QUAL=1742;DP=13,20,26;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron6/38:c.764-6T>C::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron6/38:c.1178-6T>C::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron5/35:c.863-6T>C::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:XM_005244749.3:splice_region_variant&intron_variant:LOW:intron6/36:c.1178-6T>C::,AGRN:XM_011541429.2:splice_region_variant&intron_variant:LOW:intron6/36:c.1178-6T>C::,AGRN:XR_946650.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron6/37:n.1249-6T>C::	regulatory_region_variant:promoter_flanking_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128292 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2799066	0.8852	0.9233	58337,.	0.7112,0.9515,0.9998,0.9180,0.9530				0.67		6.81>6.95		0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1042190	1042190	G	A	hom	hom	hom	off-target	QUAL=1524;DP=18,15,21;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.970+28G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1384+28G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1069+28G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron7/36:c.1384+28G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron7/36:c.1384+28G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/37:n.1455+28G>A::	regulatory_region_variant:promoter_flanking_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263159 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs2710876		0.8973	50662,.	0.4355,0.9316,0.9726,0.9149,0.9451				0.18				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1043224	1043225	CT	-	wt	wt	het	off-target	QUAL=1477;DP=58,167,186;AF=0.00,0.00,0.46;MQM=60;SAP=132;ABP=6	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.971-15_971-14del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1385-15_1385-14del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1070-15_1070-14del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron7/36:c.1385-15_1385-14del::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron7/36:c.1385-15_1385-14del::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/37:n.1456-15_1456-14del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263160 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs35881187	0.4792	0.5514	18381,.	0.0943,0.6972,0.7858,0.5385,0.5463				4.43				0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045707	1045707	A	G	hom	hom	hom	off-target	QUAL=5739;DP=67,51,64;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron14/38:c.2123-26A>G::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron14/38:c.2537-26A>G::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron13/35:c.2222-26A>G::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron14/36:c.2537-26A>G::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron14/36:c.2537-26A>G::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/37:n.2608-26A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263172 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs3128098		0.9206	56727,.	0.6365,0.9462,0.9999,0.9247,0.9552				1.44				0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1046551	1046551	A	G	hom	hom	hom		QUAL=6187;DP=51,70,93;AF=1.00,1.00,1.00;MQM=60;SAP=5;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon18/39:c.2652A>G:p.Ser884=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon18/39:c.3066A>G:p.Ser1022=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon17/36:c.2751A>G:p.Ser917=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon18/37:c.3066A>G:p.Ser1022=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon18/37:c.3066A>G:p.Ser1022=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon18/38:n.3137A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128297 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2465128		0.8865	51078,.	0.4974,0.9296,0.9677,0.9059,0.8885				0.11			COSV65068047	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047561	1047561	T	C	hom	hom	hom	off-target	QUAL=9183;DP=47,105,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron20/38:c.3103-12T>C::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron20/38:c.3517-12T>C::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron19/35:c.3202-12T>C::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron20/36:c.3517-12T>C::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron20/36:c.3517-12T>C::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/37:n.3588-12T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263181 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs3128102		0.8963	51078,.	0.4469,0.9319,0.9726,0.9133,0.9443				2.44		6.84>6.29		0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047614	1047614	T	C	hom	hom	hom		QUAL=15498;DP=140,142,208;AF=0.99,1.00,1.00;MQM=60;SAP=11;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon21/39:c.3144T>C:p.Phe1048=:PF01390 [SEA domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon21/39:c.3558T>C:p.Phe1186=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon20/36:c.3243T>C:p.Phe1081=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon21/37:c.3558T>C:p.Phe1186=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon21/37:c.3558T>C:p.Phe1186=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon21/38:n.3629T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128302 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs10267		0.9083	53403,.	0.5251,0.9388,0.9995,0.9167,0.9527				7.24			COSV65071416	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1048922	1048922	T	C	het	wt	hom		QUAL=588;DP=9,17,19;AF=0.67,0.00,1.00;MQM=60;SAP=7;ABP=5	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon24/39:c.3747T>C:p.Thr1249=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon24/39:c.4161T>C:p.Thr1387=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon23/36:c.3846T>C:p.Thr1282=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon24/37:c.4161T>C:p.Thr1387=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon24/37:c.4161T>C:p.Thr1387=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon24/38:n.4232T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128307 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs9442391		0.5883	20786,.	0.2729,0.7050,0.8196,0.5652,0.5594				0.61				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1049886	1049886	C	T	het	wt	hom	off-target	QUAL=584;DP=8,11,20;AF=0.50,0.00,1.00;MQM=60;SAP=3;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron26/38:c.4331-17C>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron26/38:c.4745-17C>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron25/35:c.4430-17C>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron26/36:c.4745-17C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron26/36:c.4745-17C>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron26/37:n.4816-17C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263188 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2275813	0.4952	0.5575	18221,.	0.1480,0.7111,0.8103,0.5353,0.5454				1.60		11.49>11.28		0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050064	1050064	G	-	hom	hom	wt	off-target	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+41del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+41del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+41del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+41del::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+41del::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+41del::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292619 [benign DISEASE=not provided];			rs71576592		0.5472	19481,.	0.7422,0.5306,0.6485,0.4549,0.4871				0.38				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050066	1050066	G	T	wt	wt	het	off-target	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+29G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+29G>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+29G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+29G>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+29G>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+29G>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263191 [benign DISEASE=not specified,not provided];			rs2275812	0.3355	0.4151	9412,.	0.1015,0.4381,0.1553,0.4588,0.4611				0.55			COSV65067816	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050069	1050069	G	A	wt	wt	hom	off-target	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=4;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+32G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+32G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+32G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+32G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+32G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+32G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263192 [benign DISEASE=not specified,not provided];			rs2799067		0.5832	13929,.	0.2618,0.5481,0.5050,0.6172,0.6162				1.25			COSV65067820	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050070	1050070	G	A	hom	hom	wt	off-target	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+33G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+33G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+33G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+33G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+33G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+33G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1232566 [benign DISEASE=not provided];			rs397834473	0.4465	0.5028	19437,.	0.6971,0.4836,0.6056,0.4288,0.4499				0.59			COSV65068887	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051820	1051820	C	T	hom	hom	hom		QUAL=10531;DP=63,134,150;AF=0.97,1.00,0.99;MQM=60;SAP=113;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron34/38:c.5249+5C>T::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron34/38:c.5663+5C>T::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron33/35:c.5348+5C>T::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:XM_005244749.3:splice_region_variant&intron_variant:LOW:intron34/36:c.5663+5C>T::,AGRN:XM_011541429.2:splice_region_variant&intron_variant:LOW:intron34/36:c.5663+5C>T::,AGRN:XR_946650.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron34/37:n.5734+5C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128317 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs9803031		0.8871	50443,.	0.4387,0.9320,0.9957,0.9082,0.8828				0.73		9.65>8.73		0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1054900	1054900	C	T	wt	het	het		QUAL=4766;DP=100,174,207;AF=0.00,0.51,0.59;MQM=60;SAP=309;ABP=12	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon39/39:c.5712C>T:p.Asp1904=:PF00054 [Laminin G domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon39/39:c.6126C>T:p.Asp2042=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon36/36:c.5754C>T:p.Asp1918=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon37/37:c.6069C>T:p.Asp2023=:,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5992+349C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6140C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128319 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs4275402		0.6764	28830,.	0.3114,0.7722,0.8138,0.6980,0.6133				0.31			COSV65070964	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055000	1055000	C	T	hom	het	het		QUAL=12295;DP=158,330,428;AF=0.97,0.44,0.49;MQM=60;SAP=121;ABP=10	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*19C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-377C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6240C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263157 [benign DISEASE=not specified];			rs3121561	0.3434	0.3513	10237,.	0.5233,0.2137,0.1794,0.2920,0.3087				0.50			COSV65069616	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055037	1055037	T	C	hom	het	het		QUAL=16508;DP=186,389,502;AF=0.99,0.46,0.49;MQM=60;SAP=15;ABP=8	AGRN,	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*56T>C::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-340T>C::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6277T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292868 [benign DISEASE=not provided];			rs2465136	0.3840	0.3856	12824,.					13.13			COSV65069776	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055137	1055137	C	T	hom	het	hom		QUAL=18346;DP=119,285,371;AF=0.99,0.48,1.00;MQM=60;SAP=198;ABP=4	AGRN,	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*156C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-240C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6377C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1185529 [benign DISEASE=Myasthenic syndrome, congenital, 8,not provided];			rs2710872		0.8800	59057,.					6.08				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055393	1055393	C	T	hom	het	hom		QUAL=22413;DP=180,296,404;AF=1.00,0.54,1.00;MQM=60;SAP=86;ABP=7	AGRN,	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+178C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*412C>T::,AGRN:XM_011541429.2:synonymous_variant:LOW:exon37/37:c.6009C>T:p.Pro2003=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6472C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799072		0.8172	51702,.					5.67				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055426	1055426	G	A	hom	het	hom		QUAL=24597;DP=214,311,448;AF=0.99,0.54,1.00;MQM=60;SAP=60;ABP=7	AGRN,	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+211G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*445G>A::,AGRN:XM_011541429.2:3_prime_UTR_variant:MODIFIER:exon37/37:c.*27G>A::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6505G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799073		0.8173	51712,.					2.88				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055604	1055604	G	A	hom	het	hom		QUAL=15857;DP=145,190,272;AF=1.00,0.59,1.00;MQM=60;SAP=270;ABP=16	AGRN,	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.184-294G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*623G>A::,AGRN:XM_011541429.2:3_prime_UTR_variant:MODIFIER:exon37/37:c.*205G>A::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6683G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs8014		0.8838	59543,.					0.15				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	2024923	2024923	G	A	hom	het	het	off-target	QUAL=6547;DP=80,172,170;AF=1.00,0.49,0.48;MQM=60;SAP=84;ABP=4	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron1/7:c.69-19G>A::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron1/8:c.69-19G>A::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron1/8:c.108-19G>A::,GABRD:XM_017000936.1:missense_variant:MODERATE:exon1/8:c.755G>A:p.Arg252Gln:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256824 [benign DISEASE=not specified];			rs2376805		0.8127	50293,.	0.7935,0.7394,0.7174,0.8311,0.7722				4.09		7.68>6.22	COSV66080160	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025598	2025598	T	C	het	wt	het		QUAL=6779;DP=156,340,399;AF=0.53,0.00,0.49;MQM=60;SAP=77;ABP=3	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon4/8:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]	GABRD:NM_000815.5:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:,GABRD:XM_011541194.3:synonymous_variant:LOW:exon4/9:c.369T>C:p.Gly123=:,GABRD:XM_017000936.1:synonymous_variant:LOW:exon3/8:c.1035T>C:p.Gly345=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256823 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs2229110	0.5613	0.6546	33171,.	0.7305,0.4736,0.3137,0.6572,0.4740				12.60			COSV66080001	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025781	2025781	G	-	het	wt	het	off-target	QUAL=1292;DP=52,54,75;AF=0.44,0.00,0.52;MQM=60;SAP=138;ABP=3	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron4/7:c.470+45del::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron4/8:c.470+45del::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron4/8:c.509+45del::,GABRD:XM_017000936.1:intron_variant:MODIFIER:intron3/7:c.1175+45del::	regulatory_region_variant:promoter	137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs3831907		0.1288	1489,.	0.2114,0.0549,0.0248,0.1141,0.0777				0.76				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029235	2029235	C	T	het	het	wt		QUAL=4927;DP=119,265,386;AF=0.49,0.56,0.01;MQM=60;SAP=18;ABP=7	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon7/8:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon7/9:c.900C>T:p.Ser300=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:	GABRD:NM_000815.5:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:,GABRD:XM_011541194.3:synonymous_variant:LOW:exon7/9:c.855C>T:p.Ser285=:,GABRD:XM_017000936.1:synonymous_variant:LOW:exon6/8:c.1521C>T:p.Ser507=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256825 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs28408173	0.1983	0.1918	1790,.	0.0319,0.2378,0.4717,0.1428,0.2543				3.35			COSV66080067	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029969	2029969	C	T	het	het	wt	off-target	QUAL=1614;DP=67,64,73;AF=0.57,0.50,0.01;MQM=60;SAP=45;ABP=4	GABRD	intron,synonymous	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::,GABRD:ENST00000638771.1:synonymous_variant:LOW:exon8/8:c.1266C>T:p.Thr422=:,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron8/8:c.1144-14C>T::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron8/8:c.991-14C>T::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron8/8:c.1099-14C>T::,GABRD:XM_017000936.1:intron_variant:MODIFIER:intron7/7:c.1765-14C>T::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256822 [benign DISEASE=not specified];			rs28431879	0.1999	0.1856	1826,.	0.0295,0.2369,0.4852,0.1366,0.2428				0.64		7.61>6.94	COSV66079834	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2405838	2405838	C	T	het	n/a	n/a		QUAL=108;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=5	PEX10	splice_region&intron,intron	PEX10:ENST00000288774.8:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513.7:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron5/5:c.913-10G>A::	PEX10:NM_001374425.1:splice_region_variant&intron_variant:LOW:intron5/5:c.970-4G>A::,PEX10:NM_001374426.1:splice_region_variant&intron_variant:LOW:intron5/5:c.538-4G>A::,PEX10:NM_001374427.1:splice_region_variant&intron_variant:LOW:intron5/5:c.481-4G>A::,PEX10:NM_002617.4:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:NM_153818.2:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:NR_164636.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron5/5:n.1028-4G>A::,PEX10:XR_946666.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron5/5:n.978-4G>A::		602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	262791 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs11586985	0.0809	0.1050	808,.	0.0217,0.0584,0.1222,0.1219,0.1099				0.04		13.68>13.46,-18.79>-18.77	COSV56580725	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2406687	2406687	C	A	wt	het	het	off-target	QUAL=1037;DP=46,44,55;AF=0.00,0.48,0.49;MQM=60;SAP=34;ABP=3	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron4/5:c.776+33G>T::	PEX10:NM_001374425.1:intron_variant:MODIFIER:intron4/5:c.833+33G>T::,PEX10:NM_001374426.1:intron_variant:MODIFIER:intron4/5:c.401+33G>T::,PEX10:NM_001374427.1:intron_variant:MODIFIER:intron4/5:c.344+33G>T::,PEX10:NM_002617.4:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:NM_153818.2:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:NR_164636.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.891+33G>T::,PEX10:XR_946666.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.841+33G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1180486 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,not provided];			rs3795269	0.3391	0.4016	12033,.	0.2892,0.4078,0.2649,0.4329,0.3642				3.45			COSV56579855	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2408761	2408761	T	C	wt	het	het		QUAL=985;DP=41,39,48;AF=0.02,0.44,0.54;MQM=60;SAP=47;ABP=3	PEX10	synonymous	PEX10:ENST00000288774.8:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.7:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.5:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]	PEX10:NM_001374425.1:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NM_001374426.1:5_prime_UTR_variant:MODIFIER:exon3/6:c.-142A>G::,PEX10:NM_001374427.1:5_prime_UTR_variant:MODIFIER:exon3/6:c.-142A>G::,PEX10:NM_002617.4:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NM_153818.2:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NR_164636.1:non_coding_transcript_exon_variant:MODIFIER:exon3/6:n.410A>G::,PEX10:XM_011541576.2:synonymous_variant:LOW:exon3/4:c.291A>G:p.Thr97=:,PEX10:XR_946666.2:non_coding_transcript_exon_variant:MODIFIER:exon3/6:n.360A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	129884 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,Zellweger syndrome,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs2494598		0.7735	42746,.	0.5917,0.7710,0.7184,0.8112,0.7245				0.15			COSV56581176	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5862774	5862774	C	A	het	wt	hom	off-target	QUAL=1524;DP=54,26,42;AF=0.35,0.00,1.00;MQM=60;SAP=127;ABP=13	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156.9:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::			607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]				rs12133533	0.0966	0.1268	1586,.	0.0152,0.0833,0.0529,0.1640,0.1101				0.69					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866447	5866447	T	C	het	wt	hom		QUAL=8932;DP=271,153,183;AF=0.50,0.00,0.99;MQM=60;SAP=31;ABP=3	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon23/27:c.2031A>G:p.Glu677=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon22/26:c.2034A>G:p.Glu678=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon29/33:n.4337A>G::,NPHP4:XM_006710563.3:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541213.1:synonymous_variant:LOW:exon25/29:c.3567A>G:p.Glu1189=:,NPHP4:XM_011541214.1:synonymous_variant:LOW:exon25/29:c.3528A>G:p.Glu1176=:,NPHP4:XM_011541215.1:synonymous_variant:LOW:exon24/28:c.3459A>G:p.Glu1153=:,NPHP4:XM_011541216.2:synonymous_variant:LOW:exon27/31:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541217.2:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541218.2:synonymous_variant:LOW:exon27/31:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000996.1:synonymous_variant:LOW:exon25/29:c.3525A>G:p.Glu1175=:,NPHP4:XM_017000997.1:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000998.1:synonymous_variant:LOW:exon25/26:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000999.1:synonymous_variant:LOW:exon26/30:c.3042A>G:p.Glu1014=:,NPHP4:XM_017001000.2:synonymous_variant:LOW:exon25/29:c.3042A>G:p.Glu1014=:,NPHP4:XM_017001001.1:synonymous_variant:LOW:exon20/24:c.2772A>G:p.Glu924=:,NPHP4:XM_017001003.1:synonymous_variant:LOW:exon18/22:c.2031A>G:p.Glu677=:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon25/28:n.3608A>G::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon24/28:n.3421A>G::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95683 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs555164	0.3197	0.3926	10237,.	0.2002,0.3706,0.2558,0.4222,0.4302				2.05			COSV65394708	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866971	5866971	A	G	het	wt	hom	off-target	QUAL=3779;DP=81,65,97;AF=0.48,0.00,1.00;MQM=60;SAP=150;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron22/26:c.2019+59T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron21/25:c.2022+59T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron28/32:n.4325+59T>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron24/28:c.3555+59T>C::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron24/28:c.3516+59T>C::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron23/27:c.3447+59T>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron26/30:c.3558+59T>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron26/30:c.3558+59T>C::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron24/28:c.3513+59T>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron24/25:c.3558+59T>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron25/29:c.3030+59T>C::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron24/28:c.3030+59T>C::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron19/23:c.2760+59T>C::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron17/21:c.2019+59T>C::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron24/27:n.3596+59T>C::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/27:n.3409+59T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233249 [benign DISEASE=not provided];			rs12122135	0.1028	0.1287	1581,.					1.83			COSV65397177	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867883	5867883	G	A	wt	wt	het		QUAL=3638;DP=132,269,358;AF=0.00,0.00,0.48;MQM=60;SAP=44;ABP=5	NPHP4	missense	NPHP4:ENST00000378156.9:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:	NPHP4:NM_001291593.2:missense_variant:MODERATE:exon21/27:c.1790C>T:p.Ala597Val:,NPHP4:NM_001291594.2:missense_variant:MODERATE:exon20/26:c.1793C>T:p.Ala598Val:,NPHP4:NM_015102.5:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon27/33:n.4096C>T::,NPHP4:XM_006710563.3:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541213.1:missense_variant:MODERATE:exon23/29:c.3326C>T:p.Ala1109Val:,NPHP4:XM_011541214.1:missense_variant:MODERATE:exon23/29:c.3287C>T:p.Ala1096Val:,NPHP4:XM_011541215.1:missense_variant:MODERATE:exon22/28:c.3218C>T:p.Ala1073Val:,NPHP4:XM_011541216.2:missense_variant:MODERATE:exon25/31:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541217.2:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541218.2:missense_variant:MODERATE:exon25/31:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000996.1:missense_variant:MODERATE:exon23/29:c.3284C>T:p.Ala1095Val:,NPHP4:XM_017000997.1:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000998.1:missense_variant:MODERATE:exon23/26:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000999.1:missense_variant:MODERATE:exon24/30:c.2801C>T:p.Ala934Val:,NPHP4:XM_017001000.2:missense_variant:MODERATE:exon23/29:c.2801C>T:p.Ala934Val:,NPHP4:XM_017001001.1:missense_variant:MODERATE:exon18/24:c.2531C>T:p.Ala844Val:,NPHP4:XM_017001003.1:missense_variant:MODERATE:exon16/22:c.1790C>T:p.Ala597Val:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon23/28:n.3367C>T::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon22/28:n.3180C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95682 [benign/likely benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0014	0.0037	2,.	0.0012,0.0030,0.0000,0.0060,0.0008		T(0.55)	B(0.01)	0.12	0.32		COSV65394401	0.01	2	161	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874430	5874430	A	G	hom	het	hom	off-target	QUAL=5942;DP=73,68,112;AF=0.99,0.49,1.00;MQM=60;SAP=474;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron19/26:c.1692+41T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron18/25:c.1695+41T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/32:n.3998+41T>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron21/28:c.3228+41T>C::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron21/28:c.3189+41T>C::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron20/27:c.3120+41T>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron23/30:c.3231+41T>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron23/30:c.3231+41T>C::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron21/28:c.3186+41T>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron21/25:c.3231+41T>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron22/29:c.2703+41T>C::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron21/28:c.2703+41T>C::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron16/23:c.2433+41T>C::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron14/21:c.1692+41T>C::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron21/27:n.3269+41T>C::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/27:n.3082+444T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260554 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs868163	0.5693	0.6401	31634,.	0.7125,0.4989,0.2688,0.6436,0.6148				0.03			COSV65397189	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875102	5875102	T	A	het	wt	het		QUAL=2668;DP=88,87,127;AF=0.61,0.00,0.47;MQM=60;SAP=225;ABP=5	NPHP4	splice_acceptor	NPHP4:ENST00000378156.9:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::	NPHP4:NM_001291593.2:splice_acceptor_variant:HIGH:intron17/26:c.1279-2A>T::,NPHP4:NM_001291594.2:splice_acceptor_variant:HIGH:intron16/25:c.1282-2A>T::,NPHP4:NM_015102.5:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:NR_111987.2:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron23/32:n.3585-2A>T::,NPHP4:XM_006710563.3:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_011541213.1:splice_acceptor_variant:HIGH:intron19/28:c.2815-2A>T::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron19/28:c.2818-44A>T::,NPHP4:XM_011541215.1:splice_acceptor_variant:HIGH:intron18/27:c.2707-2A>T::,NPHP4:XM_011541216.2:splice_acceptor_variant:HIGH:intron21/30:c.2818-2A>T::,NPHP4:XM_011541217.2:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_011541218.2:splice_acceptor_variant:HIGH:intron21/30:c.2818-2A>T::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron19/28:c.2815-44A>T::,NPHP4:XM_017000997.1:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_017000998.1:splice_acceptor_variant:HIGH:intron19/25:c.2818-2A>T::,NPHP4:XM_017000999.1:splice_acceptor_variant:HIGH:intron20/29:c.2290-2A>T::,NPHP4:XM_017001000.2:splice_acceptor_variant:HIGH:intron19/28:c.2290-2A>T::,NPHP4:XM_017001001.1:splice_acceptor_variant:HIGH:intron14/23:c.2020-2A>T::,NPHP4:XM_017001003.1:splice_acceptor_variant:HIGH:intron12/21:c.1279-2A>T::,NPHP4:XR_001737114.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron19/27:n.2856-2A>T::,NPHP4:XR_001737115.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron19/27:n.2856-2A>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]		CS057899 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=NPHP4];		rs1287637		0.1543	1975,.					24.40		9.27>0.90			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5877331	5877331	C	T	n/a	n/a	hom	off-target;low_conf_region	QUAL=158;DP=1,0,4;AF=1.00,,1.00;MQM=60;SAP=7;ABP=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron16/26:c.1073-33G>A::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron15/25:c.1076-33G>A::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/32:n.3116-33G>A::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron18/28:c.2609-33G>A::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron18/28:c.2612-33G>A::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron17/27:c.2501-33G>A::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron20/30:c.2612-33G>A::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron20/30:c.2612-33G>A::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron18/28:c.2609-33G>A::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron18/25:c.2612-33G>A::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron19/29:c.2084-33G>A::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron18/28:c.2084-33G>A::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron13/23:c.1814-33G>A::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron18/19:c.2612-33G>A::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron11/21:c.1073-33G>A::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/27:n.2650-33G>A::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/27:n.2650-33G>A::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/17:n.2489-33G>A::	regulatory_region_variant:CTCF_binding_site	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260547 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs3747989		0.8314	52841,.	0.9382,0.7305,0.8517,0.8010,0.7363				0.18				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887248	5887248	G	A	wt	wt	het	off-target	QUAL=1781;DP=129,147,187;AF=0.00,0.01,0.42;MQM=60;SAP=88;ABP=13	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+38C>T::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron15/26:c.946+38C>T::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron14/25:c.949+38C>T::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/32:n.2702+38C>T::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron17/28:c.2482+38C>T::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron17/28:c.2485+38C>T::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron16/27:c.2374+38C>T::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron19/30:c.2485+38C>T::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron19/30:c.2485+38C>T::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron17/28:c.2482+38C>T::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron17/25:c.2485+38C>T::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron18/29:c.1957+38C>T::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron17/28:c.1957+38C>T::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron12/23:c.1687+38C>T::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron17/19:c.2485+38C>T::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron10/21:c.946+38C>T::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/27:n.2523+38C>T::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/27:n.2523+38C>T::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/17:n.2362+38C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260546 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs41280814	0.0863	0.1342	1363,.	0.0275,0.0789,0.0795,0.1716,0.1155				0.01			COSV65397198	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905321	5905321	C	T	wt	wt	het		QUAL=2693;DP=207,206,262;AF=0.00,0.00,0.43;MQM=60;SAP=34;ABP=15	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:ENST00000622020.4:synonymous_variant:LOW:exon15/20:c.1923G>A:p.Glu641=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon12/27:c.387G>A:p.Glu129=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon11/26:c.390G>A:p.Glu130=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon15/33:n.2143G>A::,NPHP4:XM_006710563.3:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_011541213.1:synonymous_variant:LOW:exon14/29:c.1923G>A:p.Glu641=:,NPHP4:XM_011541214.1:synonymous_variant:LOW:exon14/29:c.1926G>A:p.Glu642=:,NPHP4:XM_011541215.1:synonymous_variant:LOW:exon13/28:c.1815G>A:p.Glu605=:,NPHP4:XM_011541216.2:synonymous_variant:LOW:exon16/31:c.1926G>A:p.Glu642=:,NPHP4:XM_011541217.2:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_011541218.2:synonymous_variant:LOW:exon16/31:c.1926G>A:p.Glu642=:,NPHP4:XM_017000996.1:synonymous_variant:LOW:exon14/29:c.1923G>A:p.Glu641=:,NPHP4:XM_017000997.1:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_017000998.1:synonymous_variant:LOW:exon14/26:c.1926G>A:p.Glu642=:,NPHP4:XM_017000999.1:synonymous_variant:LOW:exon15/30:c.1398G>A:p.Glu466=:,NPHP4:XM_017001000.2:synonymous_variant:LOW:exon14/29:c.1398G>A:p.Glu466=:,NPHP4:XM_017001001.1:synonymous_variant:LOW:exon9/24:c.1128G>A:p.Glu376=:,NPHP4:XM_017001002.1:synonymous_variant:LOW:exon14/20:c.1926G>A:p.Glu642=:,NPHP4:XM_017001003.1:synonymous_variant:LOW:exon7/22:c.387G>A:p.Glu129=:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon14/28:n.1964G>A::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon14/28:n.1964G>A::,NPHP4:XR_946605.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1964G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95673 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs12120967	0.0841	0.1317	1357,.	0.0271,0.0767,0.0768,0.1672,0.1125				1.57			COSV65395162	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927636	5927636	T	C	wt	wt	het	off-target	QUAL=2465;DP=132,152,186;AF=0.00,0.02,0.54;MQM=60;SAP=33;ABP=6	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron11/19:c.1441+13A>G::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron10/26:c.75+13A>G::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron9/25:c.75+13A>G::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/32:n.1661+13A>G::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron10/27:c.1441+13A>G::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron12/30:c.1441+13A>G::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron12/30:c.1441+13A>G::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron10/25:c.1441+13A>G::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron11/29:c.913+13A>G::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron10/28:c.913+13A>G::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron5/23:c.643+13A>G::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron10/19:c.1441+13A>G::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron5/21:c.75+13A>G::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/27:n.1479+13A>G::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/27:n.1479+13A>G::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/17:n.1479+13A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95671 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs7520105	0.1412	0.1709	2301,.	0.2101,0.0876,0.0770,0.1681,0.1150				12.77			COSV65395165	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5986372	5986372	C	G	wt	wt	het	off-target	QUAL=795;DP=53,46,52;AF=0.00,0.02,0.63;MQM=60;SAP=40;ABP=11	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron1/19:c.-38-45G>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron1/26:c.-1267-45G>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron1/25:c.-1088+5872G>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/32:n.183-45G>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron2/30:c.-38-45G>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron2/30:c.-38-45G>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron1/29:c.-471-140G>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1263812 [benign DISEASE=not provided];			rs1295111	0.3878	0.4116	13024,.					2.27				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5992511	5992511	G	A	wt	wt	het	off-target	QUAL=398;DP=3,29,39;AF=0.00,0.00,0.51;MQM=60;SAP=46;ABP=3	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::		regulatory_region_variant:promoter	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1258554 [benign DISEASE=not provided];			rs61760765	0.0218	0.0406	183,.					10.42				0	0	18	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	5992521	5992521	G	A	n/a	het	hom	off-target	QUAL=1335;DP=1,28,33;AF=1.00,0.68,1.00;MQM=60;SAP=118;ABP=11	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::		regulatory_region_variant:promoter,TF_binding_site_variant	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252161 [benign DISEASE=not provided];			rs806109		0.8360	53596,.					7.55				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6466123	6466123	G	A	het	wt	het		QUAL=380;DP=12,5,20;AF=0.50,0.00,0.70;MQM=60;SAP=7;ABP=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::	TNFRSF25:NM_001039664.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1468C>T::,TNFRSF25:NM_003790.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148965.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148966.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148967.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148970.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297904 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs3007417	0.2023	0.1886	5413,.	0.5020,0.0510,0.0004,0.0703,0.0791				9.16			COSV61068166	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466143	6466150	CGTGCTCT	-	het	wt	het		QUAL=349;DP=11,6,20;AF=0.55,0.00,0.65;MQM=60;SAP=6;ABP=6	TNFRSF25	5'UTR	TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::	TNFRSF25:NM_001039664.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1441_*1448del::,TNFRSF25:NM_003790.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:NM_148965.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:NM_148966.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148967.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148970.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733		0.1889	5410,.	0.4251,0.0464,0.0006,0.0579,0.0691				8.04				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466181	6466184	CGCC	-	hom	wt	het		QUAL=317;DP=4,3,15;AF=1.00,0.00,0.73;MQM=60;SAP=4;ABP=10	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1407_*1410del::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640		0.1884	5413,.					11.15				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466259	6466259	C	T	het	wt	het		QUAL=296;DP=30,30,32;AF=0.37,0.00,0.38;MQM=60;SAP=53;ABP=12	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1332G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297910 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs45604837	0.0863	0.0883	827,.					3.58				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466405	6466405	C	G	het	wt	het		QUAL=3444;DP=82,150,199;AF=0.49,0.00,0.54;MQM=60;SAP=110;ABP=4	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1186G>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297912 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];		MIR3 (SINE/MIR)	rs2986754	0.2043	0.1881	5643,.					3.06				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466798	6466798	A	-	het	het	het		QUAL=265;DP=44,6,7;AF=0.25,0.50,0.14;MQM=60;SAP=7;ABP=31	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*793del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062		0.0703	880,.					0.44				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467273	6467273	A	G	het	wt	het		QUAL=1562;DP=75,53,59;AF=0.49,0.00,0.47;MQM=60;SAP=3;ABP=3	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.10:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728.8:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377740.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748.6:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.8:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000673471.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000675123.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*290T>C::,PLEKHG5:ENST00000675694.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::	PLEKHG5:NM_001042663.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265592.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:NM_020631.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_198681.4:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297928 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,not provided];			rs14708	0.2670	0.2613	8164,.					12.38				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469123	6469125	TCC	-	het	wt	het		QUAL=1322;DP=47,63,106;AF=0.38,0.05,0.45;MQM=60;SAP=37;ABP=9	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850.10:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.5:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.8:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732.5:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377740.5:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377748.6:inframe_deletion:MODERATE:exon20/22:c.2340_2342del:p.Glu781del:,PLEKHG5:ENST00000400913.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915.8:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000535355.6:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245.6:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000673471.2:inframe_deletion:MODERATE:exon20/22:c.2463_2465del:p.Glu822del:,PLEKHG5:ENST00000675123.1:inframe_deletion:MODERATE:exon18/20:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675694.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:	PLEKHG5:NM_001042663.3:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:NM_001042664.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001042665.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001265592.2:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:NM_001265593.1:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:NM_001265594.2:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_020631.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_198681.4:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,Distal spinal muscular atrophy,not specified,not provided];		(TCC)n (Simple_repeat)	rs113541584		0.0876	707,.	0.1890,0.0573,0.0085,0.0753,0.0956				10.16				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469383	6469383	A	G	het	wt	het		QUAL=9691;DP=312,391,487;AF=0.48,0.00,0.48;MQM=60;SAP=16;ABP=6	PLEKHG5	synonymous	PLEKHG5:ENST00000340850.10:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.5:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.8:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732.5:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377740.5:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377748.6:synonymous_variant:LOW:exon19/22:c.2175T>C:p.Ser725=:,PLEKHG5:ENST00000400913.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915.8:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000535355.6:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245.6:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000673471.2:synonymous_variant:LOW:exon19/22:c.2298T>C:p.Ser766=:,PLEKHG5:ENST00000675123.1:synonymous_variant:LOW:exon17/20:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675694.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:	PLEKHG5:NM_001042663.3:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:NM_001042664.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001042665.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001265592.2:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:NM_001265593.1:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:NM_001265594.2:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:NM_020631.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_198681.4:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194881 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified,not provided];			rs730600	0.2696	0.2624	8213,.	0.5922,0.0937,0.0041,0.1423,0.1761				5.83				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470375	6470375	A	G	het	wt	het	off-target	QUAL=1086;DP=40,49,55;AF=0.45,0.00,0.53;MQM=60;SAP=3;ABP=3	PLEKHG5	intron	PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron16/21:c.1855-20T>C::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron16/21:c.1978-20T>C::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron14/19:c.1681-20T>C::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::	PLEKHG5:NM_001042663.3:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001265592.2:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:NM_020631.6:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_198681.4:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1260549 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs2986753	0.1717	0.1818	3225,.	0.3429,0.0779,0.0039,0.1301,0.1509				0.44		7.80>7.76		0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470905	6470905	-	G	hom	hom	hom	off-target	QUAL=6021;DP=42,84,117;AF=0.98,0.99,1.00;MQM=60;SAP=18;ABP=0	PLEKHG5	intron	PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron14/21:c.1567-22dup::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron14/21:c.1690-22dup::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron12/19:c.1393-22dup::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::	PLEKHG5:NM_001042663.3:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001265592.2:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:NM_020631.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_198681.4:intron_variant:MODIFIER:intron14/21:c.1393-22dup::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670557 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs111312565		1.0000	75882,.	1.0000,1.0000,0.9999,1.0000,1.0000				2.28				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471529	6471529	C	T	het	wt	het		QUAL=1642;DP=35,115,114;AF=0.66,0.00,0.45;MQM=60;SAP=50;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon13/22:c.1414G>A:p.Ala472Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon13/22:c.1537G>A:p.Ala513Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon11/20:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain]	PLEKHG5:NM_001042663.3:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001265592.2:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_020631.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_198681.4:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297959 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs74809741	0.0553	0.0610	308,.	0.0889,0.0369,0.0002,0.0593,0.0518		T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.42),T(0.45),T(0.43),T(0.41),T(0.43),T(0.44),T(0.47),T(0.45)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00),B(0.00),B(0.01)	18.48	0.04		COSV61699881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6473333	6473333	G	C	het	wt	het		QUAL=479;DP=25,19,25;AF=0.44,0.00,0.56;MQM=60;SAP=57;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon9/22:c.887C>G:p.Thr296Ser:,PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon9/22:c.1010C>G:p.Thr337Ser:,PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon7/20:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:	PLEKHG5:NM_001042663.3:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001265592.2:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_020631.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_198681.4:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	198895 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified,not provided];			rs61741379	0.2857	0.2765	9529,.	0.6445,0.0990,0.0072,0.1406,0.1621		T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.76),T(0.68),T(0.70),T(0.78),T(0.70),T(0.66),T(0.66),T(0.68)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	4.56	0.07		COSV61700195	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6519461	6519461	G	C	het	het	het		QUAL=3428;DP=121,76,91;AF=0.53,0.46,0.52;MQM=60;SAP=320;ABP=3	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670484 [likely benign DISEASE=not provided];			rs17438786	0.0136	0.0242	48,.	0.0050,0.0165,0.0000,0.0326,0.0176				6.88					19	813	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519547	6519547	C	T	hom	hom	hom		QUAL=20041;DP=176,204,269;AF=1.00,1.00,1.00;MQM=60;SAP=739;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	380860 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified];			rs1556035		0.8595	48522,.	0.5189,0.9267,0.7933,0.8816,0.8645				7.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519783	6519783	C	T	hom	hom	hom		QUAL=41973;DP=291,456,585;AF=0.99,1.00,1.00;MQM=60;SAP=143;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667919 [benign DISEASE=not provided];			rs1010584		0.7731	47329,.					1.89					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10258594	10258594	C	G	wt	het	wt		QUAL=2875;DP=316,229,251;AF=0.00,0.50,0.00;MQM=60;SAP=5;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083.5:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377093.9:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon3/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]	KIF1B:NM_001365951.3:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365953.1:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:,KIF1B:NM_183416.4:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs12402052	0.2300	0.2766	4955,.	0.0864,0.3446,0.2917,0.2914,0.2293				10.86			COSV55805367	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10261996	10261996	G	A	wt	het	wt	off-target	QUAL=2023;DP=317,179,272;AF=0.00,0.46,0.00;MQM=60;SAP=10;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+26G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.429+26G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1266483 [benign DISEASE=not provided];			rs4846209	0.3399	0.3477	9287,.	0.3418,0.3938,0.3671,0.3431,0.2578				1.71			COSV55815439	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10267349	10267349	A	T	wt	het	wt	off-target	QUAL=1116;DP=256,100,130;AF=0.00,0.50,0.00;MQM=60;SAP=55;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.430-31A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.430-31A>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1181451 [benign DISEASE=not provided];			rs12141246	0.3806	0.3717	10656,.	0.4133,0.3974,0.4087,0.3425,0.2575				0.98			COSV55808764	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10268280	10268280	C	T	wt	het	wt	off-target	QUAL=2383;DP=239,186,187;AF=0.00,0.52,0.00;MQM=60;SAP=46;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron6/46:c.720+17C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron7/20:c.720+17C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	260542 [benign DISEASE=Pheochromocytoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,not specified,not provided];			rs1339458	0.2540	0.2817	5356,.	0.1535,0.3485,0.2906,0.2919,0.2301				2.36			COSV55802811	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282571	10282571	G	A	wt	het	het	off-target	QUAL=5608;DP=180,218,224;AF=0.01,0.50,0.50;MQM=60;SAP=99;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron13/46:c.1392+38G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron14/47:c.1356+38G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292705 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs3748576	0.7127	0.7041	39359,.	0.9335,0.7352,0.5293,0.5971,0.6222				0.35			COSV55814192	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10295776	10295776	C	T	wt	het	wt		QUAL=1539;DP=135,128,157;AF=0.01,0.48,0.00;MQM=60;SAP=11;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron18/47:c.1777+10C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron17/46:c.1735+10C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron18/47:c.1699+10C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs3753037	0.2640	0.2844	5574,.	0.1871,0.3503,0.2912,0.2920,0.2295				6.71			COSV55805392	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297149	10297149	T	-	het	het	het	off-target	QUAL=3797;DP=178,164,233;AF=0.34,0.29,0.32;MQM=60;SAP=3;ABP=168	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron20/47:c.2043-9del::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron19/46:c.2001-9del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron20/47:c.1965-9del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron19/20:c.1905-9del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917114 [benign DISEASE=Charcot-Marie-Tooth disease];		(T)n (Simple_repeat)	rs58344165		0.4250	1,.	0.4308,0.4320,0.4215,0.4277,0.4367				0.09				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306429	10306429	T	G	wt	het	wt		QUAL=2589;DP=248,230,227;AF=0.00,0.45,0.00;MQM=60;SAP=4;ABP=8	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9183T>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9183T>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs8019	0.3838	0.3932	11978,.					7.79				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306634	10306634	C	G	wt	het	wt		QUAL=2901;DP=289,253,279;AF=0.00,0.47,0.00;MQM=60;SAP=84;ABP=4	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9388C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9388C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			7SLRNA (srpRNA)	rs4623	0.3343	0.3398	8848,.					2.10				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307366	10307366	G	A	wt	het	wt		QUAL=344;DP=114,43,45;AF=0.01,0.42,0.00;MQM=60;SAP=29;ABP=5	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10120G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10120G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs2004034	0.2316	0.2379	5002,.					3.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307533	10307533	T	C	wt	het	wt		QUAL=1161;DP=190,87,99;AF=0.00,0.59,0.01;MQM=60;SAP=116;ABP=9	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10287T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10287T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs1065828	0.3341	0.3397	8901,.					2.54				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10324118	10324118	-	TTGAAA	het	het	het	off-target	QUAL=4473;DP=227,136,185;AF=0.42,0.42,0.38;MQM=60;SAP=437;ABP=44	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2495+57_2495+58insTGAAAT::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2459+57_2459+58insTGAAAT::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241982 [benign DISEASE=not provided];			rs3831405		0.2394	4994,.					3.98				0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10334478	10334478	C	G	het	het	het	off-target	QUAL=8213;DP=247,151,219;AF=0.53,0.48,0.53;MQM=60;SAP=434;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron25/46:c.2883-42C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron26/47:c.2847-42C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1179832 [benign DISEASE=not provided];			rs2276100	0.3339	0.3280	8308,.	0.3230,0.3842,0.3667,0.3197,0.2621				3.79			COSV55805280	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10337022	10337022	A	G	wt	wt	het	off-target	QUAL=1132;DP=202,79,101;AF=0.00,0.00,0.47;MQM=60;SAP=47;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron27/46:c.3088-52A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron28/47:c.3052-52A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs71643087	0.0112	0.0210	51,.					0.68				0	7	740	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10348780	10348780	T	-	het	het	het	off-target	QUAL=304;DP=135,134,144;AF=0.19,0.17,0.10;MQM=60;SAP=61;ABP=436	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron35/46:c.3811+60del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron36/47:c.3949+60del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron35/46:c.3907+60del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron36/47:c.3871+60del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron35/46:c.3811+60del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs35253111		0.2842	11,.	0.2232,0.3608,0.4320,0.2693,0.2557				0.70				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360879	10360879	C	T	het	het	het	off-target	QUAL=11881;DP=257,298,372;AF=0.52,0.51,0.49;MQM=60;SAP=367;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-50C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-50C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,LOC105376725:XR_946953.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.276+542G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248757 [benign DISEASE=not provided];			rs3748579	0.3341	0.3279	8292,.	0.3225,0.3839,0.3664,0.3196,0.2625				1.47			COSV55805298	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365060	10365060	T	-	het	het	het	off-target	QUAL=3187;DP=97,87,111;AF=0.45,0.46,0.52;MQM=60;SAP=150;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-33del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-33del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron39/46:c.4229-33del::,LOC105376725:XR_946953.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.230+1321del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1260773 [benign DISEASE=not provided];			rs34161257		0.5276	21584,.	0.6622,0.4695,0.3722,0.4743,0.4639				2.77				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10371100	10371100	T	C	het	het	het	off-target	QUAL=7053;DP=218,156,224;AF=0.45,0.47,0.53;MQM=60;SAP=385;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron42/46:c.4783-41T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron43/47:c.4747-41T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1228335 [benign DISEASE=not provided];			rs17411502	0.2490	0.2841	5473,.	0.1495,0.3490,0.2841,0.2958,0.2375				5.68			COSV55805429	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375266	10375266	C	A	het	het	het		QUAL=7267;DP=295,115,148;AF=0.45,0.57,0.52;MQM=60;SAP=4;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon46/47:c.5259C>A:p.Thr1753=:PF00169 [PH domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon47/48:c.5223C>A:p.Thr1741=:PF00169 [PH domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain]	KIF1B:NM_001365951.3:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs11121552	0.2316	0.2795	5097,.	0.0874,0.3464,0.2848,0.2956,0.2374				5.52			COSV55805449	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376834	10376834	-	AC	het	het	wt		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=28;ABP=222	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473_5367-1472dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473_5331-1472dup::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs111663673		0.0543	195,.					2.16				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376866	10376866	C	T	het	wt	het		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=15;ABP=6	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473C>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291594 [benign DISEASE=Neuroblastoma];		(AC)n (Simple_repeat)	rs78490707	0.0403	0.0079	49,.					0.41				0	0	3	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10377948	10377948	A	T	het	het	wt		QUAL=1163;DP=76,54,72;AF=0.41,0.48,0.00;MQM=60;SAP=80;ABP=7	KIF1B	intron,3'UTR	KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-391A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-391A>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*1361A>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291610 [benign DISEASE=Neuroblastoma];		AluSg (SINE/Alu)	rs2847347	0.0182	0.0380	153,.					2.28					1	18	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378629	10378629	C	T	het	het	het		QUAL=12151;DP=253,281,354;AF=0.56,0.51,0.51;MQM=60;SAP=4;ABP=7	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*227C>T::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2042C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291618 [benign DISEASE=Neuroblastoma];			rs1536262	0.5465	0.5518	24286,.					0.55					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378834	10378834	G	A	het	het	het		QUAL=8764;DP=281,160,191;AF=0.52,0.57,0.52;MQM=60;SAP=71;ABP=9	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*432G>A::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2247G>A::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291619 [benign DISEASE=Neuroblastoma];			rs1002076	0.3337	0.3278	8298,.					2.91					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10380498	10380498	A	G	het	het	het		QUAL=9089;DP=324,182,224;AF=0.51,0.49,0.48;MQM=51;SAP=11;ABP=3	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2096A>G::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*3911A>G::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291652 [benign DISEASE=Neuroblastoma];		AluSx (SINE/Alu)	rs1138791	0.3488	0.3571	9821,.					2.62					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10381606	10381606	T	C	het	het	het		QUAL=13658;DP=453,272,349;AF=0.53,0.44,0.50;MQM=60;SAP=304;ABP=3	KIF1B,	downstream_gene	KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000620295.2:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000622724.3:downstream_gene_variant:MODIFIER::::,:ENST00000641117.1:downstream_gene_variant:MODIFIER::::,:ENST00000641619.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000676179.1:downstream_gene_variant:MODIFIER::::			605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Somatic mutation, Autosomal dominant; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581		0.5321	22184,.					9.11					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11024947	11024947	-	TGTTT	het	het	hom		QUAL=16206;DP=371,256,267;AF=0.49,0.50,1.00;MQM=60;SAP=32;ABP=3	TARDBP	3'UTR	TARDBP:ENST00000240185.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::	TARDBP:NM_007375.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::,TARDBP:XM_017000863.2:3_prime_UTR_variant:MODIFIER:exon6/7:c.*2294_*2295insGTTTT::,TARDBP:XM_017000864.2:intron_variant:MODIFIER:intron6/8:c.*1682-162_*1682-161insGTTTT::,TARDBP:XM_017000865.2:intron_variant:MODIFIER:intron6/7:c.*1682-162_*1682-161insGTTTT::,TARDBP:XM_017000866.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1560_*1561insGTTTT::,TARDBP:XM_017000867.2:intron_variant:MODIFIER:intron7/8:c.*948-162_*948-161insGTTTT::,TARDBP:XM_017000868.2:intron_variant:MODIFIER:intron6/6:c.*676-162_*676-161insGTTTT::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs3059695		0.8802	59078,.					4.86				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11786035	11786035	-	T	het	hom	het		QUAL=4368;DP=116,37,50;AF=0.75,0.89,0.90;MQM=60;SAP=250;ABP=129	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4644dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3639+757dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3702+757dup::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3702+757dup::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3702+757dup::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3648+757dup::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1983+757dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775		0.9840	72489,.					1.54				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786195	11786195	G	A	hom	het	het		QUAL=15057;DP=330,159,181;AF=1.00,0.50,0.54;MQM=60;SAP=44;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4485C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3639+906G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3702+906G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3702+906G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3702+906G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3648+906G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1983+906G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs4846048		0.6780	35684,.					3.52				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786390	11786390	G	A	hom	hom	hom		QUAL=25307;DP=382,181,214;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4290C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-998G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-998G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-998G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-998G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-998G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-998G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs4845884		0.9395	67802,.					0.77				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786606	TTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.64,0.48,0.61;MQM=58;SAP=29;ABP=14	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4074_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-770_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-770_3703-767del::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-770_3703-767del::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-770_3703-767del::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-770_3649-767del::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-770_1984-767del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505		0.5416	21354,.					0.58				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786607	TTTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.23,0.38,0.11;MQM=59;SAP=3;ABP=78	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4073_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-771_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-771_3568-767del::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-771_3703-767del::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-771_3703-767del::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-771_3703-767del::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-771_3649-767del::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-771_1984-767del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs55780505		0.0017	0,.					0.57				0.02	0	45	0 / 0					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787277	11787277	-	GAA	hom	het	het		QUAL=9454;DP=223,132,220;AF=0.96,0.58,0.40;MQM=60;SAP=71;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*3400_*3402dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-108_3640-106dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-108_3703-106dup::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-108_3703-106dup::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-108_3703-106dup::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-108_3649-106dup::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-108_1984-106dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs35134728		0.5655	25339,.					0.59				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787702	11787702	C	T	hom	het	het		QUAL=11991;DP=189,243,289;AF=0.99,0.51,0.52;MQM=60;SAP=40;ABP=4	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2978G>A::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron17/20:c.3746-171C>T::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron18/21:c.3809-171C>T::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron18/21:c.3809-171C>T::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron19/21:c.3809-171C>T::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron18/20:c.3755-171C>T::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron13/15:c.2090-171C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs3737966		0.5525	24365,.					4.70			COSV57172225	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788082	11788082	G	A	wt	het	het		QUAL=2663;DP=122,84,122;AF=0.01,0.55,0.48;MQM=60;SAP=4;ABP=3	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2598C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron18/20:c.3920+35G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron19/21:c.3983+35G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron19/21:c.3983+35G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron20/21:c.3983+35G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron19/20:c.3929+35G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron14/15:c.2264+35G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs11559040	0.1268	0.1685	1758,.	0.0352,0.0850,0.1026,0.1856,0.2669				2.70			COSV57171817	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788822	11788822	A	G	hom	hom	hom		QUAL=19132;DP=244,151,217;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron20/20:c.4230+76A>G::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron21/21:c.4308+76A>G::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron21/21:c.4214+76A>G::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron20/20:c.4119+444A>G::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron20/20:c.4213+444A>G::,C1orf167:XM_024446506.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446507.1:missense_variant:MODERATE:exon22/22:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446508.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446509.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446512.1:missense_variant:MODERATE:exon21/21:c.4330A>G:p.Thr1444Ala:,C1orf167:XM_024446514.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446515.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446517.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446518.1:missense_variant:MODERATE:exon16/16:c.2665A>G:p.Thr889Ala:	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs2077360		0.9371	67508,.					0.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11789390	11789390	A	G	hom	hom	hom		QUAL=17765;DP=149,188,226;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,C1orf167:ENST00000433342.5:missense_variant:MODERATE:exon21/21:c.4351A>G:p.Arg1451Gly:	C1orf167:NM_001010881.2:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,C1orf167:XM_011541272.3:missense_variant:MODERATE:exon22/22:c.4429A>G:p.Arg1477Gly:,C1orf167:XM_011541276.3:synonymous_variant:LOW:exon22/22:c.4335A>G:p.Pro1445=:,C1orf167:XM_011541277.3:missense_variant:MODERATE:exon21/21:c.4240A>G:p.Arg1414Gly:,C1orf167:XM_024446506.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*347A>G::,C1orf167:XM_024446508.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446509.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446512.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446514.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446515.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446517.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446518.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*347A>G::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs868014		0.9874	67781,.	0.7812,0.9875,1.0000,0.9990,0.9997		 , , , ,T(0.22)	 , , , ,B(0.00)	0.01	0.03		COSV57171235	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790308	11790308	T	G	hom	het	het		QUAL=19144;DP=316,347,383;AF=1.00,0.49,0.49;MQM=60;SAP=228;ABP=4	MTHFR	3'UTR	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000423400.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::	MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263460.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263462.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263463.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_011541495.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_011541496.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*232A>C::,MTHFR:XM_024447198.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292223 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs4846049		0.6320	31075,.					1.52				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790946	11790946	G	C	wt	het	het	off-target	QUAL=3881;DP=208,168,179;AF=0.00,0.48,0.43;MQM=60;SAP=43;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1753-230C>G::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1018-48C>G::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron11/11:c.1507-48C>G::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron11/11:c.1876-230C>G::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron11/11:c.1876-198C>G::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron11/11:c.1507-48C>G::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.2854-230C>G::	TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1224887 [benign DISEASE=not provided];			rs3818762		0.2600	4602,.	0.1340,0.1420,0.2153,0.2748,0.4137				0.05			COSV100453746	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11792243	11792243	C	T	wt	het	het	off-target	QUAL=4655;DP=170,197,207;AF=0.01,0.47,0.48;MQM=60;SAP=13;ABP=5	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron6/7:c.897+35G>A::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron10/11:c.1386+35G>A::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron10/11:c.1386+35G>A::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/10:n.2733+35G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1170841 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs1476413	0.2512	0.2614	4505,.	0.1509,0.1389,0.2267,0.2731,0.4203				1.21			COSV57171175	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794400	11794400	G	A	hom	hom	hom		QUAL=18568;DP=120,204,264;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	MTHFR	synonymous	MTHFR:ENST00000376583.7:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.6:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590.9:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592.6:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000423400.7:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:ENST00000641407.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:,MTHFR:ENST00000641820.1:synonymous_variant:LOW:exon4/8:c.570C>T:p.Phe190=:	MTHFR:NM_001330358.2:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:NM_005957.5:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263460.5:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263462.4:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263463.4:synonymous_variant:LOW:exon8/12:c.1059C>T:p.Phe353=:,MTHFR:XM_011541495.3:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:XM_011541496.3:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:XM_017001328.2:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:XM_024447198.1:synonymous_variant:LOW:exon8/12:c.1059C>T:p.Phe353=:,MTHFR:XR_002956640.1:non_coding_transcript_exon_variant:MODIFIER:exon7/11:n.2406C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	167306 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Homocystinuria due to MTHFR deficiency,not specified];			rs4846051		0.9748	64232,.	0.6780,0.9819,0.9991,0.9983,0.9993				4.72				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794419	11794419	T	G	wt	het	het		QUAL=7183;DP=166,228,287;AF=0.01,0.54,0.54;MQM=60;SAP=7;ABP=11	MTHFR	missense	MTHFR:ENST00000376583.7:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.6:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590.9:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592.6:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000423400.7:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:ENST00000641407.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000641820.1:missense_variant:MODERATE:exon4/8:c.551A>C:p.Glu184Ala:	MTHFR:NM_001330358.2:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:NM_005957.5:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263460.5:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263462.4:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263463.4:missense_variant:MODERATE:exon8/12:c.1040A>C:p.Glu347Ala:,MTHFR:XM_011541495.3:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:XM_011541496.3:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:XM_017001328.2:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:XM_024447198.1:missense_variant:MODERATE:exon8/12:c.1040A>C:p.Glu347Ala:,MTHFR:XR_002956640.1:non_coding_transcript_exon_variant:MODIFIER:exon7/11:n.2387A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	3521 [conflicting interpretations of pathogenicity, other DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stromal tumor,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Neural tube defects, folate-sensitive,MTHFR deficiency, thermolabile type,Homocystinuria due to MTHFR deficiency,not specified,none provided,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2494	0.2890	5754,.	0.1582,0.1594,0.2198,0.3186,0.4116		T(0.15),T(0.15),T(0.14),T(0.14),T(0.16),T(0.19),T(0.12)	B(0.07),B(0.07),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01)	20.90	0.20		COSV57171183	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794698	11794698	G	A	hom	het	het	off-target	QUAL=3045;DP=70,57,54;AF=1.00,0.46,0.39;MQM=60;SAP=192;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.431+31C>T::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron7/11:c.920+31C>T::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron7/11:c.920+31C>T::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/10:n.2267+31C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177042 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs1994798	0.5793	0.6074	24771,.	0.4333,0.7727,0.7596,0.5879,0.4685				0.05			COSV64877997	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11949898	11949898	C	T	het	het	het		QUAL=6852;DP=125,190,248;AF=0.46,0.53,0.49;MQM=60;SAP=59;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs7529452	0.2678	0.3295	6298,.	0.0589,0.3522,0.3748,0.3160,0.4236				13.23			COSV52144592	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11949899	11949899	G	A	wt	het	wt		QUAL=1997;DP=151,186,243;AF=0.00,0.47,0.00;MQM=60;SAP=4;ABP=5	PLOD1	missense	PLOD1:ENST00000196061.5:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:	PLOD1:NM_000302.4:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:NM_001316320.2:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2995	0.2590	7475,.	0.5503,0.0894,0.2527,0.1526,0.2126		T(1.00)	B(0.00)	15.53	0.15		COSV52140857	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956900	11956900	T	G	wt	het	wt	off-target	QUAL=3761;DP=108,311,391;AF=0.00,0.50,0.00;MQM=60;SAP=70;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.644-17T>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron6/18:c.644-17T>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron7/19:c.785-17T>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	384719 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified];			rs41307745	0.0769	0.0679	271,.	0.0104,0.0250,0.1423,0.0613,0.1356				17.56		10.55>8.84	COSV52140829	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11964178	11964178	C	T	het	het	het		QUAL=1167;DP=17,35,53;AF=0.59,0.40,0.53;MQM=60;SAP=3;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs1130529	0.3484	0.3609	8715,.	0.2929,0.3668,0.3896,0.3275,0.4443				6.42			COSV52140468	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967147	11967147	C	T	het	hom	het	off-target	QUAL=9535;DP=39,205,211;AF=0.46,1.00,0.52;MQM=60;SAP=125;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron17/19:c.1896+56C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1297286 [benign DISEASE=not provided];			rs2273293		0.5040	19900,.					0.01			COSV52142788	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973056	11973056	A	G	het	hom	het	off-target	QUAL=11278;DP=134,209,263;AF=0.51,1.00,0.48;MQM=60;SAP=389;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron19/19:c.2169+59A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1278494 [benign DISEASE=not provided];			rs3737961		0.5670	26077,.					3.69			COSV52144992	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11980146	11980146	A	G	het	hom	het	off-target	QUAL=880;DP=23,20,24;AF=0.43,1.00,0.46;MQM=60;SAP=84;ABP=4	PLOD1,MFN2,	downstream_gene,upstream_gene	PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.5:upstream_gene_variant:MODIFIER::::,:ENST00000660216.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674548.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675053.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675298.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1290963 [benign DISEASE=not provided];			rs2236053		0.5015	19724,.					3.38					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980267	11980267	A	G	het	hom	het		QUAL=4117;DP=30,101,123;AF=0.47,1.00,0.36;MQM=60;SAP=111;ABP=22	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-312A>G::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-270A>G::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-367A>G::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-367A>G::	MFN2:XM_005263543.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-435A>G::,MFN2:XM_005263548.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-431A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2,Ehlers-Danlos syndrome, hydroxylysine-deficient,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2236054		0.5066	20255,.					3.28				0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980422	11980422	T	C	het	hom	het		QUAL=5098;DP=54,113,128;AF=0.43,1.00,0.43;MQM=60;SAP=138;ABP=11	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-157T>C::,MFN2:ENST00000674658.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-310T>C::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674910.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-189T>C::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-115T>C::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-212T>C::	MFN2:XM_005263543.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-280T>C::,MFN2:XM_005263545.3:5_prime_UTR_variant:MODIFIER:exon1/19:c.-208T>C::,MFN2:XM_005263548.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-276T>C::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2,Ehlers-Danlos syndrome, hydroxylysine-deficient,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2180183		0.5325	22800,.					9.63				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTT	het	het	wt	off-target	QUAL=274;DP=86,34,137;AF=0.06,0.26,0.11;MQM=59;SAP=49;ABP=365	MFN2	intron,5'UTR	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1443_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-43_-247-38dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1443_-127+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-140_-52-135dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-43_-211-38dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-43_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-43_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-43_-271-38dup::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron1/19:c.-217-43_-217-38dup::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron1/18:c.-145-47_-145-42dup::,MFN2:XM_005263547.3:5_prime_UTR_variant:MODIFIER:exon2/19:c.-192_-187dup::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron1/19:c.-213-47_-213-42dup::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1251375 [benign DISEASE=not provided];			rs34602102		0.0259	202,.					3.98				0.01	1	25	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTTT	wt	het	het	off-target	QUAL=274;DP=86,34,137;AF=0.08,0.21,0.08;MQM=58;SAP=58;ABP=338	MFN2	intron,5'UTR	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1442_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-44_-247-38dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1442_-127+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-141_-52-135dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-44_-211-38dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-44_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-44_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-44_-271-38dup::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron1/19:c.-217-44_-217-38dup::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron1/18:c.-145-48_-145-42dup::,MFN2:XM_005263547.3:5_prime_UTR_variant:MODIFIER:exon2/19:c.-193_-187dup::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron1/19:c.-213-48_-213-42dup::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1238604 [benign DISEASE=not provided];			rs34602102		0.3259	8015,.					3.93				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002148	12002148	A	G	hom	hom	hom	off-target	QUAL=14610;DP=179,138,190;AF=0.98,0.99,0.99;MQM=60;SAP=1067;ABP=0	MFN2	intron	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+45A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+45A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263547.3:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:XM_024451299.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]				rs2236057		0.6522	32381,.	0.6479,0.5317,0.6765,0.6679,0.7034				0.13			COSV52420984	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011623	12011623	A	G	hom	hom	hom		QUAL=29424;DP=256,323,417;AF=0.99,0.99,1.00;MQM=60;SAP=135;ABP=0	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1897A>G::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292381 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not specified,not provided];			rs1042842	0.7324	0.7082	39029,.					1.04			COSV52422477	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012461	12012461	G	C	hom	hom	hom		QUAL=12738;DP=105,142,172;AF=0.99,1.00,1.00;MQM=60;SAP=78;ABP=0	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1796G>C::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292393 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs3088064		0.5546	23926,.					4.22				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012477	12012477	C	T	wt	het	wt		QUAL=1661;DP=101,143,189;AF=0.00,0.50,0.00;MQM=60;SAP=4;ABP=3	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1780C>T::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292394 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs14305	0.0843	0.0535	318,.					6.51				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16043933	16043937	GGGGG	-	n/a	n/a	hom	off-target	QUAL=51;DP=0,0,3;AF=,,1.00;MQM=60;SAP=10;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron1/13:c.-8+61_-8+65del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+61_-8+65del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-545_-7-541del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+61_-8+65del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs140434107		0.4821	10036,.					0.91				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044572	16044572	G	T	het	n/a	hom		QUAL=235;DP=4,1,5;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5	CLCNKB	missense	CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000619181.4:missense_variant:MODERATE:exon2/14:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon4/22:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon3/21:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon5/23:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	regulatory_region_variant:promoter_flanking_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447107 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2015352		0.6267	24634,.	0.2881,0.7293,0.6328,0.6333,0.6878		D(0.01),D(0.03),D(0.01),D(0.01),D(0.02),D(0.01),D(0.01)	B(0.16),B(0.02),B(0.16),B(0.16),B(0.01),B(0.16),B(0.16)	18.63	0.30		COSV65159885	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045508	16045508	G	C	het	het	hom	off-target	QUAL=6436;DP=55,128,148;AF=0.42,0.48,1.00;MQM=60;SAP=355;ABP=6	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron2/13:c.101-50G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-50G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-50G>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-50G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron2/19:c.101-50G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209775 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs6604910	0.5665	0.6357	24662,.	0.2698,0.7354,0.6801,0.6380,0.7118				4.26			COSV65160072	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046476	16046476	G	A	hom	hom	hom	off-target	QUAL=12404;DP=78,142,182;AF=1.00,1.00,1.00;MQM=60;SAP=439;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron3/13:c.230-59G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-59G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-59G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-59G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron3/19:c.230-59G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209776 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs2014841		0.7025	40551,.					1.12				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046629	16046629	A	G	hom	hom	hom		QUAL=23205;DP=180,247,314;AF=0.99,1.00,1.00;MQM=60;SAP=5;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon4/14:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon6/22:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon5/21:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon7/23:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447104 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs5257		0.8121	40534,.	0.3791,0.8994,0.9891,0.8093,0.8739				0.63				0.88	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046705	16046707	CTT	-	hom	het	hom	off-target	QUAL=9620;DP=108,146,205;AF=1.00,0.49,1.00;MQM=60;SAP=347;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron4/13:c.358+44_358+46del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+44_358+46del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+44_358+46del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+44_358+46del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1280604 [benign DISEASE=not provided];			rs35820664		0.7861	37662,.	0.3540,0.8883,0.9891,0.7803,0.8442				8.18				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048038	16048038	G	C	hom	hom	hom		QUAL=383;DP=5,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon5/14:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon7/22:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon6/21:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon8/23:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447105 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2014562		0.9317	60802,.	0.7589,0.9575,0.9997,0.9439,0.9278				7.47				0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048499	16048499	C	T	hom	hom	hom		QUAL=17965;DP=155,203,244;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000619181.4:splice_region_variant&intron_variant:LOW:intron6/13:c.577-5C>T::,CLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron8/21:c.577-5C>T::,CLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron7/20:c.577-5C>T::,CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron9/22:c.577-5C>T::,CLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	CLCNKB:NM_000085.5:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	381050 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889788		0.8104	40322,.	0.3760,0.8986,0.9890,0.8075,0.8732				5.31		4.28>4.16	COSV65161773	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048568	16048568	C	G	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+54C>G::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon9/22:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon8/21:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon10/23:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:	regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504916 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889789		0.9069	53660,.	0.5589,0.9388,0.9997,0.9259,0.9256		T(0.79), ,T(0.79),T(0.79),T(1.00),T(0.79),T(0.79)	B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	5.97	0.22		COSV65159497	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048569	16048569	A	C	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0	CLCNKB	synonymous,intron	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+55A>C::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon9/22:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon8/21:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon10/23:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504915 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889790		0.9069	53659,.	0.5589,0.9388,0.9997,0.9258,0.9256				2.40			COSV65161020	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048715	16048715	G	A	het	wt	hom	off-target	QUAL=4177;DP=96,103,100;AF=0.48,0.00,0.99;MQM=60;SAP=11;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+201G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.655+133G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.655+133G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.655+133G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1290690 [benign DISEASE=not provided];			rs9633514	0.3570	0.2987	8204,.					7.21				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048859	16048859	C	T	hom	hom	hom		QUAL=18683;DP=167,201,235;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667.7:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+345C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.656-261C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.656-261C>T::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.656-261C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:NM_001165945.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1259614 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs9442227		0.6911	39478,.					8.65				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049696	16049696	C	T	hom	hom	hom		QUAL=25484;DP=176,312,402;AF=1.00,1.00,1.00;MQM=45;SAP=275;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-820C>T::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon11/22:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon10/21:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon12/23:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447108 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs7367494		0.9249	54670,.	0.5573,0.9597,0.9988,0.9484,0.9335		T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.01), ,B(0.01),B(0.01),B(0.00),B(0.01),B(0.01)	0.08	0.22		COSV65159503	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049735	16049735	-	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-781_588-780insT::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+33_866+34insT::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+33_866+34insT::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+33_866+34insT::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277184 [benign DISEASE=not provided];			rs59006537		0.9242	54700,.	0.4294,0.9451,0.9983,0.9544,0.9487				1.60				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049737	16049737	A	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+35A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-779A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+35A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+35A>T::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+35A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+35A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209692 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs59924562		0.9253	54726,.	0.4491,0.9459,0.9984,0.9547,0.9477				0.10			COSV65161540	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049744	16049744	C	-	hom	hom	hom	off-target	QUAL=24247;DP=81,335,440;AF=0.96,0.99,0.99;MQM=52;SAP=12;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+47del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-767del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+47del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+47del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+47del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+47del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+47del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209750 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs34589727		0.9148	54759,.	0.4231,0.9419,0.9988,0.9470,0.9354				1.35				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049783	16049783	G	A	hom	hom	hom	off-target	QUAL=30508;DP=136,364,499;AF=1.00,1.00,1.00;MQM=57;SAP=40;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.360-32G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-733G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.867-32G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.867-32G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.867-32G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.360-32G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209751 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7365182		0.9209	54745,.	0.5528,0.9546,0.9999,0.9463,0.9313				5.09				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049824	16049824	T	C	hom	hom	hom		QUAL=32735;DP=180,361,483;AF=1.00,1.00,1.00;MQM=60;SAP=174;ABP=0	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-692T>C::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon12/22:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon11/21:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon13/23:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	377683 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs7368151		0.9168	54977,.	0.5579,0.9485,0.9998,0.9431,0.9271				0.08			COSV65161411	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049963	16049963	T	C	hom	hom	hom	off-target	QUAL=17634;DP=127,192,273;AF=0.99,1.00,1.00;MQM=59;SAP=231;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+47T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-553T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+47T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+47T>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+47T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron3/12:c.461+47T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209752 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7368166		0.9131	54369,.	0.5505,0.9457,0.9985,0.9398,0.9198				1.04			COSV65161797	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052154	16052154	C	G	het	het	wt	off-target	QUAL=482;DP=19,19,10;AF=0.58,0.68,0.00;MQM=60;SAP=39;ABP=9	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron7/12:c.902-44C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron11/13:c.1028-44C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron16/21:c.1409-44C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron15/20:c.1409-44C>G::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron17/22:c.1409-44C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1232843 [benign DISEASE=not provided];			rs2297726	0.1625	0.1727	1846,.	0.0715,0.1591,0.2995,0.1706,0.1631				8.76			COSV65160804	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052244	16052244	G	A	wt	het	wt		QUAL=108;DP=27,22,16;AF=0.00,0.36,0.00;MQM=60;SAP=4;ABP=7	CLCNKB	synonymous	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon12/14:c.1074G>A:p.Ala358=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon17/22:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon16/21:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon18/23:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	585703 [benign DISEASE=not specified,not provided];			rs34652156	0.0301	0.0366	145,.	0.0580,0.0117,0.0000,0.0274,0.0299				0.08			COSV65160149	0.01	20	921	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16053701	16053701	T	C	hom	hom	hom		QUAL=28466;DP=297,251,371;AF=1.00,1.00,1.00;MQM=51;SAP=166;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+11T>C::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447094 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs5253	0.8383	0.9347	61122,.	0.6863,0.9480,0.8076,0.9843,0.9317		T(0.49),T(0.46), ,T(0.46),T(0.46),T(0.63),T(0.46),T(0.46)	B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.03	0.28			0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053748	16053748	A	G	hom	het	hom		QUAL=15672;DP=139,232,313;AF=1.00,0.42,0.99;MQM=49;SAP=9;ABP=15	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+58A>G::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447096 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166		0.6948	37116,.	0.7975,0.5184,0.7947,0.6591,0.5830		T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	7.04	0.16			0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053757	16053757	C	T	hom	het	hom		QUAL=14504;DP=119,217,303;AF=1.00,0.43,1.00;MQM=49;SAP=18;ABP=13	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+67C>T::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon18/22:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon17/21:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon19/23:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447097 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2275167		0.6207	29518,.	0.5768,0.4929,0.7894,0.6443,0.5281				8.01			COSV65152867	0.31	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056382	16056382	A	G	hom	hom	hom	off-target	QUAL=11604;DP=50,147,203;AF=1.00,0.99,1.00;MQM=60;SAP=31;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-805A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-40A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-40A>G::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-40A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209753 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7517792		0.7963	45030,.	0.7061,0.8840,0.8077,0.7871,0.8423				0.23				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056834	16056834	-	C	hom	het	hom	off-target	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-29dup::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-347dup::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-29dup::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-29dup::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-29dup::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-29dup::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1246688 [benign DISEASE=not provided];			rs138507185		0.6606	29265,.					0.54				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056841	16056841	G	C	hom	het	hom	off-target	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-346G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-28G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-28G>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-28G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209827 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs12746138		0.7212	32995,.	0.4283,0.8343,0.7670,0.6997,0.7947				0.07				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056907	16056907	C	T	het	wt	wt		QUAL=698;DP=257,140,144;AF=0.26,0.00,0.07;MQM=35;SAP=168;ABP=135	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-280C>T::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon22/22:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon21/21:c.2052C>T:p.Ala684=:,CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon23/23:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	785932 [likely benign DISEASE=not provided];			rs6698427		0.0714	1,.	0.0128,0.0033,0.0132,0.0013,0.0025				4.92			COSV65152730	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056953	16056953	A	C	het	hom	hom		QUAL=15870;DP=218,241,287;AF=0.70,1.00,0.90;MQM=40;SAP=906;ABP=77	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-234A>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*37A>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*37A>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*37A>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209828 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs10803415	0.9010	0.9041	29942,.	0.8429,0.9248,0.6951,0.9399,0.8839				0.48				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057052	16057052	T	C	wt	wt	het		QUAL=542;DP=234,394,594;AF=0.05,0.00,0.19;MQM=31;SAP=272;ABP=509	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-135T>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*136T>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*136T>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*136T>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057839		0.2225	8,.					5.43			COSV65152725	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057079	16057079	A	T	het	wt	het		QUAL=888;DP=245,379,614;AF=0.13,0.00,0.20;MQM=33;SAP=342;ABP=759	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-108A>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*163A>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*163A>T::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*163A>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057841		0.2559	0,.					6.28				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057086	16057086	G	T	het	het	het		QUAL=19906;DP=249,378,613;AF=0.85,0.51,0.79;MQM=37;SAP=74;ABP=517	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-101G>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*170G>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*170G>T::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*170G>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057844		0.5151	10449,.					0.21				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057110	16057110	A	G	het	het	het		QUAL=19800;DP=196,403,645;AF=0.74,0.53,0.77;MQM=38;SAP=4;ABP=376	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-77A>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*194A>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*194A>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*194A>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057845		0.5067	9210,.					1.45				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057173	16057173	T	G	hom	hom	hom		QUAL=32874;DP=174,360,659;AF=0.99,1.00,1.00;MQM=41;SAP=399;ABP=0	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-14T>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*257T>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*257T>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*257T>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6660218		1.0000	76104,.	1.0000,1.0000,0.9998,0.9999,1.0000				3.77		-10.56>-11.38		0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057187	16057187	G	C	het	wt	het		QUAL=4440;DP=222,321,648;AF=0.19,0.00,0.36;MQM=41;SAP=38;ABP=262	CLCNKB	3'UTR,missense&splice_region	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000619181.4:missense_variant&splice_region_variant:MODERATE:exon14/14:c.1294G>C:p.Ala432Pro:,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*271G>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*271G>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*271G>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	402540 [benign DISEASE=not specified];			rs1057854		0.3286	223,.	0.4019,0.2177,0.4238,0.3039,0.2888		 , ,D(0.00), , , , , 	 , ,D(0.98), , , , , 	0.15	0.01	-10.56>-11.54	COSV65152876	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057247	16057247	C	G	het	hom	het		QUAL=18401;DP=339,224,515;AF=0.55,1.00,0.53;MQM=58;SAP=737;ABP=13	CLCNKB	3'UTR,missense	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000619181.4:missense_variant:MODERATE:exon14/14:c.1354C>G:p.Pro452Ala:,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*331C>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*331C>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*331C>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057857		0.6415	19811,.	0.5897,0.6972,0.4932,0.6536,0.6177		 , ,D(0.00), , , , , 	 , ,P(0.74), , , , , 	3.09	0.02		COSV65153970	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057359	16057359	A	G	het	wt	het	off-target	QUAL=706;DP=105,56,110;AF=0.38,0.00,0.17;MQM=38;SAP=131;ABP=98	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000619181.4:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::			602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs749928769		0.0271	9,.					2.21					0	10	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16986248	16986248	C	T	het	hom	het		QUAL=707;DP=17,19,25;AF=0.41,0.95,0.44;MQM=60;SAP=12;ABP=5	ATP13A2,	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676.9:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7136C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:XM_005245810.1:missense_variant:MODERATE:exon28/28:c.3343G>A:p.Ala1115Thr:,ATP13A2:XM_005245811.1:missense_variant:MODERATE:exon28/28:c.3331G>A:p.Ala1111Thr:,ATP13A2:XM_005245812.1:missense_variant:MODERATE:exon28/28:c.3319G>A:p.Ala1107Thr:,ATP13A2:XM_005245815.1:missense_variant:MODERATE:exon27/27:c.3229G>A:p.Ala1077Thr:,ATP13A2:XM_006710512.1:missense_variant:MODERATE:exon28/28:c.3328G>A:p.Ala1110Thr:,ATP13A2:XM_006710513.1:missense_variant:MODERATE:exon28/28:c.3304G>A:p.Ala1102Thr:,ATP13A2:XM_011541128.1:missense_variant:MODERATE:exon28/28:c.3331G>A:p.Ala1111Thr:,ATP13A2:XM_011541129.1:missense_variant:MODERATE:exon27/27:c.3139G>A:p.Ala1047Thr:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon29/29:c.3498G>A:p.Pro1166=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon29/29:c.3474G>A:p.Pro1158=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon29/29:c.3471G>A:p.Pro1157=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon28/28:c.3399G>A:p.Pro1133=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon28/28:c.3384G>A:p.Pro1128=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon28/28:c.3309G>A:p.Pro1103=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128475 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	14373,.	0.2020,0.4851,0.2946,0.5286,0.4630		 ,T(0.32), , 	 ,B(0.00), , 	0.29	0.24		COSV58697923	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986662	16986662	G	A	het	hom	het	off-target	QUAL=9679;DP=84,216,293;AF=0.39,1.00,0.50;MQM=60;SAP=38;ABP=5	ATP13A2,	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7550G>A::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:XM_005245810.1:intron_variant:MODIFIER:intron27/27:c.3232+143C>T::,ATP13A2:XM_005245811.1:intron_variant:MODIFIER:intron27/27:c.3220+143C>T::,ATP13A2:XM_005245812.1:intron_variant:MODIFIER:intron27/27:c.3208+143C>T::,ATP13A2:XM_005245815.1:intron_variant:MODIFIER:intron26/26:c.3118+143C>T::,ATP13A2:XM_006710512.1:intron_variant:MODIFIER:intron27/27:c.3217+143C>T::,ATP13A2:XM_006710513.1:intron_variant:MODIFIER:intron27/27:c.3193+143C>T::,ATP13A2:XM_011541128.1:intron_variant:MODIFIER:intron27/27:c.3220+143C>T::,ATP13A2:XM_011541129.1:intron_variant:MODIFIER:intron26/26:c.3028+143C>T::,ATP13A2:XM_017000844.1:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:XM_017000845.1:intron_variant:MODIFIER:intron27/28:c.3218-30C>T::,ATP13A2:XM_017000846.1:intron_variant:MODIFIER:intron27/28:c.3194-30C>T::,ATP13A2:XM_017000847.1:intron_variant:MODIFIER:intron27/28:c.3191-30C>T::,ATP13A2:XM_017000848.1:intron_variant:MODIFIER:intron26/27:c.3119-30C>T::,ATP13A2:XM_017000849.1:intron_variant:MODIFIER:intron26/27:c.3104-30C>T::,ATP13A2:XM_017000850.1:intron_variant:MODIFIER:intron26/27:c.3029-30C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	559000 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,not provided];			rs2076605	0.3468	0.4706	14617,.	0.2188,0.4839,0.2956,0.5242,0.4771				9.24			COSV58702203	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986750	16986761	CCCAGGGCTCCT	-	het	wt	het	off-target	QUAL=2063;DP=45,167,208;AF=0.27,0.00,0.50;MQM=60;SAP=12;ABP=7	ATP13A2,	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:XM_005245810.1:intron_variant:MODIFIER:intron27/27:c.3232+44_3232+55del::,ATP13A2:XM_005245811.1:intron_variant:MODIFIER:intron27/27:c.3220+44_3220+55del::,ATP13A2:XM_005245812.1:intron_variant:MODIFIER:intron27/27:c.3208+44_3208+55del::,ATP13A2:XM_005245815.1:intron_variant:MODIFIER:intron26/26:c.3118+44_3118+55del::,ATP13A2:XM_006710512.1:intron_variant:MODIFIER:intron27/27:c.3217+44_3217+55del::,ATP13A2:XM_006710513.1:intron_variant:MODIFIER:intron27/27:c.3193+44_3193+55del::,ATP13A2:XM_011541128.1:intron_variant:MODIFIER:intron27/27:c.3220+44_3220+55del::,ATP13A2:XM_011541129.1:intron_variant:MODIFIER:intron26/26:c.3028+44_3028+55del::,ATP13A2:XM_017000844.1:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::,ATP13A2:XM_017000845.1:intron_variant:MODIFIER:intron27/28:c.3217+44_3217+55del::,ATP13A2:XM_017000846.1:intron_variant:MODIFIER:intron27/28:c.3193+44_3193+55del::,ATP13A2:XM_017000847.1:intron_variant:MODIFIER:intron27/28:c.3190+44_3190+55del::,ATP13A2:XM_017000848.1:intron_variant:MODIFIER:intron26/27:c.3118+44_3118+55del::,ATP13A2:XM_017000849.1:intron_variant:MODIFIER:intron26/27:c.3103+44_3103+55del::,ATP13A2:XM_017000850.1:intron_variant:MODIFIER:intron26/27:c.3028+44_3028+55del::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1174788 [benign DISEASE=not specified,not provided];			rs143483351		0.2409	4929,.					4.15				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986848	16986848	G	A	het	hom	het		QUAL=10657;DP=90,199,282;AF=0.47,1.00,0.50;MQM=60;SAP=18;ABP=3	ATP13A2,	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7736G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon27/28:c.3189C>T:p.Ala1063=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon27/28:c.3177C>T:p.Ala1059=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon27/28:c.3165C>T:p.Ala1055=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon26/27:c.3075C>T:p.Ala1025=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon27/28:c.3174C>T:p.Ala1058=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon27/28:c.3150C>T:p.Ala1050=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon27/28:c.3177C>T:p.Ala1059=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon26/27:c.2985C>T:p.Ala995=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon27/29:c.3174C>T:p.Ala1058=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon27/29:c.3150C>T:p.Ala1050=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon27/29:c.3147C>T:p.Ala1049=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon26/28:c.3075C>T:p.Ala1025=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon26/28:c.3060C>T:p.Ala1020=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon26/28:c.2985C>T:p.Ala995=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128473 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	14510,.	0.1875,0.4783,0.2891,0.5225,0.4729				0.47			COSV58700662	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986959	16986959	G	A	het	wt	het		QUAL=2312;DP=59,138,178;AF=0.47,0.00,0.44;MQM=60;SAP=33;ABP=9	ATP13A2,	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000341676.9:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7847G>A::,ATP13A2:ENST00000452699.5:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	ATP13A2:NM_001141973.3:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::,ATP13A2:NM_001141974.3:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:NM_022089.4:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:XM_005245810.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3081-3C>T::,ATP13A2:XM_005245811.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3069-3C>T::,ATP13A2:XM_005245812.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3057-3C>T::,ATP13A2:XM_005245815.1:splice_region_variant&intron_variant:LOW:intron25/26:c.2967-3C>T::,ATP13A2:XM_006710512.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3066-3C>T::,ATP13A2:XM_006710513.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3042-3C>T::,ATP13A2:XM_011541128.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3069-3C>T::,ATP13A2:XM_011541129.1:splice_region_variant&intron_variant:LOW:intron25/26:c.2877-3C>T::,ATP13A2:XM_017000844.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::,ATP13A2:XM_017000845.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3066-3C>T::,ATP13A2:XM_017000846.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3042-3C>T::,ATP13A2:XM_017000847.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3039-3C>T::,ATP13A2:XM_017000848.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2967-3C>T::,ATP13A2:XM_017000849.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2952-3C>T::,ATP13A2:XM_017000850.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2877-3C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128471 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.3065	0.2819	4944,.	0.1706,0.3596,0.5506,0.2392,0.2307				8.06		9.29>9.90	COSV104399909	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16987159	16987159	C	T	het	hom	het		QUAL=10638;DP=65,245,281;AF=0.51,1.00,0.47;MQM=60;SAP=149;ABP=5	ATP13A2,	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+8047C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon26/28:c.2967G>A:p.Val989=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon26/28:c.2955G>A:p.Val985=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon26/28:c.2943G>A:p.Val981=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon25/27:c.2853G>A:p.Val951=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon26/28:c.2952G>A:p.Val984=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon26/28:c.2928G>A:p.Val976=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon26/28:c.2955G>A:p.Val985=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon25/27:c.2763G>A:p.Val921=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon26/29:c.2952G>A:p.Val984=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon26/29:c.2928G>A:p.Val976=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon26/29:c.2925G>A:p.Val975=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon25/28:c.2853G>A:p.Val951=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon25/28:c.2838G>A:p.Val946=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon25/28:c.2763G>A:p.Val921=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128470 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	14645,.	0.2158,0.4792,0.2830,0.5203,0.4730				0.19			COSV58699127	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988207	16988207	C	T	het	wt	het	low_conf_region	QUAL=11072;DP=278,493,583;AF=0.48,0.01,0.51;MQM=60;SAP=31;ABP=3	ATP13A2,	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9095C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon25/28:c.2787G>A:p.Ser929=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon25/28:c.2775G>A:p.Ser925=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon25/28:c.2763G>A:p.Ser921=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon24/27:c.2673G>A:p.Ser891=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon25/28:c.2772G>A:p.Ser924=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon25/28:c.2748G>A:p.Ser916=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon25/28:c.2775G>A:p.Ser925=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon24/27:c.2583G>A:p.Ser861=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon25/29:c.2772G>A:p.Ser924=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon25/29:c.2748G>A:p.Ser916=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon25/29:c.2745G>A:p.Ser915=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon24/28:c.2673G>A:p.Ser891=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon24/28:c.2658G>A:p.Ser886=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon24/28:c.2583G>A:p.Ser861=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128468 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2909	0.2494	3993,.	0.1518,0.3342,0.5507,0.1933,0.2217				0.37			COSV58700021	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988447	16988447	G	A	het	hom	het		QUAL=14033;DP=294,260,322;AF=0.50,0.99,0.45;MQM=60;SAP=394;ABP=6	ATP13A2,	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF00702 [haloacid dehalogenase-like hydrolase],:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9335G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon24/28:c.2634C>T:p.Gly878=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon24/28:c.2622C>T:p.Gly874=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon24/28:c.2610C>T:p.Gly870=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon23/27:c.2520C>T:p.Gly840=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon24/28:c.2619C>T:p.Gly873=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon24/28:c.2595C>T:p.Gly865=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon24/28:c.2622C>T:p.Gly874=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon23/27:c.2430C>T:p.Gly810=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon24/29:c.2619C>T:p.Gly873=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon24/29:c.2595C>T:p.Gly865=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon24/29:c.2592C>T:p.Gly864=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon23/28:c.2520C>T:p.Gly840=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon23/28:c.2505C>T:p.Gly835=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon23/28:c.2430C>T:p.Gly810=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128466 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	14422,.	0.1867,0.4771,0.2888,0.5193,0.4726				3.79			COSV58700683	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16992516	16992516	G	A	het	hom	het		QUAL=6562;DP=78,128,151;AF=0.47,1.00,0.48;MQM=60;SAP=55;ABP=4	ATP13A2,	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase],:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-12127G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon17/28:c.1812C>T:p.Pro604=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon17/28:c.1788C>T:p.Pro596=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon17/27:c.1815C>T:p.Pro605=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon17/28:c.1797C>T:p.Pro599=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon17/28:c.1773C>T:p.Pro591=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon16/27:c.1608C>T:p.Pro536=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon17/29:c.1797C>T:p.Pro599=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon17/29:c.1773C>T:p.Pro591=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon17/29:c.1770C>T:p.Pro590=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon17/28:c.1815C>T:p.Pro605=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon16/28:c.1608C>T:p.Pro536=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128465 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	23512,.	0.4404,0.5455,0.2863,0.6263,0.5184				7.24			COSV58700878	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17004773	17004773	C	T	wt	het	wt		QUAL=643;DP=133,74,121;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=9	ATP13A2,	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],:ENST00000446261.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	293803 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive];			rs140631323		0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0002				0.12			COSV58702839	0	0	8	0 / 0					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	18871570	18871570	T	G	het	wt	het		QUAL=3442;DP=95,148,185;AF=0.53,0.00,0.47;MQM=60;SAP=9;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2683A>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2836A>C::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294333 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138333	0.1793	0.2420	4696,.					12.39				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871606	18871606	C	G	het	wt	het		QUAL=3398;DP=96,144,166;AF=0.54,0.00,0.49;MQM=60;SAP=7;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2647G>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2800G>C::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294334 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138328	0.1651	0.2349	4485,.					4.21			COSV51895732	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871647	18871647	T	C	het	wt	het		QUAL=3477;DP=123,139,146;AF=0.54,0.00,0.48;MQM=60;SAP=5;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2606A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2759A>G::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294336 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7366541	0.1799	0.2420	4701,.					1.41			COSV51895747	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871920	18871920	G	A	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2333C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2486C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294341 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1140477	0.1935	0.2516	4959,.					4.94				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871924	18871924	C	T	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2329G>A::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2482G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294342 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138269	0.1933	0.2516	4960,.					5.45				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872082	18872082	A	G	hom	hom	hom		QUAL=29643;DP=366,238,311;AF=1.00,1.00,0.99;MQM=60;SAP=10;ABP=0	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2171T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2324T>C::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294344 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138267		0.6588	33624,.					0.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872133	18872133	G	A	het	wt	het		QUAL=6408;DP=291,203,262;AF=0.48,0.00,0.45;MQM=60;SAP=20;ABP=7	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2120C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2273C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294346 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs14311	0.1935	0.2509	4985,.					1.70				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872143	18872143	G	A	het	hom	het		QUAL=12547;DP=239,205,258;AF=0.49,1.00,0.53;MQM=60;SAP=6;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2110C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2263C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294347 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs3202002	0.4744	0.3984	13009,.					3.42				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872188	18872188	C	-	het	hom	het		QUAL=7778;DP=103,165,182;AF=0.49,0.99,0.53;MQM=60;SAP=6;ABP=3	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2065del::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2218del::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839		0.4073	13583,.					0.02				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872401	18872401	A	G	het	wt	het		QUAL=5039;DP=190,194,247;AF=0.48,0.00,0.45;MQM=60;SAP=10;ABP=8	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1852T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2005T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294353 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs9117	0.1102	0.1839	3075,.					4.35				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872727	18872727	C	T	het	hom	het		QUAL=20784;DP=213,404,487;AF=0.43,1.00,0.47;MQM=60;SAP=57;ABP=16	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1526G>A::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.1679G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294359 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs11740	0.4714	0.3994	13035,.					0.48			COSV51892981	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872979	18872979	T	A	het	hom	het	off-target	QUAL=12560;DP=148,227,285;AF=0.47,0.99,0.52;MQM=60;SAP=126;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1296-22A>T::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1449-22A>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188868 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28700162	0.4714	0.4724	13110,.	0.2427,0.5821,0.6726,0.4245,0.5857				7.70			COSV51895558	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872993	18872993	A	G	het	wt	het	off-target	QUAL=4653;DP=104,201,254;AF=0.62,0.00,0.48;MQM=60;SAP=108;ABP=4	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1296-36T>C::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1449-36T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35255325	0.1148	0.1962	3134,.	0.0962,0.1974,0.0007,0.2520,0.1205				5.74				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874414	18874414	G	C	het	hom	het	off-target	QUAL=6916;DP=104,121,166;AF=0.55,1.00,0.46;MQM=60;SAP=368;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1295+49C>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1448+49C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188869 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28529092		0.5001	16498,.	0.4323,0.5988,0.6738,0.4409,0.6074				11.59			COSV51895606	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18875462	18875462	A	G	hom	hom	hom		QUAL=18220;DP=311,131,136;AF=1.00,1.00,1.00;MQM=60;SAP=207;ABP=0	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:,ALDH4A1:NM_001319218.2:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon11/13:n.1096T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon12/14:n.1249T>C::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294369 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified];			rs2230708		0.7321	38866,.	0.6880,0.8178,0.7106,0.7190,0.7577				0.29				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876276	18876276	T	C	hom	hom	hom	off-target	QUAL=4035;DP=48,30,54;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1055-773A>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/13:n.1207+39A>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188872 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7550822		0.9653	65159,.	0.7709,0.9760,0.9999,0.9775,0.9836				5.29				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876402	18876402	G	A	hom	het	hom		QUAL=7422;DP=132,72,96;AF=0.99,0.33,0.99;MQM=60;SAP=26;ABP=20	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+806C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1120C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294374 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided];			rs2230707	0.5160	0.5117	17651,.	0.4402,0.6932,0.6078,0.4697,0.4989				1.01			COSV51891838	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876423	18876423	T	C	hom	hom	hom		QUAL=7586;DP=96,74,87;AF=1.00,0.97,0.99;MQM=60;SAP=4;ABP=0	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+785A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1099A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294375 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs7550938		0.6986	31974,.	0.4836,0.7945,0.7121,0.6946,0.7419				1.04			COSV51894187	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876432	18876432	T	C	hom	hom	hom		QUAL=6356;DP=65,73,87;AF=1.00,0.96,0.99;MQM=60;SAP=5;ABP=0	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+776A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1090A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294376 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs2230706		0.6978	31934,.	0.4828,0.7939,0.7102,0.6929,0.7422				2.89			COSV51893163	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877503	18877503	C	G	hom	hom	hom		QUAL=7567;DP=84,56,107;AF=0.98,1.00,1.00;MQM=60;SAP=133;ABP=0	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family]	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:,ALDH4A1:NM_001319218.2:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon9/13:n.919G>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon9/14:n.919G>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294382 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230705		0.7099	38609,.	0.7234,0.7459,0.4494,0.7190,0.5900				8.71			COSV51892136	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877660	18877660	G	A	het	hom	wt	off-target	QUAL=269;DP=14,8,20;AF=0.43,1.00,0.00;MQM=60;SAP=33;ABP=4	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-48C>T::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/12:n.810-48C>T::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/13:n.810-48C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188873 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426813		0.7698	40352,.	0.6963,0.8857,0.9544,0.7067,0.8413				0.54				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18881651	18881651	-	GGTTGCCT	hom	hom	hom	off-target	QUAL=672;DP=7,7,14;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.735+1472_735+1473insAGGCAACC::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/13:n.735+1472_735+1473insAGGCAACC::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs112548638		0.9957	73707,.	0.9437,0.9967,0.9999,0.9998,0.9995				1.51				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885436	18885436	A	C	wt	hom	wt	off-target	QUAL=55;DP=4,7,5;AF=0.00,0.86,0.00;MQM=60;SAP=9;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+37T>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron5/13:c.453+37T>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.510+37T>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.510+37T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs752213358		0.2907	0,.	0.3541,0.4488,0.4416,0.2331,0.2196				0.04			COSV51892118	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885441	18885441	G	C	n/a	het	wt	off-target	QUAL=27;DP=2,9,6;AF=0.00,0.56,0.00;MQM=60;SAP=14;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+32C>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron5/13:c.453+32C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.510+32C>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.510+32C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs188233802		0.3275	0,.	0.4060,0.4609,0.4566,0.2761,0.2668				0.57				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18889340	18889340	T	C	hom	hom	hom	off-target	QUAL=11008;DP=118,95,143;AF=1.00,1.00,1.00;MQM=60;SAP=175;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron3/13:c.249+22A>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/12:n.306+22A>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/13:n.306+22A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188912 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs941495		0.9689	71460,.	0.9926,0.9727,0.9999,0.9571,0.9863				2.91				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21563142	21563142	T	C	hom	hom	het		QUAL=4777;DP=29,90,125;AF=0.97,1.00,0.52;MQM=60;SAP=32;ABP=3	ALPL	synonymous	ALPL:ENST00000374832.5:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374840.8:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.5:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.5:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase]	ALPL:NM_000478.6:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001127501.4:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:,ALPL:NM_001177520.3:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:,ALPL:NM_001369803.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369804.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369805.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:XM_017000903.1:synonymous_variant:LOW:exon3/10:c.174T>C:p.Ser58=:		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	197678 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not specified,not provided];			rs1780316	0.9295	0.9472	65340,.	0.8650,0.9679,0.9864,0.9435,0.9535				4.19			COSV66379629	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21570432	21570432	C	T	het	wt	het	off-target	QUAL=6286;DP=187,243,304;AF=0.49,0.00,0.55;MQM=60;SAP=189;ABP=6	ALPL	intron	ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron7/10:c.697+58C>T::	ALPL:NM_000478.6:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001127501.4:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:NM_001177520.3:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:NM_001369803.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369804.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369805.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:XM_017000903.1:intron_variant:MODIFIER:intron6/9:c.706+58C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177590 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];			rs2275375	0.3231	0.2608	5477,.					0.36			COSV66376176	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577713	21577713	C	T	wt	het	wt		QUAL=1739;DP=60,173,234;AF=0.00,0.46,0.00;MQM=60;SAP=12;ABP=6	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295558 [benign DISEASE=Hypophosphatasia,not provided];			rs1697405	0.3367	0.3554	10025,.					10.69			COSV66376405	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577770	21577770	C	-	het	het	wt		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295560 [benign/likely benign DISEASE=Hypophosphatasia,not provided];			rs140511985		0.0458	213,.					11.71				0	1	18	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577774	21577774	A	G	hom	hom	hom		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295561 [benign DISEASE=Hypophosphatasia,not provided];			rs1697406		0.8719	57845,.					14.65				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577881	21577881	A	C	wt	wt	het		QUAL=2232;DP=125,190,197;AF=0.00,0.00,0.46;MQM=60;SAP=18;ABP=5	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295563 [benign DISEASE=Hypophosphatasia,not provided];			rs1772719	0.1645	0.1869	2714,.					15.42				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21822690	21822690	G	C	het	wt	hom	low_conf_region	QUAL=1349;DP=23,27,42;AF=0.43,0.00,1.00;MQM=60;SAP=91;ABP=4	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:ENST00000374695.8:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:NM_001291860.2:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:NM_005529.7:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:XM_011541318.2:3_prime_UTR_variant:MODIFIER:exon102/102:c.*626C>G::,HSPG2:XM_017001120.1:3_prime_UTR_variant:MODIFIER:exon98/98:c.*626C>G::,HSPG2:XM_017001121.1:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:XM_017001122.1:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295685 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1049644	0.3199	0.2994	7246,.					10.28			COSV60827857	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823442	21823442	T	C	hom	hom	hom		QUAL=15077;DP=110,143,232;AF=1.00,1.00,1.00;MQM=60;SAP=244;ABP=0	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon97/97:c.13053A>G:p.Ser4351=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon102/102:c.13599A>G:p.Ser4533=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon98/98:c.13245A>G:p.Ser4415=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon97/97:c.13194A>G:p.Ser4398=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon97/97:c.13191A>G:p.Ser4397=:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295695 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs897467		0.8075	47809,.	0.7083,0.7501,0.8158,0.8242,0.8256				0.96			COSV60827391	0.23	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823625	21823625	C	T	wt	wt	het		QUAL=3357;DP=145,206,313;AF=0.00,0.00,0.44;MQM=60;SAP=11;ABP=12	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-285C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12997G>A:p.Val4333Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon101/102:c.13543G>A:p.Val4515Ile:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon97/98:c.13189G>A:p.Val4397Ile:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon96/97:c.13138G>A:p.Val4380Ile:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon96/97:c.13135G>A:p.Val4379Ile:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295699 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs1138469	0.0453	0.0571	257,.	0.0286,0.0272,0.0002,0.0622,0.1027		 ,T(1.00), 	 ,B(0.00), 	0.00	0.21		COSV60828274	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823627	21823627	C	T	het	wt	het		QUAL=5826;DP=151,208,317;AF=0.46,0.01,0.55;MQM=60;SAP=8;ABP=5	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12995G>A:p.Ser4332Asn:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon101/102:c.13541G>A:p.Ser4514Asn:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon97/98:c.13187G>A:p.Ser4396Asn:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon96/97:c.13136G>A:p.Ser4379Asn:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon96/97:c.13133G>A:p.Ser4378Asn:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295700 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3736360	0.1761	0.1814	1950,.	0.0825,0.1274,0.1596,0.1792,0.2850		 ,T(0.39), 	 ,B(0.00), 	9.47	0.12		COSV60827612	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823667	21823667	G	T	het	wt	het		QUAL=8041;DP=290,205,324;AF=0.48,0.01,0.55;MQM=60;SAP=4;ABP=5	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon96/97:c.12955C>A:p.Arg4319=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon101/102:c.13501C>A:p.Arg4501=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon97/98:c.13147C>A:p.Arg4383=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon96/97:c.13096C>A:p.Arg4366=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon96/97:c.13093C>A:p.Arg4365=:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295701 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs3736358		0.1781	1837,.	0.0345,0.1263,0.1596,0.1793,0.2850				10.61			COSV60828118,COSV60829904	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823764	21823764	C	T	het	hom	wt	off-target	QUAL=3653;DP=74,108,202;AF=0.51,0.99,0.00;MQM=60;SAP=116;ABP=3	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron95/96:c.12903-45G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron100/101:c.13449-45G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron96/97:c.13095-45G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron95/96:c.13044-45G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron95/96:c.13041-45G>A::	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1225015 [benign DISEASE=not provided];			rs3736357	0.3752	0.4680	13591,.	0.1381,0.5328,0.6492,0.4898,0.3376				8.82				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828352	21828352	A	G	het	wt	hom		QUAL=1307;DP=43,37,32;AF=0.37,0.00,0.97;MQM=60;SAP=7;ABP=9	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon89/97:c.12315T>C:p.Asp4105=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon94/102:c.12861T>C:p.Asp4287=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon90/98:c.12507T>C:p.Asp4169=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon89/97:c.12456T>C:p.Asp4152=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon89/97:c.12453T>C:p.Asp4151=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295707 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228347	0.2572	0.2911	5420,.	0.1341,0.1842,0.1585,0.3076,0.4730				5.83			COSV60827859	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829348	21829348	T	C	het	wt	het	off-target	QUAL=1232;DP=37,65,75;AF=0.54,0.00,0.52;MQM=60;SAP=106;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+35A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron92/101:c.12541+35A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron88/97:c.12187+35A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron87/96:c.12136+35A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron87/96:c.12133+35A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618168 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12042189	0.1564	0.1787	1839,.	0.0343,0.1268,0.1582,0.1789,0.2840				0.12			COSV60828432	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829360	21829360	C	T	het	wt	het	off-target	QUAL=1401;DP=58,71,83;AF=0.36,0.00,0.54;MQM=60;SAP=129;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+23G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron92/101:c.12541+23G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron88/97:c.12187+23G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron87/96:c.12136+23G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron87/96:c.12133+23G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618169 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12023794	0.1715	0.1804	1944,.	0.0844,0.1273,0.1652,0.1786,0.2752				0.53			COSV60829275	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831196	21831196	G	A	hom	hom	hom	off-target	QUAL=16192;DP=94,201,254;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron84/96:c.11565+19C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron89/101:c.12111+19C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron85/97:c.11757+19C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron84/96:c.11706+19C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron84/96:c.11703+19C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1174648 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs3736355	0.7592	0.7910	45249,.	0.6961,0.7415,0.8055,0.8006,0.8091				0.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831627	21831627	G	T	het	wt	het	off-target	QUAL=2878;DP=81,101,142;AF=0.52,0.00,0.54;MQM=60;SAP=100;ABP=5	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron82/96:c.11355+25C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron87/101:c.11901+25C>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron83/97:c.11547+25C>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron82/96:c.11496+25C>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron82/96:c.11493+25C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1261831 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2270701	0.1651	0.1812	1894,.	0.0590,0.1278,0.1579,0.1796,0.2864				0.00				0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833281	21833281	G	A	het	wt	het		QUAL=4176;DP=136,207,237;AF=0.43,0.00,0.50;MQM=60;SAP=105;ABP=5	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF00054 [Laminin G domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon80/97:c.11085C>T:p.Pro3695=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon85/102:c.11631C>T:p.Pro3877=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon81/98:c.11277C>T:p.Pro3759=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon80/97:c.11226C>T:p.Pro3742=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon80/97:c.11223C>T:p.Pro3741=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295724 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229486	0.0859	0.1006	927,.	0.1725,0.0410,0.0003,0.0796,0.1105				0.71				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833550	21833550	C	T	het	wt	het		QUAL=5290;DP=183,221,284;AF=0.43,0.00,0.49;MQM=60;SAP=170;ABP=8	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon79/97:c.10898G>A:p.Arg3633Gln:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon84/102:c.11444G>A:p.Arg3815Gln:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon80/98:c.11090G>A:p.Arg3697Gln:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon79/97:c.11039G>A:p.Arg3680Gln:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon79/97:c.11036G>A:p.Arg3679Gln:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295727 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229493	0.0859	0.1008	924,.	0.1735,0.0410,0.0002,0.0796,0.1106		T(0.54)	B(0.03)	11.56	0.05			0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833655	21833655	C	T	het	hom	wt	off-target	QUAL=5299;DP=102,131,183;AF=0.60,1.00,0.00;MQM=60;SAP=285;ABP=12	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron78/96:c.10834-41G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron83/101:c.11380-41G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron79/97:c.11026-41G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron78/96:c.10975-41G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron78/96:c.10972-41G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223305 [benign DISEASE=not provided];			rs7547731	0.3750	0.4643	13557,.	0.1375,0.5314,0.6473,0.4863,0.3319				0.11				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836897	21836897	G	A	het	wt	het		QUAL=5569;DP=180,226,353;AF=0.51,0.00,0.40;MQM=60;SAP=4;ABP=22	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10263C>T:p.His3421=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon80/102:c.10809C>T:p.His3603=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon76/98:c.10455C>T:p.His3485=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon75/97:c.10404C>T:p.His3468=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon75/97:c.10401C>T:p.His3467=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295741 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35444472	0.0861	0.1002	920,.	0.1701,0.0426,0.0004,0.0797,0.1119				8.58			COSV65932770	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836909	21836909	G	A	wt	wt	het		QUAL=5289;DP=180,223,347;AF=0.01,0.00,0.60;MQM=60;SAP=3;ABP=35	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10251C>T:p.Ser3417=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon80/102:c.10797C>T:p.Ser3599=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon76/98:c.10443C>T:p.Ser3481=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon75/97:c.10392C>T:p.Ser3464=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon75/97:c.10389C>T:p.Ser3463=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295743 [benign/likely benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.0437	0.0586	257,.	0.0290,0.0287,0.0001,0.0642,0.0964				3.36			COSV65933172	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839408	21839408	A	G	het	wt	het		QUAL=2715;DP=82,39,87;AF=0.65,0.00,0.67;MQM=60;SAP=46;ABP=39	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon73/97:c.9855T>C:p.Ala3285=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon78/102:c.10401T>C:p.Ala3467=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon74/98:c.10047T>C:p.Ala3349=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon73/97:c.9996T>C:p.Ala3332=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon73/97:c.9993T>C:p.Ala3331=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295750 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2291826	0.3460	0.3351	9706,.	0.5383,0.1851,0.1598,0.2599,0.3809				1.09			COSV65933346	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841112	21841112	C	T	het	wt	het		QUAL=2082;DP=48,164,183;AF=0.46,0.00,0.42;MQM=60;SAP=94;ABP=15	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon71/97:c.9505G>A:p.Ala3169Thr:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon76/102:c.10051G>A:p.Ala3351Thr:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon72/98:c.9697G>A:p.Ala3233Thr:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon71/97:c.9646G>A:p.Ala3216Thr:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon71/97:c.9643G>A:p.Ala3215Thr:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295758 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228349	0.0837	0.0980	859,.	0.1609,0.0403,0.0002,0.0788,0.1103		T(0.71)	B(0.01)	9.06	0.12			0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841723	21841723	C	T	het	hom	wt	off-target	QUAL=6336;DP=79,181,231;AF=0.47,1.00,0.00;MQM=60;SAP=61;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron69/96:c.9197-50G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron74/101:c.9743-50G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron70/97:c.9389-50G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron69/96:c.9338-50G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron69/96:c.9335-50G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231634 [benign DISEASE=not provided];			rs7556412		0.6519	29274,.	0.5013,0.6175,0.8146,0.6580,0.6022				1.72				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842308	21842308	T	C	het	wt	het		QUAL=1449;DP=62,76,87;AF=0.47,0.00,0.43;MQM=60;SAP=37;ABP=7	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8986A>G:p.Ser2996Gly:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon73/102:c.9532A>G:p.Ser3178Gly:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon69/98:c.9178A>G:p.Ser3060Gly:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon68/97:c.9127A>G:p.Ser3043Gly:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon68/97:c.9124A>G:p.Ser3042Gly:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295764 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2229491	0.0887	0.1025	968,.	0.1818,0.0411,0.0002,0.0794,0.1100		T(1.00)	B(0.00)	3.31	0.04			0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842352	21842352	A	T	het	wt	het		QUAL=927;DP=42,44,56;AF=0.52,0.00,0.38;MQM=60;SAP=58;ABP=6	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8942T>A:p.Leu2981His:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon73/102:c.9488T>A:p.Leu3163His:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon69/98:c.9134T>A:p.Leu3045His:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon68/97:c.9083T>A:p.Leu3028His:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon68/97:c.9080T>A:p.Leu3027His:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295765 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2229489	0.0343	0.0490	177,.	0.0084,0.0237,0.0002,0.0568,0.1047		T(1.00)	B(0.00)	18.20	0.07			0.03	51	1797	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21846651	21846651	C	T	het	wt	het	off-target	QUAL=8159;DP=103,376,509;AF=0.52,0.00,0.54;MQM=60;SAP=220;ABP=12	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron62/96:c.8168-52G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron67/101:c.8714-52G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron63/97:c.8360-52G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron62/96:c.8309-52G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron62/96:c.8306-52G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1182109 [benign DISEASE=not provided];			rs34792235	0.0347	0.0493	180,.	0.0081,0.0237,0.0002,0.0568,0.1058				1.46				0	43	1520	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847497	21847497	A	G	het	wt	het		QUAL=7221;DP=159,324,425;AF=0.54,0.00,0.49;MQM=60;SAP=37;ABP=3	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::	HSPG2:NM_001291860.2:splice_region_variant&intron_variant:LOW:intron61/96:c.8029-5T>C::,HSPG2:NM_005529.7:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::,HSPG2:XM_011541318.2:splice_region_variant&intron_variant:LOW:intron66/101:c.8575-5T>C::,HSPG2:XM_017001120.1:splice_region_variant&intron_variant:LOW:intron62/97:c.8221-5T>C::,HSPG2:XM_017001121.1:splice_region_variant&intron_variant:LOW:intron61/96:c.8170-5T>C::,HSPG2:XM_017001122.1:splice_region_variant&intron_variant:LOW:intron61/96:c.8167-5T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295781 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35917892	0.0347	0.0492	179,.	0.0083,0.0237,0.0002,0.0569,0.1058				0.39		4.39>3.72		0	51	1789	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847933	21847933	T	G	het	wt	hom	off-target	QUAL=11585;DP=181,310,323;AF=0.46,0.01,0.99;MQM=60;SAP=3;ABP=6	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron60/96:c.7876+25A>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron65/101:c.8422+25A>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron61/97:c.8068+25A>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron60/96:c.8017+25A>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron60/96:c.8014+25A>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256801 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2290501	0.3748	0.3695	11153,.	0.5255,0.2081,0.1694,0.3145,0.4753				5.02			COSV65971017	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848025	21848025	G	T	het	wt	het		QUAL=7471;DP=271,358,363;AF=0.43,0.00,0.51;MQM=60;SAP=4;ABP=7	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon60/97:c.7809C>A:p.Val2603=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon65/102:c.8355C>A:p.Val2785=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon61/98:c.8001C>A:p.Val2667=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon60/97:c.7950C>A:p.Val2650=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon60/97:c.7947C>A:p.Val2649=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295785 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12737091	0.0347	0.0491	177,.	0.0083,0.0237,0.0002,0.0567,0.1058				13.41				0.98	51	1789	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848107	21848107	A	G	hom	hom	hom	off-target	QUAL=17523;DP=86,234,247;AF=1.00,1.00,1.00;MQM=60;SAP=163;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7741-14T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron64/101:c.8287-14T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron60/97:c.7933-14T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron59/96:c.7882-14T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron59/96:c.7879-14T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295787 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3767138		0.7946	46175,.	0.7018,0.6937,0.8172,0.8169,0.8136				13.76		10.37>10.27	COSV65970146	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848603	21848603	T	C	het	wt	het	off-target	QUAL=1825;DP=58,56,86;AF=0.50,0.00,0.58;MQM=60;SAP=142;ABP=6	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7740+40A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron64/101:c.8286+40A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron60/97:c.7932+40A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron59/96:c.7881+40A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron59/96:c.7878+40A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1236320 [benign DISEASE=not provided];			rs34726153	0.0349	0.0494	179,.	0.0085,0.0240,0.0002,0.0573,0.1059				0.26				0	43	1535	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851976	21851976	A	G	het	wt	het	off-target	QUAL=2489;DP=66,84,121;AF=0.61,0.02,0.53;MQM=60;SAP=7;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron53/96:c.6874-50T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron58/101:c.7420-50T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron54/97:c.7066-50T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron53/96:c.7015-50T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron53/96:c.7012-50T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223987 [benign DISEASE=not provided];			rs34346159	0.0347	0.0491	180,.	0.0080,0.0238,0.0002,0.0567,0.1058				6.02				0.05	43	1527	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852751	21852751	C	T	het	wt	het		QUAL=3486;DP=86,152,203;AF=0.43,0.00,0.51;MQM=60;SAP=20;ABP=3	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon52/97:c.6676G>A:p.Gly2226Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon57/102:c.7222G>A:p.Gly2408Ser:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon53/98:c.6868G>A:p.Gly2290Ser:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon52/97:c.6817G>A:p.Gly2273Ser:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon52/97:c.6814G>A:p.Gly2272Ser:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295807 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35669711	0.0347	0.0492	176,.	0.0084,0.0238,0.0002,0.0569,0.1059		T(0.09)	B(0.07)	11.19	0.23			0.02	50	1785	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852958	21852958	C	T	het	wt	het		QUAL=5793;DP=76,272,434;AF=0.49,0.00,0.46;MQM=60;SAP=69;ABP=9	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon51/97:c.6555G>A:p.Thr2185=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon56/102:c.7101G>A:p.Thr2367=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon52/98:c.6747G>A:p.Thr2249=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon51/97:c.6696G>A:p.Thr2232=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon51/97:c.6693G>A:p.Thr2231=:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295810 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs34443576	0.0345	0.0493	179,.	0.0085,0.0240,0.0004,0.0568,0.1060				1.04			COSV65974636	0.02	49	1782	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854230	21854230	C	T	het	wt	het		QUAL=3095;DP=83,143,196;AF=0.47,0.00,0.51;MQM=60;SAP=35;ABP=3	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon50/97:c.6405G>A:p.Val2135=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon55/102:c.6951G>A:p.Val2317=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon51/98:c.6597G>A:p.Val2199=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon50/97:c.6546G>A:p.Val2182=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon50/97:c.6543G>A:p.Val2181=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285614 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12742444	0.0345	0.0472	177,.	0.0076,0.0233,0.0002,0.0540,0.1044				2.62				0	50	1779	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854829	21854829	A	G	het	wt	het	off-target	QUAL=1210;DP=44,63,74;AF=0.55,0.00,0.43;MQM=60;SAP=108;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron48/96:c.6136+19T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron53/101:c.6682+19T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron49/97:c.6328+19T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron48/96:c.6277+19T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron48/96:c.6274+19T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1242960 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs36080251	0.0345	0.0491	180,.	0.0083,0.0239,0.0002,0.0567,0.1061				0.01				0	42	1525	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21855402	21855402	C	T	het	wt	het		QUAL=5591;DP=149,257,311;AF=0.48,0.00,0.53;MQM=60;SAP=116;ABP=4	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon47/97:c.5902G>A:p.Val1968Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon52/102:c.6448G>A:p.Val2150Ile:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon48/98:c.6094G>A:p.Val2032Ile:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon47/97:c.6043G>A:p.Val2015Ile:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon47/97:c.6040G>A:p.Val2014Ile:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295823 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229475	0.0347	0.0487	178,.	0.0082,0.0236,0.0002,0.0562,0.1053		T(0.17)	D(1.00)	22.50	0.24			0.01	50	1782	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856978	21856978	A	C	hom	hom	hom	off-target	QUAL=1037;DP=18,7,13;AF=1.00,1.00,1.00;MQM=60;SAP=77;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+37T>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+37T>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+37T>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+37T>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+37T>G::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293461 [benign DISEASE=not provided];			rs12024579	0.7490	0.7884	44462,.	0.6607,0.7038,0.8137,0.8107,0.7977				1.67				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856983	21856983	A	G	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+32T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+32T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+32T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+32T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+32T>C::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285244 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs200354565	0.0461	0.0525	206,.	0.0409,0.0256,0.0003,0.0585,0.1067				0.03				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856984	21856984	G	T	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+31C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+31C>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+31C>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+31C>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+31C>A::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285245 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12757277	0.0461	0.0525	206,.	0.0409,0.0256,0.0003,0.0584,0.1067				0.03				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21857246	21857246	A	G	hom	hom	het	off-target	QUAL=7807;DP=95,119,114;AF=1.00,1.00,0.48;MQM=60;SAP=67;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron43/96:c.5397+39T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron48/101:c.5943+39T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron44/97:c.5589+39T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron43/96:c.5538+39T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron43/96:c.5535+39T>C::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1220862 [benign DISEASE=not provided];			rs2305562	0.4469	0.5040	19217,.	0.4198,0.4836,0.4471,0.5460,0.3863				9.86			COSV65970004	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864961	21864961	G	A	het	hom	wt		QUAL=7140;DP=119,208,347;AF=0.39,1.00,0.00;MQM=60;SAP=4;ABP=14	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon36/97:c.4511C>T:p.Ala1504Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon41/102:c.5057C>T:p.Ala1686Val:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon37/98:c.4703C>T:p.Ala1568Val:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon36/97:c.4652C>T:p.Ala1551Val:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon36/97:c.4649C>T:p.Ala1550Val:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	291236 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,none provided,not provided];			rs897471		0.7321	38063,.	0.6122,0.8067,0.8922,0.7350,0.5771		T(0.06)	D(1.00)	22.80	0.15		COSV65969427	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872588	21872588	A	T	hom	hom	hom	off-target	QUAL=5905;DP=52,80,80;AF=0.98,1.00,1.00;MQM=60;SAP=3;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron32/96:c.4032+32T>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron33/101:c.4083+32T>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron33/97:c.4224+32T>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron32/96:c.4173+32T>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron32/96:c.4170+32T>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1233017 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501266		0.9958	73569,.	0.9402,0.9969,1.0000,0.9997,0.9999				0.15				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872752	21872752	C	T	het	hom	wt		QUAL=3063;DP=44,79,76;AF=0.64,1.00,0.01;MQM=60;SAP=21;ABP=10	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon32/97:c.3900G>A:p.Val1300=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon33/102:c.3951G>A:p.Val1317=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon33/98:c.4092G>A:p.Val1364=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon32/97:c.4041G>A:p.Val1347=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon32/97:c.4038G>A:p.Val1346=:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285755 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs2229482	0.4249	0.5558	21449,.	0.2867,0.4025,0.4363,0.6384,0.5035				7.98			COSV65968754	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873328	21873328	G	A	het	hom	wt	off-target	QUAL=1489;DP=44,32,39;AF=0.48,1.00,0.00;MQM=60;SAP=6;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron30/96:c.3796+47C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron31/101:c.3847+47C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron31/97:c.3988+47C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron30/96:c.3937+47C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron30/96:c.3934+47C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1235752 [benign DISEASE=not provided];			rs2454290		0.8308	45165,.	0.4849,0.9126,0.9771,0.8489,0.7345				1.96				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21875616	21875616	C	T	hom	hom	hom	off-target	QUAL=26105;DP=196,282,399;AF=0.98,1.00,1.00;MQM=60;SAP=461;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron25/96:c.3305+13G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron26/101:c.3356+13G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron26/97:c.3497+13G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron25/96:c.3446+13G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron25/96:c.3443+13G>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295864 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];		MIRb (SINE/MIR)	rs2501265		0.9858	69043,.	0.8166,0.9903,1.0000,0.9993,0.9996				0.00				0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878973	21878973	T	C	hom	hom	hom	off-target	QUAL=3619;DP=35,49,36;AF=0.97,1.00,1.00;MQM=60;SAP=28;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron18/96:c.2474+21A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron19/101:c.2525+21A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron19/97:c.2666+21A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron18/96:c.2615+21A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron18/96:c.2612+21A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1263480 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2454293		0.9890	71099,.	0.8732,0.9919,0.9977,0.9977,0.9976				2.13			COSV65975893	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880156	21880156	T	C	hom	hom	hom		QUAL=22020;DP=193,236,255;AF=1.00,1.00,1.00;MQM=60;SAP=41;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon17/97:c.2297A>G:p.Asn766Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon18/102:c.2348A>G:p.Asn783Ser:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon18/98:c.2489A>G:p.Asn830Ser:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon17/97:c.2438A>G:p.Asn813Ser:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon17/97:c.2435A>G:p.Asn812Ser:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295881 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs989994		0.9845	67938,.	0.7872,0.9901,1.0000,0.9996,0.9996		T(0.19)	B(0.02)	15.51	0.14			0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880449	21880449	G	A	hom	hom	hom		QUAL=7816;DP=118,61,73;AF=1.00,1.00,1.00;MQM=60;SAP=115;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon16/97:c.2112C>T:p.Ala704=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon17/102:c.2163C>T:p.Ala721=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon17/98:c.2304C>T:p.Ala768=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon16/97:c.2253C>T:p.Ala751=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon16/97:c.2250C>T:p.Ala750=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295882 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874793		0.9845	67904,.	0.7876,0.9901,1.0000,0.9996,0.9997				10.77			COSV65974984	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880572	21880572	G	A	het	wt	het	off-target	QUAL=807;DP=36,41,52;AF=0.33,0.00,0.48;MQM=60;SAP=8;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron15/96:c.2002-13C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron16/101:c.2053-13C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron16/97:c.2194-13C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron15/96:c.2143-13C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron15/96:c.2140-13C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295886 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs77828146	0.0082	0.0126	20,.	0.0028,0.0051,0.0000,0.0151,0.0198				0.42		5.42>5.43		0.01	7	460	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880742	21880742	T	C	hom	hom	hom		QUAL=10972;DP=156,73,131;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon15/97:c.1915A>G:p.Met639Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon16/102:c.1966A>G:p.Met656Val:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon16/98:c.2107A>G:p.Met703Val:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon15/97:c.2056A>G:p.Met686Val:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon15/97:c.2053A>G:p.Met685Val:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295887 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874792		0.9944	72826,.	0.9191,0.9964,1.0000,0.9996,1.0000		T(1.00)	B(0.00)	7.39	0.07			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881312	21881324	CCCAGGGTGGCAG	-	hom	hom	hom	off-target;low_conf_region	QUAL=6197;DP=46,70,113;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron14/96:c.1821+15_1821+27del::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron15/101:c.1872+15_1872+27del::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron15/97:c.2013+15_2013+27del::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron14/96:c.1962+15_1962+27del::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron14/96:c.1959+15_1959+27del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267614 [benign DISEASE=not provided];			rs60267433		0.9908	71087,.	0.8763,0.9931,0.9998,0.9996,0.9998				4.37				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881537	21881537	C	T	het	hom	het	off-target	QUAL=4582;DP=69,93,122;AF=0.45,1.00,0.43;MQM=60;SAP=225;ABP=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron13/96:c.1658-35G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron14/101:c.1709-35G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron14/97:c.1850-35G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron13/96:c.1799-35G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron13/96:c.1796-35G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439797 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs921847		0.9723	66533,.	0.7947,0.9850,1.0000,0.9843,0.9800				1.18				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21884729	21884729	T	C	het	het	het	off-target	QUAL=6842;DP=81,244,301;AF=0.54,0.43,0.48;MQM=60;SAP=65;ABP=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron13/101:c.1558+38A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron13/97:c.1699+38A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron12/96:c.1648+38A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron12/96:c.1648+38A>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248089 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs4654994		0.9135	62475,.	0.8502,0.8797,0.9665,0.9312,0.8939				1.28				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21887634	21887634	A	G	hom	het	hom		QUAL=12537;DP=116,181,213;AF=1.00,0.50,1.00;MQM=60;SAP=229;ABP=3	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon9/102:c.795T>C:p.Leu265=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon9/98:c.936T>C:p.Leu312=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon8/97:c.885T>C:p.Leu295=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon8/97:c.885T>C:p.Leu295=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295909 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,none provided,not provided];			rs2229478		0.4490	16869,.	0.6401,0.5793,0.6276,0.3342,0.4043				0.99			COSV65929973	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21890615	21890615	G	A	hom	hom	hom		QUAL=26146;DP=229,276,333;AF=1.00,1.00,1.00;MQM=60;SAP=262;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon4/102:c.324C>T:p.Phe108=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon4/98:c.465C>T:p.Phe155=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon4/97:c.465C>T:p.Phe155=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon4/97:c.465C>T:p.Phe155=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295913 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501260		0.9887	69966,.	0.8450,0.9934,1.0000,0.9996,0.9998				13.31				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22452666	22452666	T	C	hom	hom	hom		QUAL=28795;DP=266,256,395;AF=1.00,1.00,1.00;MQM=60;SAP=596;ABP=0	ZBTB40	intron,5'UTR	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000404138.5:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	ZBTB40:NM_001083621.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron1/17:c.-70+23652T>C::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron1/15:c.-70+23652T>C::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/18:n.154+662T>C::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/18:n.154+662T>C::	regulatory_region_variant:promoter				MER58B (DNA/hAT-Charlie)	rs10737466		0.9776	72832,.					1.63				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22506250	22506250	A	T	hom	het	hom		QUAL=15643;DP=214,167,209;AF=1.00,0.56,0.99;MQM=60;SAP=486;ABP=8	ZBTB40	intron	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::	ZBTB40:NM_001083621.2:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/18:n.1583+9A>T::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/18:n.1583+9A>T::						rs209732		0.7216	40836,.	0.8973,0.8436,0.8953,0.6147,0.7058				10.34			COSV65144922	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22509184	22509184	A	G	hom	het	hom		QUAL=24905;DP=339,273,308;AF=1.00,0.53,1.00;MQM=60;SAP=4;ABP=5	ZBTB40	missense	ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:	ZBTB40:NM_001083621.2:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:,ZBTB40:NM_001330398.2:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:XM_011542499.2:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:XM_011542500.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-941A>G::,ZBTB40:XM_024451297.1:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon9/19:n.2007A>G::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon9/19:n.2007A>G::			1260804 [benign DISEASE=not provided];			rs209729		0.7878	47731,.	0.9128,0.8838,0.8964,0.7168,0.7161		T(0.10),D(0.03),D(0.03)	B(0.00),B(0.00),B(0.00)	10.71	0.02		COSV65144925	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22520216	22520216	G	A	hom	hom	hom		QUAL=12185;DP=169,93,135;AF=1.00,1.00,1.00;MQM=60;SAP=109;ABP=0	ZBTB40	missense	ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type]	ZBTB40:NM_001083621.2:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:,ZBTB40:NM_001330398.2:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:,ZBTB40:XM_011542499.2:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:,ZBTB40:XM_011542500.2:missense_variant:MODERATE:exon7/11:c.1258G>A:p.Val420Met:,ZBTB40:XM_024451297.1:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon14/19:n.3212G>A::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon14/19:n.3212G>A::						rs209720	0.9984	0.9969	75621,.	0.9991,0.9974,1.0000,0.9948,0.9993		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	16.30	0.17			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22522510	22522510	A	C	hom	het	hom	off-target	QUAL=15091;DP=171,196,254;AF=0.99,0.48,0.99;MQM=60;SAP=341;ABP=4	ZBTB40	intron	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::	ZBTB40:NM_001083621.2:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:XM_011542500.2:intron_variant:MODIFIER:intron9/10:c.1567+47A>C::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3521+47A>C::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3521+47A>C::					MIR (SINE/MIR)	rs998978	0.3181	0.3392	8092,.	0.1520,0.1757,0.4593,0.3725,0.4202				0.01			COSV65144854	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22526222	22526222	G	C	hom	het	hom		QUAL=10743;DP=165,108,140;AF=0.99,0.46,0.99;MQM=60;SAP=169;ABP=4	ZBTB40	synonymous	ZBTB40:ENST00000374651.8:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000375647.5:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000404138.5:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:	ZBTB40:NM_001083621.2:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:,ZBTB40:NM_001330398.2:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:NM_014870.4:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:XM_011542499.2:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:XM_011542500.2:synonymous_variant:LOW:exon11/11:c.1815G>C:p.Pro605=:,ZBTB40:XM_024451297.1:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.3769G>C::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.3769G>C::						rs881646	0.3181	0.3388	8078,.	0.1520,0.1749,0.4593,0.3724,0.4203				0.27			COSV65144952	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22526648	22526648	G	A	hom	het	hom		QUAL=17240;DP=138,234,316;AF=1.00,0.50,1.00;MQM=60;SAP=18;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*252G>A::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.4195G>A::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/18:n.4037+158G>A::						rs2281354	0.2378	0.2564	6335,.					1.44			COSV65144954	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	T	het	het	het		QUAL=985;DP=34,32,39;AF=0.44,0.25,0.56;MQM=60;SAP=84;ABP=8	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2320dup::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6086dup::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.5168dup::					AluJo (SINE/Alu)	rs35637563		0.3478	8815,.					0.68				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	TT	wt	wt	het		QUAL=985;DP=34,32,39;AF=0.06,0.00,0.18;MQM=59;SAP=23;ABP=93	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2319_*2320dup::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6085_6086dup::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.5167_5168dup::					AluJo (SINE/Alu)	rs35637563		0.0016	1,.					0.65				0.01	0	5	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22530108	22530108	T	C	hom	het	hom		QUAL=18911;DP=222,216,281;AF=0.99,0.49,1.00;MQM=60;SAP=81;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3712T>C::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.7478T>C::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6560T>C::	regulatory_region_variant:promoter_flanking_region					rs1062663	0.3295	0.3161	8345,.					0.05			COSV65144958	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22638945	22638945	A	G	het	n/a	het		QUAL=333;DP=14,2,5;AF=0.64,1.00,0.60;MQM=60;SAP=13;ABP=6	C1QA	synonymous	C1QA:ENST00000374642.8:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.1:synonymous_variant:LOW:exon2/2:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)]	C1QA:NM_001347465.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_001347466.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_015991.4:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:		120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1167796 [benign DISEASE=C1q deficiency,not specified,not provided];			rs172378		0.5118	21690,.	0.7372,0.6240,0.5917,0.3861,0.5848				4.63			COSV65889459	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22639734	22639734	T	G	het	het	het	off-target	QUAL=7779;DP=141,222,257;AF=0.52,0.54,0.47;MQM=60;SAP=188;ABP=4	C1QC,C1QA	upstream_gene,downstream_gene	C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.8:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:CTCF_binding_site	120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs10917274	0.4309	0.3576	10137,.					1.34					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647804	22647804	C	A	wt	het	wt		QUAL=578;DP=125,66,94;AF=0.02,0.50,0.00;MQM=60;SAP=79;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*21C>A::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1221376 [benign DISEASE=not provided];			rs9434		0.5046	22004,.	0.8162,0.5080,0.5875,0.3688,0.4165				3.88			COSV65889466	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647887	22647903	CCACCAGATGGACTTCT	-	wt	het	wt		QUAL=68;DP=24,18,16;AF=0.00,0.50,0.00;MQM=60;SAP=23;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*106_*122del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs60255495		0.3447	9073,.					6.21				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648041	T	-	het	wt	het		QUAL=1407;DP=48,39,71;AF=0.40,0.21,0.46;MQM=60;SAP=93;ABP=23	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs10601144		0.0928	591,.					0.35				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648042	TT	-	wt	het	wt		QUAL=1407;DP=48,39,71;AF=0.13,0.26,0.10;MQM=60;SAP=45;ABP=175	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*272_*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1257095 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs10601144		0.5121	20079,.					0.35				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648073	22648073	T	G	het	wt	wt		QUAL=58;DP=46,46,61;AF=0.35,0.04,0.07;MQM=58;SAP=51;ABP=12	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*290T>G::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs1003478565		0.0029	0,.					5.99				0	0	12	0 / 0					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22653162	22653162	T	G	het	het	het	off-target	QUAL=528;DP=26,22,16;AF=0.62,0.41,0.31;MQM=60;SAP=68;ABP=4	C1QB	upstream_gene	C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::			120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs291990		0.5835	27958,.					4.53			COSV59246057		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22661465	22661465	A	G	hom	hom	hom		QUAL=38239;DP=411,347,456;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	C1QB	3'UTR	C1QB:ENST00000509305.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::	C1QB:NM_000491.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:NM_001371184.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::,C1QB:NM_001378156.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1258616 [benign DISEASE=not provided];			rs10580		0.9841	73653,.					4.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	23796496	23796496	C	T	het	het	wt	off-target	QUAL=928;DP=80,48,54;AF=0.56,0.44,0.02;MQM=60;SAP=140;ABP=3	GALE	intron	GALE:ENST00000374497.7:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:ENST00000617979.5:intron_variant:MODIFIER:intron10/11:c.873+13G>A::	GALE:NM_000403.4:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001008216.2:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001127621.2:intron_variant:MODIFIER:intron9/10:c.873+13G>A::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]	92889 [benign DISEASE=UDPglucose-4-epimerase deficiency,not specified,not provided];		G-rich (Low_complexity)	rs760941		0.6705	19762,.	0.5444,0.7020,0.6319,0.6194,0.7364				0.86			COSV100994767,COSV65720422,COSV65720626	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	23801977	23801977	C	T	hom	het	hom		QUAL=30065;DP=362,347,431;AF=1.00,0.50,1.00;MQM=60;SAP=42;ABP=3	HMGCL	3'UTR	HMGCL:ENST00000374490.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	HMGCL:NM_000191.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:NM_001166059.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	296841 [benign DISEASE=UDPglucose-4-epimerase deficiency,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs11714	0.8834	0.9131	63472,.					7.69				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23808231	23808231	T	C	hom	het	hom		QUAL=21774;DP=292,224,287;AF=1.00,0.53,1.00;MQM=60;SAP=18;ABP=4	HMGCL	synonymous	HMGCL:ENST00000374490.8:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.6:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	HMGCL:NM_000191.3:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:,HMGCL:NM_001166059.2:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	92602 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified];			rs719400	0.8874	0.9230	64880,.	0.9678,0.8940,0.7880,0.9126,0.8738				10.02				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23817442	23817442	A	G	hom	het	hom	off-target	QUAL=12961;DP=186,116,181;AF=0.99,0.50,1.00;MQM=60;SAP=388;ABP=3	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	HMGCL:NM_000191.3:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:NM_001166059.2:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	255488 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified,not provided];			rs2076344		0.9232	64954,.	0.9678,0.8946,0.7893,0.9132,0.8739				1.30				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23825506	23825506	C	A	het	het	hom	off-target	QUAL=1442;DP=24,34,34;AF=0.29,0.47,1.00;MQM=60;SAP=102;ABP=8	HMGCL	upstream_gene	HMGCL:ENST00000374490.8:upstream_gene_variant:MODIFIER::::,HMGCL:ENST00000436439.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177626 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not provided];			rs6697805	0.3928	0.4050	12241,.					0.15					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23845053	23845053	C	G	het	het	hom	off-target	QUAL=2963;DP=103,47,45;AF=0.50,0.60,0.98;MQM=60;SAP=272;ABP=4	FUCA1	downstream_gene	FUCA1:ENST00000374479.4:downstream_gene_variant:MODIFIER::::			612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]				rs4649119	0.3425	0.3654	10647,.					2.56					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854317	23854317	A	-	het	het	het	off-target	QUAL=589;DP=105,33,48;AF=0.12,0.61,0.15;MQM=59;SAP=66;ABP=134	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron5/7:c.969+43del::	FUCA1:NM_000147.5:intron_variant:MODIFIER:intron5/7:c.969+43del::,FUCA1:XM_005245821.3:intron_variant:MODIFIER:intron5/7:c.594+43del::,FUCA1:XM_011541167.3:intron_variant:MODIFIER:intron5/7:c.336+43del::,FUCA1:XM_017000905.2:intron_variant:MODIFIER:intron5/7:c.666+43del::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1252223 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs55699941		0.3054	644,.	0.2476,0.3209,0.3769,0.3017,0.3165				8.02			COSV65699151	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854472	23854472	T	C	het	wt	hom		QUAL=9719;DP=256,209,202;AF=0.50,0.00,1.00;MQM=60;SAP=12;ABP=3	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	FUCA1:NM_000147.5:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:,FUCA1:XM_005245821.3:missense_variant:MODERATE:exon5/8:c.482A>G:p.Gln161Arg:,FUCA1:XM_011541167.3:missense_variant:MODERATE:exon5/8:c.224A>G:p.Gln75Arg:,FUCA1:XM_017000905.2:missense_variant:MODERATE:exon5/8:c.554A>G:p.Gln185Arg:	regulatory_region_variant:CTCF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided];			rs13551	0.2113	0.2792	6032,.	0.1406,0.2037,0.2647,0.3358,0.1516		D(0.02)	B(0.00)	17.84	0.06		COSV65698861	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23868258	23868258	G	C	wt	het	wt		QUAL=1393;DP=157,112,122;AF=0.00,0.54,0.01;MQM=60;SAP=48;ABP=5	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-521C>G::	regulatory_region_variant:promoter	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193053 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070956	0.1430	0.1078	954,.	0.1111,0.1145,0.1998,0.0910,0.1267		T(0.16)	B(0.02)	11.56	0.09		COSV65692258	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868280	23868280	C	G	het	het	wt		QUAL=2473;DP=143,107,112;AF=0.45,0.45,0.00;MQM=60;SAP=155;ABP=8	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	296895 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs61996282	0.0134	0.0153	21,.	0.0025,0.0506,0.0000,0.0080,0.0166		D(0.02)	B(0.00)	6.24	0.07			0	3	178	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868283	23868283	G	A	wt	het	wt		QUAL=1196;DP=121,103,113;AF=0.00,0.52,0.01;MQM=60;SAP=63;ABP=4	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-546C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193052 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070955	0.1430	0.1119	952,.	0.1141,0.1164,0.2051,0.0948,0.1271		D(0.00)	B(0.00)	16.29	0.08		COSV65692243	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868298	23868298	A	G	wt	het	wt		QUAL=1137;DP=74,96,100;AF=0.00,0.52,0.01;MQM=60;SAP=55;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::	FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-561T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193051 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070954	0.1428	0.1140	953,.	0.1164,0.1167,0.2068,0.0965,0.1275				10.33					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868372	23868372	A	C	wt	het	wt		QUAL=417;DP=26,49,33;AF=0.00,0.43,0.03;MQM=60;SAP=51;ABP=5	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	368872 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs2070953	0.1428	0.1070	962,.					6.98					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868408	23868408	C	A	wt	het	wt	off-target	QUAL=322;DP=19,36,20;AF=0.00,0.47,0.00;MQM=60;SAP=40;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683915 [benign DISEASE=not provided];			rs2070952	0.1428	0.1067	961,.					5.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	25805163	25805163	G	A	hom	hom	het		QUAL=15894;DP=160,220,332;AF=1.00,1.00,0.52;MQM=60;SAP=261;ABP=4	SELENON	missense	SELENON:ENST00000354177.9:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000361547.7:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:	SELENON:NM_020451.3:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:NM_206926.2:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95963 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs7349185		0.8183	48208,.	0.7779,0.9062,0.9425,0.7826,0.8772		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.21	0.04		COSV62525203	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811645	25811645	C	A	hom	hom	het	off-target	QUAL=18745;DP=148,278,383;AF=1.00,1.00,0.53;MQM=60;SAP=42;ABP=6	SELENON	intron	SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron7/11:c.922-46C>A::,SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261271 [benign DISEASE=not specified,not provided];			rs760598	0.7470	0.7903	38885,.	0.4605,0.8803,0.9652,0.7681,0.8741				4.70				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811771	25811771	T	C	hom	hom	het		QUAL=24631;DP=211,353,488;AF=1.00,1.00,0.51;MQM=60;SAP=3;ABP=4	SELENON	synonymous	SELENON:ENST00000354177.9:synonymous_variant:LOW:exon8/12:c.1002T>C:p.Pro334=:,SELENON:ENST00000361547.7:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	SELENON:NM_020451.3:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:NM_206926.2:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs760597		0.8099	43465,.	0.6070,0.8907,0.9651,0.7838,0.8768				9.57			COSV62525913	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812646	25812646	C	T	hom	hom	het	off-target	QUAL=2973;DP=18,54,70;AF=1.00,1.00,0.54;MQM=60;SAP=79;ABP=4	SELENON	intron	SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-41C>T::,SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261274 [benign DISEASE=not specified,not provided];			rs10902685	0.6977	0.7930	36507,.	0.2898,0.8793,0.9662,0.7870,0.8780				3.13				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25814082	25814082	C	A	hom	hom	het		QUAL=22046;DP=216,321,438;AF=1.00,1.00,0.50;MQM=60;SAP=124;ABP=3	SELENON,	missense,missense&NMD_transcript	SELENON:ENST00000354177.9:missense_variant:MODERATE:exon11/12:c.1335C>A:p.Asn445Lys:,SELENON:ENST00000361547.7:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,:ENST00000527604.1:missense_variant&NMD_transcript_variant:MODERATE:exon2/4:c.27C>A:p.Asn9Lys:	SELENON:NM_020451.3:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:NM_206926.2:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95959 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs2294228		0.7864	36889,.	0.2906,0.8791,0.9655,0.7822,0.8768		T(0.10),T(0.12),T(0.14),T(0.17)	B(0.02),B(0.00),B(0.00),B(0.00)	13.69	0.09		COSV62525671	0.33	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25817213	25817213	-	TTTTG	hom	hom	het		QUAL=11752;DP=148,191,232;AF=0.97,1.00,0.43;MQM=59;SAP=211;ABP=13	SELENON,	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.304-338_304-334dup::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.387-338_387-334dup::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3051_123+3055dup::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]				rs3033477		0.7226	40659,.					1.60				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817330	25817330	T	C	hom	hom	het		QUAL=16585;DP=247,179,269;AF=1.00,0.98,0.45;MQM=55;SAP=20;ABP=8	SELENON,	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+232A>G::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.386+232A>G::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3152T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750		0.7208	40881,.					2.99				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817440	25817440	T	C	hom	hom	het		QUAL=22311;DP=341,228,349;AF=1.00,1.00,0.45;MQM=54;SAP=99;ABP=11	SELENON,	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+122A>G::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.386+122A>G::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3262T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383		0.8102	50114,.					0.80				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817947	25817947	C	-	hom	hom	het		QUAL=4521;DP=77,77,105;AF=0.99,1.00,0.61;MQM=60;SAP=269;ABP=14	SELENON,	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.152-234del::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.235-234del::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3776del::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs371383269		0.7254	41194,.					0.76				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26181802	26181802	G	A	het	het	wt	off-target	QUAL=5043;DP=208,206,281;AF=0.50,0.51,0.00;MQM=60;SAP=293;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron3/20:c.-377-55G>A::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron3/20:c.393-55G>A::	regulatory_region_variant:open_chromatin_region				MIRb (SINE/MIR)	rs3819033	0.2859	0.1250	2675,.					7.55			COSV64163468	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181989	26181989	T	C	het	het	wt	off-target	QUAL=5554;DP=211,243,318;AF=0.46,0.52,0.00;MQM=60;SAP=245;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron4/20:c.-293+48T>C::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron4/20:c.477+48T>C::	regulatory_region_variant:open_chromatin_region					rs2275945	0.3365	0.2282	3415,.	0.1604,0.4817,0.6399,0.0981,0.3757				11.55				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185209	26185209	A	G	hom	hom	hom	off-target	QUAL=20266;DP=160,212,265;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+23A>G::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron14/20:c.534+23A>G::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::						rs2783680		0.6818	27499,.	0.4561,0.8001,0.9695,0.5905,0.7834				0.29				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26780484	26780484	C	T	wt	wt	het		QUAL=3133;DP=158,190,236;AF=0.00,0.00,0.52;MQM=60;SAP=11;ABP=4	ARID1A	synonymous	ARID1A:ENST00000324856.13:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000374152.7:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000430799.7:synonymous_variant:LOW:exon20/20:c.5434C>T:p.Leu1812=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000457599.6:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa]	ARID1A:NM_006015.6:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:,ARID1A:NM_139135.4:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	210262 [benign/likely benign DISEASE=not specified,not provided];			rs149633292	0.0016	0.0051	10,.	0.0005,0.0008,0.0000,0.0050,0.0007				7.24			COSV61385556	0	1	138	0 / 0	2	"Prima Vista kein Anhalt fr Splice-Defekt; 160727 [2] ahwalds1 28.07.2016"			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26781160	26781160	A	-	het	het	het		QUAL=626;DP=86,16,24;AF=0.24,0.25,0.29;MQM=60;SAP=4;ABP=69	ARID1A	3'UTR	ARID1A:ENST00000324856.13:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:ENST00000430799.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::	ARID1A:NM_006015.6:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:NM_139135.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs71007893		0.0184	10,.					6.28				0	0	128	0 / 0					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27369520	27369520	C	T	hom	hom	hom	off-target	QUAL=26178;DP=313,256,312;AF=1.00,1.00,1.00;MQM=60;SAP=1916;ABP=0	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	FCN3:NM_003665.4:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:NM_173452.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	regulatory_region_variant:CTCF_binding_site	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs10218730	0.9924	0.9981	75011,.	0.9740,0.9990,1.0000,0.9999,0.9999				1.56				0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	32780201	32780201	C	G	het	het	het		QUAL=9592;DP=260,186,254;AF=0.54,0.61,0.46;MQM=60;SAP=65;ABP=8	YARS1	synonymous	YARS1:ENST00000373477.9:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain],YARS1:ENST00000675785.1:synonymous_variant:LOW:exon10/12:c.1071G>C:p.Leu357=:PF01588 [Putative tRNA binding domain]	YARS1:NM_003680.4:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:,YARS1:XM_011542347.2:synonymous_variant:LOW:exon9/11:c.588G>C:p.Leu196=:,YARS1:XM_011542348.1:synonymous_variant:LOW:exon10/12:c.588G>C:p.Leu196=:,YARS1:XM_017002651.2:synonymous_variant:LOW:exon12/14:c.588G>C:p.Leu196=:		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297151 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs699005	0.0875	0.1036	905,.	0.1027,0.2180,0.0003,0.0970,0.0607				9.05				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32786499	32786521	CACATGCATGACTATTCCTAGCC	-	het	het	wt	off-target;low_conf_region	QUAL=3595;DP=114,226,316;AF=0.48,0.50,0.00;MQM=60;SAP=148;ABP=3	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron6/11:c.674-74_674-52del::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron5/10:c.191-74_191-52del::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron6/11:c.191-74_191-52del::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron8/13:c.191-74_191-52del::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1175561 [benign DISEASE=not provided];		L2d (LINE/L2)	rs149745059		0.1434	1779,.	0.0236,0.0903,0.1858,0.1445,0.2117				4.89				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791283	32791283	C	A	hom	hom	het	off-target	QUAL=16364;DP=243,164,263;AF=0.99,0.99,0.52;MQM=60;SAP=278;ABP=4	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron4/11:c.445-29G>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron3/10:c.-39-29G>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron4/11:c.-39-29G>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron6/13:c.-39-29G>T::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670888 [benign DISEASE=not provided];			rs1765223	0.2911	0.3118	7496,.	0.3001,0.3504,0.2128,0.3120,0.3043				7.15			COSV65113032	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32810823	32810823	G	A	hom	hom	hom	off-target	QUAL=21306;DP=291,158,212;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron1/11:c.58-57C>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron1/10:c.-250-4212C>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron1/11:c.-297-4212C>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron2/13:c.-473-57C>T::	regulatory_region_variant:promoter_flanking_region	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670335 [benign DISEASE=not provided];			rs4951787		0.9874	74172,.					0.48				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32817174	32817174	C	A	het	het	het	off-target	QUAL=3099;DP=120,71,103;AF=0.48,0.51,0.44;MQM=60;SAP=49;ABP=5	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron1/12:c.57+14G>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron1/11:c.57+14G>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron1/12:c.57+14G>T::,S100PBP:XM_011541962.2:intron_variant:MODIFIER:intron1/6:c.-120+192C>A::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron1/10:c.-251+14G>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron1/11:c.-298+14G>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron1/13:c.-621+14G>T::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297163 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs72654020	0.0857	0.1031	890,.	0.0965,0.2176,0.0003,0.0969,0.0607				5.06				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	32817927	32817927	G	A	het	n/a	n/a		QUAL=27;DP=7,0,1;AF=0.57,,0.00;MQM=60;SAP=12;ABP=3	S100PBP	intron	S100PBP:ENST00000373475.10:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:ENST00000373476.5:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::	S100PBP:NM_001256121.2:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,S100PBP:NM_022753.4:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:XM_011541961.2:intron_variant:MODIFIER:intron1/6:c.-120+81G>A::,S100PBP:XM_011541962.2:intron_variant:MODIFIER:intron1/6:c.-120+945G>A::,S100PBP:XM_011541963.2:intron_variant:MODIFIER:intron1/7:c.-120+238G>A::,S100PBP:XM_017002098.2:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:XR_001737363.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::,S100PBP:XR_001737364.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::,S100PBP:XR_001737365.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.135+238G>A::,S100PBP:XR_946740.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297175 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not provided];			rs72654022	0.0603	0.0793	676,.					14.83				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33010464	33010464	G	A	het	het	wt		QUAL=864;DP=321,105,140;AF=0.22,0.13,0.07;MQM=34;SAP=4;ABP=337	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2717C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20571G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*567C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*365C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2717C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*414C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*365C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2940C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1024C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2142C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2237C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs143947377		0.4970	0,.	0.1568,0.4139,0.3199,0.3716,0.3520				18.09			COSV61470449		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010473	33010473	A	T	het	het	wt		QUAL=971;DP=341,110,148;AF=0.23,0.13,0.07;MQM=34;SAP=6;ABP=351	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2708T>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20562A>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*558T>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*356T>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2708T>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*405T>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*356T>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2931T>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1015T>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2133T>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2228T>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs199780633		0.4969	0,.	0.1455,0.4073,0.2964,0.3645,0.3485				15.20			COSV61467968		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010489	33010489	T	C	het	het	wt		QUAL=1331;DP=390,112,146;AF=0.24,0.11,0.08;MQM=35;SAP=8;ABP=372	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2692A>G::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20546T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*542A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*340A>G::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2692A>G::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*389A>G::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2915A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.999A>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2117A>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2212A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs140167370		0.4968	0,.	0.1035,0.3746,0.2373,0.3256,0.3048				0.37			COSV61470454		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010542	33010542	G	A	het	het	het		QUAL=70;DP=256,84,107;AF=0.14,0.12,0.11;MQM=38;SAP=5;ABP=535	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2639C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20493G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*489C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*287C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2639C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*336C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2862C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.946C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2064C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2159C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201412582		0.4968	0,.	0.0026,0.0257,0.0074,0.0132,0.0111				8.62			COSV61467875		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010623	33010624	AC	-	het	het	het		QUAL=1717;DP=219,71,72;AF=0.28,0.27,0.33;MQM=46;SAP=3;ABP=142	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2557_*2558del::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20410_246-20409del::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*407_*408del::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*205_*206del::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2557_*2558del::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*254_*255del::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2780_*2781del::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.864_865del::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1982_1983del::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2077_2078del::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs67829320		0.4992	0,.	0.2745,0.4509,0.3832,0.4501,0.4693				4.34					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010638	33010638	T	C	het	het	het		QUAL=2686;DP=268,72,78;AF=0.31,0.32,0.36;MQM=47;SAP=8;ABP=117	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2543A>G::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20397T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*393A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*191A>G::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2543A>G::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*240A>G::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2766A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.850A>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1968A>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2063A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066438		0.4994	0,.	0.3834,0.4825,0.4540,0.4748,0.4879				4.96					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010691	33010691	A	G	het	het	het		QUAL=4593;DP=269,136,117;AF=0.30,0.49,0.45;MQM=50;SAP=130;ABP=65	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2490T>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20344A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340T>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*138T>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2490T>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*187T>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2713T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.797T>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1915T>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2010T>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066439		0.4995	0,.	0.4701,0.4886,0.4898,0.4828,0.4891				6.12			COSV61466645		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010752	33010752	C	T	het	het	het		QUAL=2531;DP=231,155,143;AF=0.17,0.41,0.33;MQM=47;SAP=30;ABP=215	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2429G>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20283C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*279G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*77G>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2429G>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*126G>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2652G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.736G>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1854G>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1949G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs66599471		0.4992	4,.	0.2505,0.1430,0.1915,0.2371,0.1579				9.65			COSV61466298		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010784	33010784	C	G	het	het	het		QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2397G>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20251C>G::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*247G>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*45G>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2397G>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2620G>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.704G>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1822G>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1917G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76881767		0.4971	0,.	0.0649,0.0106,0.0261,0.0577,0.0143				19.37			COSV61466684		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010786	33010786	C	T	het	het	het		QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2395G>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20249C>T::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*245G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*43G>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2395G>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2618G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.702G>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1820G>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1915G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201842558		0.4968	0,.	0.0529,0.0087,0.0213,0.0484,0.0123				16.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010795	33010795	G	A	het	het	het		QUAL=1786;DP=230,132,136;AF=0.20,0.35,0.23;MQM=48;SAP=5;ABP=276	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2386C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20240G>A::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*236C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*34C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2386C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2609C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.693C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1811C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1906C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs79824855		0.4951	0,.	0.0220,0.0029,0.0075,0.0218,0.0043				22.60			COSV61466650		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010803	33010803	T	G	het	het	het		QUAL=1366;DP=219,128,132;AF=0.20,0.32,0.23;MQM=48;SAP=5;ABP=284	AK2,	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2378A>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20232T>G::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*228A>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*26A>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2378A>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2601A>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.685A>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1803A>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1898A>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76230073		0.4896	0,.	0.0150,0.0019,0.0038,0.0149,0.0025				20.60			COSV61467923		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013330	33013330	G	C	het	wt	wt		QUAL=530;DP=662,475,594;AF=0.18,0.04,0.02;MQM=36;SAP=23;ABP=610	AK2,	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17705G>C::,AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon5/6:c.*74C>G::,AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase]	AK2:NM_001199199.3:missense_variant:MODERATE:exon6/7:c.547C>G:p.His183Asp:,AK2:NM_001319139.3:missense_variant:MODERATE:exon7/8:c.427C>G:p.His143Asp:,AK2:NM_001319140.2:missense_variant:MODERATE:exon7/7:c.427C>G:p.His143Asp:,AK2:NM_001319141.3:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:,AK2:NM_001319142.3:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.531C>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.516C>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.611C>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279		0.0346	0,.	0.0514,0.0241,0.0262,0.0454,0.0179		D(0.01),D(0.01), ,D(0.01), ,D(0.01), ,D(0.01)	B(0.17),B(0.31), ,B(0.44), ,P(0.88), ,B(0.44)	25.30	0.78		COSV61466144	0	0	513	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013358	33013358	C	G	het	wt	wt		QUAL=667;DP=634,421,555;AF=0.17,0.03,0.02;MQM=36;SAP=18;ABP=596	AK2,	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17677C>G::,AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon5/6:c.*46G>C::,AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase]	AK2:NM_001199199.3:missense_variant:MODERATE:exon6/7:c.519G>C:p.Lys173Asn:,AK2:NM_001319139.3:missense_variant:MODERATE:exon7/8:c.399G>C:p.Lys133Asn:,AK2:NM_001319140.2:missense_variant:MODERATE:exon7/7:c.399G>C:p.Lys133Asn:,AK2:NM_001319141.3:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:,AK2:NM_001319142.3:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.503G>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.488G>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.583G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs72884305		0.1114	0,.	0.1538,0.0784,0.0983,0.1469,0.0605		D(0.03),D(0.03), ,D(0.03), ,D(0.03), ,D(0.03)	B(0.00),B(0.03), ,B(0.09), ,B(0.05), ,B(0.09)	21.60	0.19		COSV61466156	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	34781247	34781247	-	C	wt	wt	het		QUAL=151;DP=8,10,14;AF=0.00,0.00,0.57;MQM=60;SAP=20;ABP=4	GJB3,	5'UTR,intron&non_coding_transcript	GJB3:ENST00000373366.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+6740dup::	GJB3:NM_024009.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,LOC105378642:XR_001737967.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.1023+17123dup::	regulatory_region_variant:promoter,TF_binding_site_variant	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive, Digenic dominant; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs3831969		0.2563	5890,.					8.32				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34785628	34785628	G	A	wt	het	het		QUAL=9695;DP=261,357,376;AF=0.00,0.54,0.50;MQM=60;SAP=7;ABP=5	GJB3,	3'UTR,intron&non_coding_transcript	GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373366.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+2360C>T::	GJB3:NM_001005752.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:NM_024009.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,LOC105378642:XR_001737967.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.1023+12743C>T::	regulatory_region_variant:CTCF_binding_site	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive, Digenic dominant; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant, with peripheral neuropathy (3)]	297196 [benign DISEASE=Erythrokeratodermia variabilis et progressiva 1,not provided];			rs476220	0.4040	0.4781	18250,.					2.32			COSV64904373	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39026255	39026255	G	C	het	hom	het	off-target	QUAL=4562;DP=72,84,102;AF=0.46,1.00,0.50;MQM=60;SAP=165;ABP=3	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.8:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600		0.7036	39640,.					6.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39026408	39026408	G	T	het	hom	het		QUAL=4652;DP=91,91,111;AF=0.52,1.00,0.47;MQM=60;SAP=53;ABP=3	NDUFS5	intron,splice_region&intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.8:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:NM_004552.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1122472	0.5377	0.7015	39510,.					5.35		6.53>7.92		0.74	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	-	T	het	wt	wt	off-target	QUAL=360;DP=113,47,68;AF=0.09,0.38,0.22;MQM=59;SAP=92;ABP=206	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+69dup::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::	regulatory_region_variant:CTCF_binding_site					rs35464164		0.6957	35867,.					0.37				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	C	T	wt	het	het	off-target	QUAL=360;DP=113,47,68;AF=0.19,0.21,0.15;MQM=55;SAP=96;ABP=195	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	regulatory_region_variant:CTCF_binding_site					rs372159643		0.0001	0,.					0.28				0	0	79	0 / 0					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40073404	40073404	C	T	hom	het	het		QUAL=18469;DP=389,207,252;AF=1.00,0.39,0.50;MQM=60;SAP=59;ABP=13	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*657G>A::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*788G>A::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657G>A::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297230 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126973		0.7017	37586,.					7.40				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073531	40073531	-	TGAT	hom	het	het		QUAL=19323;DP=341,360,457;AF=0.99,0.44,0.47;MQM=60;SAP=62;ABP=16	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*526_*529dup::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657_*660dup::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*526_*529dup::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297233 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive,not provided];			rs397730033		0.6608	33892,.					4.99				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073556	40073556	G	C	hom	het	het		QUAL=29708;DP=534,423,540;AF=1.00,0.46,0.48;MQM=60;SAP=157;ABP=10	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*505C>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*636C>G::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*505C>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297234 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126972		0.6974	37183,.					3.29				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073776	40073776	A	C	hom	het	het		QUAL=39398;DP=859,416,464;AF=0.99,0.53,0.45;MQM=60;SAP=63;ABP=4	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*285T>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*416T>G::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*285T>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297240 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126970		0.6976	37211,.					10.22				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073900	40073900	A	G	het	wt	het		QUAL=7482;DP=342,237,267;AF=0.46,0.00,0.48;MQM=60;SAP=88;ABP=10	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*161T>C::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*292T>C::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*161T>C::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297242 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs11552578	0.1514	0.1156	1193,.					15.49			COSV61222731	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080537	40080537	C	T	het	wt	het	off-target	QUAL=6263;DP=236,222,288;AF=0.49,0.00,0.49;MQM=60;SAP=192;ABP=4	PPT1	intron	PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron5/8:c.534-50G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron5/7:c.537-50G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron5/9:c.537-50G>A::,PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron6/9:c.624-50G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron5/8:c.537-50G>A::	PPT1:NM_000310.4:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron5/7:c.537-50G>A::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180457 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs77623018	0.0881	0.0862	442,.	0.0162,0.1045,0.1396,0.0569,0.1362				0.07			COSV65655090	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091270	40091270	A	T	wt	het	wt	off-target	QUAL=2670;DP=152,207,216;AF=0.00,0.51,0.00;MQM=60;SAP=39;ABP=3	PPT1	intron	PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+59T>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+59T>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+59T>A::,PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+59T>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+59T>A::	PPT1:NM_000310.4:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron4/7:c.433+59T>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670785 [benign DISEASE=not provided];			rs56654546	0.1154	0.0958	767,.					4.78			COSV65655895	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091361	40091361	A	G	het	wt	het		QUAL=9444;DP=434,344,349;AF=0.44,0.00,0.48;MQM=60;SAP=3;ABP=13	PPT1	missense,intron	PPT1:ENST00000433473.8:missense_variant:MODERATE:exon4/9:c.398T>C:p.Ile133Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000439754.6:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::,PPT1:ENST00000641319.1:missense_variant:MODERATE:exon4/10:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000641471.1:missense_variant:MODERATE:exon5/10:c.488T>C:p.Ile163Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000642050.2:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase]	PPT1:NM_000310.4:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::,PPT1:NM_001363695.2:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	130022 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,History of neurodevelopmental disorder,not specified,not provided];			rs1800205	0.0739	0.0659	303,.	0.0097,0.0357,0.1235,0.0483,0.1213		T(0.37),T(0.36), ,T(0.38),T(0.38),T(0.37)	B(0.00),B(0.00), ,B(0.00),B(0.16),B(0.04)	16.02	0.20		COSV65655693	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097321	40097321	T	C	hom	hom	hom		QUAL=5693;DP=36,56,97;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	PPT1	upstream_gene	PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297250 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs6600313		0.8441	54447,.					8.80				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097347	40097347	G	T	het	wt	het		QUAL=1551;DP=30,46,82;AF=0.60,0.02,0.54;MQM=60;SAP=7;ABP=6	PPT1	upstream_gene	PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297251 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs41301070	0.1138	0.0865	820,.					6.03				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40270145	40270145	T	G	wt	het	wt	off-target	QUAL=327;DP=100,43,62;AF=0.00,0.40,0.00;MQM=60;SAP=4;ABP=7	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.627+18T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.627+18T>G::,ZMPSTE24:XR_001736906.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.821+18T>G::	regulatory_region_variant:open_chromatin_region	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive]	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.1154	0.1068	714,.	0.0627,0.1451,0.1617,0.0893,0.1472				7.05			COSV65638901	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40271844	40271844	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,105,126;AF=1.00,1.00,1.00;MQM=60;SAP=395;ABP=0	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.628-50T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.628-50T>G::,ZMPSTE24:XR_001736906.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.822-50T>G::		606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive]	140535 [benign DISEASE=not specified,not provided];			rs6677717		0.9875	74221,.	0.9983,0.9974,0.9999,0.9870,0.9859				0.98				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	42733051	42733051	C	T	het	n/a	n/a	off-target	QUAL=171;DP=14,0,1;AF=0.64,,1.00;MQM=58;SAP=25;ABP=5	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::			610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSg (SINE/Alu)	rs11210707		0.6347	30220,.					1.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733077	42733077	-	TC	het	n/a	het	off-target	QUAL=231;DP=25,1,3;AF=0.60,0.00,0.33;MQM=53;SAP=38;ABP=4	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::			610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs200763067		0.0823	400,.					0.41					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733353	42733353	C	T	het	wt	het		QUAL=6657;DP=213,253,333;AF=0.51,0.00,0.51;MQM=59;SAP=153;ABP=4	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2515G>A::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297316 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];		AluSx1 (SINE/Alu)	rs112310775	0.1254	0.1218	1173,.					0.93					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733444	42733444	A	G	het	wt	het		QUAL=10843;DP=405,354,441;AF=0.48,0.00,0.50;MQM=60;SAP=15;ABP=3	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2424T>C::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297318 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];			rs56345167	0.1907	0.1894	3000,.					6.35					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42734855	42734855	T	C	het	het	het		QUAL=5019;DP=134,127,142;AF=0.49,0.43,0.51;MQM=60;SAP=4;ABP=5	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1013A>G::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297335 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement,not provided];			rs912075		0.5839	26092,.					0.61					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735184	42735184	G	A	het	het	het		QUAL=7187;DP=118,210,253;AF=0.52,0.55,0.47;MQM=60;SAP=148;ABP=3	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.627-50C>T::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1276324 [benign DISEASE=not provided];			rs74885359	0.0387	0.0980	941,.	0.0235,0.0526,0.0003,0.1380,0.0400				0.27				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735545	42735545	A	C	het	het	het		QUAL=10357;DP=184,284,353;AF=0.45,0.49,0.49;MQM=60;SAP=4;ABP=5	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+333T>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1287286 [benign DISEASE=not provided];		L2b (LINE/L2)	rs12141833		0.5392	22921,.					0.82				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735863	42735863	G	A	het	wt	het		QUAL=4084;DP=87,176,242;AF=0.45,0.01,0.56;MQM=60;SAP=257;ABP=5	CLDN19	intron,3'UTR,missense	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+15C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:ENST00000539749.5:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:NM_001185117.2:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+15C>T::	regulatory_region_variant:CTCF_binding_site	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297339 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement,not provided];			rs4660658	0.1905	0.1861	2767,.	0.2412,0.2467,0.2450,0.1585,0.1289		 , ,T(0.07)	 , ,B(0.00)	0.26	0.12		COSV56418053	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42746440	42746440	C	T	het	het	het		QUAL=9051;DP=296,180,206;AF=0.49,0.54,0.48;MQM=60;SAP=25;ABP=3	P3H1	3'UTR	P3H1:ENST00000236040.8:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:ENST00000296388.10:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000397054.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::	P3H1:NM_001146289.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:NM_001243246.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:NM_022356.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:XM_005271110.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*257G>A::,P3H1:XM_011541948.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:XM_017002051.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*257G>A::,P3H1:XM_017002052.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*257G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	873598 [benign DISEASE=Osteogenesis imperfecta type 8,Osteogenesis Imperfecta, Recessive,not provided];			rs6882	0.6625	0.6422	31658,.					4.65				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747198	42747198	A	T	het	wt	het		QUAL=2939;DP=109,74,126;AF=0.48,0.00,0.50;MQM=60;SAP=3;ABP=3	P3H1	missense,intron	P3H1:ENST00000236040.8:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:NM_001243246.2:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:NM_022356.4:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:XM_005271110.2:intron_variant:MODIFIER:intron13/13:c.1047+74T>A::,P3H1:XM_011541948.1:intron_variant:MODIFIER:intron14/14:c.1080+74T>A::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron15/15:c.1080+74T>A::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron15/15:c.1077+74T>A::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674902 [benign DISEASE=not provided];			rs3738496	0.1210	0.1309	1062,.	0.0737,0.2078,0.2524,0.1144,0.0733		T(0.73), , 	B(0.03), , 	1.93	0.02		COSV52536380	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747828	42747828	C	T	het	het	het	off-target	QUAL=5978;DP=176,135,219;AF=0.47,0.49,0.47;MQM=60;SAP=137;ABP=5	P3H1	intron	P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:NM_001243246.2:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:XM_005271110.2:intron_variant:MODIFIER:intron11/13:c.831-30G>A::,P3H1:XM_011541948.1:intron_variant:MODIFIER:intron12/14:c.864-30G>A::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron13/15:c.864-30G>A::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron13/15:c.861-30G>A::,P3H1:XR_946739.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1964-30G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674901 [benign DISEASE=Osteogenesis imperfecta type 8,not provided];			rs3738499		0.6021	22679,.	0.3579,0.6219,0.6767,0.5938,0.6960				0.26				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762518	42762518	T	A	hom	hom	hom	off-target	QUAL=19167;DP=189,212,255;AF=1.00,1.00,1.00;MQM=60;SAP=533;ABP=0	P3H1	intron	P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron1/14:c.466-43A>T::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:NM_001243246.2:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron1/15:c.-565-43A>T::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron1/15:c.-565-43A>T::,P3H1:XR_946739.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.523-43A>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674899 [benign DISEASE=not provided];			rs2816593		0.9882	74272,.	0.9973,0.9974,1.0000,0.9816,0.9927				2.13				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767127	42767127	G	T	wt	het	wt	off-target	QUAL=350;DP=8,27,19;AF=0.00,0.67,0.00;MQM=60;SAP=42;ABP=10	P3H1,C1orf50,	upstream_gene	P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,:ENST00000603943.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	1290909 [benign DISEASE=not provided];			rs11210712	0.1384	0.1990	3590,.					6.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767136	42767136	C	G	het	het	het	off-target	QUAL=604;DP=11,22,18;AF=0.73,0.64,0.56;MQM=60;SAP=72;ABP=10	P3H1,C1orf50,	upstream_gene	P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,:ENST00000603943.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674898 [benign DISEASE=not provided];			rs3738504		0.5999	27569,.					10.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42926579	42926579	C	G	wt	het	wt		QUAL=2154;DP=293,227,266;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=19	SLC2A1	3'UTR	SLC2A1:ENST00000426263.10:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::,SLC2A1:ENST00000674765.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*228G>C::	SLC2A1:NM_006516.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	297374 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1];			rs4658	0.3834	0.3411	10880,.					1.42				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42927574	42927574	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=727;DP=177,99,77;AF=0.00,0.35,0.32;MQM=60;SAP=61;ABP=42	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron8/8:c.1030-718_1030-717insATTTCTCACC::	SLC2A1:NM_006516.4:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	1222935 [benign DISEASE=not provided];			rs3831326		0.5698	25919,.					1.66				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42929964	42929964	C	T	wt	het	wt		QUAL=1557;DP=118,160,234;AF=0.00,0.43,0.00;MQM=60;SAP=71;ABP=11	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon5/9:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95414 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs2229682	0.1196	0.1845	2275,.	0.0418,0.1995,0.0761,0.2078,0.1880				1.82			COSV65286860	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42930743	42930743	G	A	wt	het	wt		QUAL=2460;DP=253,154,166;AF=0.00,0.62,0.01;MQM=60;SAP=5;ABP=21	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon4/9:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:	regulatory_region_variant:CTCF_binding_site	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95411 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs11537641	0.1414	0.1897	2436,.	0.0925,0.2031,0.0999,0.2048,0.1983				4.27			COSV65287469	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943295	42943295	G	A	het	het	wt		QUAL=7385;DP=293,350,487;AF=0.43,0.52,0.00;MQM=60;SAP=70;ABP=5	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:,SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon2/9:c.45C>T:p.Ala15=:	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95413 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs1385129	0.2404	0.2416	3829,.	0.1769,0.3054,0.2876,0.2187,0.2675				7.23			COSV65287476	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43346404	43346404	G	A	het	wt	het	off-target	QUAL=3908;DP=136,111,148;AF=0.59,0.01,0.53;MQM=60;SAP=225;ABP=12	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron6/11:c.960-41G>A::	MPL:NM_005373.3:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:XM_017001320.1:intron_variant:MODIFIER:intron5/10:c.1152-41G>A::	regulatory_region_variant:promoter_flanking_region	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	259760 [benign DISEASE=not specified,not provided];			rs1760670	0.2097	0.3123	7921,.	0.2200,0.3028,0.0676,0.3792,0.1450				8.30			COSV65245058	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43354522	43354522	G	A	wt	het	wt	off-target	QUAL=1541;DP=182,121,119;AF=0.00,0.51,0.01;MQM=60;SAP=55;ABP=3	CDC20,MPL,	upstream_gene,downstream_gene	CDC20:ENST00000310955.11:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462.1:upstream_gene_variant:MODIFIER::::,MPL:ENST00000372470.9:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998.7:downstream_gene_variant:MODIFIER::::,:ENST00000424948.1:downstream_gene_variant:MODIFIER::::			159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Somatic mutation, Autosomal dominant; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	1287360 [benign DISEASE=not provided];			rs79064184	0.0295	0.0372	152,.					0.45					0	15	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54)
chr1	43824858	43824858	A	G	het	het	hom		QUAL=7889;DP=267,116,112;AF=0.46,0.41,0.98;MQM=60;SAP=25;ABP=13	ST3GAL3,	missense,intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000351035.8:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372368.7:missense_variant:MODERATE:exon4/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000372372.7:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron18/25:c.*1531+9925A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron2/10:c.161+9925A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron5/12:c.209+9925A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000647237.1:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron4/13:c.-245+9925A>G::,ST3GAL3:NM_001363573.2:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_174963.5:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron4/6:c.209+9925A>G::,ST3GAL3:NM_174968.5:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron3/5:c.161+9925A>G::,ST3GAL3:NM_174971.5:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/11:n.397+9925A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/9:n.307-13361A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/10:n.397+9925A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.307-69525A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.349+9925A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/9:n.397+9925A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.397+9925A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/12:n.397+9925A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron3/11:c.161+9925A>G::,ST3GAL3:XM_011541973.2:missense_variant:MODERATE:exon5/14:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541974.2:missense_variant:MODERATE:exon5/14:c.337A>G:p.Thr113Ala:,ST3GAL3:XM_011541976.2:missense_variant:MODERATE:exon4/13:c.289A>G:p.Thr97Ala:,ST3GAL3:XM_011541981.2:missense_variant:MODERATE:exon5/11:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron5/13:c.-74+9925A>G::,ST3GAL3:XM_011541984.2:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541985.2:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541986.3:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron4/13:c.-286+9925A>G::,ST3GAL3:XM_017002109.2:missense_variant:MODERATE:exon5/14:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_017002110.1:missense_variant:MODERATE:exon5/11:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron4/13:c.-245+9925A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron3/12:c.-245+9925A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron4/12:c.-74+9925A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron4/12:c.-286+9925A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron2/10:c.-286+9925A>G::,ST3GAL3:XR_001737368.1:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946742.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946743.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946744.2:non_coding_transcript_exon_variant:MODIFIER:exon5/14:n.575A>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::	regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	130378 [benign DISEASE=not specified,not provided];		MER5B (DNA/hAT-Charlie)	rs37458	0.2364	0.3178	7879,.	0.3232,0.2169,0.1363,0.3575,0.1441		T(0.74), , , ,T(0.70), , , , , , , , , ,T(0.71), ,T(0.74), , , , , , , , , , , , , , , ,T(0.72)	B(0.00), , , ,B(0.00), , , , , , , , , ,B(0.00), ,B(0.00), , , , , , , , , , , , , , , ,B(0.00)	0.65	0.01		COSV53510755	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899785	43899785	A	G	het	wt	het	off-target	QUAL=3725;DP=140,106,157;AF=0.49,0.00,0.56;MQM=60;SAP=219;ABP=5	ST3GAL3,	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+58A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+58A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+58A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron23/25:c.*2066+58A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+58A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+58A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+58A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.603+58A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.554+522A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.509+522A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron10/13:c.465+58A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.397+5308A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.349+5308A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/11:n.964+58A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.841+58A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1105+58A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.780+58A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.697+522A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.919+522A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.585+5308A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/12:n.964+58A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron8/11:c.696+58A>G::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron10/13:c.951+58A>G::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron10/13:c.906+58A>G::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron9/12:c.858+58A>G::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron6/9:c.579+58A>G::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.951+58A>G::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron10/13:c.462+58A>G::,ST3GAL3:XM_011541984.2:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541985.2:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541986.3:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron10/13:c.423+58A>G::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron5/8:c.423+58A>G::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron10/13:c.951+58A>G::,ST3GAL3:XM_017002110.1:intron_variant:MODIFIER:intron10/10:c.951+58A>G::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron10/13:c.465+58A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron9/12:c.465+58A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron9/12:c.462+58A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron10/12:c.423+58A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron8/10:c.423+58A>G::,ST3GAL3:XR_001737368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946742.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946743.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946744.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/13:n.1144+58A>G::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1176+58A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1233138 [benign DISEASE=not provided];			rs783304	0.2804	0.2372	5422,.					1.77			COSV53512272	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920943	43920943	A	G	hom	hom	hom	off-target	QUAL=11971;DP=76,127,210;AF=0.99,0.98,1.00;MQM=60;SAP=228;ABP=0	ST3GAL3,	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+15A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+393A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9189A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+15A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2360+15A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+15A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+15A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+15A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9189A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9189A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9189A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+15A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+15A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9189A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9189A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+15A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+15A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9189A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+15A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+15A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9189A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+15A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+15A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron10/11:c.990+15A>G::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron12/13:c.1245+15A>G::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron12/13:c.1200+15A>G::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron11/12:c.1152+15A>G::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron8/9:c.873+15A>G::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-9189A>G::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron12/13:c.756+15A>G::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron12/13:c.717+15A>G::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron7/8:c.717+15A>G::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron12/13:c.1245+15A>G::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron12/13:c.759+15A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron11/12:c.759+15A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron11/12:c.756+15A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.717+15A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.717+15A>G::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1470+15A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262909 [benign DISEASE=Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs3120803		0.8813	55812,.	0.6951,0.8484,0.8544,0.9213,0.8667				2.10				0.29	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920970	43920970	G	C	het	wt	het	off-target	QUAL=3416;DP=85,95,157;AF=0.49,0.00,0.64;MQM=60;SAP=121;ABP=19	ST3GAL3,	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+42G>C::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+420G>C::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9162G>C::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2360+42G>C::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+42G>C::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+42G>C::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+42G>C::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9162G>C::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9162G>C::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9162G>C::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+42G>C::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9162G>C::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9162G>C::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+42G>C::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+42G>C::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9162G>C::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+42G>C::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+42G>C::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9162G>C::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+42G>C::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+42G>C::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron10/11:c.990+42G>C::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron12/13:c.1245+42G>C::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron12/13:c.1200+42G>C::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron11/12:c.1152+42G>C::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron8/9:c.873+42G>C::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-9162G>C::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron12/13:c.756+42G>C::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron12/13:c.717+42G>C::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron7/8:c.717+42G>C::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron12/13:c.1245+42G>C::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron12/13:c.759+42G>C::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron11/12:c.759+42G>C::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron11/12:c.756+42G>C::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.717+42G>C::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.717+42G>C::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1470+42G>C::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261387 [benign DISEASE=not provided];			rs3764833	0.0687	0.0553	288,.	0.0891,0.0490,0.1303,0.0398,0.0432				9.06			COSV53519387	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43930114	43930114	C	T	het	hom	het	off-target	QUAL=10324;DP=170,184,258;AF=0.43,1.00,0.47;MQM=60;SAP=99;ABP=12	ST3GAL3,	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-18C>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1132-18C>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-18C>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1054-18C>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-18C>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-18C>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron12/12:c.1280-18C>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-18C>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron12/12:c.1235-18C>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2361-18C>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron10/10:c.1187-18C>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1039-18C>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron12/12:c.1166-18C>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-18C>T::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.949-18C>T::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-18C>T::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-18C>T::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-18C>T::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-18C>T::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-18C>T::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron12/12:c.1280-18C>T::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron12/12:c.1235-18C>T::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron13/13:c.956-18C>T::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-18C>T::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-18C>T::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-18C>T::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-18C>T::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1259-18C>T::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1136-18C>T::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-18C>T::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1075-18C>T::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.992-18C>T::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-18C>T::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.880-18C>T::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1455-18C>T::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron11/11:c.1187-18C>T::,ST3GAL3:XM_011541973.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*28C>T::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron13/13:c.1397-18C>T::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron12/12:c.1349-18C>T::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron9/9:c.1070-18C>T::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-18C>T::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron13/13:c.953-18C>T::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron13/13:c.914-18C>T::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron8/8:c.914-18C>T::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron13/13:c.1442-18C>T::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron13/13:c.956-18C>T::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron12/12:c.956-18C>T::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron12/12:c.953-18C>T::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.718-18C>T::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.718-18C>T::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1471-18C>T::	regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262910 [benign DISEASE=Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs2108202		0.6753	31729,.	0.2202,0.5744,0.6408,0.7772,0.6130				12.44		9.65>10.17	COSV53521961	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930524	43930524	A	G	het	wt	het		QUAL=3226;DP=153,75,118;AF=0.44,0.00,0.49;MQM=60;SAP=3;ABP=6	ST3GAL3,	3'UTR,3'UTR&NMD_transcript	ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000361812.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:ENST00000372366.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*415A>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372372.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,:ENST00000645057.1:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon26/26:c.*2753A>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*322A>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*303A>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270465.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:NM_001270466.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174965.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1651A>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1528A>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1498A>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1467A>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1384A>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1312A>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1272A>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1847A>G::,ST3GAL3:XM_006710827.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*322A>G::,ST3GAL3:XM_011541974.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541976.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_011541980.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*322A>G::,ST3GAL3:XM_011541981.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:XM_011541983.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541987.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541988.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*322A>G::,ST3GAL3:XM_017002109.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_017002113.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:XM_017002114.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_017002115.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_017002116.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_017002120.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:XM_017002121.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1863A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs12561948	0.0507	0.0381	135,.					17.29				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930974	43930974	C	G	het	hom	het		QUAL=13487;DP=226,221,263;AF=0.49,1.00,0.54;MQM=60;SAP=10;ABP=4	ST3GAL3,	3'UTR,3'UTR&NMD_transcript	ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,:ENST00000645057.1:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon26/26:c.*3203C>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*772C>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*753C>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270465.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:NM_001270466.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174965.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*772C>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2101C>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1978C>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1948C>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1917C>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1834C>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1762C>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1722C>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2297C>G::,ST3GAL3:XM_006710827.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*772C>G::,ST3GAL3:XM_011541974.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541976.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_011541980.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*772C>G::,ST3GAL3:XM_011541981.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:XM_011541983.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541987.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541988.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*772C>G::,ST3GAL3:XM_017002109.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_017002113.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:XM_017002114.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_017002115.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_017002116.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_017002120.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:XM_017002121.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2313C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs6801	0.5188	0.6003	31765,.					2.26			COSV53521971	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44819862	44819862	A	C	wt	het	wt		QUAL=164;DP=127,26,28;AF=0.00,0.42,0.00;MQM=60;SAP=19;ABP=4	PTCH2	3'UTR	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	PTCH2:NM_001166292.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::,LOC107984952:XR_001738036.2:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.741A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]				rs181782534	0.0104	0.0116	25,.					0.75					3	89	0 / 0					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819976	44819976	C	T	hom	het	het		QUAL=20079;DP=512,168,176;AF=0.99,0.55,0.49;MQM=60;SAP=681;ABP=4	RNU5E-6P,PTCH2	non_coding_transcript_exon,3'UTR	RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::,PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::	PTCH2:NM_001166292.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::,LOC107984952:XR_001738036.2:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.855C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]			U5 (snRNA)	rs41269085	0.2290	0.2278	4638,.					0.13					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44827194	44827194	G	A	hom	het	het		QUAL=9033;DP=164,147,208;AF=0.99,0.51,0.50;MQM=60;SAP=53;ABP=3	PTCH2	synonymous	PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:,PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:	PTCH2:NM_001166292.2:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166504 [benign DISEASE=Gorlin syndrome,not provided];			rs2295996	0.1478	0.1624	1775,.	0.0810,0.1773,0.2106,0.1669,0.1589				2.03			COSV64709782	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44827846	44827846	A	G	hom	het	het	low_conf_region	QUAL=12971;DP=192,271,323;AF=0.99,0.48,0.48;MQM=60;SAP=466;ABP=5	PTCH2	synonymous	PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:,PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:	PTCH2:NM_001166292.2:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166505 [benign DISEASE=Gorlin syndrome,not provided];			rs7525308	0.4455	0.4236	14614,.	0.5872,0.4169,0.4801,0.3461,0.3545				11.23			COSV64709500	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44828484	44828484	T	C	hom	het	het	off-target	QUAL=21878;DP=234,517,682;AF=1.00,0.53,0.48;MQM=60;SAP=99;ABP=3	PTCH2	intron	PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::,PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::	PTCH2:NM_001166292.2:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327456 [benign DISEASE=Gorlin syndrome];			rs2273940	0.4433	0.4221	14452,.	0.5776,0.4168,0.4807,0.3456,0.3543				0.07			COSV64709511	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44841834	44841834	G	A	hom	het	het	off-target	QUAL=7505;DP=80,183,212;AF=0.99,0.51,0.55;MQM=60;SAP=196;ABP=6	PTCH2	intron	PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron2/21:c.265+13C>T::,PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron2/22:c.265+13C>T::	PTCH2:NM_001166292.2:intron_variant:MODIFIER:intron2/22:c.265+13C>T::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron2/21:c.265+13C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327457 [benign DISEASE=Gorlin syndrome];			rs3795720	0.3720	0.3744	9477,.	0.3300,0.5242,0.4336,0.3463,0.3434				12.41			COSV64709520	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44874610	44874610	C	T	hom	het	het		QUAL=20737;DP=402,252,314;AF=1.00,0.48,0.48;MQM=60;SAP=323;ABP=5	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000372183.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::	EIF2B3:NM_001166588.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron11/11:c.815+68G>A::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron11/12:c.815+68G>A::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	1288223 [benign DISEASE=not provided];		HAL1 (LINE/L1)	rs9988451	0.4517	0.4308	14980,.	0.5880,0.5364,0.4362,0.3537,0.3517				4.60				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44879774	44879774	T	A	hom	het	het	off-target	QUAL=4407;DP=102,44,64;AF=1.00,0.57,0.48;MQM=60;SAP=296;ABP=3	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron8/9:c.975+44A>T::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron8/10:c.975+44A>T::	EIF2B3:NM_001166588.3:intron_variant:MODIFIER:intron8/9:c.975+44A>T::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron9/11:c.588+44A>T::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron9/12:c.588+44A>T::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261223 [benign DISEASE=not specified,not provided];			rs3738248	0.1448	0.1619	1830,.	0.1145,0.1545,0.1655,0.1739,0.1604				8.31			COSV64517062	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897320	44897320	T	C	hom	het	het	off-target	QUAL=6694;DP=143,71,91;AF=1.00,0.52,0.57;MQM=60;SAP=243;ABP=6	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron6/9:c.656+35A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron6/10:c.656+35A>G::	EIF2B3:NM_001166588.3:intron_variant:MODIFIER:intron6/9:c.656+35A>G::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron7/11:c.269+35A>G::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron7/12:c.269+35A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261222 [benign DISEASE=not specified,not provided];			rs263978	0.7911	0.6783	37076,.	0.9083,0.7886,0.9742,0.5467,0.6533				1.06				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44986555	44986555	G	C	hom	het	het		QUAL=6870;DP=126,107,187;AF=1.00,0.43,0.43;MQM=60;SAP=3;ABP=16	EIF2B3	5'UTR	EIF2B3:ENST00000360403.7:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000372183.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,EIF2B3:ENST00000620860.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::	EIF2B3:NM_001166588.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,EIF2B3:NM_001261418.2:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:NM_020365.5:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:XM_017002745.2:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:XM_017002746.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-526C>G::,EIF2B3:XM_017002747.1:5_prime_UTR_variant:MODIFIER:exon1/13:c.-526C>G::	regulatory_region_variant:promoter	606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	297453 [benign DISEASE=Leukoencephalopathy with vanishing white matter];			rs489676	0.4806	0.4788	18278,.					1.33				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), PPIAP35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45509417	45509417	T	-	het	het	het		QUAL=662;DP=86,111,119;AF=0.23,0.26,0.09;MQM=60;SAP=15;ABP=267	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+85del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	1208561 [likely benign DISEASE=not provided];		AluSg7 (SINE/Alu)	rs56934185		0.0367	163,.					0.14				0	1	15	0 / 0					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509494	45509494	A	G	wt	wt	het		QUAL=1064;DP=197,122,142;AF=0.01,0.00,0.38;MQM=60;SAP=46;ABP=21	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+147A>G::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*279A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297502 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not provided];		AluSg7 (SINE/Alu)	rs9729395	0.2634	0.2298	3982,.					3.67				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509628	45509628	G	A	wt	het	wt		QUAL=2026;DP=182,134,192;AF=0.01,0.59,0.01;MQM=60;SAP=40;ABP=12	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+281G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*413G>A::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297505 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.1184	0.1786	2711,.					2.18			COSV53113272	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510068	45510069	CT	-	wt	wt	het		QUAL=1771;DP=238,174,185;AF=0.00,0.01,0.49;MQM=58;SAP=22;ABP=3	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-459_*133-458del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*855_*856del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs398052965	0.2562	0.6744	33011,.					0.79				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510077	45510077	A	-	het	het	het		QUAL=968;DP=156,103,101;AF=0.19,0.24,0.17;MQM=59;SAP=3;ABP=284	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-437del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*877del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]			AluSx4 (SINE/Alu)	rs986671995		0.0722	574,.					0.74				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510475	45510475	G	A	wt	wt	het	low_conf_region	QUAL=4633;DP=344,281,402;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=3	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-54G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1260G>A::	regulatory_region_variant:promoter_flanking_region	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803		0.6691	34371,.					0.23				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510591	45510591	-	T	wt	wt	het		QUAL=3847;DP=316,259,317;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=5	MMACHC	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*195_*196insT::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1376_*1377insT::	regulatory_region_variant:promoter_flanking_region	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.7438	0.6689	34342,.					0.75			COSV53112744	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510915	45510915	A	G	wt	wt	het		QUAL=2435;DP=264,153,170;AF=0.00,0.00,0.56;MQM=60;SAP=5;ABP=8	MMACHC,PRDX1	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,PRDX1:ENST00000424390.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000447184.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*519A>G::,PRDX1:ENST00000676549.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1700A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717		0.7376	41804,.					1.16				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45698718	45698727	TTTTTTTTTT	-	hom	n/a	hom		QUAL=737;DP=21,1,5;AF=1.00,1.00,1.00;MQM=60;SAP=62;ABP=0	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron9/9:c.1651+1343_1651+1352del::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::,IPP:XM_005270839.5:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1484_*1493del::,IPP:XM_006710623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1450_*1459del::,IPP:XM_024446763.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1798+1343_1798+1352del::					AluJb (SINE/Alu)	rs78627575		0.3205	6273,.					0.78				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45699174	45699174	A	T	hom	het	hom		QUAL=21052;DP=306,179,299;AF=0.99,0.47,1.00;MQM=60;SAP=747;ABP=4	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron9/9:c.1651+896T>A::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::,IPP:XM_005270839.5:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1037T>A::,IPP:XM_006710623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1003T>A::,IPP:XM_024446763.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1798+896T>A::						rs10749856	0.3249	0.2862	6344,.					7.00				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45700203	45700203	-	A	hom	het	hom	off-target	QUAL=9574;DP=142,190,202;AF=0.86,0.41,0.88;MQM=60;SAP=190;ABP=18	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron8/8:c.1531-14dup::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron8/9:c.1531-14dup::,IPP:NM_005897.3:intron_variant:MODIFIER:intron8/8:c.1531-14dup::,IPP:XM_005270839.5:intron_variant:MODIFIER:intron8/8:c.*21-14dup::,IPP:XM_006710623.4:intron_variant:MODIFIER:intron7/7:c.1310-14dup::,IPP:XM_024446763.1:intron_variant:MODIFIER:intron8/8:c.1531-14dup::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/9:n.1678-14dup::						rs550999501		0.3258	6009,.	0.2497,0.3549,0.3603,0.3157,0.3748				15.65				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729703	45729703	T	C	hom	het	hom		QUAL=10569;DP=230,60,65;AF=1.00,0.57,0.97;MQM=60;SAP=139;ABP=5	IPP	missense	IPP:ENST00000396478.4:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	IPP:NM_001145349.2:missense_variant:MODERATE:exon4/10:c.791A>G:p.Lys264Arg:,IPP:NM_005897.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_005270839.5:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_006710623.4:missense_variant:MODERATE:exon4/8:c.791A>G:p.Lys264Arg:,IPP:XM_011541394.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_017001210.2:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_024446763.1:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XR_001737155.2:non_coding_transcript_exon_variant:MODIFIER:exon4/10:n.1050A>G::	regulatory_region_variant:promoter_flanking_region					rs28375469	0.3149	0.3037	6168,.	0.2374,0.3238,0.3392,0.2946,0.3608		T(0.22)	B(0.00)	22.40	0.19		COSV63431879	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740868	45740868	A	G	hom	het	hom	off-target	QUAL=9799;DP=270,25,37;AF=1.00,0.68,1.00;MQM=60;SAP=704;ABP=10	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+33T>C::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron3/9:c.724+33T>C::,IPP:NM_005897.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_005270839.5:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_006710623.4:intron_variant:MODIFIER:intron3/7:c.724+33T>C::,IPP:XM_011541394.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_017001210.2:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_024446763.1:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.983+33T>C::						rs28507722	0.3149	0.2999	6160,.	0.2384,0.3223,0.3345,0.2944,0.3666				8.30			COSV63433613	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46189486	46189486	T	C	hom	hom	hom		QUAL=12797;DP=140,141,131;AF=0.99,1.00,1.00;MQM=60;SAP=158;ABP=0	POMGNT1	missense,missense&splice_region,3'UTR	POMGNT1:ENST00000371984.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon18/19:c.*1536A>G::	POMGNT1:NM_001243766.2:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:NM_001290129.2:missense_variant:MODERATE:exon20/22:c.1801A>G:p.Met601Val:,POMGNT1:NM_001290130.2:missense_variant:MODERATE:exon20/22:c.1438A>G:p.Met480Val:,POMGNT1:NM_017739.4:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_005271010.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_006710755.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_006710756.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.678+4178T>C::,POMGNT1:XM_011541760.3:missense_variant:MODERATE:exon20/21:c.1801A>G:p.Met601Val:,POMGNT1:XM_017001690.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:	regulatory_region_variant:promoter_flanking_region	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	167524 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,Muscle eye brain disease,not specified];			rs6659553		0.9868	68933,.	0.8186,0.9914,1.0000,0.9996,0.9997			B(0.00),B(0.00), 	22.50	0.33	2.63>0.43		0.19	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=n/a oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193432	46193432	T	C	hom	hom	het	off-target	QUAL=40792;DP=348,624,797;AF=1.00,1.00,0.49;MQM=60;SAP=16;ABP=4	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon9/19:c.*652A>G::	POMGNT1:NM_001243766.2:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:NM_001290129.2:intron_variant:MODIFIER:intron10/21:c.961-44A>G::,POMGNT1:NM_001290130.2:intron_variant:MODIFIER:intron10/21:c.598-44A>G::,POMGNT1:NM_017739.4:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_005271010.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_006710755.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_006710756.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-2770T>C::,POMGNT1:XM_011541760.3:intron_variant:MODIFIER:intron10/20:c.961-44A>G::,POMGNT1:XM_017001690.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	260869 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,not specified,not provided];			rs7527668	0.3670	0.3772	11081,.	0.4473,0.3957,0.1454,0.3563,0.4455				4.53			COSV64339664	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193691	46193691	T	C	hom	hom	het	off-target	QUAL=23740;DP=296,318,329;AF=0.99,1.00,0.55;MQM=60;SAP=166;ABP=9	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon9/19:c.*393A>G::	POMGNT1:NM_001243766.2:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:NM_001290129.2:intron_variant:MODIFIER:intron9/21:c.885-52A>G::,POMGNT1:NM_001290130.2:intron_variant:MODIFIER:intron9/21:c.522-52A>G::,POMGNT1:NM_017739.4:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_005271010.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_006710755.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_006710756.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-2511T>C::,POMGNT1:XM_011541760.3:intron_variant:MODIFIER:intron9/20:c.885-52A>G::,POMGNT1:XM_017001690.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671035 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76,not provided];			rs7527935	0.3335	0.3552	9408,.	0.3463,0.3885,0.1456,0.3530,0.4452				1.62			COSV64339668	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46194623	46194623	T	C	hom	hom	het		QUAL=17580;DP=258,198,303;AF=1.00,0.99,0.45;MQM=60;SAP=111;ABP=11	POMGNT1	synonymous,missense	POMGNT1:ENST00000371984.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.7:missense_variant:MODERATE:exon7/19:c.563A>G:p.Asn188Ser:	POMGNT1:NM_001243766.2:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:NM_001290129.2:synonymous_variant:LOW:exon7/22:c.615A>G:p.Lys205=:,POMGNT1:NM_001290130.2:synonymous_variant:LOW:exon7/22:c.252A>G:p.Lys84=:,POMGNT1:NM_017739.4:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_005271010.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_006710755.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_006710756.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-1579T>C::,POMGNT1:XM_011541760.3:synonymous_variant:LOW:exon7/21:c.615A>G:p.Lys205=:,POMGNT1:XM_017001690.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:	regulatory_region_variant:promoter_flanking_region	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	95761 [benign DISEASE=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,Muscle eye brain disease,not specified,Congenital Muscular Dystrophy, alpha-dystroglycan related,not provided];			rs2292487	0.3335	0.3552	9428,.	0.3470,0.3886,0.1448,0.3532,0.4458			 , ,B(0.06)	10.11	0.05		COSV64339346	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47250369	47250370	AA	-	het	het	wt		QUAL=5540;DP=253,174,174;AF=0.51,0.52,0.00;MQM=56;SAP=3;ABP=4	STIL	3'UTR	STIL:ENST00000337817.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:ENST00000360380.7:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.8:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::	STIL:NM_001048166.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:NM_001282936.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282937.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282938.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_001282939.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_001377417.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_003035.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:XM_011542001.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*1490_*1491del::,STIL:XM_017002123.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:XM_017002124.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*766_*767del::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon18/18:n.4907_4908del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208		0.4249	15808,.					3.64				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47251517	47251517	A	G	het	het	wt		QUAL=8543;DP=442,231,305;AF=0.51,0.40,0.01;MQM=60;SAP=38;ABP=7	STIL	synonymous	STIL:ENST00000337817.10:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:ENST00000360380.7:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.8:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000396221.6:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:ENST00000447475.7:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:,STIL:ENST00000682977.1:synonymous_variant:LOW:exon18/18:c.3345T>C:p.Pro1115=:	STIL:NM_001048166.1:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:NM_001282936.1:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:NM_001282937.1:synonymous_variant:LOW:exon18/18:c.3432T>C:p.Pro1144=:,STIL:NM_001282938.1:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:NM_001282939.1:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:,STIL:NM_001377417.1:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:NM_003035.2:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:XM_006710834.3:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541991.2:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541992.2:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541994.2:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:XM_011541998.2:synonymous_variant:LOW:exon18/18:c.3291T>C:p.Pro1097=:,STIL:XM_011542001.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XM_017002123.1:synonymous_variant:LOW:exon18/18:c.3342T>C:p.Pro1114=:,STIL:XM_017002124.1:synonymous_variant:LOW:exon13/13:c.2775T>C:p.Pro925=:,STIL:XM_017002125.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XM_017002126.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon18/18:n.3760T>C::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94095 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs2758735	0.3934	0.5020	15893,.	0.1611,0.4426,0.4497,0.5248,0.5374				0.85				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47260415	47260415	T	C	het	het	het		QUAL=6427;DP=211,117,176;AF=0.51,0.47,0.47;MQM=60;SAP=76;ABP=4	STIL	missense	STIL:ENST00000337817.10:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:ENST00000360380.7:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.8:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000396221.6:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:ENST00000447475.7:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:,STIL:ENST00000682977.1:missense_variant:MODERATE:exon17/18:c.2813A>G:p.His938Arg:	STIL:NM_001048166.1:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:NM_001282936.1:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:NM_001282937.1:missense_variant:MODERATE:exon17/18:c.2900A>G:p.His967Arg:,STIL:NM_001282938.1:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:NM_001282939.1:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:,STIL:NM_001377417.1:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:NM_003035.2:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:XM_006710834.3:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541991.2:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541992.2:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541994.2:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:XM_011541998.2:missense_variant:MODERATE:exon17/18:c.2759A>G:p.His920Arg:,STIL:XM_011542001.2:intron_variant:MODIFIER:intron15/15:c.2829+2488A>G::,STIL:XM_017002123.1:missense_variant:MODERATE:exon17/18:c.2810A>G:p.His937Arg:,STIL:XM_017002124.1:missense_variant:MODERATE:exon12/13:c.2243A>G:p.His748Arg:,STIL:XM_017002125.1:intron_variant:MODIFIER:intron15/15:c.2826+2488A>G::,STIL:XM_017002126.1:intron_variant:MODIFIER:intron15/15:c.2775+2488A>G::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon17/18:n.3228A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94094 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs13376679	0.1783	0.2528	5203,.	0.2040,0.1450,0.0230,0.3086,0.2306		T(0.52),T(0.53),T(0.53),T(0.58),T(0.58),T(0.52)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	1.81	0.03		COSV54551803	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47269608	47269608	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60;SAP=10;ABP=3	STIL	intron	STIL:ENST00000337817.10:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000360380.7:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::	STIL:NM_001048166.1:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:NM_001282936.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282937.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282938.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_001282939.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_001377417.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_003035.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:XM_006710834.3:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541991.2:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541992.2:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541994.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:XM_011541998.2:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:XM_011542001.2:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002123.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:XM_017002124.1:intron_variant:MODIFIER:intron10/12:c.1904+27A>G::,STIL:XM_017002125.1:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002126.1:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002127.1:intron_variant:MODIFIER:intron14/14:c.2615+27A>G::,STIL:XR_001737370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/17:n.2770+27A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	160057 [benign DISEASE=not specified,not provided];			rs2742104	0.3944	0.5026	15882,.	0.1611,0.4436,0.4519,0.5254,0.5374				1.27			COSV54550059	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47302242	47302242	G	A	het	het	hom		QUAL=13720;DP=245,185,258;AF=0.51,0.54,0.99;MQM=60;SAP=33;ABP=5	STIL	missense	STIL:ENST00000337817.10:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000360380.7:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.8:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000447475.7:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000682977.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]	STIL:NM_001048166.1:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:NM_001282936.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282937.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282938.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_001282939.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_001377417.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_003035.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:XM_006710834.3:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541991.2:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541992.2:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541994.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:XM_011541998.2:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:,STIL:XM_011542001.2:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002123.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:,STIL:XM_017002125.1:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002126.1:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002127.1:missense_variant:MODERATE:exon4/15:c.257C>T:p.Ala86Val:,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon4/18:n.412C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	21354 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs3125630		0.5751	27255,.	0.8412,0.5552,0.5487,0.4763,0.4630		T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	18.91	0.17		COSV54548838	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	50600416	50600416	T	C	het	het	wt		QUAL=3511;DP=166,136,172;AF=0.43,0.48,0.00;MQM=60;SAP=78;ABP=9	FAF1	intron	FAF1:ENST00000371778.5:intron_variant:MODIFIER:intron7/15:c.539-16752A>G::,FAF1:ENST00000396153.7:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::	FAF1:NM_007051.3:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::,FAF1:XM_017000136.1:intron_variant:MODIFIER:intron9/19:c.418-4200A>G::,FAF1:XM_024452734.1:intron_variant:MODIFIER:intron8/18:c.721-4200A>G::,FAF1:XM_024452736.1:intron_variant:MODIFIER:intron9/19:c.418-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.1695	0.2326	4536,.					4.52			COSV65639546	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	53197151	53197151	C	A	het	wt	het	off-target	QUAL=1504;DP=11,61,106;AF=0.36,0.00,0.60;MQM=60;SAP=3;ABP=10	CPT2	intron	CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron1/3:c.152+56C>A::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::	CPT2:NM_000098.3:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:NM_001330589.2:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	1177631 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,not provided];			rs72673121	0.0889	0.1450	2092,.					7.72				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53210776	53210776	G	A	het	wt	hom		QUAL=11219;DP=287,215,230;AF=0.53,0.00,1.00;MQM=60;SAP=57;ABP=6	CPT2,	missense,intron&non_coding_transcript,intron	CPT2:ENST00000371486.4:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],:ENST00000452466.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.436-232C>T::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636867.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-2488G>A::,CPT2:ENST00000637252.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase]	CPT2:NM_000098.3:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92429 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,Carnitine palmitoyltransferase II deficiency,not specified,none provided,not provided]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, 4, susceptibility to];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.4131	0.4877	17289,.	0.2816,0.4382,0.7280,0.5441,0.2629		T(1.00), ,T(1.00),T(1.00),T(0.99), ,T(1.00)	B(0.00), ,B(0.01),B(0.03),B(0.01), ,B(0.01)	0.01	0.23		COSV53758728	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53213557	53213557	A	G	het	wt	het		QUAL=6125;DP=267,177,238;AF=0.48,0.00,0.46;MQM=60;SAP=8;ABP=7	CPT2,	missense,non_coding_transcript_exon,3'UTR	CPT2:ENST00000371486.4:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:PF00755 [Choline/Carnitine o-acyltransferase],:ENST00000452466.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.219T>C::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon6/6:c.1906A>G:p.Met636Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636867.1:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*192A>G::,CPT2:ENST00000636935.1:missense_variant:MODERATE:exon4/4:c.634A>G:p.Met212Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000637252.1:missense_variant:MODERATE:exon6/6:c.1975A>G:p.Met659Val:PF00755 [Choline/Carnitine o-acyltransferase]	CPT2:NM_000098.3:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92433 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,Carnitine palmitoyltransferase II deficiency,not specified];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2];		rs1799822	0.1004	0.1644	2187,.	0.0460,0.1283,0.0839,0.2198,0.1010		D(0.01), ,D(0.01),D(0.01), ,D(0.02),D(0.01)	B(0.01), ,B(0.00),B(0.01), ,B(0.07),B(0.00)	22.80	0.29		COSV53759353	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53214206	53214206	T	C	wt	wt	het		QUAL=694;DP=104,48,47;AF=0.00,0.00,0.60;MQM=60;SAP=14;ABP=7	CZIB	3'UTR	CZIB:ENST00000294360.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::	CZIB:NM_001304759.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453A>G::,CZIB:NM_001304760.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*453A>G::,CZIB:NM_017887.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.2282	0.2551	6029,.					5.30				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	54849678	54849678	T	C	hom	hom	hom		QUAL=17140;DP=246,129,156;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2555A>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.9998	0.9994	76006,.					2.33				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850268	54850268	G	T	het	wt	het		QUAL=10592;DP=445,318,385;AF=0.47,0.00,0.50;MQM=60;SAP=22;ABP=5	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1965C>A::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297621 [benign DISEASE=Desmosterolosis];			rs11555500	0.0102	0.0239	75,.					6.54				0	0	9	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850409	54850409	A	C	hom	hom	hom		QUAL=25126;DP=318,190,256;AF=1.00,1.00,1.00;MQM=60;SAP=8;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1824T>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297623 [benign DISEASE=Desmosterolosis];			rs654561		0.9895	74529,.					3.19				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54854229	54854229	A	G	hom	hom	hom		QUAL=601;DP=7,3,9;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	DHCR24	synonymous	DHCR24:ENST00000371269.9:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000436604.2:synonymous_variant:LOW:exon7/10:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.6:synonymous_variant:LOW:exon8/10:c.1062T>C:p.Ile354=:	DHCR24:NM_014762.4:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297654 [benign DISEASE=Desmosterolosis,not provided];			rs718265	0.6276	0.6648	33896,.	0.6163,0.5374,0.3983,0.6914,0.8057				9.77			COSV64875204	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54999070	54999070	T	C	hom	hom	het		QUAL=35366;DP=338,531,650;AF=0.99,1.00,0.48;MQM=60;SAP=532;ABP=5	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297673 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500340	0.5941	0.6697	35224,.					1.25			COSV64870665	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999117	54999117	C	G	hom	hom	het		QUAL=37486;DP=330,570,758;AF=0.99,1.00,0.48;MQM=60;SAP=206;ABP=5	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297674 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500341		0.6699	35240,.					2.96			COSV64871304	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008652	55008652	A	C	het	wt	hom		QUAL=18393;DP=295,321,451;AF=0.56,0.01,1.00;MQM=60;SAP=164;ABP=11	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297681 [benign DISEASE=Bartter disease type 4a,not provided];			rs6682884	0.3624	0.4178	13661,.	0.4963,0.2002,0.3039,0.4267,0.2805				3.81			COSV64871593	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008803	55008803	C	G	het	wt	hom	off-target	QUAL=5156;DP=167,81,124;AF=0.43,0.00,1.00;MQM=60;SAP=426;ABP=11	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	368877 [benign DISEASE=Bartter syndrome,not provided];			rs4339899	0.4299	0.4543	16440,.					0.18			COSV64871308	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	56875054	56875054	C	A	het	hom	wt		QUAL=5788;DP=135,141,210;AF=0.43,0.99,0.00;MQM=60;SAP=7;ABP=9	C8A	missense	C8A:ENST00000361249.4:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:	C8A:NM_000562.3:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:XM_011542079.2:missense_variant:MODERATE:exon3/8:c.277C>A:p.Gln93Lys:,C8A:XM_017002234.1:missense_variant:MODERATE:exon3/8:c.277C>A:p.Gln93Lys:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	17039 [benign DISEASE=COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM,not specified,not provided];			rs652785	0.3437	0.3653	8678,.	0.2062,0.2106,0.4662,0.3818,0.4981		T(0.67)	B(0.01)	6.82	0.10		COSV63484431	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56917685	56917685	C	T	wt	wt	het		QUAL=6231;DP=370,376,465;AF=0.00,0.00,0.53;MQM=60;SAP=4;ABP=6	C8A	missense	C8A:ENST00000361249.4:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain]	C8A:NM_000562.3:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	1166647 [benign DISEASE=not provided];			rs17300936	0.0613	0.0932	729,.	0.0305,0.0374,0.0763,0.1263,0.0758		T(0.48)	B(0.00)	14.20	0.02		COSV63486347	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56929347	56929347	A	G	het	het	wt		QUAL=14161;DP=536,529,781;AF=0.52,0.49,0.00;MQM=60;SAP=137;ABP=3	C8B	3'UTR	C8B:ENST00000371237.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000535057.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:ENST00000543257.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::	C8B:NM_000066.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:NM_001278543.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:NM_001278544.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:XM_017002235.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:XR_001737397.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1692T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs2795	0.3672	0.3185	8247,.					4.66				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929578	56929578	T	C	hom	hom	hom	off-target	QUAL=25439;DP=273,249,294;AF=1.00,1.00,1.00;MQM=60;SAP=1172;ABP=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:ENST00000535057.5:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::,C8B:ENST00000543257.5:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::	C8B:NM_000066.4:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:NM_001278543.2:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::,C8B:NM_001278544.2:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::,C8B:XM_017002235.1:intron_variant:MODIFIER:intron12/12:c.1622-20A>G::,C8B:XR_001737397.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1481-20A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1168190 [benign DISEASE=not specified,not provided];			rs605648		0.8858	55308,.	0.7906,0.9243,0.9403,0.8559,0.9700				0.13		8.84>8.35		0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56943656	56943656	A	G	wt	het	wt	off-target	QUAL=2747;DP=185,187,229;AF=0.00,0.58,0.00;MQM=60;SAP=52;ABP=14	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:ENST00000535057.5:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::,C8B:ENST00000543257.5:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::	C8B:NM_000066.4:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:NM_001278543.2:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::,C8B:NM_001278544.2:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::,C8B:XM_017002235.1:intron_variant:MODIFIER:intron9/12:c.1234+40T>C::,C8B:XR_001737397.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1093+40T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs72670361	0.0168	0.0308	92,.	0.0074,0.0201,0.0001,0.0475,0.0065				1.11				0	26	1056	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56956811	56956811	C	T	hom	hom	hom		QUAL=26277;DP=295,249,267;AF=1.00,1.00,1.00;MQM=60;SAP=156;ABP=0	C8B	missense	C8B:ENST00000371237.9:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000535057.5:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:ENST00000543257.5:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:	C8B:NM_000066.4:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:NM_001278543.2:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:,C8B:NM_001278544.2:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:XM_017002235.1:missense_variant:MODERATE:exon4/13:c.349G>A:p.Gly117Arg:,C8B:XR_001737397.1:non_coding_transcript_exon_variant:MODIFIER:exon3/11:n.449G>A::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1169777 [benign DISEASE=not provided];			rs1013579		0.9788	72908,.	0.9943,0.9755,0.9999,0.9684,0.9896		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.85	0.04			0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63415881	63415881	C	T	het	het	hom		QUAL=7295;DP=245,64,86;AF=0.56,0.44,1.00;MQM=60;SAP=252;ABP=7	ALG6	missense	ALG6:ENST00000263440.6:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]	ALG6:NM_013339.4:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	95531 [benign/likely benign DISEASE=Congenital disorder of glycosylation type 1C,not specified];			rs4630153		0.7573	44156,.	0.8699,0.8233,0.8607,0.6835,0.8564		T(0.32)	B(0.00)	21.60	0.19		COSV54765155	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63437781	63437781	T	C	het	het	hom		QUAL=2157;DP=96,14,21;AF=0.54,0.57,1.00;MQM=60;SAP=84;ABP=5	ALG6	3'UTR	ALG6:ENST00000263440.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::	ALG6:NM_013339.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	297858 [benign DISEASE=Congenital disorder of glycosylation type 1C];			rs3009572		0.6055	29520,.					1.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67000108	67000108	G	A	het	wt	wt		QUAL=287;DP=76,20,26;AF=0.37,0.05,0.00;MQM=60;SAP=66;ABP=14	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3935C>T::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4232C>T::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5884C>T::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6669C>T::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs901342235		0.0013	0,.					0.83				0	0	9	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000287	67000287	T	-	wt	wt	het		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=40	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3756del::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4053del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5705del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6490del::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu), (T)n (Simple_repeat)	rs377396719		0.0022	0,.					1.14				0	0	23	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	-	het	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=27	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3738del::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4035del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5687del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6472del::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs397861605		0.0102	28,.					0.09				0	2	61	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	T	wt	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=6;ABP=47	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3738T>A::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4035T>A::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5687T>A::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6472T>A::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs7540819		0.6460	27960,.					0.36				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047220	67047220	G	T	hom	hom	hom	off-target	QUAL=12445;DP=171,106,112;AF=1.00,1.00,1.00;MQM=60;SAP=502;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+45C>A::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+45C>A::,SLC35D1:XM_006710478.2:intron_variant:MODIFIER:intron7/13:c.636+45C>A::,SLC35D1:XM_011541070.2:intron_variant:MODIFIER:intron7/12:c.636+45C>A::,SLC35D1:XR_001737057.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/14:n.1046+45C>A::,SLC35D1:XR_001737058.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.1039+45C>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234892 [benign DISEASE=not provided];			rs1024229		0.6902	36445,.	0.7697,0.6619,0.6296,0.6613,0.7501				3.34				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047237	67047237	A	C	hom	hom	hom	off-target	QUAL=13908;DP=180,121,139;AF=0.99,1.00,1.00;MQM=60;SAP=475;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+28T>G::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+28T>G::,SLC35D1:XM_006710478.2:intron_variant:MODIFIER:intron7/13:c.636+28T>G::,SLC35D1:XM_011541070.2:intron_variant:MODIFIER:intron7/12:c.636+28T>G::,SLC35D1:XR_001737057.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/14:n.1046+28T>G::,SLC35D1:XR_001737058.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.1039+28T>G::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1270736 [benign DISEASE=not provided];			rs1024230		0.6902	36434,.	0.7700,0.6625,0.6304,0.6618,0.7505				6.35				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054377	67054378	CA	-	het	het	hom		QUAL=470;DP=23,8,12;AF=0.39,0.50,1.00;MQM=60;SAP=57;ABP=5	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	SLC35D1:XM_006710478.2:5_prime_UTR_variant:MODIFIER:exon1/14:c.-365_-364del::,SLC35D1:XM_011541070.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-365_-364del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon1/15:n.46_47del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon1/13:n.39_40del::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1250615 [benign DISEASE=not provided];			rs3840439	0.3438	0.6253	29928,.					7.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054400	67054400	C	T	het	het	wt		QUAL=196;DP=11,6,7;AF=0.82,0.50,0.00;MQM=60;SAP=29;ABP=9	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	SLC35D1:XM_006710478.2:5_prime_UTR_variant:MODIFIER:exon1/14:c.-387G>A::,SLC35D1:XM_011541070.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-387G>A::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon1/15:n.24G>A::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon1/13:n.17G>A::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1243207 [benign DISEASE=not provided];			rs3806321	0.1567	0.1451	1881,.					3.93					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054457	67054457	T	G	hom	n/a	hom	off-target	QUAL=245;DP=4,2,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1282317 [benign DISEASE=not provided];			rs2025087		0.7612	44244,.					4.56					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	75724531	75724531	G	A	hom	het	het		QUAL=2094;DP=15,71,99;AF=0.93,0.51,0.43;MQM=60;SAP=96;ABP=5	ACADM	5'UTR	ACADM:ENST00000541113.6:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000680805.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::		regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298063 [benign/likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs17848068	0.2043	0.2690	5738,.					1.45				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728545	75728545	T	-	hom	hom	hom	off-target	QUAL=16886;DP=177,157,206;AF=1.00,1.00,1.00;MQM=60;SAP=415;ABP=0	ACADM	intron	ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3731del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3186del::	ACADM:NM_000016.6:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:NM_001127328.3:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:NM_001286042.2:intron_variant:MODIFIER:intron1/10:c.10+3731del::,ACADM:NM_001286043.2:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:NM_001286044.2:intron_variant:MODIFIER:intron1/8:c.-268+3731del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	226050 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs796117827		1.0000	76091,.					0.47				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75763641	75763641	T	C	wt	het	het		QUAL=125;DP=31,6,10;AF=0.03,0.17,0.70;MQM=60;SAP=23;ABP=3	ACADM	3'UTR	ACADM:ENST00000370841.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:ENST00000681790.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::	ACADM:NM_000016.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001127328.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001286042.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*878T>C::,ACADM:NM_001286043.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*878T>C::,ACADM:NM_001286044.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*878T>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587		0.6571	32909,.					0.90				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92474854	92474854	C	T	het	wt	het		QUAL=6067;DP=278,118,165;AF=0.54,0.00,0.49;MQM=60;SAP=86;ABP=4	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::	GFI1:NM_001127215.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_001127216.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_005270749.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_011541245.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_011541246.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs41313373	0.0673	0.0947	886,.					15.72				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92475800	92475800	A	G	wt	het	wt		QUAL=3115;DP=445,227,280;AF=0.00,0.52,0.00;MQM=60;SAP=3;ABP=4	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::	GFI1:NM_001127215.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_001127216.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_005270749.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_011541245.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_011541246.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1271213 [benign DISEASE=not provided];			rs4970714		0.7118	39148,.					0.04			COSV54042587	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478757	92478757	-	AGAGAG	wt	het	wt		QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=19;ABP=65	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1170883 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,not specified,not provided];			rs35896485		0.3228	7908,.					7.21				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478759	AG	-	wt	wt	het		QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=20;ABP=194	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298182 [likely benign(replaced by megSAP based on classifications:3x1,2x3) DISEASE=Severe congenital neutropenia 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485		0.1234	1089,.					7.48				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478763	AGAGAG	-	hom	het	het		QUAL=5313;DP=60,99,154;AF=0.00,0.01,0.33;MQM=60;SAP=127;ABP=12	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298185 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485		0.1112	946,.					6.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483381	92483381	C	T	het	het	wt		QUAL=3343;DP=98,265,322;AF=0.47,0.46,0.00;MQM=60;SAP=106;ABP=8	GFI1	missense	GFI1:ENST00000294702.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	GFI1:NM_001127215.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_001127216.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_005263.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_005270749.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_011541245.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_011541246.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	259699 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,not specified,not provided];			rs34631763	0.0194	0.0404	183,.	0.0094,0.0282,0.0000,0.0564,0.0089		T(0.53),T(0.53),T(0.53)	B(0.02),B(0.02),B(0.02)	16.72	0.06		COSV54042707	0.01	41	1291	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486100	92486100	-	A	het	het	het	off-target	QUAL=2441;DP=91,67,106;AF=0.47,0.49,0.32;MQM=60;SAP=3;ABP=19	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	GFI1:NM_005263.5:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs112925059		0.1223	1259,.					6.53					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97078196	97078196	G	A	het	het	het		QUAL=16071;DP=471,323,440;AF=0.48,0.50,0.48;MQM=60;SAP=234;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*780C>T::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*780C>T::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*780C>T::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*780C>T::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100064 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291593	0.3850	0.2898	6936,.					0.19				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078208	97078208	C	T	het	het	het		QUAL=15538;DP=404,340,463;AF=0.49,0.50,0.47;MQM=60;SAP=145;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*768G>A::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*768G>A::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*768G>A::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*768G>A::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100065 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291592	0.5775	0.4520	16990,.					2.72				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078403	97078403	C	T	het	het	wt		QUAL=7022;DP=325,212,285;AF=0.52,0.44,0.00;MQM=60;SAP=214;ABP=3	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*573G>A::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*573G>A::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*573G>A::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*573G>A::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100067 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1042482	0.0895	0.0625	400,.					2.97				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97082275	97082275	G	A	hom	hom	hom	off-target	QUAL=15058;DP=185,126,164;AF=1.00,1.00,1.00;MQM=60;SAP=702;ABP=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron21/21:c.2691+55C>T::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron21/21:c.2796+55C>T::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron24/24:c.2412+55C>T::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron23/23:c.2412+55C>T::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron22/22:c.2412+55C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1255090 [benign DISEASE=not provided];			rs290854		1.0000	76061,.					2.09				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97450068	97450068	A	G	het	wt	het		QUAL=4784;DP=202,150,187;AF=0.45,0.00,0.52;MQM=60;SAP=177;ABP=4	DPYD	synonymous	DPYD:ENST00000370192.8:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]	DPYD:NM_000110.4:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:,DPYD:XM_005270562.3:synonymous_variant:LOW:exon13/22:c.1680T>C:p.Phe560=:,DPYD:XM_006710397.3:synonymous_variant:LOW:exon14/21:c.1896T>C:p.Phe632=:,DPYD:XM_017000507.1:synonymous_variant:LOW:exon13/22:c.1785T>C:p.Phe595=:,DPYD:XM_017000508.2:synonymous_variant:LOW:exon16/25:c.1401T>C:p.Phe467=:,DPYD:XM_017000509.2:synonymous_variant:LOW:exon15/24:c.1401T>C:p.Phe467=:,DPYD:XM_017000510.1:synonymous_variant:LOW:exon14/23:c.1401T>C:p.Phe467=:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100088 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];			rs17376848	0.0521	0.0510	195,.	0.0218,0.0873,0.1256,0.0411,0.0347				6.57			COSV100928729	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515686	97515686	T	C	hom	het	hom	off-target	QUAL=8027;DP=188,44,54;AF=1.00,0.45,1.00;MQM=60;SAP=546;ABP=4	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron12/21:c.1524+33874A>G::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron13/20:c.1740+40A>G::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron12/21:c.1629+40A>G::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron15/24:c.1245+40A>G::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron14/23:c.1245+40A>G::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron13/22:c.1245+40A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100090 [benign DISEASE=not provided];			rs2811178	0.6518	0.6357	29076,.	0.6347,0.7027,0.7442,0.5962,0.6264				0.88				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97679170	97679170	T	C	wt	wt	het		QUAL=586;DP=168,36,55;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=3	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:PF07992 [Pyridine nucleotide-disulphide oxidoreductase]	DPYD:NM_000110.4:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:,DPYD:XM_005270562.3:missense_variant:MODERATE:exon8/22:c.775A>G:p.Lys259Glu:,DPYD:XM_006710397.3:missense_variant:MODERATE:exon8/21:c.775A>G:p.Lys259Glu:,DPYD:XM_017000507.1:missense_variant:MODERATE:exon7/22:c.664A>G:p.Lys222Glu:,DPYD:XM_017000508.2:missense_variant:MODERATE:exon10/25:c.280A>G:p.Lys94Glu:,DPYD:XM_017000509.2:missense_variant:MODERATE:exon9/24:c.280A>G:p.Lys94Glu:,DPYD:XM_017000510.1:missense_variant:MODERATE:exon8/23:c.280A>G:p.Lys94Glu:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	235464 [likely benign(replaced by megSAP based on classifications:4x1,2x2,1x3) DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.0044	0.0062	6,.	0.0015,0.0032,0.0000,0.0082,0.0050		D(0.00)	B(0.14)	22.80	0.61		COSV99058634	0	1	266	0 / 0	1	"[3] Stephan Waldmller 18.11.2015 [n/a] comment imported from detected variant: HGMD: DM fr Dihydropyrimidine dehydrogenase deficiency, Literatur nicht berzeugend, VUS3, swal 151118 [1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC"			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97719971	97719971	A	G	hom	hom	hom		QUAL=15798;DP=206,123,150;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron5/21:c.483+1539T>C::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron5/20:c.483+1539T>C::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron4/21:c.372+1539T>C::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron6/24:c.-126+854T>C::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron5/23:c.-126+1539T>C::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron4/22:c.-126+1539T>C::,DPYD:XR_001737014.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.722+854T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs2151562		0.9953	75151,.					5.55				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97720521	97720521	T	C	hom	hom	hom		QUAL=20031;DP=282,136,192;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+989A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron5/21:c.483+989A>G::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron5/20:c.483+989A>G::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron4/21:c.372+989A>G::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron6/24:c.-126+304A>G::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron5/23:c.-126+989A>G::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron4/22:c.-126+989A>G::,DPYD:XR_001737014.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.722+304A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs1333718		0.9953	75164,.					16.20				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97883329	97883329	A	G	wt	wt	het		QUAL=2645;DP=218,162,215;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4	DPYD	missense	DPYD:ENST00000306031.5:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:,DPYD:ENST00000370192.8:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:	DPYD:NM_000110.4:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:,DPYD:NM_001160301.1:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:,DPYD:XM_005270562.3:missense_variant:MODERATE:exon2/22:c.85T>C:p.Cys29Arg:,DPYD:XM_006710397.3:missense_variant:MODERATE:exon2/21:c.85T>C:p.Cys29Arg:,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron1/21:c.39+37555T>C::,DPYD:XM_017000508.2:5_prime_UTR_variant:MODIFIER:exon2/25:c.-626T>C::,DPYD:XM_017000509.2:5_prime_UTR_variant:MODIFIER:exon2/24:c.-524T>C::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron1/22:c.-459+37555T>C::,DPYD:XR_001737014.1:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.222T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	435 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not provided];	CM970421 [CLASS=DFP MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs1801265		0.2732	6303,.			T(0.41),T(0.52)	B(0.00),B(0.00)	18.87					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97988913	97988913	G	T	wt	wt	het		QUAL=707;DP=245,71,74;AF=0.00,0.00,0.42;MQM=60;SAP=9;ABP=7	MIR137HG	non_coding_transcript_exon,intron&non_coding_transcript	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1726C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-9598C>A::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1556C>A::						rs41285694	0.0962	0.1171	1418,.					1.64					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97989572	97989572	A	-	het	het	het		QUAL=932;DP=84,17,28;AF=0.38,0.24,0.25;MQM=60;SAP=18;ABP=34	MIR137HG	splice_region&intron&non_coding_transcript,intron&non_coding_transcript	MIR137HG:ENST00000424528.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.1070-3del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-10257del::	MIR137HG:NR_046105.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.900-3del::	regulatory_region_variant:enhancer				AluSp (SINE/Alu)	rs543197080		0.0315	149,.					0.30					0	108	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97990401	97990401	G	A	wt	wt	het		QUAL=1441;DP=174,115,145;AF=0.00,0.00,0.42;MQM=60;SAP=52;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-832C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11086C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-832C>T::					L1PA13 (LINE/L1)	rs61785886	0.0966	0.1172	1417,.					1.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991087	97991087	G	A	wt	wt	het		QUAL=662;DP=144,45,76;AF=0.00,0.00,0.39;MQM=59;SAP=6;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1518C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11772C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1518C>T::					AluY (SINE/Alu)	rs61785887	0.0737	0.0851	753,.					1.32					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991175	97991175	C	T	wt	wt	het		QUAL=965;DP=214,57,114;AF=0.00,0.00,0.39;MQM=59;SAP=4;ABP=14	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1606G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11860G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1606G>A::					AluY (SINE/Alu)	rs61785888	0.0965	0.1180	1434,.					4.45					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991351	97991351	C	A	wt	wt	het		QUAL=1314;DP=192,87,96;AF=0.00,0.00,0.53;MQM=60;SAP=18;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1782G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12036G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1782G>T::						rs4573558	0.1060	0.1264	1503,.					0.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991747	97991747	C	G	wt	wt	het		QUAL=2097;DP=278,105,175;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2178G>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12432G>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2178G>C::						rs2893376	0.1492	0.1655	2247,.					0.17					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991967	97991967	A	T	wt	wt	het		QUAL=1562;DP=205,63,125;AF=0.00,0.00,0.49;MQM=60;SAP=29;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2398T>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12652T>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2398T>A::						rs2391873	0.1378	0.1545	1959,.					11.56					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994504	97994504	A	C	het	wt	het		QUAL=2944;DP=159,63,88;AF=0.48,0.00,0.51;MQM=60;SAP=216;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+412T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15189T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+412T>G::					AluSx (SINE/Alu)									2.70					0	3	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994550	97994550	G	A	hom	hom	het		QUAL=9102;DP=166,85,125;AF=1.00,1.00,0.53;MQM=60;SAP=607;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+366C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15235C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+366C>T::					AluSx (SINE/Alu)	rs9440288		0.8401	53798,.					0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995576	97995576	G	C	hom	hom	het		QUAL=22262;DP=266,282,366;AF=1.00,1.00,0.47;MQM=60;SAP=85;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-576C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16261C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-576C>G::					L2a (LINE/L2)	rs9324380		0.9147	63854,.					0.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995701	97995701	-	TTGT	hom	hom	het		QUAL=16425;DP=233,209,270;AF=0.99,1.00,0.44;MQM=60;SAP=49;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-702_985-701insACAA::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16387_141-16386insACAA::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-702_815-701insACAA::						rs10655213		0.8736	58159,.					0.46					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995887	97995887	C	T	het	het	het		QUAL=4939;DP=163,96,103;AF=0.52,0.47,0.52;MQM=60;SAP=43;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-887G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16572G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-887G>A::						rs9662365	0.4657	0.4913	18442,.					14.58					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97996398	97996398	T	C	hom	hom	het		QUAL=5956;DP=150,26,33;AF=0.99,1.00,0.58;MQM=60;SAP=260;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-1398A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-17083A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-1398A>G::						rs1938570	0.8936	0.8676	57259,.					0.32					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97997365	97997365	C	A	het	wt	het		QUAL=5225;DP=252,155,183;AF=0.50,0.00,0.48;MQM=60;SAP=70;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-2365G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-18050G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-2365G>T::						rs146033831	0.0176	0.0065	27,.					0.50					1	18	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97999972	97999972	G	A	hom	hom	het		QUAL=22731;DP=309,252,336;AF=1.00,1.00,0.50;MQM=60;SAP=336;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-4972C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20657C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-4972C>T::	regulatory_region_variant:promoter_flanking_region					rs2154403		0.8819	59505,.					3.62					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98000284	98000284	G	A	het	het	wt		QUAL=5755;DP=282,224,308;AF=0.49,0.42,0.00;MQM=60;SAP=20;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-5284C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20969C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-5284C>T::					L2a (LINE/L2)	rs116319667	0.0046	0.0095	13,.					0.33					5	94	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98001230	98001230	T	C	wt	het	wt		QUAL=1949;DP=337,144,175;AF=0.01,0.51,0.00;MQM=60;SAP=3;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-6230A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-21915A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-6230A>G::						rs12138817	0.1697	0.2270	4793,.					0.45					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98002983	98002984	TA	-	hom	hom	het		QUAL=17172;DP=329,145,205;AF=0.98,1.00,0.54;MQM=60;SAP=241;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-7984_985-7983del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-23669_141-23668del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-7984_815-7983del::	regulatory_region_variant:enhancer					rs5776390		0.8727	58049,.					0.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004131	98004131	A	-	het	wt	het		QUAL=6972;DP=211,245,312;AF=0.50,0.00,0.51;MQM=60;SAP=10;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9131del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-24816del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9131del::						rs564190891		0.0022	7,.					15.18					0	7	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004495	98004495	-	AT	hom	hom	het		QUAL=23846;DP=516,128,229;AF=1.00,1.00,0.48;MQM=60;SAP=101;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9496_985-9495insAT::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25181_141-25180insAT::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9496_815-9495insAT::						rs10655252		0.8471	54611,.					0.50					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98005049	98005049	A	G	hom	hom	het		QUAL=6773;DP=178,20,25;AF=1.00,1.00,0.44;MQM=60;SAP=228;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-10049T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25734T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-10049T>C::	regulatory_region_variant:promoter_flanking_region					rs10747495		0.8818	59481,.					5.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006231	98006231	C	A	wt	het	wt		QUAL=231;DP=278,55,89;AF=0.00,0.33,0.00;MQM=60;SAP=7;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11231G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-26916G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11231G>T::					L1ME4a (LINE/L1)	rs55635742	0.0106	0.0199	40,.					0.54					2	160	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006652	98006652	A	G	het	wt	het		QUAL=3000;DP=167,75,97;AF=0.46,0.00,0.41;MQM=60;SAP=54;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11652T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-27337T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.0633	0.0179	129,.					5.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007323	98007323	C	T	hom	hom	het		QUAL=20990;DP=326,193,254;AF=1.00,1.00,0.56;MQM=60;SAP=16;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12323G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28008G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12323G>A::	regulatory_region_variant:open_chromatin_region					rs1938564		0.8048	49545,.					0.96					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007402	98007402	T	A	hom	hom	het		QUAL=15845;DP=223,170,183;AF=1.00,1.00,0.55;MQM=60;SAP=23;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12402A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28087A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12402A>T::	regulatory_region_variant:open_chromatin_region					rs1938563		0.8809	59197,.					5.87					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98008160	98008160	T	A	hom	hom	het		QUAL=18851;DP=396,116,129;AF=1.00,1.00,0.55;MQM=60;SAP=185;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-13160A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28845A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-13160A>T::						rs1938562		0.8810	59201,.					6.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009211	98009211	C	T	hom	hom	het		QUAL=15309;DP=290,116,162;AF=1.00,1.00,0.49;MQM=60;SAP=343;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14211G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-29896G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14211G>A::						rs2391902		0.8116	50263,.					13.52					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009966	98009966	T	C	hom	hom	het		QUAL=16449;DP=306,118,172;AF=1.00,1.00,0.52;MQM=60;SAP=172;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14966A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-30651A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14966A>G::	regulatory_region_variant:promoter_flanking_region					rs2154402		0.9145	63715,.					8.88					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98010357	98010357	G	A	hom	hom	het		QUAL=14289;DP=297,87,125;AF=1.00,1.00,0.55;MQM=60;SAP=8;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-15357C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31042C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-15357C>T::						rs9324381		0.8455	54321,.					3.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011162	98011162	G	A	hom	hom	het		QUAL=26059;DP=418,218,279;AF=1.00,1.00,0.59;MQM=60;SAP=3;ABP=25	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16162C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31847C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16162C>T::						rs1938561	0.9022	0.8818	59488,.					2.41					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011394	98011394	T	C	hom	hom	het		QUAL=25126;DP=338,267,328;AF=1.00,1.00,0.55;MQM=60;SAP=3;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16394A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32079A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16394A>G::					L2c (LINE/L2)	rs9440293		0.8805	59131,.					0.90					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011402	98011402	C	T	hom	hom	het		QUAL=25405;DP=342,268,337;AF=1.00,1.00,0.55;MQM=60;SAP=6;ABP=9	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16402G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32087G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16402G>A::					L2c (LINE/L2)	rs9727941		0.8447	54228,.					3.39					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011410	98011410	G	C	hom	hom	het		QUAL=25206;DP=342,265,340;AF=1.00,1.00,0.56;MQM=60;SAP=17;ABP=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16410C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32095C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16410C>G::					L2c (LINE/L2)	rs9724773		0.8448	54214,.					3.96					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012603	98012603	-	AC	het	hom	het		QUAL=11054;DP=251,118,167;AF=0.84,0.92,0.49;MQM=60;SAP=60;ABP=150	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17605_985-17604dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-33290_141-33289dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17605_815-17604dup::					MIRb (SINE/MIR)	rs112555829		0.7836	45617,.					2.93					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012988	98012988	A	T	hom	hom	het		QUAL=29785;DP=410,332,452;AF=1.00,1.00,0.48;MQM=60;SAP=179;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17988T>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+33020T>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17988T>A::					L2c (LINE/L2)	rs1938565	0.9024	0.8818	59509,.					12.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98013425	98013425	C	T	hom	hom	het		QUAL=5322;DP=127,22,28;AF=1.00,1.00,0.43;MQM=60;SAP=13;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-18425G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+32583G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-18425G>A::						rs1938566		0.8117	50348,.					0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014572	98014572	T	C	hom	hom	het		QUAL=22105;DP=405,193,218;AF=1.00,1.00,0.49;MQM=60;SAP=88;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19572A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31436A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567		0.8603	56278,.					1.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014656	98014656	C	T	het	het	wt		QUAL=8052;DP=427,147,200;AF=0.54,0.50,0.01;MQM=60;SAP=23;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19656G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31352G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.3331	0.2957	7354,.					0.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014760	98014760	A	-	het	het	het		QUAL=645;DP=103,34,47;AF=0.12,0.18,0.34;MQM=60;SAP=3;ABP=162	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19760del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31248del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19760del::					A-rich (Low_complexity)	rs756636800		0.0134	12,.					1.28					0	129	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98016194	98016194	C	T	het	het	wt		QUAL=6616;DP=335,216,298;AF=0.46,0.47,0.01;MQM=60;SAP=22;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-21194G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+29814G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-21194G>A::						rs6683447	0.3187	0.2727	6595,.					0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017024	98017024	G	A	hom	hom	het		QUAL=14206;DP=266,104,171;AF=1.00,1.00,0.50;MQM=60;SAP=364;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22024C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28984C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22024C>T::					L1MB1 (LINE/L1)	rs2391903		0.9147	63844,.					3.34					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017137	98017137	A	G	hom	hom	het		QUAL=16875;DP=242,159,245;AF=1.00,1.00,0.54;MQM=60;SAP=3;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22137T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28871T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22137T>C::					L1MB1 (LINE/L1)	rs1892549		0.8552	55762,.					2.95					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017272	98017272	A	G	hom	hom	het		QUAL=15794;DP=301,122,139;AF=1.00,1.00,0.44;MQM=60;SAP=53;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22272T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28736T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22272T>C::					L1MB1 (LINE/L1)	rs1892550		0.8553	55794,.					0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017405	98017405	C	T	hom	hom	het		QUAL=14102;DP=278,97,134;AF=1.00,0.99,0.45;MQM=60;SAP=90;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22405G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28603G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22405G>A::					L1MB1 (LINE/L1)	rs1892551		0.8554	55797,.					9.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017479	98017479	G	A	hom	hom	het		QUAL=9869;DP=216,54,75;AF=1.00,1.00,0.48;MQM=60;SAP=270;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22479C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28529C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22479C>T::						rs1892552		0.8554	55783,.					0.56					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017594	98017594	A	G	hom	hom	het		QUAL=6154;DP=147,19,34;AF=1.00,1.00,0.62;MQM=60;SAP=4;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22594T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28414T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22594T>C::						rs2391904		0.8552	55774,.					1.50					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017674	98017674	T	A	wt	het	wt		QUAL=148;DP=225,29,54;AF=0.00,0.41,0.00;MQM=60;SAP=6;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22674A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28334A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22674A>T::						rs116414424	0.0152	0.0265	68,.					1.35					1	12	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017766	98017766	T	C	hom	hom	het		QUAL=6594;DP=154,33,49;AF=1.00,1.00,0.31;MQM=60;SAP=10;ABP=19	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22766A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28242A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22766A>G::						rs9324382	0.8692	0.8537	55543,.					8.40					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018596	98018596	T	C	hom	hom	het		QUAL=7937;DP=166,53,91;AF=1.00,1.00,0.35;MQM=60;SAP=3;ABP=20	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23596A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27412A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23596A>G::						rs1938571		0.8049	49686,.					1.56					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018735	98018735	G	A	hom	hom	het		QUAL=11189;DP=210,97,108;AF=1.00,1.00,0.36;MQM=60;SAP=11;ABP=21	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23735C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27273C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23735C>T::						rs4447033		0.8553	55776,.					1.21					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018918	98018918	T	C	hom	hom	het		QUAL=3396;DP=58,40,39;AF=1.00,1.00,0.36;MQM=57;SAP=64;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23918A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27090A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23918A>G::					AluSx1 (SINE/Alu)	rs1938572		0.8552	55611,.					0.73					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019061	98019061	C	T	hom	hom	het		QUAL=3195;DP=79,12,27;AF=1.00,1.00,0.41;MQM=60;SAP=4;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24061G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26947G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24061G>A::					AluSx1 (SINE/Alu)	rs1938573		0.8564	55598,.					0.88					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019398	98019398	G	T	hom	hom	het		QUAL=19114;DP=335,156,222;AF=1.00,1.00,0.47;MQM=60;SAP=9;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24398C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26610C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24398C>A::						rs1938558		0.8553	55812,.					8.60					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019546	98019546	G	A	hom	hom	het		QUAL=13941;DP=250,126,154;AF=1.00,1.00,0.43;MQM=60;SAP=5;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24546C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26462C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24546C>T::					MIR (SINE/MIR)	rs1938559	0.8710	0.8552	55788,.					6.77					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019636	98019636	C	T	hom	hom	het		QUAL=22291;DP=509,106,138;AF=1.00,1.00,0.43;MQM=60;SAP=50;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24636G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26372G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24636G>A::	regulatory_region_variant:open_chromatin_region				MIR (SINE/MIR)	rs1938560	0.8710	0.8553	55808,.					2.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020017	98020017	C	T	hom	hom	het		QUAL=8872;DP=148,88,74;AF=1.00,1.00,0.64;MQM=60;SAP=378;ABP=15	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25017G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25991G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25017G>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs9324383		0.8553	55769,.					3.42					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TTT	het	n/a	n/a		QUAL=232;DP=20,2,2;AF=0.55,1.00,0.00;MQM=58;SAP=17;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25145_985-25143dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25863_140+25865dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25145_815-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296		0.8121	48239,.					1.99					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020371	98020371	T	C	hom	hom	het		QUAL=6998;DP=106,83,108;AF=1.00,0.99,0.44;MQM=58;SAP=356;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25371A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25637A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25371A>G::					AluSx1 (SINE/Alu)	rs9725319		0.8552	55749,.					1.46					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020435	98020435	C	T	het	wt	het		QUAL=2544;DP=109,136,159;AF=0.38,0.00,0.45;MQM=60;SAP=55;ABP=19	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25435G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25573G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.0527	0.0144	89,.					0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020606	98020606	T	C	hom	hom	het		QUAL=7541;DP=149,66,73;AF=1.00,1.00,0.36;MQM=60;SAP=219;ABP=16	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25402A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25402A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25402A>G::						rs4477335		0.8552	55731,.					3.47					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020686	98020686	-	A	hom	hom	het		QUAL=4541;DP=130,19,24;AF=0.95,0.95,0.42;MQM=60;SAP=47;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25321dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25321dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25321dup::						rs61381274		0.8546	55581,.					0.53					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020814	98020814	G	A	hom	hom	het		QUAL=4959;DP=101,32,41;AF=1.00,1.00,0.46;MQM=60;SAP=28;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25194C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25194C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25194C>T::						rs4480407		0.8738	58306,.					3.16					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021138	98021138	A	C	wt	het	wt		QUAL=1905;DP=497,160,183;AF=0.00,0.50,0.00;MQM=60;SAP=60;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24870T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24870T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24870T>G::						rs79792869	0.0152	0.0266	69,.					2.77					1	12	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021524	98021524	A	G	wt	het	wt		QUAL=3008;DP=492,177,218;AF=0.00,0.62,0.00;MQM=60;SAP=26;ABP=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24484T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24484T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24484T>C::						rs77482155	0.0222	0.0357	123,.					15.00					1	16	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021777	98021777	A	G	hom	hom	het		QUAL=20780;DP=273,220,282;AF=1.00,1.00,0.57;MQM=60;SAP=13;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24231T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24231T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24231T>C::						rs9659624		0.8551	55733,.					13.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021954	98021954	C	A	hom	hom	het		QUAL=20765;DP=389,161,203;AF=1.00,1.00,0.55;MQM=60;SAP=13;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24054G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24054G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24054G>T::						rs5005705		0.8538	55521,.					0.21					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022010	98022010	C	T	hom	hom	het		QUAL=13857;DP=234,129,144;AF=1.00,0.99,0.53;MQM=60;SAP=48;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23998G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23998G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23998G>A::						rs9324384		0.8553	55747,.					0.76					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022207	98022207	G	A	hom	hom	het		QUAL=18181;DP=308,165,181;AF=1.00,0.99,0.50;MQM=60;SAP=42;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23801C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23801C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23801C>T::						rs4634961		0.8554	55740,.					1.66					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022343	98022343	C	A	hom	hom	het		QUAL=19917;DP=273,232,262;AF=1.00,1.00,0.52;MQM=60;SAP=76;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23665G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23665G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23665G>T::						rs9324385		0.8553	55747,.					3.16					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022403	98022403	G	A	hom	hom	het		QUAL=26136;DP=377,265,327;AF=1.00,1.00,0.51;MQM=60;SAP=11;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23605C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23605C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23605C>T::						rs9324386		0.8553	55772,.					0.88					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022474	98022474	G	A	hom	hom	het		QUAL=22613;DP=332,214,330;AF=1.00,1.00,0.50;MQM=60;SAP=106;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23534C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23534C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23534C>T::						rs9324387		0.8554	55778,.					1.57					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022599	98022599	G	A	hom	hom	het		QUAL=17798;DP=284,169,197;AF=1.00,1.00,0.46;MQM=60;SAP=3;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23409C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23409C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23409C>T::						rs9324388	0.8710	0.8554	55784,.					7.83					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023307	98023307	A	G	hom	hom	het		QUAL=16788;DP=319,127,131;AF=1.00,1.00,0.64;MQM=60;SAP=433;ABP=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22701T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22701T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22701T>C::						rs9659996		0.8552	55750,.					12.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023339	98023339	C	T	hom	hom	het		QUAL=10349;DP=169,101,92;AF=1.00,1.00,0.58;MQM=60;SAP=129;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22669G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22669G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22669G>A::						rs9658841		0.8552	55756,.					2.64					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023524	98023524	G	A	hom	hom	het		QUAL=7301;DP=173,26,38;AF=1.00,1.00,0.61;MQM=60;SAP=22;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22484C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22484C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22484C>T::						rs9661157		0.8553	55701,.					0.16					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023721	98023721	-	TACTT	het	hom	het		QUAL=5495;DP=140,56,90;AF=0.86,0.96,0.36;MQM=60;SAP=5;ABP=55	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22286_984+22287insAAGTA::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22286_140+22287insAAGTA::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22286_814+22287insAAGTA::						rs71071680		0.8548	55491,.					12.72					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023774	98023774	C	T	hom	hom	het		QUAL=9447;DP=219,52,81;AF=1.00,1.00,0.31;MQM=60;SAP=135;ABP=29	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22234G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22234G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22234G>A::						rs10747496	0.8710	0.8554	55648,.					4.42					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023922	98023922	A	G	hom	hom	het		QUAL=19522;DP=400,125,163;AF=1.00,1.00,0.42;MQM=60;SAP=5;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22086T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22086T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22086T>C::						rs4584446		0.8552	55703,.					2.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024179	98024179	T	C	hom	hom	het		QUAL=14470;DP=324,57,130;AF=1.00,1.00,0.51;MQM=60;SAP=355;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21829A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21829A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21829A>G::						rs2391905	0.8710	0.8553	55684,.					6.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024456	98024457	TT	-	hom	hom	het		QUAL=11091;DP=310,79,95;AF=0.90,0.92,0.54;MQM=60;SAP=141;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21551_984+21552del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21551_140+21552del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21551_814+21552del::					L2a (LINE/L2)	rs55633609		0.8515	53784,.					0.51					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024609	98024609	C	T	hom	hom	het		QUAL=8595;DP=179,46,72;AF=1.00,1.00,0.44;MQM=60;SAP=9;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21399G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21399G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21399G>A::						rs4950117		0.8744	58291,.					3.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024802	98024802	G	T	hom	hom	het		QUAL=16080;DP=259,154,169;AF=1.00,0.99,0.51;MQM=60;SAP=20;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21206C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21206C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21206C>A::						rs4950118		0.8549	55600,.					16.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025080	98025080	T	C	hom	hom	het		QUAL=18252;DP=373,121,172;AF=0.99,1.00,0.48;MQM=60;SAP=150;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20928A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20928A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20928A>G::						rs10783082		0.8551	55628,.					14.42					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025214	98025214	-	TTAAGTAT	hom	hom	het		QUAL=13723;DP=233,153,151;AF=0.96,1.00,0.56;MQM=60;SAP=6;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20786_984+20793dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20786_140+20793dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20786_814+20793dup::						rs5776392		0.8547	55285,.					1.86					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025692	98025692	A	C	hom	hom	het		QUAL=18386;DP=338,140,192;AF=1.00,1.00,0.45;MQM=60;SAP=6;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20316T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20316T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20316T>G::					MIR3 (SINE/MIR)	rs4950119		0.8464	54683,.					0.61					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025826	98025826	G	A	hom	hom	het		QUAL=14570;DP=269,105,175;AF=1.00,1.00,0.44;MQM=60;SAP=56;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20182C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20182C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.8710	0.8553	55570,.					3.51					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025917	98025917	A	C	hom	hom	het		QUAL=17800;DP=354,116,173;AF=1.00,0.99,0.50;MQM=60;SAP=104;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20091T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20091T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20091T>G::					MIRb (SINE/MIR)	rs4245673		0.8551	55635,.					8.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026176	98026176	T	C	hom	hom	het		QUAL=18398;DP=255,193,284;AF=1.00,1.00,0.49;MQM=60;SAP=126;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19832A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19832A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19832A>G::						rs1938568		0.8552	55670,.					13.98					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026906	98026906	C	T	hom	hom	het		QUAL=22556;DP=420,185,198;AF=1.00,0.99,0.46;MQM=60;SAP=58;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19102G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19102G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19102G>A::						rs9440393		0.8552	55613,.					0.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027024	98027024	A	G	het	het	het		QUAL=13321;DP=470,260,283;AF=0.49,0.48,0.50;MQM=60;SAP=37;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18984T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18984T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18984T>C::						rs9440302	0.4575	0.4874	18108,.					6.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027298	98027298	T	C	hom	hom	het		QUAL=16950;DP=356,95,113;AF=1.00,1.00,0.50;MQM=60;SAP=28;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18710A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18710A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18710A>G::						rs9324389	0.8710	0.8552	55628,.					0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027345	98027345	G	A	wt	het	wt		QUAL=1388;DP=320,92,90;AF=0.00,0.59,0.00;MQM=60;SAP=3;ABP=9	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18663C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18663C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18663C>T::						rs74700717	0.0106	0.0199	40,.					2.31					2	161	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027707	98027707	A	G	hom	hom	het		QUAL=13427;DP=217,123,187;AF=1.00,1.00,0.45;MQM=60;SAP=238;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18301T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18301T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18301T>C::	regulatory_region_variant:promoter_flanking_region					rs1938569	0.8706	0.8550	55541,.					5.51					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028229	98028229	G	A	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17779C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17779C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17779C>T::						rs2022864		0.8553	55035,.					1.78					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028233	98028233	A	G	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17775T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17775T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17775T>C::						rs2022865		0.8551	55020,.					7.71					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028629	98028629	G	A	hom	hom	het		QUAL=12920;DP=215,104,153;AF=1.00,0.99,0.55;MQM=60;SAP=60;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17379C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17379C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17379C>T::						rs10875124		0.8549	55334,.					5.41					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028644	98028644	A	C	hom	hom	het		QUAL=12382;DP=217,97,140;AF=1.00,0.99,0.53;MQM=60;SAP=77;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17364T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17364T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17364T>G::						rs10875125		0.8548	55305,.					1.80					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028832	98028832	-	A	hom	hom	het		QUAL=7913;DP=174,48,82;AF=0.98,1.00,0.44;MQM=60;SAP=120;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17175dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17175dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17175dup::						rs11404556		0.8552	55486,.					8.59					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029050	98029050	A	G	hom	hom	het		QUAL=14517;DP=242,132,151;AF=1.00,1.00,0.44;MQM=60;SAP=17;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16958T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16958T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16958T>C::						rs1198574	0.8712	0.8553	55488,.					18.63					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029957	98029957	T	C	hom	hom	het		QUAL=10068;DP=153,96,129;AF=1.00,1.00,0.54;MQM=60;SAP=99;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16051A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16051A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16051A>G::						rs1198573		0.8552	55357,.					16.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98030956	98030956	T	-	het	het	wt		QUAL=4251;DP=222,105,144;AF=0.51,0.60,0.03;MQM=60;SAP=190;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+15052del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+15052del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+15052del::						rs377025796		0.0104	25,.					1.85					1	59	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031620	98031620	A	C	hom	hom	het		QUAL=6039;DP=157,15,15;AF=1.00,1.00,0.67;MQM=60;SAP=6;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14388T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14388T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14388T>G::						rs1198572		0.8268	51934,.					6.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031799	98031799	A	G	het	het	wt		QUAL=777;DP=53,13,9;AF=0.51,0.62,0.00;MQM=59;SAP=30;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14209T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14209T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14209T>C::						rs188465986	0.0022	0.0082	7,.					4.16					0	66	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031807	98031807	T	C	het	wt	wt		QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=51;SAP=12;ABP=20	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14201A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14201A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14201A>G::					(AC)n (Simple_repeat)	rs796242776		0.0007	0,.					2.76					2	129	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031808	98031811	ACAC	-	wt	het	wt		QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=60;SAP=12;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14197_984+14200del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14197_140+14200del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14197_814+14200del::					(AC)n (Simple_repeat)	rs34012276		0.0445	109,.					1.56					4	7	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032116	98032116	A	G	hom	hom	het		QUAL=4984;DP=120,21,35;AF=1.00,1.00,0.37;MQM=60;SAP=89;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13892T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13892T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13892T>C::						rs1198571		0.8552	55539,.					3.24					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032783	98032783	C	T	wt	het	wt		QUAL=2115;DP=592,195,248;AF=0.00,0.47,0.00;MQM=60;SAP=11;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13225G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13225G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13225G>A::						rs17371457	0.1374	0.1802	3158,.					1.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98033342	98033342	C	A	hom	hom	het		QUAL=23989;DP=422,189,268;AF=1.00,1.00,0.47;MQM=60;SAP=210;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+12666G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+12666G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+12666G>T::						rs1782815	0.8686	0.8538	55465,.					2.66					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034034	98034034	A	-	het	wt	het		QUAL=1635;DP=86,30,36;AF=0.58,0.00,0.53;MQM=58;SAP=67;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11974del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11974del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11974del::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs143336786		0.0382	119,.					0.40					0	7	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034095	98034095	G	A	het	het	het		QUAL=1393;DP=67,17,14;AF=0.52,0.65,0.50;MQM=54;SAP=6;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11913C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11913C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11913C>T::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs1782814		0.2225	2385,.					0.86					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034107	98034107	-	AAAG	hom	hom	het		QUAL=1400;DP=41,10,7;AF=0.93,0.90,0.29;MQM=59;SAP=3;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11897_984+11900dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11897_140+11900dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11897_814+11900dup::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs780129382		0.3197	4172,.					1.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034287	98034287	T	C	hom	hom	het		QUAL=10082;DP=168,94,158;AF=0.99,1.00,0.46;MQM=60;SAP=116;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11721A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11721A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11721A>G::	regulatory_region_variant:promoter_flanking_region					rs1782813		0.8682	57430,.					3.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034489	98034489	G	C	het	het	wt		QUAL=6863;DP=388,132,168;AF=0.50,0.45,0.01;MQM=60;SAP=20;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11519C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11519C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11519C>G::	regulatory_region_variant:promoter_flanking_region				UCON1 (Unknown)	rs7554283	0.3195	0.2730	6620,.					14.87					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98035455	98035455	T	C	het	het	wt		QUAL=7037;DP=316,202,249;AF=0.48,0.53,0.00;MQM=60;SAP=30;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+10553A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+10553A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+10553A>G::	regulatory_region_variant:promoter_flanking_region					rs4950101	0.2772	0.2385	5010,.					9.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036428	98036428	T	C	hom	hom	het		QUAL=13803;DP=275,84,106;AF=0.99,1.00,0.59;MQM=60;SAP=4;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9580A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9580A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9580A>G::						rs1702294		0.8211	51425,.					1.44					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036603	98036603	G	C	hom	hom	het		QUAL=29063;DP=321,361,438;AF=1.00,1.00,0.51;MQM=60;SAP=58;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9405C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9405C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9405C>G::					Tigger3a (DNA/TcMar-Tigger)	rs1702293		0.9146	63761,.					0.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036784	98036784	G	A	hom	hom	het		QUAL=18814;DP=240,231,243;AF=1.00,1.00,0.48;MQM=60;SAP=15;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9224C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9224C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9224C>T::					Tigger3a (DNA/TcMar-Tigger)	rs1782810		0.7830	46957,.					1.79					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036854	98036854	A	C	hom	hom	het		QUAL=21528;DP=275,249,295;AF=1.00,1.00,0.51;MQM=60;SAP=63;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9154T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9154T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9154T>G::					Tigger3a (DNA/TcMar-Tigger)	rs1782811		0.8819	59450,.					0.54					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037038	98037038	A	C	hom	hom	het		QUAL=18013;DP=241,208,270;AF=1.00,1.00,0.49;MQM=60;SAP=283;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8970T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8970T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8970T>G::						rs1628294		0.9146	63749,.					2.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037378	98037378	G	T	hom	hom	het		QUAL=10749;DP=212,74,108;AF=1.00,1.00,0.38;MQM=60;SAP=25;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8630C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8630C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8630C>A::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579		0.7827	46893,.					0.73					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98040554	98040554	A	-	het	het	het		QUAL=822;DP=200,100,133;AF=0.22,0.13,0.17;MQM=60;SAP=6;ABP=388	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+5454del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+5454del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+5454del::						rs528539462		0.0068	0,.					0.04					0	99	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCA	het	wt	het		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=3;ABP=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4940_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4940_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4380_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4940_814+4947dup::						rs35835879		0.1484	1946,.					0.13					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCA	het	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=57;SAP=4;ABP=49	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4936_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4936_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4376_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4936_814+4947dup::						rs35835879		0.5573	23588,.					0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCATTCA	wt	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=6;ABP=6	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4932_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4932_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4372_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4932_814+4947dup::						rs35835879		0.1196	1303,.					0.11					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042140	98042140	A	G	hom	hom	het		QUAL=6052;DP=154,15,35;AF=0.99,1.00,0.43;MQM=60;SAP=3;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3868T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3868T>C::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3308T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3868T>C::						rs4292998	0.8129	0.7943	48245,.					5.88					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042162	98042162	C	A	hom	hom	het		QUAL=7219;DP=183,18,38;AF=1.00,1.00,0.45;MQM=60;SAP=4;ABP=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3846G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3846G>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3286G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3846G>T::						rs4411173		0.8682	57565,.					6.74					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042702	98042702	C	T	hom	hom	het		QUAL=39548;DP=576,411,500;AF=1.00,1.00,0.52;MQM=60;SAP=244;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3306G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3306G>A::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2746G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3306G>A::	regulatory_region_variant:promoter_flanking_region					rs2802535	0.8097	0.7925	47936,.					0.61					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042932	98042932	G	A	het	wt	het		QUAL=8629;DP=419,173,196;AF=0.50,0.00,0.56;MQM=60;SAP=191;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3076C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3076C>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2516C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3076C>T::						rs78924727	0.0527	0.0143	90,.					1.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98046571	98046571	G	T	hom	hom	het		QUAL=32945;DP=409,411,496;AF=1.00,1.00,0.48;MQM=60;SAP=12;ABP=6	MIR137HG	non_coding_transcript_exon	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.543C>A::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.373C>A::	regulatory_region_variant:promoter					rs2660304		0.8267	52012,.					18.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98047588	98047588	T	A	hom	hom	het		QUAL=13200;DP=231,116,132;AF=1.00,1.00,0.53;MQM=60;SAP=11;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.487-961A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.317-961A>T::						rs2660303		0.9137	63646,.					0.48					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CA	wt	wt	het		QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=60;SAP=9;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1256_486+1257dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1256_316+1257dup::	regulatory_region_variant:promoter					rs1553269771		0.0059	8,.					2.81					10	39	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CGCA	het	hom	wt		QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1257_486+1258insTGCG::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1257_316+1258insTGCG::	regulatory_region_variant:promoter					rs150117500		0.0229	98,.					2.72					0	2	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048156	98048156	-	CACACACACC	het	hom	wt		QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1221_486+1222insGGTGTGTGTG::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1221_316+1222insGGTGTGTGTG::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs750747213		0.0375	149,.					5.84					0	1	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048289	98048289	G	A	hom	hom	het		QUAL=13245;DP=147,183,260;AF=1.00,0.99,0.47;MQM=60;SAP=46;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1089C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1089C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786696		0.9146	63862,.					8.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048403	98048403	A	G	hom	hom	het		QUAL=18181;DP=248,207,277;AF=1.00,1.00,0.50;MQM=60;SAP=17;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+975T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+975T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786697		0.9147	63808,.					20.00					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049034	98049034	-	CT	wt	wt	het		QUAL=617;DP=159,97,106;AF=0.13,0.13,0.11;MQM=60;SAP=22;ABP=296	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343dup::	regulatory_region_variant:promoter					rs143725104		0.0129	20,.					13.44					2	95	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049035	98049036	CT	-	het	het	wt		QUAL=617;DP=159,97,106;AF=0.02,0.00,0.33;MQM=60;SAP=5;ABP=447	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343del::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104		0.0105	27,.					16.18					0	66	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	99851033	99851033	A	G	wt	het	wt		QUAL=1816;DP=310,107,144;AF=0.00,0.64,0.01;MQM=60;SAP=3;ABP=23	AGL	5'UTR,splice_acceptor	AGL:ENST00000294724.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000361915.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163.7:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165.7:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::	AGL:NM_000028.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000642.3:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000643.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000644.2:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::,AGL:NM_000646.2:5_prime_UTR_variant:MODIFIER:exon1/34:c.-201A>G::,AGL:XM_005270557.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	195096 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2307130	0.4271	0.4694	14073,.	0.2635,0.4393,0.5339,0.4925,0.5368				15.29		3.27>-4.68	COSV54056176	0.24	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99852537	99852537	T	-	het	het	het	off-target	QUAL=263;DP=11,6,13;AF=0.45,0.17,0.54;MQM=58;SAP=31;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron1/33:c.-109-5del::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]			AluJo (SINE/Alu)	rs58176899		0.0006	1,.					4.91				0.05	4	24	0 / 0					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99861470	99861470	C	T	het	het	het		QUAL=12734;DP=435,201,300;AF=0.53,0.48,0.46;MQM=60;SAP=4;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron1/32:c.35-33C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron2/33:c.35-33C>T::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256750 [benign DISEASE=not specified];			rs2307129	0.2272	0.2354	5048,.	0.3863,0.1314,0.1224,0.1714,0.1899				2.03			COSV54053030	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864333	99864333	G	C	het	hom	het	off-target	QUAL=2585;DP=97,33,50;AF=0.54,1.00,0.38;MQM=60;SAP=220;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron3/32:c.413-53G>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::	AGL:NM_000028.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000642.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000643.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000644.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000646.2:intron_variant:MODIFIER:intron4/33:c.413-53G>C::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676092 [benign DISEASE=not provided];			rs535461		0.7310	41149,.					2.44				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870805	99870805	C	T	het	hom	het		QUAL=8603;DP=340,98,117;AF=0.42,1.00,0.51;MQM=60;SAP=24;ABP=14	AGL	synonymous	AGL:ENST00000294724.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000361915.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.6:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]	AGL:NM_000028.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000642.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000643.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000644.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000646.2:synonymous_variant:LOW:exon7/34:c.846C>T:p.Leu282=:,AGL:XM_005270557.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	198432 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2230306		0.7588	44424,.	0.9171,0.6906,0.6850,0.7028,0.7519				11.31				0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99874669	99874669	G	A	het	hom	het	off-target	QUAL=11542;DP=218,169,229;AF=0.49,1.00,0.54;MQM=60;SAP=148;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron6/32:c.911-18G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron7/33:c.959-18G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron7/33:c.911-18G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256751 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs634880		0.7341	41276,.	0.8453,0.6822,0.7106,0.7096,0.7330				5.56		10.97>11.37	COSV54049593	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877597	99877597	A	G	wt	het	wt	off-target	QUAL=302;DP=175,22,41;AF=0.00,0.68,0.00;MQM=60;SAP=21;ABP=9	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-44A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::	AGL:NM_000028.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000642.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000643.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000644.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000646.2:intron_variant:MODIFIER:intron11/33:c.1376-44A>G::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256722 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2291638	0.2843	0.3515	8120,.	0.0899,0.3604,0.4446,0.3883,0.3040				8.44			COSV54049682	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99881185	99881185	T	C	wt	het	wt		QUAL=2719;DP=287,209,284;AF=0.00,0.51,0.00;MQM=60;SAP=4;ABP=3	AGL	splice_region&intron	AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron14/32:c.1953+8T>C::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::	AGL:NM_000028.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000642.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000643.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000644.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000646.2:splice_region_variant&intron_variant:LOW:intron15/33:c.1953+8T>C::,AGL:XM_005270557.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:XM_017000501.2:splice_region_variant&intron_variant:LOW:intron3/21:c.261+8T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296		0.5541	20632,.	0.4313,0.6220,0.6604,0.5444,0.5893				12.88			COSV54049713	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99888119	99888119	G	A	het	hom	het	off-target	QUAL=12234;DP=173,206,264;AF=0.53,1.00,0.47;MQM=60;SAP=104;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron20/32:c.2764+11G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron21/33:c.2764+11G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron9/21:c.1072+11G>A::	regulatory_region_variant:open_chromatin_region	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.6811	0.6904	33501,.	0.5852,0.7226,0.6885,0.6936,0.7307				0.59			COSV54049809	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891585	99891585	T	A	wt	het	wt	off-target	QUAL=1409;DP=198,121,186;AF=0.00,0.47,0.00;MQM=60;SAP=35;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-21T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron22/33:c.2902-21T>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron10/21:c.1210-21T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256733 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2035961		0.5367	18763,.	0.3801,0.6127,0.6593,0.5275,0.5855				5.65			COSV54051217	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892547	99892547	C	T	het	het	het		QUAL=8382;DP=251,182,223;AF=0.49,0.47,0.51;MQM=60;SAP=8;ABP=4	AGL	missense	AGL:ENST00000294724.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000361915.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.6:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000370163.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:	AGL:NM_000028.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000642.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000643.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000644.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000646.2:missense_variant:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser:,AGL:XM_005270557.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:XM_017000501.2:missense_variant:MODERATE:exon12/22:c.1459C>T:p.Pro487Ser:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256734 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.1106	0.1363	1507,.	0.1169,0.0998,0.0294,0.1496,0.1452		D(0.04),D(0.04),D(0.03),D(0.04),D(0.04)	B(0.10),B(0.10),B(0.05),B(0.10),B(0.10)	22.20	0.30			0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892644	99892644	G	A	het	hom	het	off-target	QUAL=5719;DP=136,88,117;AF=0.46,1.00,0.49;MQM=60;SAP=296;ABP=5	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron24/33:c.3211+37G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron12/21:c.1519+37G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256735 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs594249	0.6815	0.6911	33579,.	0.5841,0.7229,0.6889,0.6939,0.7346				0.01			COSV54049828	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900890	99900890	G	T	het	wt	wt	off-target	QUAL=1522;DP=81,49,51;AF=0.28,0.78,0.43;MQM=58;SAP=66;ABP=108	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+29G>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+29G>T::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron14/21:c.1848+29G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1204532 [likely benign DISEASE=not provided];		(T)n (Simple_repeat)	rs201885902		0.0169	0,.	0.0243,0.0180,0.0202,0.0153,0.0173				2.62				0.02	1	447	0 / 0	2	"[2] auto-classification 22.09.2017  "			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900891	99900892	TT	-	het	hom	het	off-target	QUAL=1522;DP=81,49,51;AF=0.27,0.06,0.08;MQM=60;SAP=183;ABP=32	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+43_3540+44del::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron14/21:c.1848+43_1848+44del::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1220869 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs35956186		0.5254	19107,.	0.3430,0.3746,0.3694,0.4285,0.3509				1.96				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910892	99910892	G	A	wt	het	wt	off-target	QUAL=2103;DP=103,176,266;AF=0.00,0.49,0.00;MQM=60;SAP=9;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+45G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+45G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron16/21:c.2096+45G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256744 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2274570	0.4613	0.4822	16702,.	0.3712,0.5710,0.5425,0.5001,0.3654				0.37			COSV54050212	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910900	99910900	T	A	wt	het	wt	off-target	QUAL=2114;DP=106,173,261;AF=0.00,0.50,0.00;MQM=60;SAP=14;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+53T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+53T>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron16/21:c.2096+53T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1224847 [benign DISEASE=not provided];			rs1541041	0.4599	0.4647	16706,.					1.85			COSV54050222	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99921923	99921923	G	T	wt	het	wt		QUAL=1097;DP=305,85,95;AF=0.00,0.52,0.00;MQM=60;SAP=4;ABP=3	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*272G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291351 [benign DISEASE=Glycogen storage disease type III,not provided];			rs1804808	0.3321	0.3249	9469,.					2.81			COSV54050326,COSV54053994	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922383	99922383	C	T	het	hom	het		QUAL=4274;DP=173,41,53;AF=0.49,1.00,0.45;MQM=60;SAP=14;ABP=4	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*732C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600		0.6176	29017,.					4.32				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922679	99922679	C	T	wt	het	wt		QUAL=258;DP=191,42,61;AF=0.01,0.38,0.00;MQM=60;SAP=6;ABP=8	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1028C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.4683	0.4734	17318,.					4.49			COSV54050336	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922947	99922947	A	C	wt	het	wt		QUAL=895;DP=221,61,69;AF=0.00,0.57,0.00;MQM=60;SAP=3;ABP=6	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1296A>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.3758	0.3799	11969,.					2.97			COSV54050348	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99923192	99923192	T	C	wt	het	wt		QUAL=1707;DP=266,123,168;AF=0.00,0.54,0.01;MQM=60;SAP=3;ABP=4	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1541T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.4018	0.4047	12947,.					0.29			COSV54050357	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100187173	100187173	G	A	wt	het	wt		QUAL=315;DP=111,37,41;AF=0.00,0.43,0.02;MQM=60;SAP=32;ABP=4	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291375 [benign DISEASE=Maple syrup urine disease,not provided];			rs72728160	0.0577	0.1172	1396,.					3.52				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100187701	100187701	T	-	het	het	het		QUAL=159;DP=18,6,10;AF=0.33,0.33,0.30;MQM=59;SAP=8;ABP=12	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1195364 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs886044938		0.0092	5,.					0.14				0	1	127	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	-	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291391 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs71709231		0.8271	49180,.					3.74				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189353	AA	-	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.48,0.00,1.00;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1200821 [likely benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71709231		0.0072	3,.					3.95				0	1	26	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	T	het	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=59;SAP=4;ABP=9	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291392 [benign DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs10783125	0.9339	0.5469	1720,.					7.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189353	100189353	A	T	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	875221 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200943386		0.8051	45023,.					7.34				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189354	100189354	A	T	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291393 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200062717		0.0074	3,.					7.53				0	0	28	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190027	100190027	T	A	hom	hom	hom		QUAL=4322;DP=104,15,13;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291395 [benign DISEASE=Maple syrup urine disease,not provided];		MER3 (DNA/hAT-Charlie)	rs4281338		0.7567	45899,.					0.15				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190140	100190141	AA	-	het	wt	het		QUAL=3494;DP=180,57,89;AF=0.49,0.02,0.65;MQM=60;SAP=194;ABP=8	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291396 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711		0.1790	3079,.					0.56				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190709	100190709	C	T	hom	hom	hom		QUAL=13994;DP=174,105,140;AF=0.99,1.00,1.00;MQM=60;SAP=30;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291404 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166412		0.7916	49079,.					0.12				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190938	100190938	A	G	wt	het	wt		QUAL=1899;DP=403,187,261;AF=0.00,0.43,0.00;MQM=60;SAP=3;ABP=10	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291406 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166413	0.2638	0.3056	8651,.					8.55			COSV64497182	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191105	100191105	T	C	hom	hom	hom		QUAL=24023;DP=361,156,207;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291407 [benign DISEASE=Maple syrup urine disease,not provided];			rs6701655		0.7590	46145,.					2.52				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191773	ATACACACACACACACACACACACAC	-	het	wt	het		QUAL=1931;DP=28,26,51;AF=0.43,0.88,0.39;MQM=58;SAP=3;ABP=4	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1228726 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs1418854977		0.0429	241,.					0.29				0	1	8	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191775	ATACACACACACACACACACACACACAC	-	het	hom	het		QUAL=1931;DP=28,26,51;AF=0.36,0.00,0.53;MQM=59;SAP=5;ABP=9	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1251386 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs140341302		0.6815	34785,.					0.28				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100193022	100193022	G	A	hom	hom	hom		QUAL=34953;DP=339,320,473;AF=0.99,1.00,1.00;MQM=60;SAP=4;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291424 [benign DISEASE=Maple syrup urine disease,not provided];			rs2784174		0.7592	46156,.					1.26				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100206310	100206310	T	A	wt	het	wt		QUAL=295;DP=244,77,112;AF=0.00,0.25,0.00;MQM=60;SAP=3;ABP=46	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron10/11:c.1336-9A>T::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron10/11:c.667-9A>T::	DBT:NM_001918.5:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::,DBT:XM_005270545.4:intron_variant:MODIFIER:intron10/11:c.667-9A>T::,DBT:XM_017000468.2:intron_variant:MODIFIER:intron11/12:c.667-9A>T::,DBT:XM_017000469.2:intron_variant:MODIFIER:intron7/8:c.667-9A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	93987 [benign DISEASE=Maple syrup urine disease,not specified];			rs34229137		0.4005	7977,.	0.1865,0.4504,0.3281,0.4141,0.3893				1.51		6.05>7.40	COSV64494912,COSV64495481	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206504	100206504	T	C	hom	hom	hom		QUAL=29048;DP=343,245,303;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0	DBT	missense	DBT:ENST00000370132.8:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681617.1:missense_variant:MODERATE:exon10/12:c.1276A>G:p.Ser426Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681780.1:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)]	DBT:NM_001918.5:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:,DBT:XM_005270545.4:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:,DBT:XM_017000468.2:missense_variant:MODERATE:exon11/13:c.607A>G:p.Ser203Gly:,DBT:XM_017000469.2:missense_variant:MODERATE:exon7/9:c.607A>G:p.Ser203Gly:		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	128885 [benign DISEASE=Maple syrup urine disease,not specified,not provided];			rs12021720		0.9174	58703,.	0.7628,0.9547,0.9692,0.9082,0.9519		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	12.46	0.12			0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100215037	100215037	-	T	het	het	het	off-target	QUAL=1313;DP=96,25,24;AF=0.55,0.48,0.42;MQM=60;SAP=125;ABP=3	DBT	intron	DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::,DBT:ENST00000370132.8:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron6/11:c.773-55dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron7/11:c.230-55dup::	DBT:NM_001918.5:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:XM_005270545.4:intron_variant:MODIFIER:intron7/11:c.230-55dup::,DBT:XM_017000468.2:intron_variant:MODIFIER:intron8/12:c.230-55dup::,DBT:XM_017000469.2:intron_variant:MODIFIER:intron4/8:c.230-55dup::,DBT:XR_946560.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.790-55dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291007 [benign DISEASE=not provided];			rs11431894		0.7788	44764,.					0.95				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100249898	100249898	G	A	hom	hom	hom	off-target	QUAL=12961;DP=46,191,275;AF=1.00,0.99,1.00;MQM=60;SAP=182;ABP=0		non_coding_transcript_exon	:ENST00000648283.1:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.272G>A::		regulatory_region_variant:promoter,TF_binding_site_variant	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1263587 [benign DISEASE=not provided];			rs3806235		0.7239	43135,.					0.49					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	109228441	109228441	T	C	hom	hom	hom		QUAL=21691;DP=237,204,230;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.288+9T>C::	SARS1:NM_001330669.1:intron_variant:MODIFIER:intron3/11:c.288+9T>C::,SARS1:NM_006513.4:intron_variant:MODIFIER:intron3/10:c.288+9T>C::	regulatory_region_variant:promoter_flanking_region	607529_[GENE=SARS1_PHENOS=?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs683182	0.6799	0.7679	39240,.	0.4629,0.8116,0.8993,0.7960,0.6581				1.81			COSV52320213	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235955	109235955	T	C	hom	hom	hom	off-target	QUAL=18717;DP=176,160,262;AF=1.00,1.00,1.00;MQM=60;SAP=443;ABP=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::	SARS1:NM_001330669.1:intron_variant:MODIFIER:intron7/11:c.970-22T>C::,SARS1:NM_006513.4:intron_variant:MODIFIER:intron7/10:c.970-22T>C::		607529_[GENE=SARS1_PHENOS=?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs658092		0.7692	39725,.	0.4870,0.8138,0.8988,0.7962,0.6586				9.53			COSV52320257	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110167097	110167097	T	C	het	het	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=76;ABP=202	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.522A>G::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1912A>G::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs7527375	0.3930	0.4958	18666,.	0.5055,0.2634,0.2103,0.5324,0.3637				0.64			COSV58991969	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167098	110167098	G	A	het	wt	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=231;ABP=7	SLC6A17,SLC6A17-AS1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.521C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::	SLC6A17:NM_001010898.4:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17:XM_006710643.2:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1911C>T::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12737742	0.2502	0.3725	10397,.	0.0887,0.2113,0.2096,0.4562,0.3459		T(0.47), , 	B(0.05), , 	13.12	0.08		COSV58993671	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167112	110167112	G	A	wt	het	wt		QUAL=4215;DP=251,312,375;AF=0.00,0.55,0.00;MQM=60;SAP=104;ABP=9	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209 [Sodium neurotransmitter symporter family],SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.507C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1897C>T::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41281364	0.0389	0.0584	279,.	0.0526,0.0342,0.0002,0.0745,0.0145				3.74			COSV58997789	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110195674	110195674	G	A	het	het	het		QUAL=16462;DP=306,383,543;AF=0.50,0.54,0.53;MQM=60;SAP=48;ABP=9	SLC6A17	synonymous	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784140	0.2897	0.4162	12538,.	0.0971,0.3307,0.2726,0.4960,0.3911				6.89			COSV58991975,COSV58995492	0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197651	110197651	G	T	het	het	het	off-target	QUAL=4715;DP=246,57,72;AF=0.54,0.40,0.58;MQM=60;SAP=372;ABP=5	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::,SLC6A17:XM_006710643.2:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603581	0.3165	0.4147	13008,.	0.1791,0.3314,0.2731,0.4937,0.3907				2.45				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198066	110198066	C	T	het	het	het	off-target	QUAL=8883;DP=177,255,329;AF=0.47,0.50,0.47;MQM=60;SAP=138;ABP=5	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::,SLC6A17:XM_006710643.2:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761445	0.3195	0.4263	13475,.	0.1831,0.3383,0.2739,0.5055,0.3988				4.71		0.77>0.84	COSV58993252	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198459	110198459	C	G	het	het	wt		QUAL=2436;DP=136,119,157;AF=0.50,0.34,0.01;MQM=60;SAP=29;ABP=15	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::,SLC6A17:XM_006710643.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761446	0.0170	0.0359	145,.	0.0071,0.0140,0.0000,0.0516,0.0315				4.22			COSV58992447	0	61	1432	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198464	110198464	C	T	wt	het	wt		QUAL=1787;DP=135,140,207;AF=0.00,0.54,0.00;MQM=60;SAP=4;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::,SLC6A17:XM_006710643.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41306175	0.0497	0.0843	569,.	0.0844,0.0451,0.0045,0.1070,0.0165				0.06			COSV58995363	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198727	110198727	G	T	het	hom	het		QUAL=17097;DP=357,269,331;AF=0.47,1.00,0.57;MQM=60;SAP=4;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603580	0.5425	0.6379	31868,.					0.32				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198961	110198961	C	G	het	hom	het		QUAL=10090;DP=171,176,215;AF=0.39,1.00,0.53;MQM=60;SAP=4;ABP=7	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784141	0.5447	0.6381	31876,.					0.26				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199463	110199463	T	C	het	hom	het		QUAL=27438;DP=292,502,680;AF=0.44,1.00,0.49;MQM=60;SAP=23;ABP=8	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603579	0.5449	0.6395	32025,.					7.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199880	110199880	A	G	het	het	het		QUAL=1558;DP=167,84,101;AF=0.32,0.25,0.26;MQM=59;SAP=156;ABP=146	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]			(GATG)n (Simple_repeat)	rs2361044	0.2883	0.4032	9505,.					5.40			COSV58997534	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199993	110199993	A	G	het	het	het		QUAL=2566;DP=123,70,108;AF=0.42,0.34,0.44;MQM=60;SAP=205;ABP=25	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]			GA-rich (Low_complexity)	rs12133992	0.2867	0.3558	11522,.					3.70				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200370	110200370	T	G	het	het	het		QUAL=7293;DP=173,180,266;AF=0.51,0.53,0.45;MQM=60;SAP=4;ABP=3	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784142	0.3079	0.3856	12839,.					8.85				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200966	110200966	G	C	het	wt	het		QUAL=8420;DP=164,388,476;AF=0.53,0.00,0.52;MQM=60;SAP=12;ABP=6	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs151008748	0.0132	0.0201	61,.					6.89				0	0	10	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201213	110201213	G	A	wt	het	wt		QUAL=2274;DP=218,164,183;AF=0.00,0.54,0.00;MQM=60;SAP=6;ABP=6	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12138403	0.0491	0.0841	565,.					2.36				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201559	110201559	C	T	wt	het	wt		QUAL=1082;DP=101,96,123;AF=0.01,0.46,0.00;MQM=60;SAP=3;ABP=4	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs62621393	0.0491	0.0841	568,.					0.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202252	110202252	G	A	wt	wt	het	off-target	QUAL=1733;DP=60,110,162;AF=0.00,0.00,0.46;MQM=60;SAP=20;ABP=6	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs45445195	0.0138	0.0216	59,.					0.43					0	6	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	114705129	114705129	A	-	wt	het	wt		QUAL=990;DP=203,75,113;AF=0.00,0.59,0.01;MQM=60;SAP=6;ABP=8	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108		0.2028	3575,.					0.07				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114707222	114707222	G	A	wt	het	wt		QUAL=1561;DP=407,125,196;AF=0.00,0.51,0.01;MQM=60;SAP=27;ABP=3	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291967 [benign DISEASE=Noonan syndrome 6];			rs14804	0.1510	0.2028	3569,.					8.30			COSV65733786	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114716780	114716780	C	T	het	wt	het		QUAL=3750;DP=185,111,128;AF=0.61,0.00,0.38;MQM=60;SAP=188;ABP=4	CSDE1,NRAS	downstream_gene,upstream_gene	CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,NRAS:ENST00000369535.5:upstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.4:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]												21.10				0	0	2	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115029744	115029744	A	G	het	hom	het	off-target	QUAL=8194;DP=163,122,179;AF=0.48,1.00,0.48;MQM=60;SAP=183;ABP=4	TSHB	upstream_gene	TSHB:ENST00000256592.3:upstream_gene_variant:MODIFIER::::			188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs1321108	0.3894	0.4225	14276,.					14.76					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033402	115033402	A	G	hom	hom	hom		QUAL=17936;DP=259,135,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	TSHB	missense	TSHB:ENST00000256592.3:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:	TSHB:NM_000549.5:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:,TSHB:XM_011542065.2:missense_variant:MODERATE:exon1/2:c.40A>G:p.Thr14Ala:		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	256640 [benign DISEASE=Congenital hypothyroidism,Secondary hypothyroidism,not specified,not provided];			rs10776792		0.9766	72526,.	0.9947,0.9916,0.9999,0.9634,0.9611		T(0.63)	B(0.00)	3.81	0.05			0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115286692	115286692	G	A	hom	het	hom		QUAL=20215;DP=183,276,388;AF=0.99,0.51,0.99;MQM=60;SAP=140;ABP=3	NGF,NGF-AS1	missense,intron&non_coding_transcript,5'UTR	NGF:ENST00000369512.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:ENST00000675637.2:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:ENST00000676038.2:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000679806.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680116.1:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000680540.1:missense_variant:MODERATE:exon1/1:c.104C>T:p.Ala35Val:,NGF:ENST00000680752.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000681124.1:5_prime_UTR_variant:MODIFIER:exon3/3:c.-368C>T::	NGF:NM_002506.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF-AS1:NR_157569.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:XM_006710663.3:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:XM_011541518.2:missense_variant:MODERATE:exon3/3:c.269C>T:p.Ala90Val:		162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers,not specified,not provided];			rs6330	0.2474	0.3695	10904,.	0.1882,0.3459,0.1629,0.4483,0.2346		D(0.04), ,D(0.04),D(0.04),D(0.04),D(0.04),D(0.04),D(0.04), 	B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), 	22.80	0.10		COSV65687373	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119422896	119422896	C	T	het	wt	het		QUAL=10751;DP=464,297,355;AF=0.54,0.00,0.41;MQM=60;SAP=11;ABP=5	HSD3B2	3'UTR	HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:NM_001166120.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292274 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency,not provided];			rs1819698	0.3101	0.2430	6732,.					4.06				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422941	119422941	C	G	het	wt	het		QUAL=10544;DP=434,291,354;AF=0.54,0.00,0.42;MQM=60;SAP=5;ABP=5	HSD3B2	3'UTR	HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:NM_001166120.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1361530	0.2560	0.1919	3633,.					0.57				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	147756396	147756396	G	A	wt	het	wt		QUAL=1649;DP=350,145,217;AF=0.00,0.46,0.00;MQM=60;SAP=15;ABP=5	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1766C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-21165G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1404290876		0.0001	0,.					3.18				0	0	2	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147756741	147756741	C	T	het	het	wt		QUAL=6287;DP=265,195,300;AF=0.51,0.55,0.00;MQM=60;SAP=5;ABP=6	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1421G>A::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20820C>T::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11240121	0.4073	0.3140	8585,.					1.23				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757166	147757166	A	G	wt	wt	het		QUAL=2009;DP=214,134,161;AF=0.00,0.00,0.50;MQM=60;SAP=54;ABP=3	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*996T>C::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20395A>G::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043806		0.1914	2906,.					10.62					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757430	147757430	G	A	het	het	wt		QUAL=7609;DP=351,316,383;AF=0.43,0.48,0.00;MQM=60;SAP=40;ABP=14	GJA5,	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.138G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*732C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20131G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043802	0.3191	0.2579	5551,.					4.57				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757496	147757520	GGGCATTTGCCAGAGGTACATACCA	-	het	het	het		QUAL=10324;DP=250,333,408;AF=0.54,0.51,0.44;MQM=60;SAP=3;ABP=5	GJA5,	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.229_253del::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*642_*666del::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20040_744-20016del::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11267274	0.4667	0.4875	18185,.					2.62					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757554	147757554	G	A	wt	wt	het		QUAL=5574;DP=432,380,483;AF=0.00,0.00,0.45;MQM=60;SAP=3;ABP=15	GJA5,	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.262G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*608C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20007G>A::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.0675	0.1431	2113,.					6.97				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147758109	147758109	C	T	wt	wt	het		QUAL=2632;DP=318,191,231;AF=0.00,0.01,0.45;MQM=60;SAP=37;ABP=7	GJA5,	3'UTR,intron&non_coding_transcript	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,:ENST00000622634.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.480-245C>T::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*53G>A::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-19452C>T::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1692141		0.1774	2590,.					4.27					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760538	147760538	G	A	wt	het	wt		QUAL=3088;DP=307,250,365;AF=0.00,0.52,0.00;MQM=60;SAP=5;ABP=4	GJA5	5'UTR,intron	GJA5:ENST00000579774.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::	GJA5:NM_005266.7:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:NM_181703.4:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:XM_005272951.4:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:XM_017001044.1:5_prime_UTR_variant:MODIFIER:exon2/3:c.-73C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-17023G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs191717313	0.0004	0.0021	0,.					7.22				0.12	0	24	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760632	147760632	T	C	het	het	het	off-target	QUAL=8401;DP=197,169,236;AF=0.49,0.56,0.58;MQM=60;SAP=257;ABP=14	GJA5	intron	GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::	GJA5:NM_005266.7:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::,GJA5:XM_005272951.4:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::,GJA5:XM_017001044.1:5_prime_UTR_variant:MODIFIER:exon2/3:c.-167A>G::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-16929T>C::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]		CR112614 [CLASS=DFP MUT=ALT PHEN="Atrial fibrillation association with" GENE=GJA5];	L2c (LINE/L2)	rs10465885		0.4568	15874,.					1.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150799227	150799227	T	C	hom	hom	hom		QUAL=34915;DP=350,341,363;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0	CTSK	synonymous,intron	CTSK:ENST00000271651.8:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000443913.2:synonymous_variant:LOW:exon7/8:c.1008A>G:p.Ala336=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676716.1:synonymous_variant:LOW:exon5/6:c.708A>G:p.Ala236=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron6/6:c.784+317A>G::,CTSK:ENST00000676824.1:synonymous_variant:LOW:exon8/9:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676966.1:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676970.1:synonymous_variant:LOW:exon7/8:c.843A>G:p.Ala281=:PF00112 [Papain family cysteine protease],CTSK:ENST00000677887.1:synonymous_variant:LOW:exon8/9:c.873A>G:p.Ala291=:PF00112 [Papain family cysteine protease],CTSK:ENST00000678337.1:synonymous_variant:LOW:exon6/7:c.867A>G:p.Ala289=:PF00112 [Papain family cysteine protease],CTSK:ENST00000679260.1:synonymous_variant:LOW:exon6/7:c.612A>G:p.Ala204=:PF00112 [Papain family cysteine protease]	CTSK:NM_000396.4:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:		601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]	1166561 [benign DISEASE=Pyknodysostosis,not provided];			rs10788796		0.9897	72569,.	0.9221,0.9930,0.9930,0.9987,0.9776				1.90				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151341298	151341298	A	G	het	hom	wt		QUAL=6590;DP=285,90,138;AF=0.49,1.00,0.01;MQM=60;SAP=37;ABP=3	RFX5,	3'UTR,intron&non_coding_transcript	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,:ENST00000422153.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.255+396A>G::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	RFX5:NM_000449.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379412.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379413.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379414.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379415.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379416.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379417.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379418.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379419.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*888T>C::,RFX5:NM_001379420.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*888T>C::,RFX5:XM_017001999.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:XM_017002000.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:XM_024448791.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292600 [benign DISEASE=Bare lymphocyte syndrome 2];			rs7552906	0.6280	0.6292	30201,.					5.21				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151341903	151341903	T	C	het	hom	het		QUAL=8308;DP=199,113,157;AF=0.56,1.00,0.47;MQM=60;SAP=416;ABP=4	RFX5,	3'UTR,non_coding_transcript_exon	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.6:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,:ENST00000422153.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.295T>C::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	RFX5:NM_000449.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379412.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379413.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379414.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379415.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379416.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379417.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379418.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379419.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*283A>G::,RFX5:NM_001379420.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*283A>G::,RFX5:XM_017001999.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:XM_017002000.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:XM_024448791.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:promoter_flanking_region	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292605 [benign DISEASE=Bare lymphocyte syndrome 2];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.7644	0.7836	46919,.					1.28			COSV51841510	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151342811	151342811	G	C	het	het	wt		QUAL=3185;DP=118,137,186;AF=0.49,0.51,0.00;MQM=60;SAP=14;ABP=3	RFX5	missense	RFX5:ENST00000290524.8:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.6:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.7:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain]	RFX5:NM_000449.4:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001025603.2:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379412.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379413.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379414.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379415.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379416.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379417.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379418.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379419.1:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:,RFX5:NM_001379420.1:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:,RFX5:XM_017001999.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:,RFX5:XM_017002000.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:,RFX5:XM_024448791.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292612 [benign DISEASE=Bare lymphocyte syndrome 2,not specified,not provided];			rs2233854	0.0635	0.1172	1332,.	0.0253,0.0720,0.0004,0.1665,0.0990		D(0.00),D(0.00),D(0.00)	B(0.11),B(0.11),B(0.11)	20.80	0.03		COSV51839208	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151343685	151343685	G	A	hom	hom	hom		QUAL=13278;DP=188,94,132;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0	RFX5	synonymous	RFX5:ENST00000290524.8:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.6:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452671.7:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:	RFX5:NM_000449.4:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001025603.2:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379412.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379413.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379414.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379415.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379416.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379417.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379418.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379419.1:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:NM_001379420.1:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:XM_017001999.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:,RFX5:XM_017002000.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:,RFX5:XM_024448791.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	403373 [benign DISEASE=Bare lymphocyte syndrome 2,not specified];			rs1752386		0.9945	72963,.	0.9251,0.9964,1.0000,0.9999,0.9998				6.86				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152302209	152302209	T	A	hom	hom	hom		QUAL=8567;DP=95,63,107;AF=1.00,1.00,1.00;MQM=60;SAP=180;ABP=0	FLG,FLG-AS1	3'UTR,intron&non_coding_transcript	FLG:ENST00000368799.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-30374T>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-30374T>A::	FLG:NM_002016.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs1933061		0.9980	75809,.					0.05				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303673	152303673	C	T	het	het	het		QUAL=43645;DP=466,1277,1871;AF=0.49,0.50,0.51;MQM=59;SAP=52;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28910C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28910C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs77422831	0.2869	0.2423	3119,.	0.0294,0.4284,0.5593,0.1422,0.3682		T(0.43), , , 	B(0.07), , , 	0.41	0.02		COSV64245538	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303901	152303901	C	G	wt	het	het		QUAL=10141;DP=502,1476,2042;AF=0.05,0.19,0.31;MQM=28;SAP=456;ABP=1783	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2068C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28682C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28682C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206244 [benign DISEASE=not specified,not provided];			rs75235053		0.0225	0,.	0.0002,0.0292,0.0645,0.0041,0.0201		D(0.01), , , 	P(0.76), , , 	14.34	0.03		COSV64238890	0	0	3489	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303983	152303983	C	T	wt	het	het		QUAL=17475;DP=424,1550,2203;AF=0.09,0.22,0.39;MQM=31;SAP=491;ABP=1094	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28600C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28600C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246453 [benign DISEASE=not provided];			rs75448155		0.0941	0,.	0.0104,0.1571,0.2732,0.0600,0.1449		D(0.00), , , 	D(0.97), , , 	22.20	0.10		COSV64238118	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304107	152304107	C	G	het	het	het		QUAL=11150;DP=352,899,632;AF=0.15,0.19,0.69;MQM=33;SAP=49;ABP=363	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2274C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28476C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28476C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274774 [benign DISEASE=not provided];			rs12083389	0.3614	0.1826	2272,.	0.4017,0.1810,0.2813,0.0226,0.1261		T(1.00), , , 	B(0.01), , , 	0.24	0.04		COSV64240501	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304122	152304122	G	A	wt	het	hom		QUAL=11614;DP=387,808,429;AF=0.07,0.21,0.98;MQM=31;SAP=140;ABP=607	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2289G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28461G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28461G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274484 [benign DISEASE=not provided];			rs12742178	0.0887	0.0890	712,.	0.0246,0.1379,0.3089,0.0141,0.1036				0.12			COSV64237396	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304150	152304150	G	C	het	het	hom		QUAL=6363;DP=445,754,313;AF=0.12,0.15,0.98;MQM=33;SAP=240;ABP=1339	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2317G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28433G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28433G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1225072 [benign DISEASE=not provided];			rs3126075	0.4778	0.2207	5466,.	0.4692,0.1227,0.3199,0.0121,0.0769		T(0.57), , , 	B(0.00), , , 	0.00	0.01		COSV64238703	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304195	152304195	C	T	wt	het	het		QUAL=1743;DP=609,884,484;AF=0.10,0.13,0.26;MQM=45;SAP=277;ABP=1243	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2362C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28388C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28388C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263753 [benign DISEASE=not provided];			rs7518080	0.2564	0.0886	1,.	0.2098,0.2029,0.3318,0.0226,0.1590		T(1.00), , , 	B(0.00), , , 	0.21	0.01		COSV64235950	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304223	152304223	A	G	het	het	het		QUAL=7750;DP=517,893,547;AF=0.25,0.14,0.55;MQM=36;SAP=808;ABP=795	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2390A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28360A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28360A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265104 [benign DISEASE=not provided];			rs12728605		0.1377	24,.	0.2392,0.2063,0.3023,0.0353,0.1825		T(0.58), , , 	B(0.12), , , 	1.06	0.01		COSV64235956	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304296	152304296	C	A	het	het	het		QUAL=32012;DP=411,1141,670;AF=0.45,0.44,0.86;MQM=57;SAP=60;ABP=99	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28287C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28287C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1237029 [benign DISEASE=not provided];			rs72697000	0.2905	0.2461	2021,.	0.0291,0.4311,0.5574,0.1447,0.3866		T(0.73), , , 	D(1.00), , , 	6.17	0.06		COSV64247197	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304395	152304395	A	G	het	het	hom		QUAL=38505;DP=531,1125,642;AF=0.41,0.47,0.99;MQM=59;SAP=8;ABP=36	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28188A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28188A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1231010 [benign DISEASE=not provided];			rs3126066	0.4471	0.2861	8359,.	0.4821,0.4531,0.5950,0.1468,0.3918				0.22			COSV64245547,COSV64251897	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304413	152304413	A	G	het	het	hom		QUAL=37803;DP=529,1141,633;AF=0.40,0.46,0.99;MQM=59;SAP=12;ABP=49	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28170A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28170A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1272130 [benign DISEASE=not provided];			rs3126067		0.3537	14148,.	0.7179,0.4684,0.5971,0.1488,0.3926				0.23			COSV64247205	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304579	152304579	C	G	het	het	het		QUAL=26788;DP=484,851,546;AF=0.38,0.46,0.89;MQM=54;SAP=36;ABP=65	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28004C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28004C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065955		0.3460	13368,.	0.7135,0.4648,0.5895,0.1467,0.3798		T(0.08), , , 	P(0.75), , , 	11.40	0.03		COSV64245550	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304692	152304692	A	G	het	het	hom		QUAL=45471;DP=527,1061,910;AF=0.47,0.45,0.99;MQM=51;SAP=250;ABP=26	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27891A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27891A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs3091276	0.4736	0.3026	9175,.	0.5216,0.4581,0.6032,0.1510,0.4066				0.95			COSV64246356	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304833	152304833	G	A	wt	wt	het		QUAL=25932;DP=619,1360,2025;AF=0.00,0.00,0.51;MQM=54;SAP=3;ABP=6	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3000G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27750G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27750G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs34687484	0.0028	0.0039	3,.	0.0006,0.0035,0.0001,0.0051,0.0057				0.07				0	4	201	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304869	152304869	C	T	het	het	het		QUAL=47271;DP=573,1337,1985;AF=0.45,0.48,0.48;MQM=59;SAP=4;ABP=26	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27714C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27714C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065956	0.2875	0.2428	3146,.	0.0290,0.4286,0.5598,0.1423,0.3712				0.30			COSV64237848	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304920	152304920	T	C	het	het	hom		QUAL=80827;DP=521,1283,1870;AF=0.45,0.49,0.99;MQM=59;SAP=47;ABP=10	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27663T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27663T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302748 [benign DISEASE=not provided];			rs6681433	0.3411	0.2728	4067,.	0.1272,0.4468,0.5789,0.1653,0.4282				0.19			COSV64251428	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305078	152305078	G	A	wt	wt	het		QUAL=19203;DP=503,1192,1542;AF=0.00,0.00,0.49;MQM=60;SAP=27;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3245G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27505G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27505G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs35621145	0.0250	0.0228	54,.	0.0041,0.0137,0.0191,0.0225,0.0564		D(0.04), , , 	P(0.84), , , 	16.54	0.11		COSV64237541	0	20	666	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305241	152305241	C	A	het	het	hom		QUAL=41729;DP=296,897,1119;AF=0.35,0.35,1.00;MQM=48;SAP=289;ABP=232	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27342C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27342C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246798 [benign DISEASE=not provided];			rs9436066	0.4696	0.3044	8533,.	0.4829,0.4618,0.6400,0.1669,0.4309				0.06			COSV64238716	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305346	152305346	T	C	het	wt	hom		QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3513T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27237T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27237T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174667 [benign DISEASE=not specified,not provided];			rs3126069	0.2238	0.1576	2574,.	0.0331,0.2724,0.4288,0.0439,0.2553				0.79			COSV64242448,COSV64251192	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305350	152305350	A	C	het	wt	hom		QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27233A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27233A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175078 [benign DISEASE=not specified,not provided];			rs2065957	0.3936	0.2652	6657,.	0.4397,0.3037,0.4669,0.0473,0.2644		T(1.00), , , 	B(0.00), , , 	0.25	0.03		COSV64246955	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305958	152305958	T	G	het	het	wt		QUAL=2702;DP=443,489,551;AF=0.23,0.24,0.00;MQM=39;SAP=487;ABP=558	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4125T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26625T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26625T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175150 [benign DISEASE=not specified,not provided];			rs61816760	0.2873	0.3726	608,.	0.3544,0.3002,0.1149,0.3919,0.3118		T(0.54), , , 	B(0.25), , , 	0.04	0.02		COSV64235961	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306008	152306008	C	T	wt	wt	het		QUAL=3359;DP=437,702,878;AF=0.00,0.00,0.25;MQM=39;SAP=485;ABP=469	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4175C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26575C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26575C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205931 [benign DISEASE=not specified,not provided];			rs61690342		0.0348	4,.	0.0988,0.0148,0.0170,0.0185,0.0459		T(0.29), , , 	B(0.00), , , 	0.24	0.04			0	0	713	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306079	152306079	T	C	het	het	het		QUAL=26888;DP=442,1310,1612;AF=0.25,0.25,0.50;MQM=46;SAP=834;ABP=480	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26504T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26504T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1242222 [benign DISEASE=not provided];			rs80221306		0.2073	5,.	0.0902,0.3298,0.4025,0.1353,0.3092		T(0.38), , , 	B(0.01), , , 	7.29	0.02		COSV64237772	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306213	152306213	C	A	het	het	hom	low_conf_region	QUAL=149780;DP=692,2559,3381;AF=0.55,0.55,1.00;MQM=50;SAP=65;ABP=87	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26370C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26370C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222401 [benign DISEASE=not provided];			rs57672167	0.3964	0.2792	5985,.	0.2106,0.4529,0.5810,0.1651,0.4244				0.19			COSV64247949	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306338	152306338	C	T	wt	het	het		QUAL=21671;DP=1099,2993,4213;AF=0.09,0.18,0.25;MQM=39;SAP=184;ABP=4853	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4505C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26245C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26245C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1260709 [benign DISEASE=not provided];			rs2184952		0.0725	0,.	0.0452,0.1831,0.2761,0.0226,0.1603		T(0.85), , , 	B(0.12), , , 	1.83	0.02		COSV64238707	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306380	152306380	T	G	het	het	het		QUAL=16088;DP=851,2690,3957;AF=0.22,0.21,0.18;MQM=51;SAP=3;ABP=6147	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26203T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26203T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246169 [benign DISEASE=not provided];			rs11582087		0.1781	0,.	0.0255,0.3147,0.3953,0.1105,0.2619		D(0.04), , , 	B(0.09), , , 	13.19	0.03		COSV64235994	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306543	152306543	G	A	het	het	het		QUAL=8471;DP=998,2435,4113;AF=0.15,0.19,0.17;MQM=35;SAP=11;ABP=7088	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4710G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26040G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26040G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178454 [benign DISEASE=not provided];			rs57670307		0.1244	0,.	0.0176,0.2495,0.3700,0.0663,0.1923				0.77			COSV64241227,COSV64246502	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307253	152307253	C	T	het	het	hom		QUAL=71302;DP=588,1193,1542;AF=0.47,0.52,0.99;MQM=59;SAP=3;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25330C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25330C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302747 [benign DISEASE=not provided];			rs3126072	0.4748	0.3095	9449,.	0.5242,0.4626,0.6041,0.1658,0.4260		T(0.45), , , 	B(0.00), , , 	1.64	0.02		COSV64248815	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307365	152307365	G	C	het	het	hom		QUAL=72640;DP=476,1191,1577;AF=0.49,0.51,1.00;MQM=59;SAP=29;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25218G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25218G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302746 [benign DISEASE=not provided];			rs3126074	0.4623	0.3011	8618,.	0.4833,0.4609,0.6037,0.1658,0.4261		T(1.00), , , 	B(0.00), , , 	0.00	0.02		COSV100910597	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307444	152307444	A	G	het	het	hom		QUAL=75444;DP=456,1213,1666;AF=0.50,0.53,1.00;MQM=59;SAP=23;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25139A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25139A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302745 [benign DISEASE=not provided];			rs55650366	0.3425	0.2723	4056,.	0.1323,0.4464,0.5791,0.1649,0.4241		T(1.00), , , 	B(0.00), , , 	0.03	0.01		COSV64245556	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307488	152307488	C	T	wt	wt	het		QUAL=22736;DP=627,1226,1675;AF=0.00,0.00,0.52;MQM=60;SAP=23;ABP=10	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5655C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25095C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25095C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265210 [benign DISEASE=not provided];			rs71625199	0.0248	0.0227	47,.	0.0034,0.0137,0.0191,0.0225,0.0559				0.11			COSV64236421	0	14	673	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307556	152307556	T	C	het	het	hom		QUAL=82483;DP=548,1329,1841;AF=0.47,0.51,1.00;MQM=58;SAP=87;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25027T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25027T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222131 [benign DISEASE=not provided];			rs71625200	0.3431	0.2723	4069,.	0.1324,0.4465,0.5790,0.1647,0.4240		T(1.00), , , 	B(0.00), , , 	1.36	0.03		COSV64248823	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307694	152307694	C	G	het	het	hom		QUAL=56696;DP=464,1162,1440;AF=0.45,0.44,0.97;MQM=47;SAP=536;ABP=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24889C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24889C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239802 [benign DISEASE=not provided];			rs71625201	0.3305	0.2585	1665,.	0.1263,0.4148,0.5201,0.1622,0.4039		T(0.37), , , 	B(0.01), , , 	0.20	0.02		COSV64237400	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307789	152307789	C	G	het	het	het		QUAL=34967;DP=503,1100,1084;AF=0.38,0.31,0.86;MQM=38;SAP=537;ABP=54	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24794C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24794C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265666 [benign DISEASE=not provided];			rs71625202		0.2131	414,.	0.0305,0.3389,0.4093,0.1431,0.3311		D(0.01), , , 	D(0.97), , , 	14.30	0.09		COSV64236000	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307871	152307871	C	T	het	het	het		QUAL=29872;DP=487,1151,1013;AF=0.34,0.29,0.79;MQM=37;SAP=262;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24712C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24712C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs139476473		0.1517	1049,.	0.0218,0.2926,0.3790,0.0742,0.2640		D(0.02), , , 	D(0.94), , , 	22.80	0.14		COSV64236201	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307896	152307896	G	A	het	het	hom		QUAL=40990;DP=507,1116,1041;AF=0.48,0.34,0.99;MQM=36;SAP=1192;ABP=187	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24687G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24687G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179883 [benign DISEASE=not provided];			rs6664985	0.4535	0.3001	8554,.	0.4379,0.4447,0.6132,0.1053,0.4062				0.07			COSV64242880	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307995	152307995	C	G	het	het	het		QUAL=9792;DP=667,1350,1875;AF=0.23,0.14,0.29;MQM=37;SAP=139;ABP=2459	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6162C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24588C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24588C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1286180 [benign DISEASE=not provided];			rs78179835		0.1955	102,.	0.0979,0.3197,0.3852,0.1256,0.3042		T(1.00), , , 	B(0.00), , , 	0.00	0.03		COSV64236496	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308209	152308209	C	A	wt	wt	het		QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6376C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24374C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24374C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs544807449	0.1833	0.0214	0,.	0.0573,0.0448,0.1537,0.0034,0.0303		T(0.07), , , 	B(0.37), , , 	9.62	0.17		COSV64242592,COSV64251050		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308211	152308211	C	T	wt	wt	het		QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6378C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24372C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24372C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244717 [benign DISEASE=not provided];			rs564482396	0.1833	0.0235	0,.	0.0637,0.0529,0.1703,0.0039,0.0338				0.36			COSV64243287,COSV64244530		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308212	152308212	A	G	wt	wt	het		QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6379A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24371A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24371A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1255099 [benign DISEASE=not provided];			rs116918835	0.1833	0.0334	0,.	0.0770,0.0904,0.2047,0.0070,0.0495		T(0.52), , , 	B(0.00), , , 	0.36	0.04		COSV64243288		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308215	152308215	A	T	wt	wt	het		QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6382A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24368A>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24368A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235186 [benign DISEASE=not provided];			rs117945779	0.1915	0.0410	0,.	0.1132,0.1120,0.2285,0.0089,0.0603		T(0.99), , , 	B(0.00), , , 	1.12	0.03		COSV64235963	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308260	152308260	T	C	het	het	het		QUAL=23848;DP=788,1503,2391;AF=0.31,0.18,0.33;MQM=55;SAP=72;ABP=1994	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6427T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24323T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24323T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1287967 [benign DISEASE=not provided];			rs66977240		0.2191	0,.	0.3443,0.3420,0.4132,0.1283,0.3119		T(0.75), , , 	B(0.00), , , 	0.00	0.01		COSV64235967	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308283	152308283	A	G	het	het	het		QUAL=36254;DP=855,1557,2674;AF=0.34,0.23,0.40;MQM=54;SAP=96;ABP=1154	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6450A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24300A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24300A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1182765 [benign DISEASE=not provided];			rs2338554	0.3672	0.2427	2529,.	0.4274,0.3505,0.4200,0.1478,0.3295				0.51			COSV64236535	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308306	152308306	A	G	het	het	hom		QUAL=131893;DP=886,1655,2790;AF=0.65,0.63,1.00;MQM=57;SAP=49;ABP=428	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24277A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24277A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244740 [benign DISEASE=not provided];			rs2184953	0.5397	0.3696	14547,.	0.7165,0.4761,0.6055,0.1680,0.4295		T(0.34), , , 	B(0.00), , , 	0.14	0.01		COSV64235971	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308312	152308312	T	G	het	het	het		QUAL=71680;DP=890,1660,2827;AF=0.31,0.27,0.73;MQM=55;SAP=110;ABP=18	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6479T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24271T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24271T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239242 [benign DISEASE=not provided];			rs66954353		0.2410	51,.	0.3644,0.3513,0.4198,0.1511,0.3321		T(1.00), , , 	B(0.00), , , 	0.66	0.02		COSV64236338	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308388	152308388	A	G	het	het	hom		QUAL=112027;DP=509,1512,2563;AF=0.61,0.66,1.00;MQM=55;SAP=3;ABP=378	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24195A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24195A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1223320 [benign DISEASE=not provided];			rs2184954	0.4637	0.3044	8796,.	0.4840,0.4611,0.6040,0.1658,0.4263				0.94			COSV100910603	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308424	152308424	T	G	het	het	het		QUAL=32395;DP=702,1473,2391;AF=0.31,0.30,0.36;MQM=51;SAP=7;ABP=1059	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24159T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24159T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174419 [benign DISEASE=not provided];			rs74129452	0.3438	0.2384	0,.	0.3643,0.3503,0.4198,0.1470,0.3280		T(1.00), , , 	B(0.00), , , 	0.01	0.11		COSV64235975	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308531	152308531	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24052A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24052A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1221916 [benign DISEASE=not provided];			rs7512553	0.3277	0.2288	0,.	0.3638,0.3437,0.4134,0.1326,0.2979		T(1.00), , , 	B(0.00), , , 	2.22	0.04		COSV64247222	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308532	152308532	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24051A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24051A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179898 [benign DISEASE=not provided];			rs7512554	0.3277	0.2286	0,.	0.3638,0.3437,0.4134,0.1326,0.2979				0.38			COSV64247223	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308563	152308563	G	A	het	het	het		QUAL=33540;DP=940,1648,2393;AF=0.30,0.32,0.31;MQM=60;SAP=26;ABP=1487	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24020G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24020G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179724 [benign DISEASE=not provided];			rs7522925		0.2282	0,.	0.3649,0.3438,0.4134,0.1327,0.2980		T(0.06), , , 	B(0.02), , , 	0.04	0.07		COSV64245563	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308752	152308752	C	G	het	het	het		QUAL=38189;DP=738,1968,2612;AF=0.25,0.35,0.33;MQM=53;SAP=26;ABP=1397	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6154C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23831C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23831C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266034 [benign DISEASE=not provided];			rs7546186		0.2233	0,.	0.3448,0.3391,0.4078,0.1243,0.2958		T(0.09), , , 	P(0.72), , , 	15.34	0.09		COSV64238126	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308814	152308814	A	G	het	het	het		QUAL=35392;DP=658,1993,2597;AF=0.22,0.34,0.33;MQM=51;SAP=15;ABP=1494	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6092A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23769A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23769A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263645 [benign DISEASE=not provided];			rs80353812	0.3281	0.2251	0,.	0.3573,0.3430,0.4129,0.1309,0.2980				0.14			COSV64245566	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308828	152308828	A	C	het	het	het		QUAL=36883;DP=666,1969,2608;AF=0.26,0.34,0.34;MQM=51;SAP=32;ABP=1376	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23755A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23755A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266162 [benign DISEASE=not provided];			rs7512857		0.2234	0,.	0.3420,0.3425,0.4133,0.1323,0.2975		T(0.18), , , 	D(0.93), , , 	10.79	0.03		COSV64245569	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308841	152308841	G	T	wt	wt	het		QUAL=21012;DP=793,2032,2642;AF=0.00,0.00,0.34;MQM=60;SAP=20;ABP=594	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6065G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23742G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23742G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1251416 [benign DISEASE=not provided];			rs71626704	0.0248	0.0227	47,.	0.0034,0.0136,0.0190,0.0224,0.0559		T(0.20), , , 	B(0.23), , , 	2.51	0.05			0	14	673	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309003	152309003	G	T	het	het	hom		QUAL=106329;DP=888,1621,1993;AF=0.60,0.68,1.00;MQM=56;SAP=144;ABP=486	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23580G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23580G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278608 [benign DISEASE=not provided];			rs3126079		0.3684	14548,.	0.7162,0.4760,0.6056,0.1679,0.4270		T(0.81), , , 	B(0.00), , , 	0.00	0.02		COSV64242281	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309047	152309047	A	C	het	het	het		QUAL=20251;DP=816,1554,1835;AF=0.19,0.30,0.30;MQM=49;SAP=188;ABP=1818	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5859A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23536A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23536A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1270895 [benign DISEASE=not specified,not provided];			rs80059102		0.2160	0,.	0.3165,0.3198,0.4060,0.1120,0.2686		T(0.31), , , 	B(0.00), , , 	2.79	0.01		COSV100912331,COSV64235980	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309058	152309058	A	T	het	het	het		QUAL=17143;DP=761,1514,1781;AF=0.18,0.28,0.28;MQM=48;SAP=241;ABP=2035	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5848A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23525A>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23525A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205946 [benign/likely benign DISEASE=not specified,not provided];			rs113544881	0.3135	0.2002	1,.	0.2351,0.2815,0.3878,0.0756,0.2233		T(1.00), , , 	B(0.00), , , 	0.06	0.05		COSV64235983	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309214	152309214	C	T	het	het	het		QUAL=41084;DP=540,1169,1371;AF=0.47,0.51,0.53;MQM=59;SAP=4;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23369C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23369C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1247656 [benign DISEASE=not provided];			rs12407748	0.2875	0.2422	3092,.	0.0292,0.4282,0.5601,0.1421,0.3676		T(0.46), , , 	B(0.17), , , 	0.01	0.05		COSV64235683	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309215	152309215	G	A	wt	wt	het		QUAL=16228;DP=558,1171,1371;AF=0.00,0.00,0.47;MQM=60;SAP=7;ABP=16	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5691G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23368G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23368G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs36006086	0.0250	0.0227	48,.	0.0041,0.0136,0.0190,0.0225,0.0559		D(0.01), , , 	D(0.98), , , 	18.13	0.04		COSV64237885,COSV64241834	0	16	671	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309269	152309269	G	T	wt	wt	het		QUAL=16358;DP=630,1185,1419;AF=0.00,0.00,0.45;MQM=60;SAP=10;ABP=33	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5637G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23314G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23314G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235678 [benign DISEASE=not provided];			rs62623409	0.0250	0.0227	50,.	0.0041,0.0136,0.0189,0.0224,0.0557		T(0.09), , , 	B(0.04), , , 	11.52	0.04		COSV64237889	0	16	671	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309472	152309472	G	A	het	het	het		QUAL=37609;DP=455,1118,1941;AF=0.48,0.51,0.39;MQM=58;SAP=12;ABP=110	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23111G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23111G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1248526 [benign DISEASE=not provided];			rs12405241	0.2875	0.2422	3081,.	0.0290,0.4278,0.5603,0.1421,0.3679		T(0.20), , , 	D(0.96), , , 	0.15	0.10		COSV64247244	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309616	152309616	T	C	wt	wt	het		QUAL=2595;DP=521,1243,1981;AF=0.00,0.00,0.17;MQM=52;SAP=3;ABP=1910	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5290T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22967T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22967T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs778942937		0.0038	0,.	0.0000,0.0000,0.0000,0.0001,0.0001		T(0.11), , , 	B(0.08), , , 	15.12	0.03		COSV64244851	0	0	20	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309791	152309791	G	A	het	het	het		QUAL=36454;DP=420,1225,1518;AF=0.48,0.47,0.48;MQM=60;SAP=11;ABP=16	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22792G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22792G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12405278	0.2877	0.2422	3128,.	0.0290,0.4279,0.5603,0.1421,0.3680		D(0.02), , , 	D(0.91), , , 	19.54	0.05		COSV64245576	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309835	152309835	C	T	het	het	het		QUAL=39271;DP=513,1234,1507;AF=0.46,0.48,0.51;MQM=60;SAP=28;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22748C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22748C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407807	0.2967	0.2447	3222,.	0.0644,0.4288,0.5603,0.1421,0.3681		T(0.55), , , 	D(0.97), , , 	2.50	0.07		COSV64247251	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310046	152310046	C	T	wt	het	wt		QUAL=11248;DP=553,1012,1246;AF=0.00,0.48,0.00;MQM=60;SAP=11;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4860C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22537C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22537C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]										T(0.20), , , 	B(0.16), , , 	3.62	0.03		COSV64246735	0	0	1	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310318	152310318	G	A	wt	wt	het		QUAL=16949;DP=442,1154,1462;AF=0.00,0.00,0.48;MQM=60;SAP=3;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4588G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22265G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22265G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1293919 [benign DISEASE=not provided];			rs12750081	0.0250	0.0227	50,.	0.0041,0.0136,0.0190,0.0225,0.0559		D(0.04), , , 	B(0.04), , , 	7.59	0.01		COSV64247535	0	16	670	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310434	152310434	G	C	wt	wt	het		QUAL=18572;DP=490,1078,1491;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4472G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22149G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22149G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278160 [benign DISEASE=not provided];			rs71626706	0.0248	0.0227	50,.	0.0034,0.0136,0.0190,0.0225,0.0560		T(1.00), , , 	B(0.00), , , 	0.00	0.05		COSV64250380	0	16	673	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310441	152310441	G	T	het	het	het		QUAL=38082;DP=478,1070,1522;AF=0.49,0.50,0.50;MQM=59;SAP=13;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22142G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22142G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1277512 [benign DISEASE=not provided];			rs11204978	0.2871	0.2422	3082,.	0.0290,0.4279,0.5602,0.1420,0.3678		D(0.00), , , 	B(0.34), , , 	12.42	0.06		COSV64247255	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310476	152310476	A	G	wt	wt	het		QUAL=19714;DP=548,1142,1570;AF=0.00,0.00,0.49;MQM=60;SAP=15;ABP=5	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4430A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22107A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22107A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1241427 [benign DISEASE=not provided];			rs12732920	0.0250	0.0227	48,.	0.0034,0.0136,0.0190,0.0225,0.0562				0.15				0	16	672	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310577	152310577	G	A	wt	wt	het		QUAL=20704;DP=588,1195,1684;AF=0.00,0.00,0.49;MQM=60;SAP=3;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4329G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22006G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22006G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	916211 [likely benign DISEASE=not provided];			rs12750571	0.0048	0.0050	4,.	0.0006,0.0049,0.0002,0.0067,0.0066		D(0.01), , , 	P(0.64), , , 	22.40	0.04			0	4	305	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310760	152310760	T	C	het	het	hom		QUAL=76306;DP=531,1305,1681;AF=0.49,0.49,1.00;MQM=55;SAP=6;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21823T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21823T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178727 [benign DISEASE=not provided];			rs11581433	0.3431	0.2728	4077,.	0.1321,0.4483,0.5792,0.1650,0.4241		T(1.00), , , 	B(0.00), , , 	0.00	0.01		COSV64246547	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310807	152310807	C	T	het	het	het		QUAL=40127;DP=523,1245,1653;AF=0.49,0.50,0.49;MQM=54;SAP=15;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21776C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21776C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1253040 [benign DISEASE=not provided];			rs11586631	0.2877	0.2423	3117,.	0.0295,0.4279,0.5602,0.1420,0.3678		T(0.83), , , 	B(0.05), , , 	0.02	0.02		COSV64245581	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311386	152311386	G	C	het	het	hom		QUAL=65048;DP=545,1105,1462;AF=0.48,0.50,1.00;MQM=54;SAP=4;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21197G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21197G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1298018 [benign DISEASE=not provided];			rs58001094	0.5341	0.3655	14267,.	0.6886,0.4595,0.5991,0.1656,0.4086		T(1.00), , , 	B(0.01), , , 	0.03	0.05		COSV64238211	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311499	152311499	A	G	het	het	hom		QUAL=75643;DP=587,1206,1698;AF=0.51,0.50,1.00;MQM=52;SAP=14;ABP=4	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21084A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21084A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1245184 [benign DISEASE=not provided];			rs66831674	0.4631	0.3011	8653,.	0.4836,0.4608,0.6036,0.1657,0.4260				0.53			COSV64248837	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311901	152311901	G	A	het	wt	het		QUAL=30466;DP=613,1314,1577;AF=0.53,0.02,0.54;MQM=56;SAP=3;ABP=30	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20682G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20682G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs373872833		0.0001	0,.	0.0000,0.0004,0.0001,0.0001,0.0001				0.12			COSV64236179	0	0	2	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311948	152311948	G	C	wt	wt	het		QUAL=21818;DP=730,1324,1653;AF=0.02,0.04,0.51;MQM=55;SAP=85;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2958G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20635G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20635G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	402869 [benign DISEASE=not specified,not provided];			rs12756586	0.0340	0.0251	52,.	0.0149,0.0140,0.0190,0.0225,0.0565		T(1.00), , , 	B(0.00), , , 	0.00	0.02		COSV64236115	0	16	702	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312002	152312002	A	G	wt	wt	het		QUAL=622;DP=539,1303,1789;AF=0.01,0.07,0.13;MQM=39;SAP=112;ABP=2096	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2904A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20581A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20581A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1200762 [likely benign DISEASE=not specified,not provided];			rs199888588		0.0222	0,.	0.0127,0.0002,0.0002,0.0001,0.0001		T(0.91), , , 	B(0.00), , , 	0.11	0.02		COSV64239582	0	0	228	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312021	152312021	A	G	wt	wt	het		QUAL=2110;DP=517,1341,1947;AF=0.02,0.07,0.16;MQM=40;SAP=12;ABP=2015	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2885A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20562A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20562A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs144437056	0.0513	0.0325	0,.	0.0280,0.0002,0.0003,0.0001,0.0001				0.18			COSV64248679	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312029	152312029	C	G	wt	wt	het		QUAL=2717;DP=545,1373,2009;AF=0.02,0.07,0.16;MQM=41;SAP=5;ABP=1993	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2877C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20554C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20554C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206179 [benign DISEASE=not specified,not provided];			rs201137357	0.1368	0.0468	55,.	0.1388,0.0031,0.0004,0.0005,0.0003		T(0.10), , , 	P(0.89), , , 	12.90	0.06		COSV64235720	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312065	152312065	G	A	wt	wt	het		QUAL=5;DP=529,1437,2146;AF=0.00,0.00,0.13;MQM=45;SAP=7;ABP=2613	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2841G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20518G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20518G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs138002269		0.0014	0,.	0.0001,0.0003,0.0001,0.0004,0.0012		D(0.01), , , 	D(0.96), , , 	18.67	0.05		COSV64245372,COSV64246254	0	0	581	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312100	152312100	C	A	wt	wt	het		QUAL=1884;DP=584,1429,2116;AF=0.03,0.05,0.15;MQM=43;SAP=110;ABP=2300	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2806C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20483C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20483C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206107 [likely benign DISEASE=not provided];			rs143382793		0.0141	0,.	0.0037,0.0001,0.0001,0.0001,0.0001		D(0.04), , , 	P(0.85), , , 	15.32	0.03		COSV64242745	0	0	742	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312121	152312121	A	C	wt	wt	het		QUAL=220;DP=519,1423,2109;AF=0.02,0.04,0.12;MQM=43;SAP=117;ABP=2583	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2785A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20462A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20462A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs201928359		0.0088	0,.	0.0000,0.0001,0.0000,0.0000,0.0000		T(1.00), , , 	B(0.00), , , 	2.17	0.02		COSV64236204	0	0	240	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312378	152312378	A	G	het	het	hom		QUAL=57578;DP=484,875,1247;AF=0.49,0.51,0.99;MQM=59;SAP=23;ABP=3	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20205A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20205A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1230019 [benign DISEASE=not provided];			rs3120653	0.4732	0.3105	9086,.	0.5223,0.4630,0.6035,0.1663,0.4245				0.35			COSV104425295,COSV64244277	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312623	152312623	C	T	het	het	hom		QUAL=86295;DP=491,1419,1884;AF=0.51,0.50,1.00;MQM=60;SAP=24;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19960C>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.48C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19960C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	377878 [benign DISEASE=not specified];			rs74129461	0.3277	0.2681	3756,.	0.0746,0.4437,0.5790,0.1649,0.4238		D(0.03), , , , 	B(0.22), , , , 	12.23	0.03		COSV64248843	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312705	152312705	G	T	wt	wt	het		QUAL=22886;DP=475,1377,1844;AF=0.00,0.00,0.48;MQM=60;SAP=31;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2201G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19878G>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.130G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19878G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs7512779	0.0250	0.0227	51,.	0.0041,0.0137,0.0190,0.0225,0.0558		T(0.07), , , , 	B(0.15), , , , 	0.00	0.01			0	16	670	0 / 0					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313454	152313454	G	A	het	het	hom		QUAL=70473;DP=524,1174,1569;AF=0.51,0.49,0.99;MQM=60;SAP=10;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19129G>A::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.879G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19129G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666623 [benign DISEASE=not specified,not provided];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.3446	0.2726	4065,.	0.1354,0.4467,0.5789,0.1649,0.4241		T(1.00), , , , 	B(0.03), , , , 	0.00	0.04		COSV64239594	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313526	152313526	T	C	het	het	hom		QUAL=68625;DP=461,1149,1578;AF=0.48,0.49,0.99;MQM=60;SAP=6;ABP=5	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19057T>C::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.951T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19057T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666624 [benign DISEASE=not specified,not provided];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.4641	0.3025	8757,.	0.4865,0.4623,0.6050,0.1660,0.4262		T(1.00), , , , , 	B(0.01), , , , , 	0.74	0.08		COSV64245598	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313556	152313556	C	T	het	het	het		QUAL=40828;DP=564,1210,1562;AF=0.48,0.50,0.46;MQM=60;SAP=5;ABP=17	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19027C>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.981C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19027C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1249558 [benign DISEASE=not provided];			rs11588170	0.2871	0.2421	3090,.	0.0290,0.4281,0.5599,0.1419,0.3677		T(0.18), , , , , 	P(0.82), , , , , 	14.31	0.04		COSV64247273	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313650	152313650	A	G	het	het	wt		QUAL=20668;DP=461,1206,1514;AF=0.50,0.50,0.00;MQM=60;SAP=4;ABP=3	FLG,FLG-AS1	synonymous,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18933A>G::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1075A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18933A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1259919 [benign DISEASE=not specified,not provided];			rs11582620	0.0861	0.1159	914,.	0.0178,0.0931,0.1025,0.1188,0.2011				0.81			COSV64236548	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313891	152313891	C	A	het	het	hom		QUAL=59514;DP=569,910,1279;AF=0.51,0.50,1.00;MQM=60;SAP=142;ABP=3	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18692C>A::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1316C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18692C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs41267154	0.3407	0.2719	4024,.	0.1270,0.4463,0.5787,0.1648,0.4240		D(0.04), , , , , 	D(1.00), , , , , 	14.12	0.02		COSV64246426	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154156196	154156196	G	A	wt	het	wt		QUAL=797;DP=183,86,125;AF=0.01,0.45,0.00;MQM=60;SAP=7;ABP=5	TPM3	3'UTR	TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001278190.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2773C>T::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.2285C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]			AluSq2 (SINE/Alu)	rs4540651		0.6116	29444,.					1.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154156789	154156789	A	G	wt	het	wt		QUAL=132;DP=105,11,19;AF=0.00,0.73,0.00;MQM=60;SAP=7;ABP=8	TPM3	3'UTR	TPM3:ENST00000330188.13:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001278190.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2180T>C::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.1692T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]				rs1051370	0.3229	0.3058	8025,.					9.61					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154162081	154162081	A	C	wt	het	wt		QUAL=1949;DP=461,217,366;AF=0.00,0.44,0.00;MQM=60;SAP=22;ABP=10	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.467-4360T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.776-3033T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*5856T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.760-4360T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292625 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];			rs3196889	0.3215	0.3024	7823,.					5.62					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165752	154165752	G	A	wt	het	wt		QUAL=640;DP=198,37,56;AF=0.01,0.76,0.00;MQM=60;SAP=36;ABP=24	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4648C>T::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2185C>T::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4648C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292666 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSq2 (SINE/Alu)	rs10908723	0.3201	0.3196	7583,.					2.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165790	154165790	A	-	het	het	het		QUAL=1014;DP=145,27,40;AF=0.21,0.22,0.30;MQM=59;SAP=68;ABP=141	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4610del::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2147del::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4610del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292667 [likely benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSq2 (SINE/Alu)	rs68185418		0.2384	1418,.					0.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166689	154166689	-	T	wt	het	wt		QUAL=117;DP=183,36,38;AF=0.12,0.00,0.08;MQM=60;SAP=8;ABP=350	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3710dup::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1247dup::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3710dup::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292677 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];			rs72189266		0.4314	13897,.					6.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166690	154166690	T	-	het	wt	wt		QUAL=117;DP=183,36,38;AF=0.03,0.31,0.00;MQM=60;SAP=23;ABP=232	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3710del::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1247del::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3710del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]			AluSx1 (SINE/Alu)	rs72189266		0.0004	0,.					5.50					0	10	0 / 0					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166905	154166905	A	C	wt	het	wt		QUAL=552;DP=147,61,71;AF=0.00,0.44,0.01;MQM=60;SAP=18;ABP=5	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3495T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1032T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3495T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	292682 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSx1 (SINE/Alu)	rs6673171	0.3229	0.3035	7855,.					4.45					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154169432	154169432	A	G	wt	het	wt	off-target	QUAL=3050;DP=183,250,303;AF=0.00,0.50,0.00;MQM=60;SAP=50;ABP=3	TPM3	intron	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000368530.7:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:ENST00000651641.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+968T>C::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364682.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_001364683.1:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_152263.4:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+968T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal recessive, Autosomal dominant; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal recessive, Autosomal dominant]	262627 [benign DISEASE=not specified,not provided];			rs4845364		0.6275	31338,.	0.8127,0.7172,0.8686,0.5117,0.6475				18.83				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154272666	154272666	T	G	wt	wt	het		QUAL=2989;DP=377,166,244;AF=0.00,0.02,0.50;MQM=60;SAP=3;ABP=3	HAX1	5'UTR	HAX1:ENST00000328703.12:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000457918.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	HAX1:NM_001018837.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:NM_006118.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	regulatory_region_variant:promoter	605998_[GENE=HAX1_PHENOS=Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive]	292700 [benign DISEASE=Kostmann syndrome,not provided];			rs11265425		0.2172	4607,.					2.40			COSV55171217	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBAP2L (inh=n/a oe_syn=1.01 oe_mis=0.62 oe_lof=0.03), HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154576245	154576245	T	C	hom	hom	het		QUAL=9000;DP=115,126,108;AF=0.98,1.00,0.52;MQM=60;SAP=12;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2074T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072660		0.7061	38418,.					0.27				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576404	154576404	G	A	wt	wt	het		QUAL=1186;DP=76,62,106;AF=0.00,0.02,0.48;MQM=60;SAP=3;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2233G>A::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072661	0.2646	0.2534	4804,.					5.30				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576994	154576994	T	C	wt	wt	het		QUAL=3420;DP=299,241,299;AF=0.00,0.00,0.45;MQM=60;SAP=16;ABP=10	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2823T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs12130403	0.2859	0.2979	6706,.					6.02				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154578468	154578469	AG	-	wt	wt	het		QUAL=3336;DP=271,211,267;AF=0.00,0.00,0.49;MQM=60;SAP=23;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::,CHRNB2:XR_001736952.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.4014+285_4014+286del::	regulatory_region_variant:promoter_flanking_region	118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs3841062		0.2699	5508,.					1.36				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154579534	154579534	C	G	het	het	wt		QUAL=8445;DP=296,338,412;AF=0.55,0.48,0.00;MQM=60;SAP=3;ABP=4	CHRNB2,	3'UTR,intron&non_coding_transcript	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,:ENST00000421866.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.47+83G>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.4549C>G::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs1049998302		0.0001	0,.					1.19				0	0	2	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155234893	155234893	A	G	wt	het	wt		QUAL=74;DP=52,18,27;AF=0.00,0.56,0.00;MQM=27;SAP=25;ABP=3	GBA	3'UTR	GBA:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::	GBA:NM_000157.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA:NM_001005741.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA:NM_001005742.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA:NM_001171811.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA:NM_001171812.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs368275143	0.0278	0.0194	14,.					6.97				0	0	6	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155234903	155234903	C	T	wt	het	wt		QUAL=123;DP=49,24,31;AF=0.00,0.58,0.00;MQM=28;SAP=33;ABP=4	GBA	3'UTR	GBA:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::	GBA:NM_000157.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA:NM_001005741.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA:NM_001005742.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA:NM_001171811.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA:NM_001171812.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs708606		0.0071	1,.					6.12			COSV59168994	0	4	29	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155235878	155235878	G	T	hom	hom	hom	off-target	QUAL=21497;DP=144,252,338;AF=0.98,1.00,1.00;MQM=56;SAP=755;ABP=0	GBA	intron	GBA:ENST00000327247.9:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:ENST00000368373.8:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:ENST00000427500.7:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::	regulatory_region_variant:promoter_flanking_region	606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	256871 [benign DISEASE=Gaucher disease type I,Gaucher disease, perinatal lethal,Gaucher disease,not specified,not provided];			rs3115534		0.9866	68942,.	0.8399,0.9923,0.9996,0.9975,0.9983				1.83				0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155237596	155237596	A	T	het	het	wt	off-target	QUAL=4084;DP=191,140,174;AF=0.52,0.54,0.00;MQM=53;SAP=333;ABP=5	GBA	intron	GBA:ENST00000327247.9:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:ENST00000368373.8:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:ENST00000427500.7:intron_variant:MODIFIER:intron5/9:c.615-18T>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron5/9:c.501-18T>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron5/9:c.615-18T>A::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0018	0.0086	6,.	0.0026,0.0034,0.0001,0.0130,0.0014				7.07		10.84>7.92		0.03	4	426	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155754524	155754524	G	T	het	het	wt	off-target	QUAL=212;DP=59,47,81;AF=0.41,0.11,0.04;MQM=50;SAP=72;ABP=50	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron28/30:c.*1298-1937C>A::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron27/31:c.5002-36C>A::,GON4L:XM_005245286.3:intron_variant:MODIFIER:intron12/16:c.3106-36C>A::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron26/30:c.5431-36C>A::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron27/31:c.5002-36C>A::					AluSg (SINE/Alu)	rs200722936		0.0585	0,.	0.0370,0.0498,0.0430,0.0547,0.0982				1.70			COSV55185833		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767594	155767594	C	T	hom	hom	hom	off-target	QUAL=8270;DP=38,118,156;AF=1.00,1.00,1.00;MQM=45;SAP=151;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron19/30:c.2647-53G>A::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron19/21:c.2647-53G>A::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron19/31:c.2131-53G>A::,GON4L:XM_005245286.3:intron_variant:MODIFIER:intron4/16:c.235-53G>A::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron18/30:c.2560-53G>A::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron19/31:c.2131-53G>A::						rs849712		0.9365	67305,.					3.66				0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785306	155785306	G	A	hom	hom	hom	off-target	QUAL=25676;DP=234,248,305;AF=1.00,1.00,1.00;MQM=60;SAP=188;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron13/30:c.1788+28C>T::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron13/21:c.1788+28C>T::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron13/31:c.1272+28C>T::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron13/30:c.1788+28C>T::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron13/31:c.1272+28C>T::						rs822021		0.9836	67377,.	0.7734,0.9901,0.9999,0.9996,0.9996				5.37				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815788	155815791	AACT	-	hom	hom	hom	off-target	QUAL=22150;DP=249,210,270;AF=1.00,1.00,1.00;MQM=60;SAP=212;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron8/30:c.1161+14_1161+17del::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron8/21:c.1161+14_1161+17del::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron8/31:c.645+14_645+17del::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron8/30:c.1161+14_1161+17del::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron8/31:c.645+14_645+17del::						rs148569012		0.9332	57983,.	0.6358,0.9666,0.9991,0.9504,0.9506				6.23				0.19	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156055305	156055305	C	T	wt	het	wt		QUAL=1260;DP=86,108,167;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3	LAMTOR2	synonymous	LAMTOR2:ENST00000368302.3:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368304.9:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368305.9:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain]	LAMTOR2:NM_001145264.2:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:,LAMTOR2:NM_014017.4:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:	regulatory_region_variant:promoter	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1165734 [benign DISEASE=not provided];			rs7541	0.0717	0.1214	1270,.	0.0514,0.0910,0.0004,0.1614,0.0814				8.58			COSV64145997	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156135237	156135237	T	C	wt	het	wt		QUAL=341;DP=91,36,54;AF=0.01,0.47,0.00;MQM=60;SAP=20;ABP=3	LMNA	synonymous	LMNA:ENST00000361308.9:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368301.6:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038 [Intermediate filament protein],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038 [Intermediate filament protein],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon7/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_170708.4:synonymous_variant:LOW:exon5/11:c.861T>C:p.Ala287=:,LMNA:XM_011509533.1:synonymous_variant:LOW:exon5/12:c.525T>C:p.Ala175=:,LMNA:XM_011509534.2:missense_variant:MODERATE:exon5/12:c.197T>C:p.Leu66Pro:,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon5/12:n.1108T>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48088 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM217020 [CLASS=DM? MUT=ALT PHEN="Cardiomyopathy dilated modifier of" GENE=LMNA];		rs538089	0.1931	0.1760	4475,.	0.4582,0.0653,0.0191,0.0722,0.1383				5.54				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136137	156136137	G	A	wt	het	wt	off-target	QUAL=3073;DP=90,261,311;AF=0.01,0.49,0.00;MQM=60;SAP=14;ABP=3	LMNA	intron	LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron7/12:c.860+16G>A::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron7/11:c.1157+16G>A::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron8/12:c.1157+16G>A::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron7/11:c.1157+16G>A::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:NM_001282624.2:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:NM_001282625.2:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_005572.4:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_170708.4:intron_variant:MODIFIER:intron6/10:c.1157+16G>A::,LMNA:XM_011509533.1:intron_variant:MODIFIER:intron6/11:c.821+16G>A::,LMNA:XM_011509534.2:intron_variant:MODIFIER:intron6/11:c.533+16G>A::,LMNA:XR_921781.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.1444+16G>A::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	36474 [benign/likely benign DISEASE=Primary dilated cardiomyopathy,Charcot-Marie-Tooth disease,not specified,not provided];			rs534807	0.1923	0.1757	4477,.	0.4589,0.0650,0.0191,0.0713,0.1322				3.25				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136394	156136394	T	C	wt	het	wt		QUAL=1107;DP=46,108,140;AF=0.00,0.46,0.00;MQM=60;SAP=14;ABP=4	LMNA	synonymous	LMNA:ENST00000361308.9:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368301.6:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932 [Lamin Tail Domain],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon9/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_170708.4:synonymous_variant:LOW:exon7/11:c.1338T>C:p.Asp446=:,LMNA:XM_011509533.1:synonymous_variant:LOW:exon7/12:c.1002T>C:p.Asp334=:,LMNA:XM_011509534.2:synonymous_variant:LOW:exon7/12:c.714T>C:p.Asp238=:,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon7/12:n.1625T>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48037 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs505058	0.2492	0.2268	8429,.	0.6399,0.0747,0.0198,0.0734,0.1436				5.62			COSV61542738	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137072	156137072	C	T	wt	het	wt	off-target	QUAL=2815;DP=183,239,371;AF=0.00,0.53,0.00;MQM=60;SAP=33;ABP=5	LMNA	intron	LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron9/12:c.1192-41C>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron10/12:c.1489-41C>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:NM_001282624.2:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:NM_001282625.2:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_005572.4:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_170708.4:intron_variant:MODIFIER:intron8/10:c.1489-41C>T::,LMNA:XM_011509533.1:intron_variant:MODIFIER:intron8/11:c.1153-41C>T::,LMNA:XM_011509534.2:intron_variant:MODIFIER:intron8/11:c.865-41C>T::,LMNA:XR_921781.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.1776-41C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66834 [benign DISEASE=not specified,not provided];			rs553016	0.1823	0.1672	3896,.	0.4276,0.0634,0.0192,0.0716,0.1376				6.84			COSV61542554	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137743	156137743	C	T	het	wt	het		QUAL=6933;DP=148,261,349;AF=0.61,0.00,0.55;MQM=60;SAP=26;ABP=21	LMNA	splice_region&synonymous,synonymous,intron	LMNA:ENST00000361308.9:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000368297.5:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000368299.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368300.9:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368301.6:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000448611.6:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000473598.6:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:,LMNA:ENST00000675667.1:splice_region_variant&synonymous_variant:LOW:exon11/12:c.1698C>T:p.His566=:,LMNA:ENST00000675939.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron11/12:c.1608+511C>T::,LMNA:ENST00000677389.1:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron10/11:c.1608+511C>T::,LMNA:ENST00000683032.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:	LMNA:NM_001257374.3:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:NM_001282626.2:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:NM_170707.4:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_170708.4:intron_variant:MODIFIER:intron9/10:c.1608+511C>T::,LMNA:XM_011509533.1:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1362C>T:p.His454=:,LMNA:XM_011509534.2:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1074C>T:p.His358=:,LMNA:XR_921781.2:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon10/12:n.1985C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48048 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.2202	0.2627	4003,.	0.0906,0.3237,0.2650,0.2651,0.2933				8.23		9.30>7.83	COSV61541921	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139185	156139185	G	C	wt	het	wt		QUAL=36;DP=68,7,15;AF=0.00,0.57,0.00;MQM=60;SAP=5;ABP=3	LMNA	3'UTR,intron	LMNA:ENST00000361308.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:ENST00000473598.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000675667.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*206G>C::,LMNA:ENST00000675939.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000682650.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000683032.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170708.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*79G>C::,LMNA:XM_011509533.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:XM_011509534.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2361G>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66756 [benign DISEASE=not specified,not provided];			rs7339	0.1853	0.1697	4048,.					2.75			COSV61542559	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139303	156139303	-	A	wt	het	wt		QUAL=51;DP=57,33,51;AF=0.02,0.24,0.04;MQM=60;SAP=8;ABP=22	LMNA	3'UTR,intron	LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+215dup::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+215dup::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170708.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*211dup::,LMNA:XM_011509533.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:XM_011509534.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2493dup::		150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Restrictive dermopathy, lethal, 275210 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1267964 [benign DISEASE=not provided];			rs200317083		0.1338	1718,.					13.27				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156815825	156815825	G	A	hom	hom	hom		QUAL=22395;DP=196,210,298;AF=1.00,1.00,1.00;MQM=60;SAP=54;ABP=0	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000392302.7:5_prime_UTR_variant:MODIFIER:exon1/17:c.-77G>A::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000674537.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-217G>A::	NTRK1:NM_001007792.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-5G>A::,SH2D2A:NM_001161441.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:NM_001161442.2:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:NM_001161443.2:intron_variant:MODIFIER:intron1/7:c.39+181C>T::,SH2D2A:NM_001161444.2:intron_variant:MODIFIER:intron2/7:c.123+181C>T::,SH2D2A:NM_003975.4:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:XM_006711615.2:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002762.2:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002763.1:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002764.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:XM_017002765.1:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:XM_017002766.1:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:XM_017002767.1:intron_variant:MODIFIER:intron2/7:c.141+181C>T::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	380853 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs1800601		0.6740	31197,.	0.4989,0.6951,0.8177,0.6775,0.6549				0.22			COSV63884607	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GT	wt	wt	het	off-target	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=15;ABP=82	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70dup::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291502 [benign DISEASE=not provided];			rs56185968		0.0960	1280,.					1.16				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GTGT	wt	wt	het	off-target	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=24;ABP=3	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+67_1321+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+67_1321+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+67_1393+70dup::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1236121 [benign DISEASE=not provided];			rs56185968		0.5038	19742,.					1.11				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875701	156875702	GT	-	wt	het	wt	off-target	QUAL=932;DP=16,39,44;AF=0.06,0.03,0.30;MQM=60;SAP=24;ABP=4	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70del::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70del::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70del::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291500 [benign DISEASE=not provided];		(GT)n (Simple_repeat)	rs56185968		0.1423	1562,.					0.83				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156876441	156876441	G	A	het	hom	wt		QUAL=6437;DP=146,147,146;AF=0.51,1.00,0.00;MQM=60;SAP=50;ABP=3	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon14/17:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon15/18:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon14/17:c.1566G>A:p.Gln522=:,NTRK1:NM_001012331.2:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:,NTRK1:NM_002529.4:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	292889 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified,not provided];			rs6334	0.2129	0.2203	3221,.	0.1314,0.2163,0.3494,0.2144,0.2352				8.92			COSV62323674	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879203	156879203	C	T	het	wt	hom		QUAL=3877;DP=48,104,128;AF=0.33,0.01,0.97;MQM=60;SAP=11;ABP=15	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon15/17:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon16/18:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon15/17:c.1779C>T:p.Ala593=:,NTRK1:NM_001012331.2:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:,NTRK1:NM_002529.4:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	138564 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6337	0.3341	0.5779	25959,.	0.1981,0.5752,0.0396,0.7242,0.3929				1.64			COSV62325231	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160039331	160039331	A	C	het	het	wt		QUAL=3042;DP=172,68,80;AF=0.50,0.46,0.00;MQM=60;SAP=7;ABP=3	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2715T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1171T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293090 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs1053074	0.4810	0.4563	16600,.					8.27			COSV63635370	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039353	160039353	G	C	hom	hom	hom		QUAL=8538;DP=143,59,69;AF=1.00,0.97,1.00;MQM=60;SAP=24;ABP=0	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2693C>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1149C>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293091 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs2486254		0.9977	74911,.					3.99				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039375	AC	-	wt	wt	het		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=16	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2671_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1127_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293094 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397		0.1202	987,.					0.96				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039377	ACAC	-	wt	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=39	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2669_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1125_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293095 [benign/likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397		0.1668	1899,.					5.44				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039379	ACACAC	-	het	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=5;ABP=46	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2667_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1123_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293097 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397		0.0898	553,.					5.31				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039629	160039629	A	C	hom	hom	hom		QUAL=31991;DP=368,263,345;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2417T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+873T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293102 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs2486253		0.8189	51070,.					7.94				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160040361	160040361	C	T	wt	het	wt		QUAL=2265;DP=332,195,282;AF=0.00,0.50,0.00;MQM=60;SAP=6;ABP=3	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+1685G>A::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+141G>A::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	874513 [benign/likely benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs17375748	0.0244	0.0447	208,.					1.55				0	1	17	0 / 0					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160277200	160277200	T	-	het	het	het		QUAL=1365;DP=292,136,193;AF=0.18,0.22,0.17;MQM=60;SAP=3;ABP=538	PEX19,	3'UTR,intron	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,:ENST00000485079.1:intron_variant:MODIFIER:intron5/6:c.487+931del::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2359del::,PEX19:NM_002857.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,PEX19:NR_036492.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3150del::,PEX19:NR_036493.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3174del::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]			Charlie10 (DNA/hAT-Charlie)	rs751979135		0.2519	0,.	0.2253,0.2326,0.2514,0.2578,0.2549				0.23				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277395	160277395	G	C	het	wt	hom		QUAL=10190;DP=282,165,217;AF=0.44,0.01,1.00;MQM=60;SAP=12;ABP=13	PEX19,	3'UTR,intron	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,:ENST00000485079.1:intron_variant:MODIFIER:intron5/6:c.487+736C>G::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2164C>G::,PEX19:NM_002857.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,PEX19:NR_036492.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2955C>G::,PEX19:NR_036493.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2979C>G::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.4523	0.4950	16142,.	0.3382,0.4808,0.3476,0.5072,0.6152				3.34			COSV63619513	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160282002	160282002	A	G	het	wt	hom	off-target	QUAL=6879;DP=209,91,148;AF=0.44,0.00,1.00;MQM=60;SAP=298;ABP=9	PEX19,	intron	PEX19:ENST00000368072.10:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,:ENST00000485079.1:intron_variant:MODIFIER:intron2/6:c.204+37T>C::	PEX19:NM_001193644.1:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NM_002857.4:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NR_036492.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.493+37T>C::,PEX19:NR_036493.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.517+37T>C::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	1227462 [benign DISEASE=Peroxisome biogenesis disorder 12A,not provided];			rs2795067		0.6435	32988,.	0.8687,0.5589,0.4645,0.5555,0.7045				0.16			COSV63619299	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161170488	161170488	A	-	het	wt	het		QUAL=6439;DP=229,326,376;AF=0.46,0.00,0.46;MQM=60;SAP=80;ABP=12	PPOX	frameshift,intron	PPOX:ENST00000352210.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-132del::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-132del::	PPOX:NM_000309.5:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001122764.3:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001350128.2:frameshift_variant:HIGH:exon9/12:c.968del:p.Gln323ArgfsTer10:,PPOX:NM_001350129.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001350130.2:frameshift_variant:HIGH:exon10/13:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001350131.2:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001365398.1:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001365399.1:intron_variant:MODIFIER:intron9/11:c.988-132del::,PPOX:NM_001365400.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001365401.1:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_005245291.4:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:XM_005245295.3:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_006711402.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_006711403.2:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:XM_006711404.4:frameshift_variant:HIGH:exon10/13:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_006711406.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509663.2:frameshift_variant:HIGH:exon10/13:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_011509664.1:frameshift_variant:HIGH:exon10/13:c.1181del:p.Gln394ArgfsTer10:,PPOX:XM_011509665.2:frameshift_variant:HIGH:exon10/12:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_011509666.2:intron_variant:MODIFIER:intron9/11:c.1117-132del::,PPOX:XM_011509667.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509668.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509670.2:frameshift_variant:HIGH:exon9/12:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509671.1:frameshift_variant:HIGH:exon10/13:c.1181del:p.Gln394ArgfsTer10:,PPOX:XM_011509672.3:frameshift_variant:HIGH:exon9/12:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509673.2:frameshift_variant:HIGH:exon8/11:c.932del:p.Gln311ArgfsTer10:,PPOX:XM_011509674.2:intron_variant:MODIFIER:intron7/9:c.937-132del::,PPOX:XM_011509678.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509679.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509681.1:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_011509682.1:frameshift_variant:HIGH:exon9/12:c.365del:p.Gln122ArgfsTer10:,PPOX:XM_017001559.1:intron_variant:MODIFIER:intron9/11:c.1117-132del::,PPOX:XM_017001562.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001563.2:frameshift_variant:HIGH:exon10/13:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_017001564.1:frameshift_variant:HIGH:exon6/9:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_017001566.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001567.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001570.1:frameshift_variant:HIGH:exon7/10:c.365del:p.Gln122ArgfsTer10:,PPOX:XM_017001571.1:intron_variant:MODIFIER:intron3/5:c.337-132del::,PPOX:XM_024447864.1:frameshift_variant:HIGH:exon8/11:c.932del:p.Gln311ArgfsTer10:,PPOX:XM_024447865.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_024447866.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_024447867.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XR_921850.2:non_coding_transcript_exon_variant:MODIFIER:exon9/12:n.1300del::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]																0.12	0	2	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161214269	161214269	-	TG	wt	wt	het		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=69;ABP=729	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*149_*150dup::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1621_1622dup::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293284 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Mitochondrial complex I deficiency,not provided];			rs10629771		0.2808	5965,.					1.48				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TGTG	wt	het	wt		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=42;ABP=454	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*104_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*147_*150dup::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1619_1622dup::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1253405 [benign DISEASE=not provided];			rs10629771		0.1292	1280,.					1.43				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214270	161214271	TG	-	het	wt	wt		QUAL=1662;DP=228,160,212;AF=0.02,0.08,0.27;MQM=60;SAP=92;ABP=691	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107del::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*149_*150del::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1621_1622del::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293286 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771		0.0013	0,.					2.26				0	0	17	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214307	161214307	A	G	wt	wt	het		QUAL=2153;DP=361,186,251;AF=0.00,0.00,0.39;MQM=60;SAP=112;ABP=29	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*114A>G::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*157A>G::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1629A>G::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293289 [benign DISEASE=Mitochondrial complex I deficiency, nuclear type 1,not provided];			rs1136224	0.1821	0.1418	1776,.					1.40				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161304858	161304858	G	C	wt	het	het		QUAL=71;DP=35,28,33;AF=0.00,0.29,0.30;MQM=60;SAP=42;ABP=25	MPZ	3'UTR	MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::,MPZ:XM_017001321.2:intron_variant:MODIFIER:intron5/5:c.676-517C>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]				rs185093979		0.2822	1,.					0.46				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161305115	161305115	T	C	wt	het	wt		QUAL=172;DP=68,29,18;AF=0.00,0.38,0.00;MQM=60;SAP=3;ABP=7	MPZ	3'UTR	MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::,MPZ:XM_017001321.2:intron_variant:MODIFIER:intron5/5:c.676-774A>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	293304 [benign DISEASE=Charcot-Marie-Tooth disease, demyelinating, type 1b,Roussy-Levy syndrome,Congenital hypomyelinating neuropathy 1, autosomal recessive,Charcot-Marie-Tooth disease dominant intermediate d,Congenital hypomyelinating neuropathy 2,not provided];			rs16832786	0.1364	0.1292	1547,.					2.00				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	167430631	167430631	-	AG	hom	hom	hom		QUAL=15215;DP=189,147,177;AF=0.99,0.99,0.99;MQM=60;SAP=781;ABP=0	CD247,POU2F1	downstream_gene	CD247:ENST00000362089.10:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.3:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs5778549		0.9877	74289,.					0.42					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430725	167430725	T	C	hom	hom	hom		QUAL=39572;DP=382,380,464;AF=1.00,1.00,1.00;MQM=60;SAP=331;ABP=0	CD247	3'UTR	CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:NM_001378515.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:NM_001378516.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:NM_198053.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:XM_011510144.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:XM_011510145.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::	regulatory_region_variant:promoter_flanking_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs947480		0.9877	74309,.					1.51				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430837	167430837	T	A	hom	hom	hom		QUAL=44558;DP=402,433,558;AF=1.00,1.00,1.00;MQM=60;SAP=15;ABP=0	CD247	3'UTR	CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:NM_001378515.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:NM_001378516.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:NM_198053.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:XM_011510144.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:XM_011510145.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs1052231		0.8188	51196,.					2.97				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167439433	167439433	C	T	het	het	hom	off-target	QUAL=11562;DP=76,218,288;AF=0.54,0.49,0.99;MQM=60;SAP=166;ABP=3	CD247	intron	CD247:ENST00000362089.10:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron2/7:c.163-33G>A::	CD247:NM_000734.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:NM_001378515.1:intron_variant:MODIFIER:intron3/8:c.256-33G>A::,CD247:NM_001378516.1:intron_variant:MODIFIER:intron3/8:c.256-33G>A::,CD247:NM_198053.3:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:XM_011510144.2:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:XM_011510145.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1179252 [benign DISEASE=not provided];			rs840016	0.1907	0.3109	7499,.	0.0805,0.2358,0.1048,0.3992,0.2976				10.89			COSV62980812	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167518349	167518349	C	G	het	het	wt	off-target	QUAL=1448;DP=49,67,87;AF=0.53,0.55,0.00;MQM=60;SAP=115;ABP=5	CD247	intron	CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron1/7:c.58+59G>C::	CD247:NM_000734.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:NM_001378515.1:intron_variant:MODIFIER:intron1/8:c.58+59G>C::,CD247:NM_001378516.1:intron_variant:MODIFIER:intron1/8:c.58+59G>C::,CD247:NM_198053.3:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:XM_011510144.2:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:XM_011510145.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1237879 [benign DISEASE=not provided];		(CCACTC)n (Simple_repeat)	rs35864197	0.1108	0.1429	1771,.					6.53				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	173826666	173826666	T	-	het	het	het	off-target	QUAL=777;DP=119,21,45;AF=0.22,0.33,0.22;MQM=60;SAP=96;ABP=118	DARS2	intron	DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron1/14:c.128-5del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron1/16:c.128-5del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron1/16:c.128-5del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs746151025		0.4237	4,.	0.3542,0.4108,0.4051,0.4329,0.4481				1.78				0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850284	173850284	A	-	het	het	het	off-target	QUAL=443;DP=66,19,29;AF=0.23,0.26,0.24;MQM=60;SAP=62;ABP=72	DARS2	intron	DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1129-29del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron12/13:c.1192-29del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5007del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-3051del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron12/16:c.1192-29del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron12/13:c.1192-29del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron12/16:c.1192-29del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs199872112		0.1305	0,.	0.0973,0.1303,0.0955,0.1534,0.1207				0.11					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179550503	179550506	TTTC	-	wt	wt	het	off-target	QUAL=485;DP=124,52,58;AF=0.00,0.00,0.41;MQM=60;SAP=55;ABP=7	AXDND1	intron	AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4006_*1207-4003del::	AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-4006_3080-4003del::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-4006_2975-4003del::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-4006_2930-4003del::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-4006_2816-4003del::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-4006_2810-4003del::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-4006_2741-4003del::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-4006_2402-4003del::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-4006_1961-4003del::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-4006_2297-4003del::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-4006_2159-4003del::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs147171656		0.2023	3759,.					9.71				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550745	179550745	T	C	hom	hom	hom		QUAL=27861;DP=267,272,327;AF=1.00,1.00,1.00;MQM=60;SAP=214;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3767T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3767T>C::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*428A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3767T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3767T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3767T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3767T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3767T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3767T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3767T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3767T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3767T>C::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*428A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224486 [benign DISEASE=Idiopathic nephrotic syndrome];			rs1060775		0.9045	62357,.					3.71				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550915	179550915	T	C	het	hom	wt		QUAL=7961;DP=328,121,177;AF=0.45,1.00,0.00;MQM=60;SAP=42;ABP=9	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3597T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3597T>C::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*258A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3597T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3597T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3597T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3597T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3597T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3597T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3597T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3597T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3597T>C::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*258A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224485 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];			rs2274622	0.2831	0.2418	4892,.					6.33				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551016	179551016	C	T	hom	hom	hom		QUAL=24187;DP=285,194,263;AF=1.00,1.00,0.99;MQM=60;SAP=29;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3496C>T::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3496C>T::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*157G>A::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3496C>T::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3496C>T::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3496C>T::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3496C>T::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3496C>T::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3496C>T::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3496C>T::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3496C>T::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3496C>T::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*157G>A::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224483 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];			rs1410590		0.9072	62758,.					0.37				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551119	179551119	C	G	hom	hom	hom		QUAL=22283;DP=391,131,174;AF=0.99,0.99,0.99;MQM=60;SAP=195;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3393C>G::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3393C>G::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*54G>C::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3393C>G::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3393C>G::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3393C>G::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3393C>G::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3393C>G::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3393C>G::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3393C>G::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3393C>G::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3393C>G::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*54G>C::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	293845 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];			rs1410591		0.6147	28851,.					5.38			COSV62634863	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551371	179551371	G	A	hom	hom	hom		QUAL=20877;DP=349,128,184;AF=0.99,0.99,1.00;MQM=60;SAP=27;ABP=0	NPHS2,AXDND1	synonymous,intron	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3141G>A::	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3141G>A::,NPHS2:XM_005245483.3:synonymous_variant:LOW:exon6/6:c.777C>T:p.Ala259=:,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3141G>A::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3141G>A::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3141G>A::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3141G>A::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3141G>A::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3141G>A::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3141G>A::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3141G>A::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3141G>A::,NPHS2:XM_017002298.1:synonymous_variant:LOW:exon5/5:c.621C>T:p.Ala207=:,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260432 [benign DISEASE=Steroid-resistant nephrotic syndrome,Idiopathic nephrotic syndrome,not specified,not provided];			rs1410592		0.6190	28786,.	0.6004,0.6654,0.4727,0.6310,0.6037				2.36			COSV62634578	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552549	179552549	T	C	het	wt	het	off-target	QUAL=3037;DP=147,83,124;AF=0.44,0.00,0.47;MQM=60;SAP=156;ABP=8	NPHS2,AXDND1	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1963T>C::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1963T>C::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron5/5:c.696+54A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-1963T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-1963T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-1963T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-1963T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-1963T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-1963T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-1963T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-1963T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-1963T>C::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron4/4:c.540+54A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1227202 [benign DISEASE=not provided];			rs11808359	0.0214	0.0468	265,.					4.38				0	62	1638	0 / 0					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552596	179552596	T	C	wt	het	wt		QUAL=1100;DP=137,113,196;AF=0.01,0.44,0.00;MQM=60;SAP=18;ABP=6	NPHS2,AXDND1	splice_region&intron,intron	NPHS2:ENST00000367615.9:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,NPHS2:ENST00000367616.4:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1916T>C::	NPHS2:NM_001297575.2:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,NPHS2:NM_014625.4:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1916T>C::,NPHS2:XM_005245483.3:splice_region_variant&intron_variant:LOW:intron5/5:c.696+7A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-1916T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-1916T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-1916T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-1916T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-1916T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-1916T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-1916T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-1916T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-1916T>C::,NPHS2:XM_017002298.1:splice_region_variant&intron_variant:LOW:intron4/4:c.540+7A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260430 [benign/likely benign DISEASE=Idiopathic nephrotic syndrome,not specified,not provided];			rs115778946	0.0160	0.0305	97,.	0.0082,0.0236,0.0000,0.0488,0.0103				1.92				0.06	52	1513	0 / 0					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559782	179559782	G	A	wt	wt	het	off-target	QUAL=2053;DP=167,134,157;AF=0.00,0.00,0.53;MQM=60;SAP=12;ABP=4	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-21C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-21C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron1/5:c.275-21C>T::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron2/4:c.379-21C>T::,NPHS2:XM_017002299.1:intron_variant:MODIFIER:intron3/4:c.452-21C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180466 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];			rs12401708	0.1334	0.2376	3794,.	0.0633,0.2414,0.0433,0.2751,0.2021				2.16				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559807	179559807	G	A	wt	wt	het	off-target	QUAL=1838;DP=145,114,138;AF=0.00,0.00,0.54;MQM=60;SAP=21;ABP=5	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-46C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-46C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron1/5:c.275-46C>T::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron2/4:c.379-46C>T::,NPHS2:XM_017002299.1:intron_variant:MODIFIER:intron3/4:c.452-46C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180467 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];			rs12401711	0.1334	0.2370	3795,.	0.0631,0.2396,0.0434,0.2736,0.2011				1.72			COSV62635112	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179575763	179575763	T	C	n/a	hom	hom		QUAL=442;DP=1,3,13;AF=1.00,1.00,1.00;MQM=60;SAP=4;ABP=0	NPHS2	synonymous	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:XM_005245483.3:synonymous_variant:LOW:exon1/6:c.102A>G:p.Gly34=:,NPHS2:XM_017002298.1:synonymous_variant:LOW:exon1/5:c.102A>G:p.Gly34=:,NPHS2:XM_017002299.1:synonymous_variant:LOW:exon1/5:c.102A>G:p.Gly34=:		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260424 [benign DISEASE=Idiopathic nephrotic syndrome,not specified,not provided];			rs1079292		0.9774	68551,.	0.8073,0.9855,0.9753,0.9928,0.9446				2.12			COSV62634486	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575915	179575915	C	A	n/a	wt	het		QUAL=196;DP=1,9,18;AF=0.00,0.00,0.61;MQM=60;SAP=3;ABP=5	NPHS2	5'UTR	NPHS2:ENST00000367615.9:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::	NPHS2:NM_001297575.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::,NPHS2:NM_014625.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:XM_005245483.3:5_prime_UTR_variant:MODIFIER:exon1/6:c.-51G>T::,NPHS2:XM_017002298.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-51G>T::,NPHS2:XM_017002299.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-51G>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	225144 [benign DISEASE=Idiopathic nephrotic syndrome,not specified,not provided]; 225143 [pathogenic DISEASE=Idiopathic nephrotic syndrome];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.1833	0.2545	4502,.	0.1427,0.3448,0.0981,0.2766,0.1991				4.19			COSV62635817	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575980	179575980	G	A	n/a	hom	wt	off-target	QUAL=67;DP=1,4,7;AF=1.00,1.00,0.00;MQM=60;SAP=14;ABP=0	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615.9:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::	NPHS2:XM_017002298.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-116C>T::,NPHS2:XM_017002299.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-116C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1165811 [benign DISEASE=Idiopathic nephrotic syndrome,not provided];	CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.2746	0.2331	4745,.					0.94					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180230249	180230249	-	AG	het	hom	wt	off-target	QUAL=207;DP=30,8,9;AF=0.37,1.00,0.00;MQM=60;SAP=44;ABP=8	LHX4	upstream_gene	LHX4:ENST00000263726.4:upstream_gene_variant:MODIFIER::::	LHX4:XM_011510105.2:intron_variant:MODIFIER:intron1/5:c.-108+1339_-108+1340dup::,LHX4:XM_011510106.3:intron_variant:MODIFIER:intron1/5:c.-108+1099_-108+1100dup::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]			G-rich (Low_complexity)	rs138033992		0.4142	13157,.					18.33					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180266593	180266593	C	T	het	wt	het		QUAL=1863;DP=74,91,107;AF=0.51,0.00,0.42;MQM=60;SAP=88;ABP=6	LHX4	splice_region&synonymous	LHX4:ENST00000263726.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	LHX4:NM_033343.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:,LHX4:XM_011510105.2:splice_region_variant&synonymous_variant:LOW:exon3/6:c.267C>T:p.Asn89=:,LHX4:XM_011510106.3:splice_region_variant&synonymous_variant:LOW:exon3/6:c.267C>T:p.Asn89=:,LHX4:XM_011510108.2:splice_region_variant&synonymous_variant:LOW:exon3/6:c.225C>T:p.Asn75=:,LHX4:XM_017002755.1:splice_region_variant&synonymous_variant:LOW:exon2/5:c.225C>T:p.Asn75=:	regulatory_region_variant:promoter_flanking_region	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262223 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified,not provided];			rs16855642	0.0427	0.0389	261,.	0.1045,0.0092,0.0111,0.0105,0.0175				8.34		9.89>9.26		0	9	471	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271375	180271375	T	C	het	het	wt		QUAL=1647;DP=67,77,115;AF=0.52,0.47,0.00;MQM=60;SAP=76;ABP=3	LHX4,ACBD6	splice_region&intron,3'UTR	LHX4:ENST00000263726.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1850A>G::	LHX4:NM_033343.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,LHX4-AS1:NR_037642.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.945A>G::,LHX4:XM_011510105.2:splice_region_variant&intron_variant:LOW:intron3/5:c.269-5T>C::,LHX4:XM_011510106.3:splice_region_variant&intron_variant:LOW:intron3/5:c.269-5T>C::,LHX4:XM_011510108.2:splice_region_variant&intron_variant:LOW:intron3/5:c.227-5T>C::,LHX4:XM_017002755.1:splice_region_variant&intron_variant:LOW:intron2/4:c.227-5T>C::,ACBD6:XR_001737484.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.5372A>G::,ACBD6:XR_001737485.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.5355A>G::,ACBD6:XR_002957801.1:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.5274A>G::,ACBD6:XR_921977.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.5499A>G::,ACBD6:XR_921978.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.5503A>G::	regulatory_region_variant:promoter_flanking_region	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	293866 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not provided];			rs2764449	0.0413	0.0658	357,.	0.0140,0.0291,0.0113,0.0780,0.0791				8.63		10.03>9.20	COSV55378051	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180274389	180274389	A	G	het	het	het		QUAL=7700;DP=210,155,203;AF=0.48,0.48,0.57;MQM=60;SAP=6;ABP=4	LHX4,ACBD6	missense,intron	LHX4:ENST00000263726.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron10/13:c.*936+262T>C::	LHX4:NM_033343.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,LHX4-AS1:NR_037642.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.31+262T>C::,LHX4:XM_011510105.2:missense_variant:MODERATE:exon6/6:c.800A>G:p.Asn267Ser:,LHX4:XM_011510106.3:missense_variant:MODERATE:exon6/6:c.800A>G:p.Asn267Ser:,LHX4:XM_011510108.2:missense_variant:MODERATE:exon6/6:c.758A>G:p.Asn253Ser:,LHX4:XM_017002755.1:missense_variant:MODERATE:exon5/5:c.758A>G:p.Asn253Ser:,ACBD6:XR_001737484.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.2358T>C::,ACBD6:XR_001737485.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.2341T>C::,ACBD6:XR_002957801.1:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.2260T>C::,ACBD6:XR_921977.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2485T>C::,ACBD6:XR_921978.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2489T>C::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262225 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified];			rs7536561	0.4263	0.4824	15297,.	0.1826,0.2569,0.5889,0.5227,0.6011		T(1.00), 	B(0.00), 	13.78	0.26		COSV55374116	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180288557	180288557	A	C	hom	hom	hom	off-target	QUAL=19073;DP=249,155,202;AF=1.00,1.00,1.00;MQM=60;SAP=827;ABP=0	ACBD6	intron	ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.695-40T>G::	ACBD6:NM_032360.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::,ACBD6:XR_001737484.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1006-40T>G::,ACBD6:XR_001737485.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1006-40T>G::,ACBD6:XR_002957801.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1006-40T>G::,ACBD6:XR_921977.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1006-40T>G::,ACBD6:XR_921978.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1006-40T>G::	regulatory_region_variant:promoter_flanking_region					rs2254465		0.9499	68664,.	0.9632,0.9680,0.9876,0.9423,0.9138				0.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183186093	183186093	C	A	wt	het	wt		QUAL=2642;DP=173,249,306;AF=0.00,0.49,0.01;MQM=60;SAP=59;ABP=3	LAMC2	upstream_gene	LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	293975 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276544	0.1603	0.1395	1751,.					13.66					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186170	183186170	G	A	het	wt	hom		QUAL=19348;DP=265,354,500;AF=0.54,0.00,1.00;MQM=60;SAP=65;ABP=7	LAMC2	upstream_gene	LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	293977 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276543	0.2989	0.2732	5955,.					21.50					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186264	183186264	A	G	wt	het	wt		QUAL=3317;DP=364,283,397;AF=0.00,0.48,0.00;MQM=60;SAP=3;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::,LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::,LAMC2:XM_017001273.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-89A>G::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	293979 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs2276542	0.2091	0.1811	2655,.					17.56			COSV51459231		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186347	183186347	C	A	wt	wt	het		QUAL=791;DP=26,68,90;AF=0.00,0.00,0.47;MQM=60;SAP=28;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::,LAMC2:XM_017001273.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-6C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	293983 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs684527	0.2748	0.3122	5789,.	0.0999,0.3338,0.4192,0.2979,0.3598				18.61				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	T	het	het	het	off-target	QUAL=1124;DP=55,54,46;AF=0.13,0.39,0.28;MQM=60;SAP=84;ABP=78	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-31dup::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron1/14:c.80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	1224645 [benign DISEASE=not provided];			rs10668798		0.2688	2245,.	0.2697,0.2585,0.3149,0.2623,0.2771				7.18			COSV51458071	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	TT	wt	wt	het	off-target	QUAL=1124;DP=55,54,46;AF=0.11,0.06,0.39;MQM=60;SAP=62;ABP=146	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron1/14:c.80-32_80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	1229395 [benign DISEASE=not provided];			rs10668798		0.3407	8268,.	0.2093,0.2541,0.2462,0.1999,0.1521				6.90			COSV51458071	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208083	183208083	A	G	het	wt	hom	off-target	QUAL=9050;DP=136,212,242;AF=0.47,0.00,1.00;MQM=60;SAP=220;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.268+14A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron2/21:c.268+14A>G::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron2/14:c.268+14A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259785 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];		GA-rich (Low_complexity)	rs647347	0.4962	0.4732	16114,.	0.4660,0.5096,0.5629,0.4381,0.5155				0.14			COSV51456075,COSV51458451	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215481	183215481	C	T	wt	het	wt		QUAL=2930;DP=271,244,345;AF=0.00,0.48,0.01;MQM=60;SAP=3;ABP=4	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon3/15:c.297C>T:p.Ser99=:	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259787 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2274980	0.3137	0.2562	5744,.	0.3883,0.3782,0.3433,0.1766,0.3155				9.04			COSV51453066	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218359	183218359	T	C	wt	het	wt	off-target	QUAL=3569;DP=342,295,465;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.405-31T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron3/21:c.405-31T>C::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron3/14:c.405-31T>C::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	1180478 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs10911285	0.3139	0.2563	5750,.	0.3884,0.3788,0.3433,0.1766,0.3153				6.51			COSV51453509	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218468	183218468	C	T	wt	het	wt		QUAL=3073;DP=195,249,323;AF=0.00,0.50,0.00;MQM=60;SAP=28;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon4/15:c.483C>T:p.Val161=:	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259789 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1129723	0.3139	0.2563	5756,.	0.3875,0.3784,0.3423,0.1762,0.3155				12.32			COSV51453519	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223169	183223169	T	G	wt	het	wt		QUAL=2777;DP=226,207,280;AF=0.00,0.53,0.00;MQM=60;SAP=14;ABP=5	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon7/15:c.798T>G:p.Gly266=:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259790 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047980	0.3550	0.2931	8160,.	0.5145,0.3869,0.3442,0.1779,0.3165				10.35			COSV51453536	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223361	183223361	A	G	wt	het	wt	off-target	QUAL=2028;DP=216,137,173;AF=0.00,0.59,0.00;MQM=60;SAP=123;ABP=13	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.953+37A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron7/21:c.953+37A>G::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron7/14:c.953+37A>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	1268335 [benign DISEASE=not provided];			rs3738824	0.1132	0.1316	1242,.	0.1116,0.1648,0.1782,0.1267,0.0906				5.28			COSV51456347	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183232835	183232835	G	C	wt	het	wt		QUAL=907;DP=128,109,163;AF=0.00,0.39,0.00;MQM=60;SAP=28;ABP=15	LAMC2	missense	LAMC2:ENST00000264144.5:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000493293.5:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:	LAMC2:NM_005562.3:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:NM_018891.3:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:,LAMC2:XM_017001273.2:missense_variant:MODERATE:exon14/15:c.2198G>C:p.Ser733Thr:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259784 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2296303	0.1450	0.1609	2136,.	0.2289,0.1701,0.1797,0.1272,0.0914		D(0.05),D(0.05)	B(0.13),B(0.17)	13.16	0.07		COSV51456358	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183237438	183237438	G	A	wt	het	wt		QUAL=3682;DP=364,276,404;AF=0.00,0.51,0.00;MQM=60;SAP=27;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:	LAMC2:NM_005562.3:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	259786 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047981	0.3524	0.2922	8099,.	0.5110,0.3851,0.3431,0.1779,0.3162				0.17			COSV51453550	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183238468	183238468	T	C	wt	het	wt	off-target	QUAL=1090;DP=197,82,112;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]				rs1925043	0.3588	0.2989	8644,.	0.5345,0.3875,0.3445,0.1784,0.3163				0.62			COSV51453562	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183241246	183241246	A	-	het	het	wt		QUAL=143;DP=18,9,4;AF=0.28,0.67,0.00;MQM=60;SAP=5;ABP=5	LAMC2	intron,3'UTR	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:ENST00000493293.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:NM_018891.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs11318188		0.1926	1395,.					0.78				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243413	183243413	T	G	wt	het	wt		QUAL=2485;DP=214,174,247;AF=0.00,0.56,0.00;MQM=60;SAP=9;ABP=8	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	294025 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa];			rs3768593	0.3109	0.2421	5110,.	0.3628,0.3779,0.3678,0.1651,0.3129				7.28			COSV51452226	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244275	183244275	G	T	wt	het	wt		QUAL=2295;DP=275,178,200;AF=0.00,0.49,0.01;MQM=60;SAP=3;ABP=3	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	294036 [benign DISEASE=Junctional epidermolysis bullosa];			rs10797863	0.0913	0.0988	861,.					0.43				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244798	183244798	C	T	wt	wt	het		QUAL=4919;DP=472,284,395;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=6	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive]	294053 [uncertain significance DISEASE=Junctional epidermolysis bullosa];			rs564740740	0.0012	0.0023	0,.					4.86			COSV51452086	0	0	19	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183555720	183555720	C	A	hom	hom	hom		QUAL=43677;DP=452,380,543;AF=1.00,0.99,0.99;MQM=60;SAP=109;ABP=0	NCF2	3'UTR	NCF2:ENST00000367535.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:ENST00000367536.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000413720.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::	NCF2:NM_000433.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:NM_001127651.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:NM_001190789.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:NM_001190794.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:XM_005245207.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:XM_011509580.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:XM_011509581.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	294066 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2];			rs796860		0.9016	61925,.					1.14				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183565800	183565800	C	T	hom	hom	het	off-target	QUAL=13707;DP=147,193,253;AF=1.00,1.00,0.51;MQM=60;SAP=61;ABP=3	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron7/12:c.682-21G>A::	NCF2:NM_000433.4:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:NM_001127651.3:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:NM_001190789.2:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:NM_001190794.2:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:XM_005245207.1:intron_variant:MODIFIER:intron8/13:c.817-21G>A::,NCF2:XM_011509580.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:XM_011509581.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1235081 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2,not provided];			rs2296164	0.4776	0.4930	16095,.	0.3535,0.6456,0.6096,0.4669,0.4657				0.01			COSV62315476	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183573252	183573252	T	C	hom	hom	het		QUAL=18366;DP=257,192,266;AF=0.98,1.00,0.55;MQM=60;SAP=6;ABP=8	NCF2	missense,intron	NCF2:ENST00000367535.8:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000367536.5:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.5:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::	NCF2:NM_000433.4:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:NM_001127651.3:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:NM_001190789.2:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:NM_001190794.2:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:XM_005245207.1:intron_variant:MODIFIER:intron4/13:c.501+1235A>G::,NCF2:XM_011509580.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:XM_011509581.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:	regulatory_region_variant:promoter_flanking_region	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	256116 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2,not specified,not provided];			rs2274064	0.4916	0.4988	16259,.	0.3588,0.6448,0.6234,0.4659,0.5073		T(0.81),T(0.81),T(0.88), 	B(0.00),B(0.00),B(0.00), 	16.25	0.08		COSV62314890	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196672942	196672942	C	T	wt	het	wt	off-target	QUAL=324;DP=121,48,74;AF=0.00,0.38,0.00;MQM=60;SAP=15;ABP=10	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron1/8:c.59-36C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/22:n.144-36C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1209735 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,not provided];			rs551397	0.4681	0.3977	15215,.	0.7248,0.3721,0.4170,0.2314,0.3114				1.01			COSV62776788	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673103	196673103	G	A	wt	het	wt		QUAL=924;DP=231,83,139;AF=0.00,0.48,0.00;MQM=60;SAP=5;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:,CFH:NM_001014975.3:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:,CFH:XM_017001108.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon2/23:n.269G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	16550 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs800292	0.4681	0.3968	15151,.	0.7254,0.3751,0.4206,0.2350,0.3144		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	7.64	0.14		COSV62776782	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673839	196673839	-	TT	wt	het	wt	off-target	QUAL=947;DP=98,110,131;AF=0.00,0.39,0.00;MQM=60;SAP=5;ABP=14	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron2/8:c.245-10_245-9dup::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::	CFH:NM_000186.4:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/22:n.330-10_330-9dup::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1166414 [benign DISEASE=not specified,not provided];	CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs35507625		0.2426	4684,.					1.21				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196685194	196685194	A	C	het	het	het		QUAL=9406;DP=284,209,266;AF=0.49,0.48,0.48;MQM=60;SAP=61;ABP=5	CFH	synonymous	CFH:ENST00000359637.2:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:,CFH:NM_001014975.3:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:XM_017001108.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon7/23:n.1006A>C::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294488 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061147		0.6762	30581,.	0.5734,0.8312,0.9540,0.6166,0.6976				6.10			COSV62778986	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689367	196689367	G	T	het	het	het	off-target	QUAL=1495;DP=93,15,17;AF=0.55,0.53,0.18;MQM=60;SAP=138;ABP=3	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/22:n.1050-53G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1276326 [benign DISEASE=not provided];			rs482934		0.6916	37045,.					1.48			COSV62776949	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196690107	196690107	C	T	het	het	het		QUAL=5483;DP=190,104,108;AF=0.57,0.41,0.49;MQM=57;SAP=134;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:,CFH:NM_001014975.3:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:,CFH:XM_017001108.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon9/23:n.1289C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294490 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061170		0.6797	31967,.	0.6270,0.8335,0.9541,0.6159,0.6976		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00	0.09		COSV62776341	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196713817	196713817	G	A	het	het	het		QUAL=8591;DP=262,192,257;AF=0.42,0.49,0.48;MQM=60;SAP=100;ABP=13	CFH	synonymous	CFH:ENST00000367429.9:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.1504G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294491 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.4790	0.4435	14776,.	0.4618,0.4590,0.4312,0.4121,0.5459				1.75			COSV66406791	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196736796	196736796	C	A	het	het	het	off-target	QUAL=139;DP=16,4,13;AF=0.25,0.50,0.38;MQM=60;SAP=19;ABP=11	CFH	intron	CFH:ENST00000367429.9:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::	CFH:NM_000186.4:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/22:n.2600-28C>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1274202 [benign DISEASE=not provided];		(TTAATT)n (Simple_repeat)	rs375046		0.6730	35062,.	0.7404,0.7100,0.9333,0.5543,0.6854				0.85				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196740686	196740686	G	T	het	wt	het		QUAL=6993;DP=283,187,216;AF=0.53,0.00,0.51;MQM=60;SAP=40;ABP=5	CFH	missense	CFH:ENST00000367429.9:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon19/23:n.3036G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294510 [likely benign(replaced by megSAP based on classifications:1x1,6x2,1x3) DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.0016	0.0040	0,.	0.0008,0.0019,0.0000,0.0060,0.0001		D(0.04)	D(0.99)	16.35	0.32		COSV99054698	0	0	167	0 / 0	2	"[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743447	196743447	T	C	wt	het	wt		QUAL=305;DP=179,132,120;AF=0.00,0.23,0.00;MQM=45;SAP=70;ABP=84	CFH	splice_region&intron	CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	CFH:NM_000186.4:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::,CFH:XR_001737134.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron20/22:n.3320-5T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	875337 [uncertain significance DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];			rs513699		0.0468	0,.	0.0370,0.0684,0.1172,0.0401,0.0177				9.48		9.26>8.55	COSV66406795	0.04	0	5394	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743456	196743456	C	T	wt	het	wt		QUAL=512;DP=192,149,135;AF=0.00,0.26,0.00;MQM=47;SAP=57;ABP=76	CFH	synonymous	CFH:ENST00000367429.9:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	CFH:NM_000186.4:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon21/23:n.3324C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294519 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified];			rs61822181		0.1278	0,.	0.1049,0.1903,0.2414,0.1127,0.0746				2.55			COSV66406800	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197084243	197084243	G	A	hom	hom	hom		QUAL=19004;DP=240,138,197;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0	ASPM	3'UTR	ASPM:ENST00000294732.11:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:ENST00000367409.9:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::,ASPM:ENST00000680265.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*81C>T::	ASPM:NM_001206846.2:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:NM_018136.5:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	294591 [benign DISEASE=Primary autosomal recessive microcephaly 5,not provided];			rs12677		0.7844	49972,.					4.41				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084432	197084432	A	-	het	het	het		QUAL=420;DP=97,26,41;AF=0.21,0.12,0.29;MQM=59;SAP=48;ABP=120	ASPM	splice_region&intron	ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10554-6del::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10308-6del::	ASPM:NM_001206846.2:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1204775 [likely benign DISEASE=not provided];			rs200839523		0.2071	2,.	0.2939,0.2902,0.2922,0.1565,0.2351				0.01				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086795	197086795	T	C	hom	hom	hom		QUAL=13633;DP=168,108,137;AF=1.00,1.00,1.00;MQM=60;SAP=199;ABP=0	ASPM	splice_region&intron	ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10553+8A>G::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10307+8A>G::	ASPM:NM_001206846.2:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157775 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs10754213		0.8877	49989,.	0.4435,0.9346,0.9998,0.9062,0.8985				1.86				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090798	197090798	A	G	hom	hom	hom	off-target	QUAL=8873;DP=104,80,101;AF=1.00,1.00,1.00;MQM=60;SAP=483;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+52T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+52T>C::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673922 [benign DISEASE=Primary autosomal recessive microcephaly 5,not provided];			rs4915316		0.7625	48460,.					5.16				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101391	197101391	C	G	wt	het	wt		QUAL=1189;DP=299,97,129;AF=0.00,0.49,0.00;MQM=60;SAP=12;ABP=3	ASPM	intron,missense	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21609 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs12138336	0.0288	0.0507	237,.	0.0130,0.0317,0.0001,0.0715,0.0310		 ,T(0.10),T(0.08),T(0.12)	 ,B(0.03),B(0.05),B(0.00)	2.86	0.08		COSV54130527	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101646	197101646	C	T	het	het	het		QUAL=8718;DP=227,189,246;AF=0.55,0.46,0.49;MQM=60;SAP=13;ABP=3	ASPM	intron,synonymous	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21603 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs10922162	0.2949	0.2570	3827,.	0.0395,0.4648,0.7055,0.1568,0.2767				1.00			COSV54139486	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101685	197101685	T	C	hom	hom	hom		QUAL=19698;DP=237,155,197;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0	ASPM	intron,synonymous	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21602 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1412640		0.8954	52003,.	0.5426,0.9393,0.9997,0.9064,0.8990				1.00				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101771	197101771	A	G	hom	hom	hom		QUAL=23179;DP=318,167,205;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0	ASPM	intron,missense	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21599 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs964201	0.9974	0.9967	75383,.	0.9990,0.9992,1.0000,0.9936,0.9974		 ,T(1.00),T(1.00),T(1.00)	 ,B(0.00),B(0.00),B(0.01)	15.59	0.19			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197122407	197122407	A	T	hom	hom	hom		QUAL=24410;DP=311,201,250;AF=1.00,1.00,1.00;MQM=60;SAP=141;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000367409.9:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon14/29:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain]	ASPM:NM_001206846.2:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21578 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs4915337	0.7825	0.8873	49965,.	0.4432,0.9345,0.9998,0.9060,0.8986				7.32				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124900	197124900	C	T	het	het	het		QUAL=9389;DP=392,152,183;AF=0.50,0.48,0.48;MQM=60;SAP=298;ABP=4	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon12/29:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21573 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs6676084	0.2167	0.2794	5398,.	0.1541,0.2515,0.1110,0.3145,0.3089				0.48			COSV54127589,COSV54135932	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133615	197133615	A	G	het	het	het	off-target	QUAL=3220;DP=142,70,73;AF=0.49,0.40,0.45;MQM=60;SAP=228;ABP=8	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2174-20T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95887 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs4915344	0.2997	0.2574	3862,.	0.0421,0.4639,0.7053,0.1566,0.2815				16.16		6.91>6.50	COSV54132578	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197139816	197139816	A	G	het	het	wt		QUAL=4128;DP=256,109,143;AF=0.42,0.44,0.00;MQM=60;SAP=27;ABP=21	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon4/29:c.1977T>C:p.Ile659=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21561 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs17550662	0.0192	0.0444	178,.	0.0080,0.0217,0.0001,0.0655,0.0106				6.35				0.2	56	1713	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139912	197139912	C	T	hom	hom	hom	off-target	QUAL=12561;DP=234,65,88;AF=1.00,1.00,1.00;MQM=60;SAP=452;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron3/28:c.1922-41G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157788 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1332663	0.7825	0.8877	50010,.	0.4400,0.9344,0.9998,0.9052,0.8984				5.70			COSV54136485	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143403	197143403	G	A	hom	hom	hom		QUAL=7450;DP=111,61,52;AF=1.00,0.98,1.00;MQM=60;SAP=10;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon3/29:c.849C>T:p.Ser283=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95890 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs6677082		0.8802	48487,.	0.3650,0.9303,0.9816,0.9055,0.8983				2.02				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143943	197143943	G	A	hom	hom	hom	off-target	QUAL=4412;DP=107,14,21;AF=1.00,1.00,1.00;MQM=60;SAP=311;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron2/27:c.441+14C>T::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron2/28:c.441+14C>T::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95888 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1571964		0.8798	48485,.	0.3621,0.9305,0.9817,0.9049,0.8982				4.14				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	198692539	198692539	G	A	het	het	wt		QUAL=808;DP=56,7,5;AF=0.46,0.86,0.00;MQM=60;SAP=10;ABP=3	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000367364.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000413409.6:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.100+166G>A::	PTPRC:NM_001267798.2:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:NM_002838.5:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:NR_052021.2:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.407G>A::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron3/31:c.100+166G>A::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron3/31:c.100+166G>A::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron3/30:c.100+166G>A::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]				rs115067628	0.0040	0.0098	17,.					0.15				0	0	72	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696788	198696788	C	G	wt	het	wt		QUAL=3192;DP=449,205,293;AF=0.00,0.58,0.00;MQM=60;SAP=8;ABP=15	PTPRC	intron,synonymous	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:ENST00000442510.8:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:	PTPRC:NM_002838.5:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:XM_006711472.4:synonymous_variant:LOW:exon4/32:c.177C>G:p.Pro59=:,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron3/31:c.101-2776C>G::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron3/30:c.101-2776C>G::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]	378444 [benign/likely benign DISEASE=Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive,not specified,none provided];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.0044	0.0088	8,.	0.0022,0.0038,0.0001,0.0134,0.0117				3.33			COSV100723197	0	3	423	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198708291	198708291	T	A	wt	wt	het	off-target	QUAL=521;DP=105,37,45;AF=0.00,0.00,0.51;MQM=60;SAP=24;ABP=3	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron9/31:c.889+30T>A::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron9/31:c.835+30T>A::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron8/30:c.691+30T>A::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]	1271164 [benign DISEASE=not provided];			rs2274368	0.0845	0.0597	282,.	0.0735,0.1212,0.1401,0.0311,0.0774				0.39				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198748089	198748089	-	T	het	het	het	off-target	QUAL=700;DP=50,16,33;AF=0.30,0.56,0.24;MQM=60;SAP=42;ABP=30	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron23/29:c.2365-4dup::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron26/32:c.2848-4dup::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron26/32:c.2848-4dup::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron23/29:c.2365-4dup::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron25/31:c.2704-4dup::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron25/31:c.2650-4dup::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron24/30:c.2506-4dup::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]			(T)n (Simple_repeat)	rs57296163		0.2602	5361,.	0.1448,0.2047,0.2027,0.2855,0.2463				0.22				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198749603	198749603	A	G	het	wt	het	off-target	QUAL=3828;DP=213,80,109;AF=0.47,0.00,0.50;MQM=60;SAP=298;ABP=4	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron27/31:c.2928+54A>G::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron27/31:c.2874+54A>G::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron26/30:c.2730+54A>G::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]				rs549239314	0.0004	0.0010	0,.					0.07				0	0	37	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201039454	201039454	-	G	hom	het	het	off-target	QUAL=1995;DP=46,29,54;AF=0.91,0.52,0.50;MQM=60;SAP=185;ABP=3		intron&non_coding_transcript	:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-2397dup::	LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-2397dup::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-2397dup::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-2397dup::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-2397dup::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-2397dup::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-2397dup::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-2397dup::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-2397dup::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-2397dup::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-2397dup::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-2397dup::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-2397dup::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-2397dup::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-2397dup::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-2397dup::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-2397dup::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs35360610		0.5501	24814,.					0.94					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040428	201040428	A	G	hom	het	het	off-target	QUAL=5964;DP=131,63,83;AF=0.99,0.52,0.48;MQM=60;SAP=125;ABP=3	CACNA1S,	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::,:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1427A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron41/42:c.5167-54T>C::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::,LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-1427A>G::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-1427A>G::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-1427A>G::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-1427A>G::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-1427A>G::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-1427A>G::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-1427A>G::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-1427A>G::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-1427A>G::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-1427A>G::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-1427A>G::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-1427A>G::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-1427A>G::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-1427A>G::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-1427A>G::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-1427A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678243 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs1546416	0.3325	0.3581	9989,.					0.78			COSV62945146	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040769	201040769	T	C	hom	hom	hom	off-target	QUAL=3848;DP=54,30,46;AF=1.00,1.00,1.00;MQM=60;SAP=121;ABP=0	CACNA1S,	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::,:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1086T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron40/42:c.5075-56A>G::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::,LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-1086T>C::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-1086T>C::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-1086T>C::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-1086T>C::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-1086T>C::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-1086T>C::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-1086T>C::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-1086T>C::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-1086T>C::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-1086T>C::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-1086T>C::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-1086T>C::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-1086T>C::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-1086T>C::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-1086T>C::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-1086T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678241 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs6427875		0.9933	75086,.					0.00				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201043469	201043469	G	A	hom	wt	hom		QUAL=365;DP=10,3,4;AF=1.00,0.00,1.00;MQM=60;SAP=25;ABP=0	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:,CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon39/43:c.4800C>T:p.Pro1600=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254841 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified];			rs41267497	0.0461	0.1051	1167,.	0.0262,0.0673,0.0004,0.1612,0.0264				0.12				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047168	201047168	G	A	wt	wt	het		QUAL=3275;DP=343,183,245;AF=0.00,0.00,0.52;MQM=60;SAP=14;ABP=4	CACNA1S	missense	CACNA1S:ENST00000362061.4:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:ENST00000367338.7:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:,CACNA1S:ENST00000681874.1:missense_variant:MODERATE:exon37/43:c.4555C>T:p.Arg1519Cys:	CACNA1S:NM_000069.3:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:XM_005245478.3:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	197021 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs3850625	0.0841	0.1157	823,.	0.0206,0.0958,0.0333,0.1184,0.2102		D(0.01),D(0.01),D(0.01)	B(0.30),B(0.30),B(0.09)	26.80	0.28		COSV62938023	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201050977	201050977	A	G	wt	het	het		QUAL=6114;DP=131,211,276;AF=0.01,0.53,0.49;MQM=60;SAP=98;ABP=3	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron32/42:c.4053+7T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:XM_005245478.3:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	199680 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs6702590	0.8804	0.7786	47206,.	0.9371,0.8682,0.9959,0.6687,0.8663				3.11				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201069559	201069559	A	G	het	wt	het		QUAL=8030;DP=214,341,426;AF=0.47,0.00,0.51;MQM=60;SAP=19;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254814 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs7415038	0.2941	0.4211	14602,.	0.5285,0.2185,0.0030,0.4491,0.1847				12.17			COSV62939654	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073490	201073490	G	A	het	wt	hom	off-target	QUAL=4972;DP=80,101,140;AF=0.49,0.00,1.00;MQM=60;SAP=127;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678298 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs9333652		0.4396	16095,.					1.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201075620	201075620	A	G	het	wt	hom		QUAL=10528;DP=149,258,278;AF=0.52,0.00,1.00;MQM=60;SAP=25;ABP=4	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:XM_005245478.3:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254804 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs1998721	0.7596	0.7819	40463,.	0.5463,0.7202,0.9604,0.7765,0.8902				0.14		11.27>10.69		0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201076897	201076897	G	T	het	wt	het	off-target	QUAL=4279;DP=79,275,331;AF=0.48,0.01,0.52;MQM=60;SAP=313;ABP=4	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1293266 [benign DISEASE=not provided];		L2c (LINE/L2)	rs7549030	0.0457	0.0679	411,.	0.0773,0.0392,0.0001,0.0739,0.0251				1.74				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077934	201077934	G	A	hom	hom	het		QUAL=15001;DP=139,260,266;AF=0.99,1.00,0.48;MQM=60;SAP=126;ABP=4	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254801 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.1909	0.2250	4045,.	0.2594,0.2751,0.0403,0.2290,0.1119				9.80			COSV62944479	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077947	201077947	A	G	hom	hom	het		QUAL=17369;DP=184,267,286;AF=0.99,1.00,0.50;MQM=60;SAP=117;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254800 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs4915477	0.5711	0.6848	37747,.	0.8959,0.5864,0.2246,0.6543,0.3215				3.40			COSV62938741	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201085069	201085069	G	T	wt	het	wt	off-target	QUAL=923;DP=82,88,113;AF=0.00,0.50,0.00;MQM=60;SAP=19;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678295 [benign DISEASE=not provided];			rs41267505	0.1286	0.1585	2027,.	0.1434,0.2471,0.0363,0.1667,0.0878				0.41			COSV62945385	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201091737	201091737	G	A	wt	wt	het		QUAL=2468;DP=165,158,185;AF=0.01,0.00,0.54;MQM=60;SAP=6;ABP=5	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254852 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs2296383	0.3051	0.3897	9768,.	0.1009,0.3501,0.3592,0.4292,0.4506				8.08			COSV62936330	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	209614868	209614868	T	C	hom	het	het		QUAL=5677;DP=152,41,72;AF=0.99,0.59,0.46;MQM=60;SAP=455;ABP=3	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.9:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	368859 [benign DISEASE=Junctional epidermolysis bullosa];			rs926387	0.7748	0.7480	43642,.					0.23					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209615169	209615169	G	A	het	wt	het		QUAL=5466;DP=185,240,262;AF=0.53,0.00,0.46;MQM=60;SAP=108;ABP=3	LAMB3	3'UTR	LAMB3:ENST00000356082.9:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000367030.7:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::	LAMB3:NM_000228.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:NM_001017402.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:NM_001127641.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:XM_005273124.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:XM_017001272.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	295059 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.2951	0.2740	5818,.					8.92			COSV50521190	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618670	209618670	-	C	hom	hom	hom	off-target	QUAL=12635;DP=161,131,180;AF=0.94,0.94,0.98;MQM=60;SAP=697;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron17/21:c.2702-12dup::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:NM_001017402.2:intron_variant:MODIFIER:intron17/21:c.2702-12dup::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:XM_005273124.4:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron17/21:c.2510-12dup::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255590 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs397807887		0.9574	69717,.	0.9896,0.9832,0.9998,0.9314,0.9883				12.76				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209625908	209625908	A	G	het	hom	het		QUAL=21487;DP=299,382,547;AF=0.41,1.00,0.50;MQM=60;SAP=292;ABP=10	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:XM_017001272.2:synonymous_variant:LOW:exon13/22:c.1524T>C:p.Cys508=:	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255587 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2179402		0.7542	42675,.	0.7692,0.7728,0.8231,0.7368,0.7431				1.56			COSV61918520	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209630750	209630750	G	A	hom	hom	hom	off-target	QUAL=12072;DP=112,124,157;AF=1.00,1.00,1.00;MQM=60;SAP=153;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron7/21:c.823-15C>T::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:NM_001017402.2:intron_variant:MODIFIER:intron7/21:c.823-15C>T::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:XM_005273124.4:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron7/21:c.631-15C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255598 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs4844863		0.8455	53847,.	0.8295,0.8277,0.8233,0.8546,0.8121				1.56		8.37>7.66	COSV61919103	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209634627	209634627	G	A	hom	hom	hom		QUAL=5400;DP=34,58,91;AF=1.00,1.00,1.00;MQM=60;SAP=81;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron5/21:c.373-1494C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255596 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1130667	0.2454	0.3424	8286,.	0.1309,0.2131,0.2290,0.4051,0.3404				0.33			COSV61916410	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638541	209638541	T	G	hom	hom	hom		QUAL=19054;DP=255,137,210;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:XM_017001272.2:synonymous_variant:LOW:exon4/22:c.291A>C:p.Ser97=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255592 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2076356	0.4325	0.5679	25022,.	0.4101,0.4441,0.2859,0.6558,0.4959				5.33			COSV61915034	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209651362	209651362	A	T	hom	hom	hom	off-target	QUAL=9345;DP=169,80,84;AF=0.99,1.00,1.00;MQM=60;SAP=724;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:NM_001017402.2:5_prime_UTR_variant:MODIFIER:exon1/22:c.-418T>A::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:XM_005273124.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-312T>A::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron1/21:c.-37-381T>A::	regulatory_region_variant:promoter,TF_binding_site_variant	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3), Autosomal recessive; Epidermolysis bullosa, junctional, Herlitz type, 226700 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1252656 [benign DISEASE=not provided];			rs10779510	0.8966	0.8772	58763,.					3.32				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209786269	209786269	G	T	het	wt	het		QUAL=6852;DP=337,125,185;AF=0.53,0.00,0.50;MQM=58;SAP=12;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295175 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs1044516	0.3099	0.2288	4638,.					0.98				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786527	209786527	G	A	hom	hom	hom		QUAL=19090;DP=313,125,150;AF=1.00,0.99,0.99;MQM=57;SAP=4;ABP=0	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295178 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs680331	0.8081	0.8087	49753,.					1.32				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786742	209786742	A	-	wt	wt	het		QUAL=1633;DP=253,130,118;AF=0.00,0.00,0.53;MQM=60;SAP=3;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295181 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs141112353		0.1927	2876,.					0.86				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786807	209786807	T	A	wt	wt	het		QUAL=1217;DP=263,101,104;AF=0.00,0.00,0.48;MQM=60;SAP=9;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs1195550606								0.75				0	0	1	0 / 0					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787091	209787091	G	A	het	wt	het		QUAL=6312;DP=254,200,249;AF=0.46,0.00,0.51;MQM=60;SAP=56;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295184 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		AluJo (SINE/Alu)	rs2235372	0.2991	0.2258	4426,.					1.31			COSV50551228	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787577	209787577	A	C	het	hom	wt		QUAL=2820;DP=123,44,124;AF=0.47,1.00,0.00;MQM=60;SAP=13;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295189 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs599021	0.3043	0.3629	10686,.					4.92				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787580	209787580	T	C	het	wt	het		QUAL=3153;DP=129,44,123;AF=0.54,0.00,0.45;MQM=60;SAP=35;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295190 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742214	0.2971	0.2246	4383,.					0.99				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787678	209787678	T	A	het	wt	het		QUAL=2226;DP=97,51,81;AF=0.51,0.02,0.49;MQM=60;SAP=19;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295193 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742215	0.3037	0.2306	4595,.					10.13			COSV54213600	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787969	209787969	T	C	het	wt	het		QUAL=6617;DP=266,188,239;AF=0.52,0.01,0.47;MQM=60;SAP=3;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295199 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs17317411	0.0875	0.1074	1158,.					13.74			COSV54213602	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209788009	209788009	G	A	wt	wt	het		QUAL=2560;DP=332,163,207;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295200 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		MIR3 (SINE/MIR)	rs187379424	0.0008	0.0047	4,.					10.32				0	0	25	0 / 0					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209790458	209790458	G	A	het	wt	het	off-target	QUAL=3830;DP=194,88,127;AF=0.52,0.00,0.52;MQM=60;SAP=363;ABP=4	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron5/6:c.775+37C>T::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::	regulatory_region_variant:promoter_flanking_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291060 [benign DISEASE=not provided];			rs2235373	0.2883	0.2356	4031,.	0.2316,0.3481,0.4833,0.1761,0.2970				0.88			COSV65418889	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209792242	209792242	G	C	het	wt	hom	off-target	QUAL=10466;DP=195,213,261;AF=0.46,0.00,1.00;MQM=60;SAP=256;ABP=6	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron4/6:c.382+27C>G::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron6/8:c.667+27C>G::	regulatory_region_variant:promoter_flanking_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259926 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not specified,not provided];			rs2235375	0.4052	0.4101	10636,.	0.2825,0.5576,0.5725,0.3734,0.4171				2.36			COSV65418892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795339	209795339	C	A	het	wt	hom		QUAL=18555;DP=339,325,459;AF=0.45,0.00,1.00;MQM=60;SAP=7;ABP=10	IRF6	synonymous	IRF6:ENST00000367021.8:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.5:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	IRF6:NM_001206696.2:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:,IRF6:NM_006147.4:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259925 [benign DISEASE=van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs2013162	0.4038	0.4098	10523,.	0.2750,0.5605,0.5730,0.3733,0.4156				0.79			COSV65418898	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796557	209796557	G	C	het	wt	hom		QUAL=4842;DP=209,51,86;AF=0.47,0.02,0.99;MQM=60;SAP=346;ABP=4	IRF6	splice_region&intron	IRF6:ENST00000367021.8:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.5:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	IRF6:NM_001206696.2:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::,IRF6:NM_006147.4:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259923 [benign DISEASE=van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs7552506	0.2710	0.3223	7901,.	0.2672,0.2976,0.1538,0.3585,0.3323				13.91		9.65>6.86	COSV65419346	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209802041	209802041	A	G	het	hom	wt		QUAL=11934;DP=284,263,350;AF=0.49,1.00,0.00;MQM=60;SAP=57;ABP=3	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.8:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::,IRF6:NM_006147.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295214 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,not specified,not provided];			rs861019	0.3864	0.4329	14686,.					2.01		10.77>11.03	COSV65419778	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806173	209806173	T	A	wt	wt	het		QUAL=1266;DP=34,94,126;AF=0.00,0.00,0.54;MQM=60;SAP=71;ABP=5	IRF6	5'UTR	IRF6:ENST00000542854.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-338A>T::		regulatory_region_variant:promoter,TF_binding_site_variant	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295219 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.1180	0.1588	2392,.					6.99			COSV65419508		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806184	209806184	A	T	wt	wt	het		QUAL=1207;DP=25,83,117;AF=0.00,0.00,0.53;MQM=60;SAP=98;ABP=4	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	368864 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.1182	0.1589	2397,.					16.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215622854	215622854	-	TTATT	het	het	wt	off-target	QUAL=649;DP=95,18,34;AF=0.35,0.22,0.00;MQM=60;SAP=83;ABP=32	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::			608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs75551431		0.2360	4938,.					1.74					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215623008	215623008	T	G	het	wt	hom		QUAL=13548;DP=353,178,266;AF=0.52,0.00,1.00;MQM=60;SAP=224;ABP=4	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::	USH2A:NM_206933.4:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs6667509	0.1030	0.1045	856,.					5.40				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215624672	215624672	G	A	hom	hom	hom		QUAL=33458;DP=445,226,327;AF=1.00,1.00,1.00;MQM=60;SAP=39;ABP=0	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::	USH2A:NM_206933.4:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs2797255	0.9912	0.9908	74692,.					0.14				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215634665	215634665	G	A	het	het	wt		QUAL=3678;DP=174,136,193;AF=0.48,0.50,0.00;MQM=60;SAP=189;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:	USH2A:NM_206933.4:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48455 [benign/likely benign DISEASE=Usher syndrome, type 2A,Retinitis pigmentosa 39,not specified,none provided,not provided];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.0060	0.0156	24,.	0.0031,0.0030,0.0000,0.0192,0.0102		D(0.02),D(0.02)	B(0.15),B(0.30)	16.64	0.09		COSV99048303	0.01	5	489	0 / 0	1	"[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018"			USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215674720	215674720	C	T	het	het	wt		QUAL=8189;DP=377,246,314;AF=0.51,0.50,0.01;MQM=60;SAP=28;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48413 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs2009923	0.2035	0.2029	2361,.	0.0531,0.1748,0.3522,0.1842,0.2862				0.97			COSV56336645	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675245	215675245	T	C	wt	het	wt		QUAL=3267;DP=276,245,319;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48403 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs2797234	0.3031	0.3698	9406,.	0.2132,0.4699,0.3257,0.3857,0.3019				0.69			COSV56342646	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675299	215675299	T	C	het	het	hom		QUAL=20675;DP=383,280,374;AF=0.47,0.50,0.99;MQM=60;SAP=40;ABP=4	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177993 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs2797235		0.7669	43036,.	0.6285,0.8089,0.6474,0.8124,0.6953				0.59			COSV56342874	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680407	215680407	T	-	het	het	het	off-target	QUAL=3605;DP=149,53,68;AF=0.52,0.62,0.85;MQM=60;SAP=320;ABP=40	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-31del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron61/71:c.12067-31del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1225305 [benign DISEASE=not provided];			rs5780842		0.8933	58941,.	0.6261,0.6573,0.7264,0.7176,0.6117				0.52				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215728150	215728150	C	T	hom	het	hom		QUAL=39513;DP=410,542,641;AF=0.99,0.42,0.99;MQM=60;SAP=125;ABP=34	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48387 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs2820718	0.1188	0.1684	2287,.	0.1669,0.0795,0.0013,0.1845,0.1444				4.65				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215741409	215741409	G	T	het	het	wt		QUAL=5393;DP=207,192,253;AF=0.53,0.52,0.00;MQM=60;SAP=65;ABP=5	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48380 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.0062	0.0158	19,.	0.0033,0.0035,0.0000,0.0225,0.0137		D(0.03),D(0.03)	D(0.98),D(1.00)	24.80	0.34		COSV99048391	0.01	10	553	0 / 0	3	"[3] auto-classification 14.09.2017"		"gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215758586	215758586	T	A	wt	wt	het		QUAL=2193;DP=223,176,196;AF=0.00,0.00,0.46;MQM=60;SAP=42;ABP=6	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron58/72:c.11389+9A>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48372 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs12095085	0.0749	0.1232	1271,.	0.1320,0.0683,0.0003,0.1292,0.0526				5.50				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759615	215759615	G	A	wt	het	wt	off-target	QUAL=1056;DP=203,82,122;AF=0.00,0.55,0.00;MQM=60;SAP=76;ABP=5	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+45C>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177014 [benign/likely benign DISEASE=Usher syndrome, type 2A,not provided];			rs17025373	0.1322	0.1066	739,.	0.0135,0.2038,0.3716,0.0655,0.0847				0.20			COSV56338606	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782962	215782962	A	G	hom	hom	hom	off-target	QUAL=3921;DP=79,22,27;AF=0.99,1.00,1.00;MQM=60;SAP=262;ABP=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177015 [benign DISEASE=Usher syndrome, type 2A,not provided];			rs7518466		0.5906	27103,.	0.7315,0.5765,0.6322,0.5268,0.4964				0.04				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786825	215786825	T	G	hom	hom	hom		QUAL=26925;DP=220,286,366;AF=1.00,1.00,1.00;MQM=60;SAP=226;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48344 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs10864198		0.5798	25934,.	0.6867,0.5749,0.6342,0.5215,0.4946		T(1.00),T(1.00)	B(0.00),B(0.00)	11.04	0.09		COSV56336661	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215790032	215790032	G	A	wt	wt	het	off-target	QUAL=1532;DP=129,110,128;AF=0.00,0.00,0.50;MQM=60;SAP=109;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron51/72:c.10182+27C>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1290575 [benign DISEASE=not provided];			rs11120629	0.0805	0.1279	1381,.	0.1483,0.0687,0.0004,0.1292,0.0529				3.33			COSV56371467	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215813880	215813880	T	C	wt	wt	het		QUAL=3234;DP=271,169,280;AF=0.00,0.00,0.46;MQM=60;SAP=22;ABP=6	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:	USH2A:NM_206933.4:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48631 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs4129843	0.0871	0.0557	299,.	0.0814,0.0613,0.1694,0.0373,0.0812		T(1.00),T(1.00)	B(0.00),B(0.00)	0.54	0.04		COSV56343447	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215838019	215838019	T	C	wt	wt	het		QUAL=3248;DP=340,238,263;AF=0.00,0.00,0.49;MQM=60;SAP=5;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48623 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs56032526	0.0647	0.0497	169,.	0.0089,0.0581,0.1691,0.0373,0.0814		T(1.00),T(1.00)	B(0.00),B(0.00)	0.79	0.14		COSV56343459	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215846085	215846085	A	-	wt	wt	het	off-target	QUAL=404;DP=124,42,44;AF=0.02,0.00,0.50;MQM=60;SAP=55;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron44/71:c.8846-52del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron44/72:c.8846-52del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron44/71:c.8846-52del::	regulatory_region_variant:promoter_flanking_region	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1256903 [benign DISEASE=not provided];			rs77889398		0.0657	173,.	0.0131,0.0781,0.2087,0.0500,0.1034				0.15			COSV56391224	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877783	215877783	G	A	wt	wt	het		QUAL=2907;DP=195,198,215;AF=0.00,0.00,0.52;MQM=60;SAP=12;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:	USH2A:NM_206933.4:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48607 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.0777	0.0523	222,.	0.0607,0.0625,0.1561,0.0365,0.0799		T(1.00),T(1.00)	B(0.00),B(0.00)	18.56	0.14		COSV56343477	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215993112	215993112	T	G	het	het	wt		QUAL=2819;DP=125,94,98;AF=0.48,0.57,0.00;MQM=60;SAP=11;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48568 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.0076	0.0222	47,.	0.0052,0.0173,0.0001,0.0284,0.0151		D(0.00),D(0.00)	P(0.91),D(0.99)	25.00	0.27		COSV56370381	0	19	737	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign"	USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999038	215999038	A	G	hom	hom	hom		QUAL=18994;DP=180,188,228;AF=0.99,1.00,1.00;MQM=60;SAP=432;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48562 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs10864219		0.5628	20294,.	0.4335,0.6697,0.8405,0.5004,0.5979		T(0.12),T(0.12)	B(0.02),B(0.08)	17.40	0.11		COSV56370398	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216046439	216046439	A	G	het	het	hom		QUAL=8822;DP=201,124,147;AF=0.49,0.51,1.00;MQM=60;SAP=328;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	167815 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs6657250	0.5956	0.6674	34516,.	0.7709,0.3526,0.4408,0.6711,0.5082		T(1.00),T(1.00)	B(0.00),B(0.00)	9.86	0.13		COSV56342913	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216073334	216073334	G	-	het	het	het	off-target	QUAL=5119;DP=174,98,132;AF=0.51,0.53,0.55;MQM=60;SAP=423;ABP=6	USH2A,USH2A-AS2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron27/72:c.5573-34del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A-AS2:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A-AS2:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.136+736del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1243806 [benign DISEASE=not provided];			rs35944387		0.7336	39926,.	0.7474,0.7849,0.9538,0.6880,0.7713				13.09				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216084852	216084852	G	T	het	het	het		QUAL=6000;DP=155,133,176;AF=0.49,0.51,0.51;MQM=60;SAP=170;ABP=3	USH2A,USH2A-AS2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,USH2A-AS2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A:ENST00000674083.1:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:,USH2A-AS2:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A-AS2:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.137-1870G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48527 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs56110889	0.1058	0.1624	2189,.	0.1935,0.0944,0.0001,0.1752,0.0772				8.24			COSV56425186	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216174110	216174110	C	A	het	het	wt		QUAL=3548;DP=218,108,121;AF=0.41,0.45,0.00;MQM=60;SAP=3;ABP=18	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::	USH2A:NM_007123.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295405 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs401269	0.1945	0.2034	3220,.					4.30				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216174214	216174214	A	G	het	het	wt		QUAL=3712;DP=224,56,55;AF=0.48,0.54,0.00;MQM=60;SAP=78;ABP=3	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::	USH2A:NM_007123.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs439940	0.1953	0.2042	3243,.					7.15				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216175422	216175422	C	T	het	het	hom		QUAL=29624;DP=479,455,509;AF=0.53,0.49,1.00;MQM=60;SAP=151;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:	USH2A:NM_007123.6:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:NM_206933.4:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177992 [benign DISEASE=Usher syndrome, type 2A,not specified,none provided,not provided];			rs1805049		0.6605	30303,.	0.5814,0.7160,0.7813,0.6225,0.6986		T(0.56),T(0.30),T(0.57)	B(0.03),B(0.03),B(0.05)	6.63	0.02		COSV56346078	0.29	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216196766	216196766	C	T	het	het	wt	off-target	QUAL=3479;DP=188,93,127;AF=0.51,0.51,0.00;MQM=60;SAP=278;ABP=3	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::	USH2A:NM_007123.6:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A-AS1:XR_922595.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.1076+841C>T::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1076+841C>T::,USH2A-AS1:XR_922598.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.484+841C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177619 [benign DISEASE=Usher syndrome, type 2A,not provided];			rs447102	0.1645	0.2094	2763,.	0.0693,0.1891,0.2103,0.2388,0.2321				0.01			COSV56445389	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216198592	216198592	A	C	het	het	wt		QUAL=4100;DP=223,82,90;AF=0.54,0.55,0.00;MQM=60;SAP=336;ABP=7	USH2A,USH2A-AS1	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::	USH2A:NM_007123.6:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A:NM_206933.4:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A-AS1:XR_922595.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.1076+2667A>C::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1076+2667A>C::,USH2A-AS1:XR_922598.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.484+2667A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48508 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,not provided];			rs646094	0.1977	0.2133	3257,.	0.1641,0.1892,0.2059,0.2339,0.2298				8.66		9.73>8.94		0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216217352	216217352	C	T	het	het	hom	off-target	QUAL=7335;DP=178,110,125;AF=0.48,0.52,1.00;MQM=60;SAP=358;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::	USH2A:NM_007123.6:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1077-8035C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177621 [benign DISEASE=Usher syndrome, type 2A,not provided];		L3b (LINE/CR1)	rs1324330		0.6376	25206,.	0.3347,0.7025,0.7786,0.6182,0.6829				2.32			COSV56329695	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216418661	216418661	T	C	hom	hom	hom		QUAL=18986;DP=160,189,255;AF=1.00,0.99,1.00;MQM=60;SAP=131;ABP=0	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]	USH2A:NM_007123.6:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:,USH2A:NM_206933.4:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48528 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,none provided,not provided];			rs4253963		0.6527	29431,.	0.4930,0.6943,0.8390,0.6474,0.6011				0.35				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216421964	216421964	C	T	hom	hom	hom		QUAL=33057;DP=294,279,443;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:	USH2A:NM_007123.6:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:NM_206933.4:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48507 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,none provided,not provided];			rs10779261		0.7323	40838,.	0.7567,0.7303,0.8364,0.7049,0.7321		T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.92	0.08			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR+AD oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220150107	220150107	T	-	het	het	het		QUAL=1404;DP=143,38,46;AF=0.27,0.37,0.26;MQM=60;SAP=13;ABP=93	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295627 [uncertain significance DISEASE=Warburg micro syndrome,Cataract-intellectual disability-hypogonadism syndrome];		FLAM_C (SINE/Alu)	rs11316594		0.4708	14619,.					0.07				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150452	T	-	het	het	het		QUAL=699;DP=53,14,21;AF=0.30,0.43,0.29;MQM=60;SAP=41;ABP=28	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354		0.1647	2069,.					3.64				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150453	TT	-	het	wt	wt		QUAL=699;DP=53,14,21;AF=0.25,0.21,0.14;MQM=60;SAP=12;ABP=65	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354		0.0015	0,.					3.62				0	0	44	0 / 0					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150847	220150847	A	G	het	wt	het		QUAL=9846;DP=414,217,267;AF=0.55,0.00,0.53;MQM=60;SAP=283;ABP=13	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295635 [benign DISEASE=Warburg micro syndrome 2,Cataract-intellectual disability-hypogonadism syndrome];			rs1059140	0.0627	0.0717	520,.					6.90				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157330	220157330	C	T	het	wt	het		QUAL=9501;DP=416,209,288;AF=0.55,0.00,0.48;MQM=60;SAP=266;ABP=5	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.7:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130080 [benign DISEASE=Warburg micro syndrome 2,Cataract-intellectual disability-hypogonadism syndrome,not specified];			rs11547779	0.0605	0.0866	510,.	0.0150,0.0479,0.0566,0.0976,0.1336				5.52			COSV62784001	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157863	220157863	C	G	het	wt	het		QUAL=6490;DP=291,182,248;AF=0.45,0.00,0.46;MQM=60;SAP=3;ABP=11	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.7:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130079 [benign DISEASE=Warburg micro syndrome 2,Cataract-intellectual disability-hypogonadism syndrome,not specified];			rs2289189	0.0603	0.0859	507,.	0.0150,0.0456,0.0565,0.0969,0.1333		D(0.05)	P(0.86)	25.70	0.18		COSV62784008	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220196404	220196404	A	-	wt	het	wt		QUAL=829;DP=165,91,94;AF=0.05,0.48,0.01;MQM=60;SAP=88;ABP=3	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951.7:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::	RAB3GAP2:NM_012414.4:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295665 [benign DISEASE=Warburg micro syndrome 2,Warburg micro syndrome,Cataract-intellectual disability-hypogonadism syndrome,not provided];			rs35396665		0.3794	5003,.	0.3400,0.4778,0.4509,0.3419,0.3871				1.96				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), MIR664A (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SNORA36B (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222928597	222928597	A	C	het	het	het	off-target	QUAL=5401;DP=179,136,156;AF=0.42,0.47,0.50;MQM=60;SAP=264;ABP=9	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-14210A>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron1/7:c.-17-14210A>C::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-18+27A>C::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron1/8:c.-99+27A>C::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron1/7:c.-17-14210A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.2486	0.3181	8061,.					5.90				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222942767	222942767	C	T	het	het	het	off-target	QUAL=3237;DP=101,91,104;AF=0.48,0.51,0.48;MQM=60;SAP=316;ABP=3	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-17-40C>T::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::			1247665 [benign DISEASE=not provided];			rs75109669	0.1220	0.1771	2527,.					8.58				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222983040	222983040	C	T	hom	hom	hom	off-target	QUAL=17389;DP=272,113,154;AF=1.00,1.00,1.00;MQM=60;SAP=477;ABP=0	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron3/8:c.-378-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron4/9:c.510-40C>T::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_006711594.3:intron_variant:MODIFIER:intron2/7:c.-73-40C>T::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:XM_017002612.1:intron_variant:MODIFIER:intron2/8:c.-242-40C>T::			1250961 [benign DISEASE=not provided];			rs2926159		0.9999	75770,.	0.9992,1.0000,1.0000,1.0000,1.0000				10.88				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222994871	222994871	T	C	wt	wt	het	off-target	QUAL=1100;DP=181,56,93;AF=0.00,0.00,0.48;MQM=60;SAP=7;ABP=3	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron7/8:c.161-14T>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron8/9:c.890-14T>C::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_006711594.3:intron_variant:MODIFIER:intron6/7:c.308-14T>C::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:XM_017002612.1:intron_variant:MODIFIER:intron7/8:c.308-14T>C::	regulatory_region_variant:promoter_flanking_region		262132 [benign DISEASE=not specified,not provided];			rs2609359	0.3796	0.3510	9713,.	0.4328,0.3755,0.3002,0.3011,0.4574				8.15		10.87>9.80	COSV52656379	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223004232	223004232	A	G	wt	wt	het		QUAL=5304;DP=505,262,406;AF=0.00,0.00,0.50;MQM=60;SAP=28;ABP=3	DISP1	synonymous	DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.2106A>G:p.Lys702=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:NM_001377228.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:NM_001377229.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.2835A>G:p.Lys945=:,DISP1:XM_006711592.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_006711594.3:synonymous_variant:LOW:exon8/8:c.2253A>G:p.Lys751=:,DISP1:XM_011510072.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510073.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510074.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510075.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_017002611.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:XM_017002612.1:synonymous_variant:LOW:exon9/9:c.2253A>G:p.Lys751=:			262128 [benign DISEASE=not specified,none provided,not provided];			rs2609355	0.2414	0.2896	5579,.	0.1816,0.2986,0.2129,0.3013,0.3117				3.67			COSV52659190	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223005219	223005219	A	C	hom	hom	het		QUAL=20467;DP=190,288,371;AF=1.00,1.00,0.53;MQM=60;SAP=3;ABP=6	DISP1	synonymous	DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.3093A>C:p.Pro1031=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:NM_001377228.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:NM_001377229.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.3822A>C:p.Pro1274=:,DISP1:XM_006711592.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_006711594.3:synonymous_variant:LOW:exon8/8:c.3240A>C:p.Pro1080=:,DISP1:XM_011510072.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510073.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510074.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510075.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_017002611.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:XM_017002612.1:synonymous_variant:LOW:exon9/9:c.3240A>C:p.Pro1080=:			262131 [benign DISEASE=not specified,none provided,not provided];			rs9441941	0.4980	0.5467	21985,.	0.4474,0.5375,0.5131,0.5771,0.4763				1.93			COSV52656581	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=n/a oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225401771	225401771	C	T	het	wt	het		QUAL=8397;DP=322,266,352;AF=0.50,0.00,0.44;MQM=60;SAP=9;ABP=8	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:NM_194442.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:XM_005273125.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1532G>A::,LBR:XM_011544185.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.3403G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.2726	0.2527	6962,.					9.24				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225403048	225403048	G	C	het	wt	het		QUAL=4482;DP=310,46,55;AF=0.47,0.00,0.51;MQM=60;SAP=150;ABP=4	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:NM_194442.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:XM_005273125.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*255C>G::,LBR:XM_011544185.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2126C>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295928 [benign DISEASE=Greenberg dysplasia,not provided];			rs11551874	0.1020	0.0917	844,.					2.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225412650	225412650	A	-	het	het	het		QUAL=185;DP=88,28,35;AF=0.20,0.11,0.17;MQM=59;SAP=62;ABP=138	LBR	splice_region&intron	LBR:ENST00000272163.9:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:ENST00000338179.6:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::	LBR:NM_002296.4:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:NM_194442.3:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:XM_005273125.3:splice_region_variant&intron_variant:LOW:intron7/12:c.893-5del::,LBR:XM_011544185.3:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:XR_001737168.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron7/12:n.1020-5del::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	439855 [benign/likely benign DISEASE=not specified,none provided,not provided];			rs78306811		0.3160	5,.	0.3032,0.3126,0.3256,0.3146,0.3230				2.55				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225419442	225419442	C	T	het	hom	het		QUAL=1842;DP=75,20,47;AF=0.40,1.00,0.45;MQM=60;SAP=45;ABP=10	LBR	missense	LBR:ENST00000272163.9:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.6:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:	LBR:NM_002296.4:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:NM_194442.3:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:XM_005273125.3:missense_variant:MODERATE:exon5/13:c.461G>A:p.Ser154Asn:,LBR:XM_011544185.3:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.588G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258619 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs2230419		0.8115	43266,.	0.4185,0.8721,0.9579,0.8381,0.6987		T(0.41),T(0.41)	B(0.01),B(0.01)	0.00	0.17		COSV55291160	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225422182	225422182	A	G	het	hom	het		QUAL=2336;DP=123,15,17;AF=0.57,1.00,0.59;MQM=60;SAP=7;ABP=9	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.6:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	LBR:NM_002296.4:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:NM_194442.3:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:XM_005273125.3:synonymous_variant:LOW:exon3/13:c.261T>C:p.Pro87=:,LBR:XM_011544185.3:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon3/13:n.388T>C::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258617 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056608		0.7631	38102,.	0.3854,0.8478,0.8973,0.7866,0.6557				2.29				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225423959	225423959	C	T	het	het	hom		QUAL=17163;DP=364,210,283;AF=0.53,0.49,1.00;MQM=60;SAP=13;ABP=4	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.6:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]	LBR:NM_002296.4:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:NM_194442.3:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:XM_005273125.3:synonymous_variant:LOW:exon2/13:c.117G>A:p.Val39=:,LBR:XM_011544185.3:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon2/13:n.244G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258616 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,none provided,not provided];			rs1056607		0.7177	38809,.	0.6399,0.7860,0.7681,0.7349,0.5212				1.22			COSV55289527	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225424143	225424143	C	T	wt	het	het	off-target	QUAL=2274;DP=183,83,110;AF=0.00,0.43,0.52;MQM=60;SAP=114;ABP=4	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::	LBR:NM_002296.4:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:NM_194442.3:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:XM_005273125.3:intron_variant:MODIFIER:intron1/12:c.-14-54G>A::,LBR:XM_011544185.3:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:XR_001737168.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.114-54G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	810884 [benign DISEASE=not specified,not provided];			rs1340867		0.6202	29478,.					0.31				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225428676	225428676	G	C	het	het	wt	off-target	QUAL=4190;DP=197,179,249;AF=0.55,0.50,0.00;MQM=60;SAP=305;ABP=5	LBR	intron	LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	LBR:NM_194442.3:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]				rs75691342	0.0996	0.0776	565,.					4.82					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226360853	226360853	A	G	wt	het	wt		QUAL=860;DP=168,77,97;AF=0.01,0.49,0.00;MQM=60;SAP=38;ABP=3	PARP1	3'UTR	PARP1:ENST00000366794.10:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::,PARP1:ENST00000677203.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*607T>C::	PARP1:NM_001618.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.1428	0.1659	2639,.					1.46				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367601	226367601	A	G	het	wt	het		QUAL=5930;DP=196,218,300;AF=0.49,0.00,0.47;MQM=60;SAP=64;ABP=5	PARP1	missense	PARP1:ENST00000366794.10:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain],PARP1:ENST00000677203.1:missense_variant:MODERATE:exon16/22:c.2156T>C:p.Val719Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]	PARP1:NM_001618.4:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:			1261945 [benign DISEASE=not provided];	CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.1969	0.2131	2589,.	0.0487,0.4231,0.4477,0.1664,0.1026		D(0.02),D(0.01)	P(0.68),B(0.15)	27.40	0.18		COSV64689246	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367647	226367647	G	A	wt	het	wt	off-target	QUAL=2128;DP=205,175,243;AF=0.00,0.49,0.00;MQM=60;SAP=37;ABP=3	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron15/21:c.2149-39C>T::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::						rs3219123	0.0266	0.0445	198,.	0.0086,0.0237,0.0004,0.0601,0.0452				3.05				0	57	1758	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226383139	226383139	T	C	het	hom	het		QUAL=4875;DP=92,72,92;AF=0.58,1.00,0.51;MQM=60;SAP=35;ABP=6	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:,PARP1:ENST00000677203.1:synonymous_variant:LOW:exon8/22:c.1056A>G:p.Lys352=:	PARP1:NM_001618.4:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:						rs1805415		0.8276	52662,.	0.9002,0.5748,0.5531,0.8337,0.8974				8.59			COSV64689254	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226385663	226385663	A	G	het	wt	het		QUAL=4736;DP=157,208,247;AF=0.54,0.00,0.45;MQM=60;SAP=152;ABP=4	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon7/22:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain]	PARP1:NM_001618.4:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414		0.4262	14726,.	0.5525,0.5538,0.8133,0.3377,0.3647				0.42			COSV64689261	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390398	226390398	T	C	hom	het	hom	off-target	QUAL=8987;DP=90,121,162;AF=1.00,0.55,0.99;MQM=60;SAP=435;ABP=5	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron4/22:c.617+12A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron4/21:c.617+12A>G::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron4/22:c.617+12A>G::						rs1805403		0.8340	53408,.	0.9411,0.8703,0.9388,0.7678,0.7385				0.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402257	226402257	G	A	het	wt	het		QUAL=9316;DP=297,299,469;AF=0.46,0.00,0.48;MQM=60;SAP=6;ABP=7	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon2/22:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]	PARP1:NM_001618.4:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:						rs1805404	0.2183	0.2184	2944,.	0.1230,0.4261,0.4479,0.1663,0.1030				11.98			COSV64687027	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226407946	226407946	C	G	het	wt	het		QUAL=2211;DP=42,138,146;AF=0.52,0.00,0.50;MQM=60;SAP=3;ABP=3	PARP1	5'UTR	PARP1:ENST00000366794.10:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::,PARP1:ENST00000677203.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-17G>C::	PARP1:NM_001618.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::	regulatory_region_variant:promoter,TF_binding_site_variant					rs907187	0.1991	0.2135	2724,.	0.0465,0.4177,0.4433,0.1652,0.1020				12.41			COSV64687065	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226961502	226961502	G	A	wt	het	wt		QUAL=294;DP=72,31,35;AF=0.00,0.48,0.00;MQM=60;SAP=4;ABP=3	COQ8A,	synonymous,splice_region&intron,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron1/14:c.-34-6G>A::,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon19/32:c.*4844G>A::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon4/17:c.117G>A:p.Ala39=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128273 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs11549708	0.0807	0.1645	2570,.	0.0465,0.0978,0.0005,0.2379,0.0769				3.92		-0.47>-4.84	COSV64658484	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226964961	226964961	C	T	wt	het	wt	off-target	QUAL=926;DP=82,67,85;AF=0.01,0.63,0.00;MQM=60;SAP=80;ABP=12	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron2/14:c.22-39C>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron19/31:c.*4905-39C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron4/16:c.178-39C>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759581953		0.0001	0,.	0.0000,0.0000,0.0001,0.0001,0.0001				0.06				0	0	1	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977534	226977534	C	T	het	wt	het	off-target	QUAL=433;DP=18,31,24;AF=0.50,0.00,0.50;MQM=60;SAP=3;ABP=3	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron5/14:c.574+11C>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron22/31:c.*5457+11C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron7/16:c.730+11C>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759489004		0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000				6.46				0	0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982842	226982842	C	G	het	het	wt	off-target	QUAL=3779;DP=114,177,294;AF=0.61,0.47,0.01;MQM=60;SAP=90;ABP=4	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron24/31:c.*5667-52C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron9/16:c.940-52C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671531 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs2297413	0.1983	0.2028	3383,.					2.96			COSV64657732	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983509	226983509	G	A	het	wt	hom	off-target	QUAL=5893;DP=84,143,175;AF=0.49,0.00,0.99;MQM=60;SAP=204;ABP=3	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron25/31:c.*5808-43G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron10/16:c.1081-43G>A::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671619 [benign DISEASE=not provided];			rs12739480	0.0871	0.1248	1139,.	0.0331,0.0460,0.0446,0.1408,0.2082				0.57			COSV64659018	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983884	226983884	T	-	het	hom	wt	off-target	QUAL=1937;DP=103,40,77;AF=0.44,1.00,0.00;MQM=60;SAP=69;ABP=7	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1100+32del::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5983+32del::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1256+32del::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1183738 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs3215919		0.3693	10965,.	0.2910,0.2790,0.1388,0.4449,0.2053				0.16				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984035	226984035	-	T	wt	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-59_1101-58insT::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-59_*5984-58insT::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-59_1257-58insT::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1294314 [benign DISEASE=not provided];			rs149374145		0.1614	2411,.					3.95				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984036	226984036	G	T	het	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-58G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-58G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1291028 [benign DISEASE=not provided];			rs1574184	0.2812	0.2469	4060,.					4.23			COSV64656763	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984037	226984037	G	T	wt	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-57G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-57G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-57G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1262417 [benign DISEASE=not provided];			rs377335668		0.1554	2351,.					0.99				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984038	226984038	G	T	het	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-56G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-56G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1188901 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs1574185	0.2802	0.2348	3739,.					0.81				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984257	226984257	G	C	wt	het	wt	off-target	QUAL=1013;DP=114,75,107;AF=0.00,0.53,0.00;MQM=60;SAP=4;ABP=4	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron11/14:c.1242+22G>C::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron28/31:c.*6125+22G>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron13/16:c.1398+22G>C::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1247645 [benign DISEASE=not provided];			rs7530213	0.1683	0.2505	5196,.	0.1551,0.2011,0.0930,0.3134,0.1314				6.30			COSV64657987	0.32	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984589	226984589	C	T	het	hom	wt		QUAL=15686;DP=331,380,506;AF=0.47,0.98,0.00;MQM=60;SAP=6;ABP=5	COQ8A,	synonymous,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon29/32:c.*6167C>T::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon14/17:c.1440C>T:p.Phe480=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128274 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs12593	0.2386	0.3534	10345,.	0.1976,0.2696,0.1758,0.4533,0.2031				4.88			COSV64656797	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226985202	226985202	G	A	het	hom	wt	off-target	QUAL=8133;DP=101,230,303;AF=0.60,0.98,0.00;MQM=60;SAP=98;ABP=12	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron30/31:c.*6300-52G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron15/16:c.1573-52G>A::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	676090 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs2297415	0.2696	0.3780	11508,.					1.16			COSV62011699,COSV62017351	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226985234	226985234	C	G	het	hom	wt	off-target	QUAL=9709;DP=115,265,340;AF=0.62,1.00,0.00;MQM=60;SAP=18;ABP=17	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-20C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron30/31:c.*6300-20C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron15/16:c.1573-20C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	518313 [benign/likely benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,not provided];			rs2297416	0.2652	0.3737	11314,.	0.2678,0.2816,0.1674,0.4597,0.2070				3.50		12.28>10.93	COSV62011473	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986421	226986421	C	G	wt	het	wt	off-target	QUAL=940;DP=87,73,139;AF=0.00,0.56,0.00;MQM=60;SAP=6;ABP=5	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-32C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron31/31:c.*6387-32C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron16/16:c.1660-32C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671534 [benign DISEASE=not provided];			rs41303131	0.1136	0.1980	3668,.	0.0873,0.1155,0.0030,0.2805,0.1235				0.17			COSV62005838	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986444	226986444	T	C	het	hom	wt		QUAL=4063;DP=103,89,168;AF=0.53,1.00,0.00;MQM=60;SAP=50;ABP=4	COQ8A,	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-9T>C::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron31/31:c.*6387-9T>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron16/16:c.1660-9T>C::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296024 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs7552783	0.3516	0.4430	15303,.	0.4148,0.3047,0.2207,0.5014,0.2758				5.40		11.51>10.71	COSV62011703,COSV62011928	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986509	226986509	T	C	het	hom	wt		QUAL=5374;DP=162,118,185;AF=0.45,1.00,0.00;MQM=60;SAP=3;ABP=6	COQ8A,	synonymous,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:c.*6443T>C::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon17/17:c.1716T>C:p.Ser572=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128275 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs3738725	0.3139	0.4134	13639,.	0.3106,0.2982,0.2240,0.5020,0.2756				0.04			COSV62011476	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987122	226987122	-	T	het	hom	wt		QUAL=13740;DP=246,373,474;AF=0.46,1.00,0.00;MQM=60;SAP=75;ABP=7	COQ8A,	3'UTR,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366778.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:c.*7060dup::	COQ8A:NM_020247.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_005273201.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_011544238.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::,COQ8A:XM_011544239.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*389dup::,COQ8A:XM_011544241.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_017001852.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_024448517.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::,COQ8A:XM_024448518.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839		0.4035	13225,.					1.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987544	226987544	-	T	het	hom	wt		QUAL=7958;DP=163,221,329;AF=0.45,0.96,0.00;MQM=60;SAP=26;ABP=6		3'UTR&NMD_transcript	:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:::		regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296050 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs3215920		0.3726	12089,.					1.93				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987552	226987552	C	T	het	hom	wt		QUAL=8644;DP=165,214,324;AF=0.48,1.00,0.00;MQM=60;SAP=45;ABP=4	CDC42BPA,COQ8A,	downstream_gene,upstream_gene	CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366764.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,:ENST00000366779.6:downstream_gene_variant:MODIFIER::::,:ENST00000433837.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	368867 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs10495274	0.4191	0.5257	22087,.					0.26					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228159235	228159235	G	A	het	wt	het		QUAL=2189;DP=43,92,130;AF=0.53,0.00,0.54;MQM=60;SAP=25;ABP=5	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]	1265470 [benign DISEASE=not provided];			rs45491398	0.0234	0.0576	366,.					0.34				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228159651	228159651	A	G	hom	hom	hom		QUAL=1506;DP=30,8,13;AF=1.00,1.00,1.00;MQM=60;SAP=105;ABP=0	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]				rs6668719		0.8480	55985,.					4.20				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228425137	228425137	G	T	het	het	hom		QUAL=18667;DP=288,285,384;AF=0.51,0.46,1.00;MQM=60;SAP=428;ABP=4	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]	H3-4:NM_003493.3:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:	regulatory_region_variant:CTCF_binding_site					rs2230656		0.8318	44714,.	0.3976,0.9254,0.6604,0.8863,0.8559				8.50			COSV64210568	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425191	228425191	G	A	wt	wt	het		QUAL=2236;DP=186,211,259;AF=0.00,0.00,0.47;MQM=60;SAP=158;ABP=5	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:PF00125 [Core histone H2A/H2B/H3/H4]	H3-4:NM_003493.3:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:	regulatory_region_variant:CTCF_binding_site					rs56336130	0.0433	0.0708	417,.	0.0128,0.0359,0.0198,0.0923,0.0907				6.19			COSV64210887	0.67	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425351	228425351	T	C	het	het	hom	off-target	QUAL=1615;DP=58,34,30;AF=0.40,0.41,1.00;MQM=60;SAP=148;ABP=11	H3-4	5'UTR	H3-4:ENST00000366696.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::	H3-4:NM_003493.3:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::						rs1188474		0.8923	60765,.	0.9285,0.9608,0.6693,0.8916,0.8646				0.35					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229432484	229432484	T	G	hom	hom	hom	off-target	QUAL=2169;DP=8,34,46;AF=1.00,1.00,1.00;MQM=60;SAP=194;ABP=0	ACTA1	intron	ACTA1:ENST00000366683.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000366684.7:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000684723.1:intron_variant:MODIFIER:intron2/5:c.320-53A>C::	ACTA1:NM_001100.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:promoter_flanking_region	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	676564 [benign DISEASE=Nemaline myopathy 3,Congenital myopathy with fiber type disproportion,Myopathy, scapulohumeroperoneal,not provided];			rs527621	0.9990	0.9984	72810,.					3.26				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434056	229434056	A	G	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5	ACTA1	5'UTR	ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-59T>C::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	296060 [benign DISEASE=Nemaline myopathy 3,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605430	0.6302	0.6324	30966,.					19.39			COSV64203106	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434057	229434057	G	A	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5	ACTA1	5'UTR	ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-60C>T::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal recessive, Autosomal dominant]	296062 [benign DISEASE=Nemaline myopathy 3,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605428	0.6436	0.6322	30962,.					17.21			COSV64204088	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231241335	231241335	C	T	hom	hom	het		QUAL=18934;DP=293,250,316;AF=0.98,0.99,0.55;MQM=60;SAP=187;ABP=10	GNPAT	5'UTR	GNPAT:ENST00000366647.9:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	GNPAT:NM_001316350.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-44C>T::,GNPAT:NM_014236.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::,GNPAT:XM_005273313.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::,GNPAT:XM_011544303.3:5_prime_UTR_variant:MODIFIER:exon1/17:c.-459C>T::,GNPAT:XM_011544304.2:5_prime_UTR_variant:MODIFIER:exon1/16:c.-276C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified];			rs518686		0.5542	23065,.	0.5701,0.6072,0.5936,0.5291,0.6243				10.49			COSV59641814	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265458	231265458	T	C	hom	het	het	off-target	QUAL=12319;DP=212,178,232;AF=1.00,0.48,0.51;MQM=60;SAP=114;ABP=3	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron5/15:c.696+38T>C::	GNPAT:NM_001316350.2:intron_variant:MODIFIER:intron4/14:c.513+38T>C::,GNPAT:NM_014236.4:intron_variant:MODIFIER:intron5/15:c.696+38T>C::,GNPAT:XM_005273313.4:intron_variant:MODIFIER:intron5/15:c.693+38T>C::,GNPAT:XM_011544303.3:intron_variant:MODIFIER:intron6/16:c.369+38T>C::,GNPAT:XM_011544304.2:intron_variant:MODIFIER:intron5/15:c.369+38T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1256935 [benign DISEASE=not provided];			rs6702011	0.2678	0.2745	5526,.	0.2822,0.3909,0.2137,0.2542,0.2725				7.53			COSV64154015	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231266156	231266156	G	A	hom	het	het		QUAL=17595;DP=348,202,257;AF=1.00,0.49,0.50;MQM=60;SAP=91;ABP=3	GNPAT	synonymous	GNPAT:ENST00000366647.9:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:	GNPAT:NM_001316350.2:synonymous_variant:LOW:exon6/15:c.732G>A:p.Glu244=:,GNPAT:NM_014236.4:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:,GNPAT:XM_005273313.4:synonymous_variant:LOW:exon7/16:c.912G>A:p.Glu304=:,GNPAT:XM_011544303.3:synonymous_variant:LOW:exon8/17:c.588G>A:p.Glu196=:,GNPAT:XM_011544304.2:synonymous_variant:LOW:exon7/16:c.588G>A:p.Glu196=:		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided];			rs574553		0.5883	26756,.	0.6931,0.6150,0.5972,0.5398,0.6247				5.21			COSV64153484	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231364607	231364607	-	T	hom	het	hom		QUAL=17883;DP=350,162,185;AF=0.97,0.44,0.97;MQM=60;SAP=15;ABP=7	EGLN1,	3'UTR	EGLN1:ENST00000366641.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::,:ENST00000653908.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1909dup::	EGLN1:NM_001377260.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1864dup::,EGLN1:NM_001377261.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1909dup::,EGLN1:NM_022051.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2277+3227dup::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]				rs541569859		0.5742	25902,.					7.84				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	-	het	wt	het	off-target	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=50;ABP=587	EGLN1,	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24del::,:ENST00000653908.1:intron_variant:MODIFIER:intron4/4:c.*42-24del::,:ENST00000662216.1:intron_variant:MODIFIER:intron6/6:c.356-24del::	EGLN1:NM_001377260.1:intron_variant:MODIFIER:intron3/3:c.1149-24del::,EGLN1:NM_001377261.1:intron_variant:MODIFIER:intron3/3:c.*42-24del::,EGLN1:NM_022051.3:intron_variant:MODIFIER:intron4/4:c.1217-24del::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2278-3052del::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1243379 [benign DISEASE=not provided];			rs371204614		0.1471	0,.	0.0682,0.1075,0.1613,0.1716,0.1280				2.38			COSV64150067		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	A	het	het	het	off-target	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=211;ABP=17	EGLN1,	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::,:ENST00000653908.1:intron_variant:MODIFIER:intron4/4:c.*42-24A>T::,:ENST00000662216.1:intron_variant:MODIFIER:intron6/6:c.356-24A>T::	EGLN1:NM_001377260.1:intron_variant:MODIFIER:intron3/3:c.1149-24A>T::,EGLN1:NM_001377261.1:intron_variant:MODIFIER:intron3/3:c.*42-24A>T::,EGLN1:NM_022051.3:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2278-3055T>A::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1292828 [benign DISEASE=not provided];			rs1435167		0.5720	25166,.	0.3345,0.3784,0.4142,0.4517,0.4127				5.73			COSV64150067	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231421509	231421509	C	G	het	hom	wt		QUAL=206;DP=3,9,3;AF=0.67,1.00,0.00;MQM=60;SAP=27;ABP=4	EGLN1,	missense,intron	EGLN1:ENST00000366641.4:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:,:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+40929G>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+40929G>C::	EGLN1:NM_001377260.1:missense_variant:MODERATE:exon1/4:c.380G>C:p.Cys127Ser:,EGLN1:NM_001377261.1:missense_variant:MODERATE:exon1/4:c.380G>C:p.Cys127Ser:,EGLN1:NM_022051.3:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:,EGLN1:XM_024447734.1:missense_variant:MODERATE:exon1/3:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	242640 [benign DISEASE=Erythrocytosis, familial, 3,not provided]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.2604	0.1558	2912,.	0.4444,0.2239,0.5097,0.0939,0.3281		T(0.74), , 	B(0.00), , 	12.82	0.21		COSV64149723	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231423480	231423480	A	G	het	hom	wt		QUAL=5114;DP=197,71,82;AF=0.51,1.00,0.02;MQM=60;SAP=19;ABP=3		intron	:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+38958T>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+38958T>C::		regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296223 [benign DISEASE=Erythrocytosis, familial, 3];			rs12406290	0.2915	0.1928	3232,.					10.08				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231424474	231424474	A	G	het	hom	wt		QUAL=15143;DP=598,209,205;AF=0.52,1.00,0.00;MQM=60;SAP=357;ABP=5		intron	:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+37964T>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+37964T>C::			606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296240 [benign DISEASE=Erythrocytosis, familial, 3];			rs2153364	0.2939	0.1935	3262,.					4.11				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235380162	235380165	TGTG	-	wt	wt	het	off-target	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=4;ABP=10	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+62_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+62_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+62_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34222_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			(TG)n (Simple_repeat)	rs10524346		0.0584	275,.	0.0194,0.0288,0.0438,0.0234,0.0253				1.36				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380175	TGTGTGTGTGTGTG	-	wt	het	wt	off-target	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=8;ABP=45	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+52_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+52_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+52_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34232_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245486 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346		0.2818	6210,.	0.1041,0.1006,0.0754,0.2091,0.0685				1.46				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380177	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=59;SAP=38;ABP=78	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+50_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+50_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+50_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34234_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1232644 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346		0.0770	200,.	0.0784,0.0478,0.0847,0.0917,0.0437				1.54				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380179	TGTGTGTGTGTGTGTGTG	-	wt	het	wt	off-target	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=6;ABP=11	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+48_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+48_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+48_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34236_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	403520 [benign/likely benign DISEASE=not specified,not provided];		(TG)n (Simple_repeat)	rs10524346		0.1408	1840,.	0.1339,0.2137,0.3190,0.0680,0.1604				1.55				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235449005	235449005	C	T	het	hom	wt	off-target	QUAL=4405;DP=134,84,91;AF=0.54,0.99,0.00;MQM=60;SAP=268;ABP=5	B3GALNT2,TBCE	3'UTR	B3GALNT2:ENST00000366600.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::,TBCE:ENST00000406207.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:ENST00000642610.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::	TBCE:NM_001079515.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:NM_001287801.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*243C>T::,TBCE:NM_001287802.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*243C>T::,TBCE:NM_003193.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:NM_152490.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::,B3GALNT2:XM_006711749.3:intron_variant:MODIFIER:intron12/12:c.1469+1235G>A::,B3GALNT2:XM_017000394.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1201G>A::,B3GALNT2:XM_017000395.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1380G>A::,B3GALNT2:XR_001736987.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2808G>A::,B3GALNT2:XR_001736989.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2729G>A::,B3GALNT2:XR_001736990.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2691G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]&610194_[GENE=B3GALNT2_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3), Autosomal recessive]				rs704705	0.7446	0.7373	42460,.					9.48			COSV64003592		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235662343	235662343	G	A	het	het	wt		QUAL=2801;DP=205,30,66;AF=0.47,0.33,0.00;MQM=60;SAP=20;ABP=7	LYST	3'UTR	LYST:ENST00000389793.7:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon52/53:c.*7427C>T::	LYST:NM_000081.4:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:NM_001301365.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:XM_011544031.1:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544032.1:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544033.2:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544034.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:XM_011544036.2:3_prime_UTR_variant:MODIFIER:exon50/50:c.*597C>T::,LYST:XM_017000150.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs1400168809		0.0001	0,.					4.70				0	0	2	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663083	235663083	A	-	hom	het	hom		QUAL=15554;DP=238,195,277;AF=0.90,0.51,0.91;MQM=60;SAP=137;ABP=3	LYST	splice_region&intron	LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:ENST00000389794.7:splice_region_variant&intron_variant:LOW:intron51/52:c.*6692-5del::	LYST:NM_000081.4:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:NM_001301365.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:XM_011544031.1:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544032.1:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544033.2:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544034.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11292-5del::,LYST:XM_011544036.2:splice_region_variant&intron_variant:LOW:intron49/49:c.9093-5del::,LYST:XM_017000150.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11199-5del::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994		0.5533	24831,.	0.6809,0.4483,0.2392,0.5340,0.4148				1.92				0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235697040	235697040	C	T	hom	het	hom	off-target	QUAL=3255;DP=69,29,23;AF=1.00,0.59,1.00;MQM=60;SAP=190;ABP=5	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron45/52:c.*5988+43G>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron46/52:c.10588+43G>A::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron43/49:c.8389+43G>A::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron46/52:c.10495+43G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254908 [benign DISEASE=not specified,not provided];			rs7541057	0.4000	0.5321	23439,.	0.7306,0.2734,0.0498,0.5150,0.1857				0.01				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235709365	235709365	T	C	hom	het	hom	off-target	QUAL=7693;DP=179,47,56;AF=0.99,0.51,1.00;MQM=60;SAP=563;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron42/52:c.*5350-57A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron43/52:c.9950-57A>G::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron40/49:c.7751-57A>G::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron44/52:c.10088-57A>G::	regulatory_region_variant:promoter_flanking_region	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684363 [benign DISEASE=not provided];			rs2275856	0.4137	0.4999	22426,.					1.43				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235723976	235723976	G	T	hom	het	hom	off-target	QUAL=9236;DP=134,99,116;AF=0.99,0.52,1.00;MQM=60;SAP=399;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron38/52:c.*4739+52C>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron39/52:c.9339+52C>A::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron40/43:c.9477+52C>A::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron36/49:c.7140+52C>A::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron40/52:c.9477+52C>A::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron40/42:n.10350+52C>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684361 [benign DISEASE=not provided];			rs6667717	0.4117	0.4978	22275,.					0.00			COSV67704991	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235758928	235758928	T	C	het	wt	het	off-target	QUAL=2274;DP=140,28,43;AF=0.56,0.04,0.44;MQM=60;SAP=216;ABP=4	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron22/52:c.*2305+44A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron22/52:c.6743+44A>G::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron23/43:c.6881+44A>G::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron19/49:c.4544+44A>G::,LYST:XM_011544037.2:intron_variant:MODIFIER:intron23/32:c.6881+44A>G::,LYST:XM_011544039.2:intron_variant:MODIFIER:intron23/27:c.6881+44A>G::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:XR_001736946.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/33:n.7063+44A>G::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/42:n.7063+44A>G::,LYST:XR_001736948.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/27:n.7063+44A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254935 [benign DISEASE=not specified,not provided];			rs3738519	0.2300	0.2969	7328,.	0.4262,0.1913,0.0094,0.2694,0.1679				0.03				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235777150	235777150	C	T	hom	het	hom		QUAL=17693;DP=240,202,237;AF=1.00,0.43,1.00;MQM=60;SAP=220;ABP=13	LYST	synonymous,3'UTR	LYST:ENST00000389793.7:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon16/53:c.*797G>A::	LYST:NM_000081.4:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon17/44:c.5373G>A:p.Lys1791=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon13/50:c.3036G>A:p.Lys1012=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon17/33:c.5373G>A:p.Lys1791=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon17/28:c.5373G>A:p.Lys1791=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon17/22:c.5373G>A:p.Lys1791=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon17/34:n.5555G>A::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon17/43:n.5555G>A::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon17/28:n.5555G>A::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon17/24:n.5555G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254927 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs2273584	0.3009	0.4042	13083,.	0.5010,0.2776,0.0588,0.4050,0.2022				6.01			COSV67705051	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781886	235781886	G	A	het	het	het	off-target	QUAL=4553;DP=135,92,152;AF=0.44,0.53,0.51;MQM=60;SAP=171;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron14/52:c.*447+41C>T::	LYST:NM_000081.4:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron15/43:c.5023+41C>T::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron11/49:c.2686+41C>T::,LYST:XM_011544037.2:intron_variant:MODIFIER:intron15/32:c.5023+41C>T::,LYST:XM_011544039.2:intron_variant:MODIFIER:intron15/27:c.5023+41C>T::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_017000151.1:intron_variant:MODIFIER:intron15/21:c.5023+41C>T::,LYST:XR_001736946.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/33:n.5205+41C>T::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/42:n.5205+41C>T::,LYST:XR_001736948.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/27:n.5205+41C>T::,LYST:XR_002959252.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/23:n.5205+41C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254924 [benign DISEASE=not specified,not provided];		AluJo (SINE/Alu)	rs72763416	0.0707	0.1070	971,.	0.0709,0.0880,0.0493,0.1372,0.0408				0.38			COSV67705060	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781994	235781994	T	C	hom	het	hom		QUAL=15483;DP=184,150,232;AF=0.99,0.51,1.00;MQM=60;SAP=5;ABP=3	LYST	synonymous,3'UTR	LYST:ENST00000389793.7:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon14/53:c.*380A>G::	LYST:NM_000081.4:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon15/44:c.4956A>G:p.Leu1652=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon11/50:c.2619A>G:p.Leu873=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon15/33:c.4956A>G:p.Leu1652=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon15/28:c.4956A>G:p.Leu1652=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon15/22:c.4956A>G:p.Leu1652=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon15/34:n.5138A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon15/43:n.5138A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon15/28:n.5138A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon15/24:n.5138A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254923 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs6696123	0.3035	0.4050	13154,.	0.5020,0.2780,0.0588,0.4053,0.2079				2.91			COSV67705068	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235791850	235791850	G	A	wt	wt	het		QUAL=6557;DP=587,414,524;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4	LYST	synonymous,intron	LYST:ENST00000389793.7:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron11/52:c.4116+1653C>T::	LYST:NM_000081.4:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon12/44:c.4392C>T:p.Asn1464=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon8/50:c.2055C>T:p.Asn685=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon12/33:c.4392C>T:p.Asn1464=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon12/28:c.4392C>T:p.Asn1464=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon12/22:c.4392C>T:p.Asn1464=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon12/34:n.4574C>T::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon12/43:n.4574C>T::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon12/28:n.4574C>T::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon12/24:n.4574C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254921 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs11583387	0.0643	0.0908	711,.	0.0660,0.0778,0.0491,0.1125,0.0381				8.58				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235808463	235808463	A	G	het	het	het		QUAL=8421;DP=201,197,267;AF=0.53,0.51,0.51;MQM=60;SAP=50;ABP=4	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.2355T>C:p.Leu785=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.2355T>C:p.Leu785=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.2355T>C:p.Leu785=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.2355T>C:p.Leu785=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.2537T>C::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.2537T>C::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.2537T>C::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.2537T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254915 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3768066	0.0707	0.1073	975,.	0.0716,0.0882,0.0494,0.1374,0.0413				6.68				0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809135	235809135	T	C	hom	het	hom		QUAL=27836;DP=481,195,286;AF=0.99,0.52,1.00;MQM=60;SAP=24;ABP=4	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.1683A>G:p.Leu561=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.1683A>G:p.Leu561=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.1683A>G:p.Leu561=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.1683A>G:p.Leu561=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.1865A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.1865A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.1865A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.1865A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254912 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3820553	0.3027	0.4052	13166,.	0.5025,0.2785,0.0589,0.4057,0.2077				0.53			COSV67705097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809567	235809567	T	C	hom	het	hom		QUAL=27986;DP=456,190,307;AF=1.00,0.56,0.99;MQM=60;SAP=22;ABP=10	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.1251A>G:p.Gln417=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.1251A>G:p.Gln417=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.1251A>G:p.Gln417=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.1251A>G:p.Gln417=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.1433A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.1433A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.1433A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.1433A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs1063128	0.3033	0.4054	13165,.	0.5029,0.2784,0.0588,0.4057,0.2078				4.14			COSV67705101	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235866977	235866977	C	G	n/a	n/a	het	off-target	QUAL=25;DP=0,1,6;AF=,0.00,0.50;MQM=60;SAP=4;ABP=3	LYST	upstream_gene	LYST:ENST00000389793.7:upstream_gene_variant:MODIFIER::::,LYST:ENST00000389794.7:upstream_gene_variant:MODIFIER::::	LYST:NM_001301365.1:intron_variant:MODIFIER:intron1/52:c.-98+16210G>C::,LYST:NR_102436.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.527+16210G>C::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron1/53:c.-98+16210G>C::	regulatory_region_variant:promoter	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs3820556	0.0561	0.0876	745,.					16.17					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236394471	236394471	G	A	hom	hom	hom		QUAL=24570;DP=251,225,289;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0	EDARADD	missense,intron	EDARADD:ENST00000334232.9:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14745G>A::	EDARADD:NM_145861.4:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not specified,none provided,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs966365		0.8410	46074,.	0.5373,0.9067,0.9186,0.8370,0.9121		T(0.45), 	B(0.00), 	9.15	0.13		COSV62061862	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409175	236409175	A	G	het	hom	het	off-target	QUAL=10261;DP=180,171,161;AF=0.50,1.00,0.55;MQM=60;SAP=68;ABP=5	EDARADD	intron	EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-41A>G::,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-41A>G::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron1/5:c.32-41A>G::,EDARADD:NM_145861.4:intron_variant:MODIFIER:intron1/5:c.62-41A>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255368 [benign DISEASE=Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not provided];			rs669710	0.4619	0.5331	22044,.	0.4768,0.4369,0.2597,0.5943,0.4913				4.54			COSV62061755	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427359	236427359	G	C	het	hom	het	off-target	QUAL=6538;DP=150,89,153;AF=0.51,0.99,0.51;MQM=60;SAP=87;ABP=3	EDARADD	intron	EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-33G>C::,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-33G>C::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron3/5:c.131-33G>C::,EDARADD:NM_145861.4:intron_variant:MODIFIER:intron3/5:c.161-33G>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255369 [benign DISEASE=Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not provided];		(T)n (Simple_repeat)	rs636048	0.3582	0.4936	17437,.	0.1851,0.4187,0.2266,0.5866,0.4570				5.45				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236482370	236482370	C	T	wt	wt	het		QUAL=5233;DP=210,356,479;AF=0.00,0.01,0.44;MQM=60;SAP=4;ABP=17	EDARADD	synonymous	EDARADD:ENST00000334232.9:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362.6:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:,EDARADD:ENST00000637660.1:synonymous_variant:LOW:exon6/6:c.303C>T:p.Asp101=:	EDARADD:NM_080738.4:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:,EDARADD:NM_145861.4:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262602 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not specified,none provided,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs604070	0.1332	0.1998	3128,.	0.0709,0.1097,0.0906,0.2558,0.1497				4.39			COSV62061161	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484211	236484211	T	C	het	het	hom		QUAL=13064;DP=276,142,225;AF=0.54,0.49,1.00;MQM=60;SAP=16;ABP=4	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296476 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs7513402	0.2540	0.3140	8022,.					3.08			COSV62064204		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484250	236484250	C	G	het	het	hom		QUAL=13847;DP=328,127,225;AF=0.54,0.53,1.00;MQM=60;SAP=3;ABP=8	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296479 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs3916983	0.2033	0.2326	4538,.					3.23			COSV62063742		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484436	236484436	C	T	het	het	hom		QUAL=7196;DP=153,73,129;AF=0.55,0.53,0.99;MQM=60;SAP=3;ABP=7	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296481 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs6428955	0.1378	0.1786	2989,.					0.74			COSV62066249		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484708	236484708	G	-	het	het	wt		QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=59;SAP=23;ABP=8	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296489 [uncertain significance DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];		AluSc (SINE/Alu)	rs886046200		0.0001	0,.					0.09					1	3	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484709	A	-	wt	wt	het		QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=60;SAP=27;ABP=29	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1270976 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs11358746		0.4615	12220,.					0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484710	AA	-	het	wt	het		QUAL=140;DP=14,12,19;AF=0.29,0.42,0.00;MQM=60;SAP=31;ABP=20	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluSc (SINE/Alu)	rs11358746		0.0009	0,.					0.11					2	26	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236795232	236795232	G	T	het	het	hom	off-target	QUAL=1137;DP=14,23,29;AF=0.50,0.48,1.00;MQM=60;SAP=105;ABP=3	MTR	upstream_gene	MTR:ENST00000366577.10:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.6:upstream_gene_variant:MODIFIER::::,MTR:ENST00000674797.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:upstream_gene_variant:MODIFIER::::	MTR:XM_011544194.3:5_prime_UTR_variant:MODIFIER:exon1/32:c.-89G>T::,MTR:XM_017001329.2:5_prime_UTR_variant:MODIFIER:exon1/31:c.-89G>T::,MTR:XM_017001330.2:5_prime_UTR_variant:MODIFIER:exon1/30:c.-89G>T::	regulatory_region_variant:promoter	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1249677 [benign DISEASE=not provided];			rs28372871	0.4673	0.4633	16574,.					2.91					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236815692	236815692	-	TCTG	het	het	het	off-target	QUAL=7150;DP=161,110,172;AF=0.46,0.48,0.90;MQM=60;SAP=80;ABP=75	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.321+32_321+33insGTCT::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.669+32_669+33insGTCT::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.669+32_669+33insGTCT::	MTR:NM_000254.3:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron7/31:c.-440+32_-440+33insGTCT::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron7/32:c.666+32_666+33insGTCT::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron3/26:c.-105+32_-105+33insGTCT::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron6/31:c.837+32_837+33insGTCT::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron6/30:c.837+32_837+33insGTCT::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron6/29:c.837+32_837+33insGTCT::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1263040 [benign DISEASE=not provided];			rs5781924		0.7224	40879,.	0.9264,0.6865,0.8106,0.6222,0.7313				2.49				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236825293	236825293	-	T	het	het	hom	off-target	QUAL=3942;DP=137,36,48;AF=0.56,0.67,1.00;MQM=60;SAP=209;ABP=14	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron8/31:c.518-40dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron9/30:c.866-40dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron9/29:c.866-40dup::	MTR:NM_000254.3:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron9/31:c.-243-40dup::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron9/32:c.863-40dup::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron4/26:c.-9-1531dup::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron8/31:c.1034-40dup::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron8/30:c.1034-40dup::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron8/29:c.1034-40dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1236260 [benign DISEASE=not provided];			rs5781926		0.3832	9854,.	0.2055,0.4468,0.4037,0.4058,0.3105				0.79				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236826841	236826841	G	A	wt	het	wt		QUAL=1794;DP=295,153,221;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=4	MTR	missense	MTR:ENST00000366577.10:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000535889.6:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000674797.2:missense_variant:MODERATE:exon10/32:c.592G>A:p.Asp198Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000679842.1:missense_variant:MODERATE:exon11/31:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681102.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681177.1:missense_variant:MODERATE:exon11/30:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase]	MTR:NM_000254.3:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:,MTR:NM_001291939.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:,MTR:NM_001291940.2:5_prime_UTR_variant:MODIFIER:exon11/32:c.-169G>A::,MTR:XM_005273141.5:missense_variant:MODERATE:exon11/33:c.937G>A:p.Asp313Asn:,MTR:XM_006711770.3:missense_variant:MODERATE:exon5/27:c.4G>A:p.Asp2Asn:,MTR:XM_011544194.3:missense_variant:MODERATE:exon10/32:c.1108G>A:p.Asp370Asn:,MTR:XM_017001329.2:missense_variant:MODERATE:exon10/31:c.1108G>A:p.Asp370Asn:,MTR:XM_017001330.2:missense_variant:MODERATE:exon10/30:c.1108G>A:p.Asp370Asn:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296556 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified,none provided];			rs2229274	0.0084	0.0186	30,.	0.0080,0.0152,0.0001,0.0255,0.0049		T(0.26),T(0.26),T(0.26),T(0.30),T(0.16),T(0.37)	B(0.19),B(0.19),B(0.19),B(0.01),B(0.01),B(0.05)	22.50	0.12			0	15	727	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838626	236838626	A	G	het	het	hom	off-target	QUAL=12894;DP=177,180,256;AF=0.51,0.51,1.00;MQM=60;SAP=492;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+27A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+27A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+27A>G::	MTR:NM_000254.3:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron14/31:c.294+27A>G::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron15/32:c.1512+27A>G::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron9/26:c.579+27A>G::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron14/31:c.1683+27A>G::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron14/30:c.1683+27A>G::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron14/29:c.1683+27A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278171 [benign DISEASE=not provided];			rs3820568	0.3277	0.3931	10400,.	0.2101,0.4522,0.4331,0.4117,0.3140				0.09				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874699	236874699	T	-	het	het	hom	off-target	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-18del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-18del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-18del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-18del::	MTR:NM_000254.3:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18del::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18del::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron23/32:c.2471-18del::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron17/26:c.1538-18del::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron22/31:c.2642-18del::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron21/30:c.2489-18del::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-6047del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1220586 [benign DISEASE=Methylcobalamin deficiency type cblG,not provided];			rs150727404		0.6418	30382,.	0.5590,0.4889,0.5359,0.4505,0.4878				0.07				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874708	236874708	T	A	het	het	hom	off-target	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-18T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-18T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-18T>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18T>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron23/32:c.2471-18T>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron17/26:c.1538-18T>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron22/31:c.2642-18T>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron21/30:c.2489-18T>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-6047T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	378884 [benign DISEASE=Methylcobalamin deficiency type cblG,not specified];			rs10925256		0.4559	12428,.	0.4750,0.4576,0.4459,0.4159,0.3773				1.12		-1.58>-1.77	COSV63966075	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874861	236874861	T	C	het	het	wt	off-target	QUAL=2570;DP=81,126,168;AF=0.47,0.52,0.00;MQM=60;SAP=38;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron23/31:c.2246+15T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-5894T>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron23/31:c.2414+15T>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron21/29:c.2156+15T>C::	MTR:NM_000254.3:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron23/31:c.1373+15T>C::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron24/32:c.2591+15T>C::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron18/26:c.1658+15T>C::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron23/31:c.2762+15T>C::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron22/30:c.2609+15T>C::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-5894T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138288 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1770449	0.2322	0.3220	7111,.	0.0701,0.3134,0.1923,0.3749,0.2791				3.53			COSV63964725	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236885262	236885262	G	A	het	het	hom	off-target	QUAL=11132;DP=332,113,149;AF=0.55,0.50,1.00;MQM=60;SAP=438;ABP=9	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2427+43G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2586+43G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2595+43G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2337+43G>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron25/31:c.1554+43G>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron26/32:c.2772+43G>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron20/26:c.1839+43G>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron25/31:c.2943+43G>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron24/30:c.2790+43G>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron23/29:c.2754+43G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1258762 [benign DISEASE=not provided];			rs2275566		0.7161	40112,.	0.9063,0.6827,0.8081,0.6227,0.7187				0.29				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891269	236891269	A	G	het	het	hom		QUAL=7199;DP=98,101,144;AF=0.55,0.50,1.00;MQM=60;SAP=21;ABP=4	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon28/32:c.2796A>G:p.Ala932=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon27/31:c.2955A>G:p.Ala985=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon28/32:c.2964A>G:p.Ala988=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon26/30:c.2706A>G:p.Ala902=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon28/32:c.1923A>G:p.Ala641=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon29/33:c.3141A>G:p.Ala1047=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon23/27:c.2208A>G:p.Ala736=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon28/32:c.3312A>G:p.Ala1104=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon27/31:c.3159A>G:p.Ala1053=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon26/30:c.3123A>G:p.Ala1041=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138290 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs2229276	0.3233	0.3896	9993,.	0.1936,0.4474,0.4430,0.4047,0.3210				0.76			COSV63966508	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236894308	236894308	G	A	het	het	hom	off-target	QUAL=7988;DP=96,140,175;AF=0.51,0.50,1.00;MQM=60;SAP=510;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2857-49G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3016-49G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3025-49G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2767-49G>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron28/31:c.1984-49G>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron29/32:c.3202-49G>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron23/26:c.2269-49G>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron28/31:c.3373-49G>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron27/30:c.3220-49G>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron26/29:c.3184-49G>A::	regulatory_region_variant:open_chromatin_region	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1270532 [benign DISEASE=not provided];			rs2297965		0.5905	24176,.	0.4581,0.6321,0.5411,0.5949,0.6252				2.45			COSV63966743	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895444	236895444	C	A	het	het	hom		QUAL=14604;DP=215,222,309;AF=0.50,0.45,1.00;MQM=60;SAP=12;ABP=5	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3144C>A:p.Arg1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3303C>A:p.Arg1101=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3312C>A:p.Arg1104=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3054C>A:p.Arg1018=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2271C>A:p.Arg757=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon31/33:c.3489C>A:p.Arg1163=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon25/27:c.2556C>A:p.Arg852=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon30/32:c.3660C>A:p.Arg1220=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon29/31:c.3507C>A:p.Arg1169=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon28/30:c.3471C>A:p.Arg1157=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138283 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs12070777	0.3215	0.3869	10032,.	0.1981,0.4453,0.4322,0.4014,0.3121				2.36			COSV63966512	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895528	236895528	C	T	wt	het	het		QUAL=4192;DP=136,168,182;AF=0.00,0.43,0.53;MQM=60;SAP=117;ABP=4	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3228C>T:p.Leu1076=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3387C>T:p.Leu1129=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3396C>T:p.Leu1132=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3138C>T:p.Leu1046=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2355C>T:p.Leu785=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon31/33:c.3573C>T:p.Leu1191=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon25/27:c.2640C>T:p.Leu880=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon30/32:c.3744C>T:p.Leu1248=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon29/31:c.3591C>T:p.Leu1197=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon28/30:c.3555C>T:p.Leu1185=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138284 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1131449		0.5762	22891,.	0.4608,0.6146,0.5430,0.5720,0.6205				0.04			COSV63964165	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897133	236897133	G	T	het	het	hom	off-target	QUAL=12444;DP=205,200,245;AF=0.42,0.50,0.99;MQM=60;SAP=228;ABP=9	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron31/31:c.3363+15G>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron30/30:c.3522+15G>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron31/31:c.3531+15G>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron29/29:c.3273+15G>T::	MTR:NM_000254.3:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron31/31:c.2490+15G>T::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron32/32:c.3708+15G>T::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron26/26:c.2775+15G>T::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron31/31:c.3879+15G>T::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron30/30:c.3726+15G>T::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron29/29:c.3690+15G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138285 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs3820571		0.7079	39138,.	0.8870,0.6808,0.8080,0.6181,0.7188				0.40				0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897646	236897646	T	-	het	het	het		QUAL=502;DP=153,73,117;AF=0.18,0.19,0.11;MQM=60;SAP=8;ABP=347	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*16del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*16del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*16del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296586 [likely benign(replaced by megSAP based on classifications:2x1,1x3) DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not provided];		(T)n (Simple_repeat)	rs67705775		0.4627	1955,.	0.4550,0.4608,0.4615,0.4659,0.4674				10.14				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897756	236897756	A	C	het	het	hom		QUAL=10723;DP=308,80,153;AF=0.54,0.53,1.00;MQM=60;SAP=19;ABP=7	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*112A>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*112A>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*112A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not provided];			rs2853522		0.5619	24345,.					3.07				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898405	236898405	T	-	het	het	hom		QUAL=2222;DP=96,26,38;AF=0.55,0.58,0.82;MQM=58;SAP=90;ABP=6	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*773del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*773del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*773del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs796166778		0.6811	32753,.					0.92				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898549	236898549	G	A	het	het	wt		QUAL=1308;DP=82,34,65;AF=0.44,0.59,0.00;MQM=51;SAP=71;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*905G>A::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*905G>A::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*905G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs1131450	0.2460	0.2844	6957,.					1.57				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898898	236898898	A	C	het	het	hom		QUAL=16901;DP=263,243,297;AF=0.55,0.47,1.00;MQM=60;SAP=15;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*1254A>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*1254A>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1254A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523		0.7192	40590,.					4.71				0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236899005	236899005	A	G	het	het	hom		QUAL=22005;DP=413,294,370;AF=0.53,0.52,0.99;MQM=60;SAP=5;ABP=7	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*1361A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*1361A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1361A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993		0.7193	40616,.					1.96				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900035	236900035	G	C	het	het	hom		QUAL=12882;DP=227,207,221;AF=0.49,0.53,1.00;MQM=60;SAP=134;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2391G>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2391G>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2391G>C::	regulatory_region_variant:CTCF_binding_site	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996		0.6886	36703,.					3.37				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900204	236900204	A	G	het	het	hom		QUAL=11976;DP=379,107,148;AF=0.50,0.54,1.00;MQM=60;SAP=7;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2560A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2560A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2560A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.3219	0.3704	9841,.	0.1885,0.4325,0.4310,0.3913,0.2992				0.18				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900409	236900409	-	A	het	het	hom		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=3;ABP=22	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2774dup::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2774dup::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2774dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098		0.7261	32751,.					0.29				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900418	236900419	AG	-	het	het	wt		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=11;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2775_*2776del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2775_*2776del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2775_*2776del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1553332314		0.2796	7193,.					1.01				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236901326	236901326	T	G	het	het	hom		QUAL=33907;DP=419,512,670;AF=0.50,0.48,0.99;MQM=60;SAP=22;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*3682T>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*3682T>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*3682T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866		0.5628	24374,.					7.27				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902026	236902026	C	T	het	het	hom		QUAL=8138;DP=170,112,157;AF=0.55,0.47,1.00;MQM=60;SAP=141;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4382C>T::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4382C>T::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4382C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746		0.5684	24904,.					0.80				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902283	236902283	G	T	het	het	hom		QUAL=13218;DP=219,175,256;AF=0.51,0.57,1.00;MQM=60;SAP=8;ABP=8	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4639G>T::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4639G>T::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4639G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264		0.7190	40491,.					0.95				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902510	236902510	T	G	het	wt	het		QUAL=4890;DP=179,178,171;AF=0.53,0.00,0.55;MQM=60;SAP=145;ABP=8	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4866T>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4866T>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4866T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.0076	0.0156	21,.					2.04				0	5	122	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902814	236902814	A	G	het	het	wt		QUAL=3170;DP=157,84,113;AF=0.50,0.58,0.00;MQM=60;SAP=99;ABP=5	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*5170A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*5170A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*5170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.0104	0.0197	53,.					2.80				0	1	102	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240775804	240775804	G	A	het	hom	wt		QUAL=9113;DP=345,146,165;AF=0.48,0.99,0.00;MQM=60;SAP=178;ABP=4	RGS7,	3'UTR,splice_acceptor&non_coding_transcript	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,:ENST00000644500.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron6/6:n.1110-1G>A::,:ENST00000653456.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron4/4:n.670-1G>A::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*359C>T::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*359C>T::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*359C>T::						rs35557904	0.1727	0.1723	3026,.					19.19		11.28>2.53		0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775852	240775852	A	G	het	hom	wt		QUAL=9495;DP=318,181,209;AF=0.44,0.99,0.00;MQM=60;SAP=90;ABP=13	RGS7,	3'UTR,non_coding_transcript_exon	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,:ENST00000644500.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1157A>G::,:ENST00000653456.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.717A>G::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*311T>C::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*311T>C::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*311T>C::						rs16840577	0.1727	0.1721	3026,.					16.55				0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776091	240776091	C	T	het	het	wt		QUAL=12747;DP=505,550,687;AF=0.46,0.47,0.00;MQM=60;SAP=22;ABP=16	RGS7,	3'UTR,non_coding_transcript_exon	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,:ENST00000653456.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.956C>T::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*72G>A::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*72G>A::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*72G>A::						rs12757054	0.0497	0.0610	353,.					10.68			COSV58544216	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240811913	240811913	T	C	het	wt	hom		QUAL=11013;DP=254,201,238;AF=0.54,0.00,1.00;MQM=60;SAP=132;ABP=6	RGS7	splice_region&intron	RGS7:ENST00000348120.6:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::	RGS7:NM_001282773.2:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:NM_001282775.2:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:NM_001282778.2:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:NM_001350113.2:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350114.2:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350115.2:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:NM_001350116.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1004+5A>G::,RGS7:NM_001364886.1:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:NM_001374806.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1031+5A>G::,RGS7:NM_001374807.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1031+5A>G::,RGS7:NM_001374808.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001374809.1:splice_region_variant&intron_variant:LOW:intron14/16:c.803+5A>G::,RGS7:NM_001374810.1:splice_region_variant&intron_variant:LOW:intron14/18:c.803+5A>G::,RGS7:NM_001374811.1:splice_region_variant&intron_variant:LOW:intron12/14:c.923+5A>G::,RGS7:NM_001374812.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1007+5A>G::,RGS7:NM_001374813.1:splice_region_variant&intron_variant:LOW:intron11/13:c.569+5A>G::,RGS7:NM_001374814.1:splice_region_variant&intron_variant:LOW:intron12/16:c.923+5A>G::,RGS7:NM_001374815.1:splice_region_variant&intron_variant:LOW:intron13/16:c.971+5A>G::,RGS7:NM_001374816.1:splice_region_variant&intron_variant:LOW:intron13/15:c.971+5A>G::,RGS7:NM_002924.6:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:XM_006711800.4:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_011544246.3:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_011544247.3:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_017002001.2:splice_region_variant&intron_variant:LOW:intron13/17:c.1031+5A>G::,RGS7:XM_017002002.2:splice_region_variant&intron_variant:LOW:intron15/19:c.1004+5A>G::,RGS7:XM_017002005.2:splice_region_variant&intron_variant:LOW:intron14/17:c.1004+5A>G::,RGS7:XM_017002009.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1004+5A>G::,RGS7:XM_017002011.2:splice_region_variant&intron_variant:LOW:intron11/15:c.830+5A>G::,RGS7:XM_017002012.2:splice_region_variant&intron_variant:LOW:intron11/14:c.830+5A>G::,RGS7:XM_017002013.1:splice_region_variant&intron_variant:LOW:intron11/13:c.830+5A>G::	regulatory_region_variant:CTCF_binding_site					rs2275742	0.4046	0.5076	18434,.	0.2546,0.4101,0.4598,0.5768,0.4338				8.97		8.38>10.57	COSV58534718	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814664	240814664	G	T	hom	het	hom	off-target	QUAL=9579;DP=169,64,108;AF=0.99,0.44,1.00;MQM=60;SAP=300;ABP=5	RGS7	intron	RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron12/18:c.845+52C>A::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron12/16:c.767+52C>A::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron11/16:c.794+52C>A::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron11/15:c.794+52C>A::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron12/16:c.566+52C>A::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron12/18:c.566+52C>A::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron10/14:c.686+52C>A::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron11/15:c.770+52C>A::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron9/13:c.332+52C>A::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron10/16:c.686+52C>A::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron12/15:c.845+52C>A::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:XM_006711800.4:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_011544246.3:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_011544247.3:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron11/17:c.794+52C>A::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron13/19:c.767+52C>A::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron12/17:c.767+52C>A::,RGS7:XM_017002009.1:intron_variant:MODIFIER:intron11/15:c.767+52C>A::,RGS7:XM_017002011.2:intron_variant:MODIFIER:intron9/15:c.593+52C>A::,RGS7:XM_017002012.2:intron_variant:MODIFIER:intron9/14:c.593+52C>A::,RGS7:XM_017002013.1:intron_variant:MODIFIER:intron9/13:c.593+52C>A::						rs12744536	0.5292	0.6105	29908,.					0.01			COSV58534726	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240983022	240983022	A	G	het	wt	het	off-target	QUAL=4096;DP=215,57,82;AF=0.52,0.00,0.54;MQM=60;SAP=217;ABP=5	RGS7	intron	RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.226+57T>C::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron4/16:c.148+57T>C::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron3/16:c.176-46316T>C::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron3/15:c.176-46316T>C::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron4/16:c.-64+57T>C::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron4/18:c.-64+57T>C::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron4/14:c.226+57T>C::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron4/13:c.-64+57T>C::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:XM_006711800.4:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_011544246.3:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_011544247.3:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron3/17:c.176-46316T>C::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron5/19:c.148+57T>C::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron4/17:c.148+57T>C::,RGS7:XM_017002009.1:intron_variant:MODIFIER:intron3/15:c.148+57T>C::						rs7520707	0.3560	0.3710	10701,.					3.57				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241355798	241355798	T	A	hom	hom	hom		QUAL=35403;DP=440,286,418;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0	RGS7	5'UTR	RGS7:ENST00000366563.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.5:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000440928.6:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::	RGS7:NM_001282773.2:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001282775.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:NM_001282778.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001350113.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-204A>T::,RGS7:NM_001350114.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-172A>T::,RGS7:NM_001350115.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:NM_001350116.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-172A>T::,RGS7:NM_001364886.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:NM_001374806.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374807.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001374808.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-246A>T::,RGS7:NM_001374809.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-311A>T::,RGS7:NM_001374810.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-311A>T::,RGS7:NM_001374811.1:5_prime_UTR_variant:MODIFIER:exon2/15:c.-22A>T::,RGS7:NM_001374812.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001374813.1:5_prime_UTR_variant:MODIFIER:exon2/14:c.-311A>T::,RGS7:NM_001374814.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374815.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374816.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_002924.6:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:XM_017002001.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:XM_017002002.2:5_prime_UTR_variant:MODIFIER:exon2/20:c.-204A>T::,RGS7:XM_017002005.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-1222A>T::						rs4659599	0.9483	0.9795	69621,.	0.8691,0.9883,0.9973,0.9877,0.9871				12.93				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356888	241356888	T	C	n/a	hom	hom	off-target	QUAL=980;DP=0,17,16;AF=,1.00,1.00;MQM=60;SAP=14;ABP=0	RGS7	intron	RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron1/18:c.-51+11A>G::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron1/18:c.-233+11A>G::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron1/18:c.-201+11A>G::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron1/17:c.-233+11A>G::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron1/18:c.-51+11A>G::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron1/18:c.-275+11A>G::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron1/16:c.-340+11A>G::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron1/18:c.-340+11A>G::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron1/14:c.-51+11A>G::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron1/13:c.-340+11A>G::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron1/19:c.-233+11A>G::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron1/17:c.-1251+11A>G::	regulatory_region_variant:promoter					rs1891130	0.9485	0.9558	69329,.					15.45				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241500602	241500602	-	GAGA	wt	het	het	off-target	QUAL=1184;DP=3,59,94;AF=0.00,0.17,0.28;MQM=60;SAP=38;ABP=96	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-16_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-16_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296866 [uncertain significance(replaced by megSAP based on classifications:1x1,1x2,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,Multiple Cutaneous and Uterine Leiomyomas,not provided];			rs144131869		0.2553	4500,.					0.08				0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGA	wt	het	wt	off-target	QUAL=1184;DP=3,59,94;AF=0.00,0.00,0.26;MQM=60;SAP=22;ABP=191	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-18_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-18_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296867 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas,not provided];			rs144131869		0.2024	2698,.					0.07				0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGAGAGA	wt	wt	het	off-target	QUAL=1184;DP=3,59,94;AF=0.00,0.20,0.07;MQM=60;SAP=16;ABP=52	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-22_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-22_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296869 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas,not provided];			rs144131869		0.0401	148,.					0.07				0.08	26	190	0 / 0					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247418258	247418258	A	T	het	wt	het		QUAL=12752;DP=501,340,454;AF=0.51,0.00,0.53;MQM=60;SAP=51;ABP=7	NLRP3	5'UTR	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-543A>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543A>T::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-537A>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::	NLRP3:NM_001079821.3:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-537A>T::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-543A>T::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-537A>T::,NLRP3:XM_017000181.1:5_prime_UTR_variant:MODIFIER:exon2/11:c.-126A>T::,NLRP3:XM_017000182.1:5_prime_UTR_variant:MODIFIER:exon2/11:c.-71A>T::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-537A>T::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-537A>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs116502550	0.0030	0.0069	13,.					6.13				0.01	0	59	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418390	247418390	T	C	hom	hom	hom		QUAL=17863;DP=268,161,168;AF=1.00,1.00,1.00;MQM=59;SAP=749;ABP=0	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-411T>C::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-411T>C::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-405T>C::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-405T>C::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-411T>C::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-405T>C::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron2/10:c.-94+100T>C::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron2/10:c.-39+100T>C::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-405T>C::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-405T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296931 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs7523422		0.9978	75709,.					2.76				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418570	247418570	G	A	het	het	het		QUAL=5099;DP=217,68,85;AF=0.54,0.56,0.44;MQM=59;SAP=22;ABP=5	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-231G>A::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-231G>A::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-225G>A::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-225G>A::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-231G>A::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-225G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron2/10:c.-93-132G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron2/10:c.-38-187G>A::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-225G>A::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-225G>A::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296932 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs138900557	0.0158	0.0347	139,.					4.10				0	1	18	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418761	247418761	G	T	het	het	het		QUAL=9847;DP=332,231,285;AF=0.48,0.41,0.50;MQM=60;SAP=28;ABP=11	NLRP3	5'UTR	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-40G>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-40G>T::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-34G>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:ENST00000474792.2:5_prime_UTR_variant:MODIFIER:exon1/3:c.-40G>T::,NLRP3:ENST00000643234.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::	NLRP3:NM_001079821.3:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-34G>T::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-40G>T::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-34G>T::,NLRP3:XM_017000181.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::,NLRP3:XM_017000182.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-34G>T::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-34G>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296937 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,none provided,not provided];			rs73136263	0.0270	0.0437	166,.	0.0360,0.0125,0.0009,0.0471,0.0219				2.48				0.01	46	1278	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424175	247424175	G	A	het	het	het		QUAL=6254;DP=161,152,190;AF=0.48,0.41,0.57;MQM=60;SAP=66;ABP=3	NLRP3	synonymous	NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366497.6:synonymous_variant:LOW:exon4/9:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain]	NLRP3:NM_001079821.3:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:,NLRP3:NM_001127461.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:,NLRP3:NM_001127462.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:,NLRP3:NM_001243133.2:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:,NLRP3:NM_004895.5:synonymous_variant:LOW:exon4/10:c.732G>A:p.Ala244=:,NLRP3:NM_183395.3:synonymous_variant:LOW:exon4/8:c.726G>A:p.Ala242=:,NLRP3:XM_011544048.2:synonymous_variant:LOW:exon4/10:c.732G>A:p.Ala244=:,NLRP3:XM_017000181.1:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:,NLRP3:XM_017000182.1:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:,NLRP3:XM_024452862.1:synonymous_variant:LOW:exon4/8:c.732G>A:p.Ala244=:,NLRP3:XM_024452874.1:synonymous_variant:LOW:exon4/7:c.732G>A:p.Ala244=:		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	138528 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,none provided];			rs3806268	0.3874	0.5025	16379,.	0.1030,0.4077,0.5315,0.5585,0.5436				1.72			COSV60221462	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424229	247424229	A	G	hom	hom	hom		QUAL=14061;DP=154,117,161;AF=1.00,1.00,1.00;MQM=60;SAP=49;ABP=0	NLRP3	synonymous	NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366497.6:synonymous_variant:LOW:exon4/9:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain]	NLRP3:NM_001079821.3:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:,NLRP3:NM_001127461.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:,NLRP3:NM_001127462.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:,NLRP3:NM_001243133.2:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:,NLRP3:NM_004895.5:synonymous_variant:LOW:exon4/10:c.786A>G:p.Arg262=:,NLRP3:NM_183395.3:synonymous_variant:LOW:exon4/8:c.780A>G:p.Arg260=:,NLRP3:XM_011544048.2:synonymous_variant:LOW:exon4/10:c.786A>G:p.Arg262=:,NLRP3:XM_017000181.1:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:,NLRP3:XM_017000182.1:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:,NLRP3:XM_024452862.1:synonymous_variant:LOW:exon4/8:c.786A>G:p.Arg262=:,NLRP3:XM_024452874.1:synonymous_variant:LOW:exon4/7:c.786A>G:p.Arg262=:		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	403243 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,none provided];			rs4925543		0.9463	65724,.	0.8482,0.9714,0.9988,0.9579,0.8828				6.58				0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434047	247434047	-	GAGCTCTCTGGTCAGATGTGTTCTGAGGCCTTCTCTATTCCA	wt	het	hom	off-target	QUAL=1161;DP=104,12,44;AF=0.00,0.75,1.00;MQM=51;SAP=118;ABP=10	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron5/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-101_2322-100insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron5/8:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron5/9:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron4/7:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron5/9:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+4307_2327+4308insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2156+8463_2156+8464insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs566064212		0.0001	0,.					0.35				0.03	4739	1920	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434063	247434063	G	A	hom	hom	hom	off-target	QUAL=9015;DP=131,70,114;AF=1.00,1.00,1.00;MQM=57;SAP=579;ABP=0	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-40G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-40G>A::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron5/8:c.2328-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-100G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron5/9:c.2328-40G>A::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron4/7:c.2151-40G>A::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron5/9:c.2328-40G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+4308G>A::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2156+8464G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10925022		0.3101	10181,.					0.36				0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435930	247435930	G	A	het	het	het	off-target	QUAL=1373;DP=46,38,62;AF=0.50,0.39,0.50;MQM=60;SAP=29;ABP=4	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1657G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1657G>A::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron6/8:c.2498+1657G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-40G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron6/8:c.2492+1657G>A::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron6/9:c.2499-40G>A::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron5/7:c.2321+1657G>A::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron6/9:c.2499-40G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+6175G>A::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2157-8042G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1259697 [benign DISEASE=not provided];			rs10754557	0.4840	0.5915	22556,.	0.2406,0.4940,0.6688,0.6219,0.6035				1.37				0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247448358	247448359	AG	-	het	het	wt	off-target	QUAL=2097;DP=181,39,76;AF=0.44,0.54,0.00;MQM=60;SAP=197;ABP=6	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron6/6:c.2664-45_2664-44del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron7/7:c.2835-45_2835-44del::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron8/8:c.2841-45_2841-44del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron8/8:c.2946-45_2946-44del::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron9/9:c.3012-45_3012-44del::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron7/7:c.2664-45_2664-44del::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron9/9:c.3012-45_3012-44del::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron7/7:c.2670-45_2670-44del::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron6/6:c.2499-45_2499-44del::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs201053423		0.0494	185,.	0.0102,0.0263,0.0341,0.0561,0.0969				1.81				0.01	38	1362	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247448734	247448734	G	C	hom	hom	hom		QUAL=50334;DP=702,384,501;AF=1.00,1.00,1.00;MQM=60;SAP=991;ABP=0	NLRP3	3'UTR	NLRP3:ENST00000336119.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000348069.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000366497.6:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391827.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391828.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::	NLRP3:NM_001079821.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:NM_001127461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_001127462.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_001243133.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:NM_004895.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:NM_183395.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:XM_011544048.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:XM_017000181.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:XM_017000182.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:XM_024452862.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:XM_024452874.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296956 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome];			rs10754558		0.6356	31418,.					7.16			COSV59510002	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247449133	247449133	A	T	hom	hom	n/a	off-target	QUAL=1339;DP=38,3,1;AF=1.00,1.00,1.00;MQM=60;SAP=78;ABP=0	OR2B11	3'UTR	OR2B11:ENST00000641149.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1896T>A::,OR2B11:ENST00000641527.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1896T>A::	OR2B11:NR_169840.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.3504T>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs4925547	0.4157	0.3635	10790,.					7.58					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	hom	wt		QUAL=255790;DP=4341,4379,4604;AF=0.99,0.99,0.00;MQM=55;SAP=1233;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879158303													482	24	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	wt	hom		QUAL=124489;DP=4274,4418,4697;AF=0.01,0.00,1.00;MQM=51;SAP=319;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs869183622													8501	195	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	wt	hom		QUAL=128428;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs62581312													1388	77	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	wt	hom		QUAL=128428;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs117135796													3137	218	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	wt	hom		QUAL=108106;DP=3712,2438,3379;AF=0.00,0.00,1.00;MQM=60;SAP=968;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs2857291													2823	185	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	wt	hom		QUAL=100254;DP=3334,2041,3148;AF=0.00,0.00,0.99;MQM=60;SAP=1009;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879219259													180	17	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=195056;DP=2667,1158,2350;AF=1.00,1.00,1.00;MQM=60;SAP=2871;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515													14804	25	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	wt	hom		QUAL=56806;DP=2186,774,1909;AF=0.00,0.00,0.99;MQM=60;SAP=792;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41528348													1235	63	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	het	wt		QUAL=47818;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=1768;ABP=175	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::																			514	1606	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	het	wt		QUAL=47818;DP=771,308,1292;AF=0.75,0.75,0.00;MQM=58;SAP=162;ABP=396	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::																			36	335	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	hom	wt		QUAL=47818;DP=771,308,1292;AF=0.04,0.01,0.00;MQM=59;SAP=42;ABP=638	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs369786048													10881	1120	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	wt	hom		QUAL=47818;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=452;ABP=655	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs1556422422													126	10	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	wt	hom		QUAL=49710;DP=1969,475,1656;AF=0.00,0.00,0.99;MQM=60;SAP=365;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879055956													175	5	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	wt	hom		QUAL=54755;DP=2897,1254,1857;AF=0.00,0.00,0.99;MQM=60;SAP=547;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs1603218409													6	1	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	wt	hom		QUAL=66241;DP=3034,1850,2270;AF=0.00,0.00,0.99;MQM=60;SAP=361;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs28625645													1614	69	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	wt	hom		QUAL=66411;DP=3168,1837,2288;AF=0.00,0.00,0.99;MQM=60;SAP=69;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-TW,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879162984													214	15	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=291960;DP=3350,2666,3125;AF=1.00,1.00,1.00;MQM=59;SAP=176;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::	::intergenic_variant:MODIFIER::::			441148 [not provided DISEASE=not provided];			rs2853518													14962	18	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=710808;DP=8518,6306,7279;AF=1.00,1.00,1.00;MQM=56;SAP=599;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::	::intergenic_variant:MODIFIER::::			42220 [benign DISEASE=not specified,not provided];			rs2001030													14554	19	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	wt	hom		QUAL=121522;DP=5784,3332,3825;AF=0.00,0.00,0.99;MQM=60;SAP=11;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::	::intergenic_variant:MODIFIER::::						rs878878913													121	15	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=181791;DP=3107,1273,1453;AF=1.00,1.00,1.00;MQM=60;SAP=239;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::	::intergenic_variant:MODIFIER::::					LSU-rRNA_Hsa (rRNA)	rs2854128													8733	280	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3107	3107	N	C	het	het	het		QUAL=6718;DP=156,47,61;AF=0.56,0.38,0.39;MQM=60;SAP=20;ABP=3	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1437N>C::	::intergenic_variant:MODIFIER::::																			258	353	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3107	3107	N	T	het	het	het		QUAL=6718;DP=156,47,61;AF=0.44,0.60,0.61;MQM=60;SAP=6;ABP=3	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1437N>T::	::intergenic_variant:MODIFIER::::																			200	252	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	wt	hom		QUAL=105469;DP=3787,3101,3517;AF=0.00,0.00,0.99;MQM=45;SAP=243;ABP=0	MT-ND1	missense	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase]	::intergenic_variant:MODIFIER::::			9724 [benign DISEASE=Leber optic atrophy,Leigh syndrome,not provided];			rs1599988						T(1.00)	B(0.01)				COSV62293824		2360	115	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	hom	wt		QUAL=102690;DP=2456,1672,1946;AF=0.99,0.99,0.00;MQM=31;SAP=14;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs28357975													283	8	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=170622;DP=2340,2039,2312;AF=1.00,1.00,1.00;MQM=33;SAP=1560;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::			441150 [not provided DISEASE=not provided];			rs3021086													11516	19	0 / 0	1	"[1] ahharmf1 10.08.2021; most likely WT; NGSD: >13000 other homo samples; gnomAD 3.1: >98% are also homo"			MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=309502;DP=3122,3481,4000;AF=0.99,1.00,1.00;MQM=43;SAP=343;ABP=0	MT-CO1	synonymous	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I]	::intergenic_variant:MODIFIER::::						rs2015062													8272	647	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	wt	hom		QUAL=45025;DP=4058,1392,1603;AF=0.00,0.00,0.99;MQM=43;SAP=195;ABP=0	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::	::intergenic_variant:MODIFIER::::			42228 [benign/likely benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke,not specified];		tRNA-Ser-TCA(m) (tRNA)	rs201950015													227	12	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	wt	hom		QUAL=142185;DP=7840,5642,4982;AF=0.00,0.00,0.99;MQM=58;SAP=4418;ABP=0	MT-CO2	synonymous	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain]	::intergenic_variant:MODIFIER::::			376897 [benign DISEASE=not provided];			rs386829014													230	44	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=172704;DP=1893,2140,2331;AF=1.00,1.00,1.00;MQM=34;SAP=12;ABP=0	MT-ATP6	missense	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain]	::intergenic_variant:MODIFIER::::			693004 [benign DISEASE=Leigh syndrome];			rs2001031						T(0.10)	B(0.00)						12152	30	0 / 0	1	"[1] ahharmf1 10.08.2021; most likely WT variant; MitoMap: in >99% of gnomAD 3.1 sequences homo; NGSD: almost existing in each sample homo"			MT-ND1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	wt	hom		QUAL=119866;DP=4708,3107,3733;AF=0.00,0.00,0.99;MQM=60;SAP=202;ABP=0	MT-ND3	missense	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:	::intergenic_variant:MODIFIER::::			9713 [benign DISEASE=Leigh syndrome,Parkinson disease, resistance to];			rs2853826						T(1.00)	B(0.00)						2707	102	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	wt	hom		QUAL=122661;DP=4622,3081,3752;AF=0.00,0.00,0.99;MQM=60;SAP=6;ABP=0	MT-ND4L	synonymous	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L]	::intergenic_variant:MODIFIER::::			376866 [benign DISEASE=not provided];			rs1057520074													165	21	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	wt	hom		QUAL=178485;DP=6509,4782,5630;AF=0.00,0.00,0.99;MQM=60;SAP=79;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs869096886											COSV62293827		2634	345	0 / 0					MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	wt	hom		QUAL=145312;DP=6159,4070,4560;AF=0.00,0.00,0.99;MQM=60;SAP=410;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs193302938													270	71	0 / 0					MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	wt	hom		QUAL=166017;DP=6942,4183,5325;AF=0.00,0.01,1.00;MQM=57;SAP=15;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs2853495											COSV104668829		7689	639	0 / 0					MT-CO1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	wt	hom		QUAL=164517;DP=7635,4367,5142;AF=0.00,0.00,0.99;MQM=60;SAP=167;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus]	::intergenic_variant:MODIFIER::::						rs28359172													1123	223	0 / 0					MT-CO2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	wt	hom		QUAL=51211;DP=4575,1555,1715;AF=0.00,0.00,0.99;MQM=60;SAP=5;ABP=0	MT-ND5	missense	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			9696 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs28359178						T(0.19)	B(0.00)						1434	129	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	wt	hom		QUAL=53889;DP=4657,1669,1807;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377244 [benign DISEASE=not provided];			rs386829190													172	19	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	wt	hom		QUAL=97116;DP=3887,2752,3083;AF=0.00,0.00,0.99;MQM=60;SAP=27;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377029 [benign DISEASE=not provided];			rs879100848													164	29	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	hom	wt		QUAL=192537;DP=3958,2175,2360;AF=0.99,0.99,0.00;MQM=60;SAP=48;ABP=0	MT-ND6	synonymous	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6]	::intergenic_variant:MODIFIER::::						rs1603224697													15	1	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	wt	hom		QUAL=71339;DP=3291,2101,2288;AF=0.00,0.01,1.00;MQM=60;SAP=263;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:	::intergenic_variant:MODIFIER::::			140587 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs193302980						D(0.04)	B(0.00)						7709	292	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	wt	hom		QUAL=122515;DP=4505,3615,3830;AF=0.00,0.00,0.99;MQM=60;SAP=23;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF00033 [Cytochrome b/b6/petB]	::intergenic_variant:MODIFIER::::			9674 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs41518645						D(0.01)	B(0.01)				COSV62378578		266	61	0 / 0					MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=370563;DP=4451,3485,3653;AF=1.00,1.00,1.00;MQM=60;SAP=208;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF00033 [Cytochrome b/b6/petB]	::intergenic_variant:MODIFIER::::			140592 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs2853508						T(0.28)	B(0.01)						14953	56	0 / 0	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	wt	hom		QUAL=107039;DP=6681,3238,3396;AF=0.00,0.00,0.99;MQM=60;SAP=15;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:	::intergenic_variant:MODIFIER::::			143925 [benign DISEASE=Neoplasm of ovary,Leigh syndrome];			rs193302994						T(0.51)	B(0.24)						2654	286	0 / 0					MT-TR (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	hom	wt		QUAL=301744;DP=5974,3321,3771;AF=0.99,0.99,0.00;MQM=60;SAP=21;ABP=0	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::	::intergenic_variant:MODIFIER::::			690224 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];			rs35788393													364	17	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	wt	hom		QUAL=119059;DP=5768,3606,3741;AF=0.00,0.00,0.99;MQM=60;SAP=21;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147903261													1214	73	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	wt	hom		QUAL=123839;DP=5728,4018,3919;AF=0.00,0.00,0.99;MQM=60;SAP=165;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147029798													2706	329	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	wt	hom		QUAL=124342;DP=5664,4053,3945;AF=0.00,0.00,0.99;MQM=60;SAP=148;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41419246													477	86	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	wt	hom		QUAL=149870;DP=6609,4462,4804;AF=0.00,0.00,0.99;MQM=60;SAP=112;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					(CAACTAT)n (Simple_repeat)	rs386829286													154	27	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	wt	hom		QUAL=149995;DP=7144,4286,4789;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs138126107													580	113	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	hom	wt		QUAL=332631;DP=6107,4219,4816;AF=0.99,0.99,0.00;MQM=60;SAP=110;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs148377232													648	127	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	hom	wt		QUAL=378419;DP=6991,5418,5370;AF=1.00,1.00,0.02;MQM=55;SAP=15;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs3937033													9573	288	0 / 0		"hohe Frequenz [1] ahbecks1 15.09.2021 [n/a] ahbecks1 15.09.2021"			MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
